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Abstract  
Background:  
Multiple sclerosis is a chronic neurodegenerative condition that can significantly impair 
length and quality of life. Comorbidity (the presence of additional chronic conditions) has 
been reported as common in multiple sclerosis and is associated with diagnostic delays, 
increased disability, and higher mortality rates in people with multiple sclerosis. Multiple 
sclerosis is a stressful condition, with a highly unpredictable disease course, often 
necessitating complex and unpleasant treatment regimens. Stress in multiple sclerosis 
raises the risk of significant mental illness, impacts negatively on quality of life, and may 
be associated with an increased risk of disease relapse (although the evidence supporting 
this latter link is limited). Current stress management strategies in multiple sclerosis are 
limited, with a recent systematic review identifying only one high quality study supporting 
the use of cognitive behavioural therapy. Mindfulness-based interventions have been 
demonstrated to help with stress management in other long-term conditions, such as 
anxiety and recurrent depression. Very little is known about the use and effectiveness of 
mindfulness-based interventions in people with multiple sclerosis. 
Methods:  
This thesis followed the United Kingdom Medical Research Council guidance (2008) on 
developing and evaluating complex interventions. The research commenced with an 
epidemiological study of comorbidity in multiple sclerosis using a nationally 
representative cross-sectional primary care database from Scotland (n=1,268,859, of whom 
3,826 had multiple sclerosis). The analysis focused on 39 other long-term conditions, 
comparing prevalence rates for people with multiple sclerosis aged 25 or over versus 
matched controls, controlling for age, sex, and socio-economic status. Results are 
presented as odds ratios (ORs) with 95% confidence intervals (95%CI), and p values. 
Secondly, a systematic review was conducted to evaluate the evidence for the effectiveness 
of mindfulness-based interventions in people with multiple sclerosis in terms of reducing 
perceived stress and other relevant secondary outcomes, including mental health, physical 
health, and quality of life. Study quality was determined using the Cochrane Collaboration 
quality assessment tool.  
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Following this, a phase-2 randomised controlled trial was undertaken, testing the feasibility 
of delivering a Mindfulness-Based Stress Reduction course to a group of (n=25) people 
with multiple sclerosis versus wait-list control (n=25). Primary patient report outcome 
measures were perceived stress (Perceived Stress Scale-10) and health-related quality of 
life (EQ-5D-5L). Secondary patient report outcomes included the Multiple Sclerosis 
Quality of Life Inventory, mindfulness (the Mindful Attention Awareness Scale), self-
compassion (the Self-Compassion Scale-short form), and emotional lability (the Emotional 
Lability Questionnaire). Results are reported in ‘p’ values and effect sizes (ES - Cohen’s 
‘d’) with 95%CIs. 
A linked qualitative process evaluation nested within the randomised controlled trial 
assessed Mindfulness-Based Stress Reduction instructor and participant experience 
through semi-structured interviews with 17 participants and the two instructors. In order to 
organise and summarise the data, the Framework Approach to thematic analysis was 
employed. The emergent themes from the thematic analysis were then scrutinised under 
the theoretical ‘lens’ of Normalisation Process Theory, as a means of conceptualising the 
data and assessing potential implementation issues. 
Results:  
Epidemiology People with multiple sclerosis in Scotland aged 25 years or over were more 
than twice as likely to have comorbidity of one or more long-term conditions than matched 
controls (OR 2.44; 95%CI 2.26-2.64). Mental health comorbidity was particularly 
prevalent in people with multiple sclerosis, being almost three times as common compared 
with controls (OR 2.94; 95% CI 2.75-3.14). Depression (OR 3.30; 95%CI 3.10 – 3.57) and 
anxiety (OR 3.18; 95%CI 2.89 – 3.50) were particularly common. As the number of 
physical health conditions rose in people with multiple sclerosis, so too did the prevalence 
of mental health comorbidity. Certain neurological conditions (epilepsy, pain, migraine, 
visual impairment) and gastrointestinal conditions (constipation, irritable bowel syndrome) 
were also more common in people with multiple sclerosis.  
Systematic review Three published controlled outcome studies using mindfulness-based 
interventions in people with multiple sclerosis were identified. Only one study was of high 
methodological quality. The findings suggested that mindfulness-based interventions may 
improve quality of life, mental health (anxiety and depression), and some physical 
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outcome measures (fatigue, pain, standing balance), with effects lasting for up to six 
months post-treatment. Meta-analysis was not possible due to heterogeneity amongst 
studies. Since the systematic review was conducted, three further studies of mindfulness-
based interventions in people with multiple sclerosis have been published. These studies 
were generally of low methodological quality, but they did add some further evidence that 
such interventions can improve scores for anxiety, depression, stress, pain, fatigue, co-
ordination, balance, and quality of life. However, the overall weight of evidence 
supporting the use of mindfulness-based interventions in people with multiple sclerosis 
remains limited. 
Randomised controlled trial The recruitment target of 50 participants was met within the 
pre-defined three-month window. Outcome measure completion rates were good 
immediately post-intervention (90%) and at study end-point, three months post-
intervention (88%). However, participant attendance at the weekly 2.5 hours mindfulness 
sessions was only 60%, and average home practice times were less than the suggested 
amount of 45 minutes, six days per week. 
In adjusted models (controlling for age, sex, deprivation, previous yoga/meditation 
experience) for primary patient-report outcomes immediately post-intervention, perceived 
stress scores improved with a large overall effect size (ES 0.93; p<0.01), and large effects 
were also evident on subscales of negative stress appraisal (ES 0.82; p<0.05), and on stress 
resilience items (ES 0.92; p<0.05). Quality of life scores showed only very small 
improvements overall (ES 0.17; p=0.48), with only the anxiety/depression subscale 
showing a small effect size immediately post-intervention (ES 0.41; p=0.16).  
Secondary patient report outcomes showed improvements with large effect sizes 
immediately post-intervention in scores for depression (ES 1.35; p<0.05), positive affect 
(ES 0.87; p=0.13), anxiety (ES 0.85; p=0.05), and self-compassion (ES 0.80; p<0.01).  
At study endpoint three-months post-intervention, adjusted models revealed that the 
beneficial effects on perceived stress and improvements in stress resilience had diminished 
to small effect sizes (ES 0.26; p=0.39, and ES 0.46; p=0.05 respectively). Quality of life 
scores showed negligible improvement overall (ES 0.08; p=0.71), but a small beneficial 
effect persisted on the anxiety/depression subscale (ES 0.26; p=0.42).  
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For secondary patient-report outcomes at study endpoint, the large effect sizes found 
immediately post-intervention for depression were no longer apparent (ES 0.01; p=1.00), 
but remained evident for positive affect (ES 0.90; p=0.54), anxiety (ES 0.82; p=0.15), and 
self-compassion (ES 0.83; p<0.05), with large effect size improvements also noted for 
mindfulness (ES 1.13; p<0.001) and prospective memory (ES 0.81; p<0.05). 
Qualitative evaluation People who came on the Mindfulness-Based Stress Reduction 
course generally reported benefits, namely reduced stress, less pain, and improved 
relationships. Four main themes were identified in the thematic analysis: 1) ‘Coming 
together for the course’ 2) ‘Doing the work’ 3) ‘Getting it, or not’, and 4) ‘Moving forward 
and improving the course’. Using the ‘lens’ of Normalisation Process Theory, these themes 
were further scrutinised, and potential barriers and facilitators to taking part were 
identified. Recommendations derived from this process included: a) inclusion of a pre-
course orientation session in future courses to address participant expectations; b) making 
the course environment more disability-friendly; c) making the course materials more 
multiple sclerosis- and ability-appropriate; and d) embedding routine monitoring into 
future courses. 
Conclusions: 
The work of this thesis has demonstrated that among multiple sclerosis patients in 
Scotland, both physical and mental health comorbidities are common. There is limited 
published evidence supporting the use of mindfulness-based interventions in people with 
multiple sclerosis, but some indication that these interventions may improve anxiety, 
depression, stress, pain, fatigue, balance, co-ordination, and quality of life. Findings from 
the exploratory phase-2 randomised controlled trial suggest that delivering Mindfulness-
Based Stress Reduction to people with multiple sclerosis under trial conditions is feasible 
with some evidence of likely effectiveness. Mindfulness-Based Stress Reduction generally 
appears to be acceptable, accessible, and implementable for people with multiple sclerosis, 
but an orientation session should be provided pre-course, and course materials may need to 
be carefully tailored to meet the complex needs of more disabled individuals with multiple 
sclerosis. These optimisation processes may lead to improved engagement and adherence 
with the mindfulness practices, which could potentially lead to more stable treatment 
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effects. Prior to proceeding to a phase-3 efficacy trial, such modifications should be 
piloted. More high quality research is required before definitive recommendations on the 
effectiveness of mindfulness-based interventions for people with multiple sclerosis can be 
made. 
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Chapter 1 Introduction 
1.1 Overview 
The focus of this thesis is on the needs of people with multiple sclerosis (MS), and in 
particular whether mindfulness-based interventions (MBIs) may be beneficial. This thesis 
examines the epidemiology of comorbidity in people with MS in Scotland, the extent and 
scope of the evidence for effectiveness of MBIs, the feasibility and effects of conducting a 
trial of Mindfulness-Based Stress Reduction (MBSR) for people with MS, and explores 
participant views on MBSR. It highlights potential facilitators and barriers to wider 
implementation, and finally explores optimisation of MBSR prior to proceeding to a 
definitive phase-3 trial.  
1.2 Background 
MS is a chronic neurological condition characterised by neurodegenerative changes in the 
central nervous system (CNS) which result from damage to nervous tissue from 
pathological inflammation that targets the myelin sheaths surrounding nerves [1]. It is one 
of the most common neurological conditions to affect young adults and can lead to 
extreme levels of disability [1]. It is a condition that is on the increase, whilst disease 
mechanisms remain poorly understood and treatment options are limited, expensive, and 
potentially dangerous [1]. For reasons that are not totally clear, Scotland has the highest 
incidence and prevalence of MS worldwide [2]. The effects of the condition are manifold 
reflecting in part the variety of symptoms that nerve damage in distinct CNS locations can 
produce. They also reflect the diverse ways in which affected individuals react and adjust 
to having MS, including coping with the uncertainty that the condition brings [1]. MS can 
be a stressful condition, with negative consequences for the affected individual on a 
personal, social, and societal level. People with MS are thought to have particularly low 
health-related quality of life (QOL), more so than other, comparable long-term conditions 
(LTCs) [3, 4]. Stress is thought to play a key mediating role in the development of mood 
disorders and reduced QOL in people with MS [5], and may even affect adversely disease 
activity [6-8]. Mood disorders are thought to be very common [9], yet very little is known 
about how or why these evolve in people with MS, let alone how best they should be 
Mindfulness-based interventions for people with MS 
 
 
 24 
treated [10]. Evidence for effective psychosocial interventions is limited, and a general 
consensus amongst researchers, clinicians, and patients is that novel and effective 
interventions are needed [10-12].  
Mindfulness is a concept derived from ancient Oriental meditation techniques (Buddhist 
and Yogic) [13]. The construct has been variously adapted to operate as a stress reduction 
technique in Western medical settings for people with LTCs [14], although its 
contemporary usage now extends far beyond this scope [15]. MBSR is the format most 
widely used in a medical context, and is taught in a group format where participants are 
encouraged to explore their experiences through pre-defined meditation techniques, whilst 
adopting an open, non-elaborative and accepting attitude. Doing so is postulated to 
facilitate the development of ‘mindful awareness’ and this is thought to have a range of 
benefits in those with LTCs [13]. MBIs have been applied in a range of LTCs [16, 17], and 
have accrued a considerable evidence base for effectiveness, particularly in the treatment 
of recurrent depression [18]. Whether MBIs might help people with MS reduce stress and 
improve QOL has not been widely researched. Given the paucity of evidence for effective 
psychosocial interventions in this population, gaining a clearer understanding of whether 
and how MBIs might be of help can be seen as a relative research priority. This thesis has 
explored the area in detail. The section below highlights the specific aims and objectives 
addressed by this thesis. 
1.3 Aims and objectives 
The overall aim of this thesis was to characterise the needs of people with MS and the 
potential role, if any, for MBIs to reduce stress and improve QOL.  
Specific research objectives were to: 
1. Measure comorbidity in people with MS in Scotland by characterising the number 
and type of conditions compared with the general population. 
2. Delineate the existing evidence for effectiveness of MBIs in people with MS by 
carrying out a systematic review. 
3. Test the feasibility and effects of conducting a randomised controlled trial (RCT) of 
a MBI for people with MS, and clarify whether a future definitive trial is currently 
merited. 
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4. Explore the perceptions and views of people with MS participating in a MBI 
(MBSR) 
5. Examine the potential barriers to and facilitators of implementing a MBI for people 
with MS  
 
1.4  Thesis outline 
This thesis set out to examine systematically the potential role of MBIs in people with MS. 
The plan was to study MBIs as a ‘complex intervention’, and thus methodology 
appropriate for this task was employed, based on the United Kingdom Medical Research 
Council (MRC) guidance [19] for developing and evaluating complex interventions. The 
MRC guidelines suggest that multiple and complementary research methods are likely to 
be required when researching complex interventions. This is in order to capture the broad 
range and scope of issues that can arise when trying to make sense of whether, how, and 
why a complex intervention may work in a study population. The MRC guidance [19] 
emphasises the importance of preparatory and developmental work before undertaking a 
definitive trial of effectiveness, where identifying issues at an early stage can pre-empt and 
avoid costly mistakes. Key features of the MRC framework involve having a clear 
distinction about the target population for the research question, a plausible working model 
for how the intervention may exert its effects, a thorough and up-to-date knowledge of the 
relevant literature for the intervention, and awareness of the potential for context to 
influence outcomes. This thesis followed the MRC guidance [19] in a systematic and 
iterative fashion, reflected in the chapter outlines below. 
Chapter 2 provides the background chapter, and focuses first on the population under study 
i.e. people with MS. The chapter describes the aetiology, epidemiology, pathophysiology, 
and common signs and symptoms of MS. Particular emphasis is placed on the role played 
by stress. Existing treatments for stress management in MS are covered, noting the 
limitations that remain in the empirical literature on this subject. Next, attention turns to a 
potential treatment strategy i.e. mindfulness, or more specifically MBIs. The origins, 
purported mechanisms of action, evidence for effectiveness and use of MBIs in healthcare 
settings is then explored, with particular attention paid to their potential relevance for 
people with MS. 
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Chapter 3 outlines the methodology for the thesis, describing the overarching framework 
used [19]. The chapter also describes the specific research methods chosen for each 
subsection of the thesis. 
Chapter 4 covers comorbidity in MS. The chapter describes in detail results from a 
secondary analysis of a nationally representative cross-sectional primary care database 
from Scotland. 
Chapter 5 delineates the scope and extent of the existing evidence for effectiveness for 
MBIs in people with MS. The chapter describes the process involved in undertaking a 
systematic review, which included setting specific research questions, searching the 
literature in a rigorous and reproducible manner, collating results, and producing an 
accessible and informative report on findings. This chapter has both a quantitative and a 
narrative component, acting as an evidence synthesis, explaining why further work in this 
area is required.  
Chapter 6 outlines the research process of undertaking a feasibility RCT of MBSR in a 
group of people with MS in Scotland. Key feasibility outcomes, such as recruitment, 
retention, adherence, outcome measure completion, follow-up, and likely effectiveness are 
covered in detail. 
Chapter 7 focuses on qualitative feedback from the feasibility RCT. A thematic analysis on 
the feedback from participants is outlined in detail, where emergent themes are reported 
detailing how MBSR was experienced, and where it might be improved. This chapter also 
explored implementability using Normalisation Process Theory (NPT), to identify 
potential facilitators and barriers to the use of MBSR for people with MS in a NHS setting. 
Chapter 8, the final chapter, is a general discussion of the research findings from the thesis 
as a whole. Discussion in this chapter focuses upon optimisation of MBSR, based upon the 
research findings from this thesis. Implications of the findings from this thesis for 
clinicians and researchers working in this area are considered, and future directions for 
research are suggested.
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Chapter 2 Background 
2.1 Introduction 
This chapter introduces what is known about MS, in terms of its epidemiology, 
aetiology, pathology, and symptoms. LTCs can be stressful and this is particularly the 
case in MS. The mechanisms underlying stress in MS are discussed, noting the role 
that stress may play in diminishing QOL, increasing vulnerability to depression, and 
its possible impact on pathological disease processes. Following this, mindfulness is 
introduced as a potential treatment strategy for managing stress in people with MS.  
2.2 Literature covered 
The literature covered in this chapter reflects the focus of the thesis on the potential 
use of MBIs in people with MS. Primary searches in Pubmed which used the search 
terms ‘stress*’ AND ‘multiple sclerosis’, ‘mindful*’ AND ‘multiple sclerosis’, and 
‘comorbid*’ AND ‘multiple sclerosis’ were carried out in August 2012. The results 
were accessed to gain a broad overview of what was known about stress in people 
with MS, about comorbidity in MS, and whether MBIs had been used as a treatment 
strategy. Additionally, weekly search update ‘alerts’ were set-up via Pubmed using 
these same search terms, whereby a weekly email was received detailing literature 
developments. References from key papers were used in a ‘snowballing’ manner, 
where interesting citations were retrieved and reviewed for relevance.  
2.3 Multiple sclerosis – epidemiology, aetiology, and 
pathology 
2.3.1 Epidemiology 
 MS is characteristically spilt into two main categories [20]:  
1. Relapsing Remitting MS (RRMS), where periods of disease quiescence are 
interspersed between exacerbations. Relapses are unpredictable, vary widely 
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in duration and severity, and can leave people with significant residual 
disability. However, in others, recovery from a relapse may mean a return to a 
functional level approximate to their pre-exacerbation state.  
2. Progressive MS, which is by convention spilt into cases progressive from the 
outset (Primary Progressive MS – PPMS), or those that become progressive 
against a background of RRMS (Secondary Progressive MS – SPMS). 
Around 80% of cases fall into the RRMS category. A typical RRMS pattern of 
relapses is usually superseded by SPMS, a progressive stage that is most associated 
with the development of disability [20]. Roughly 20% of cases of MS are progressive 
from onset, where the disease evolves more rapidly (PPMS) [20]. Around 25% of 
people with MS do not develop much impairment in activities of daily living (ADL), 
but 60% of people are no longer able to walk after 20 years with the condition. About 
15% progress very rapidly to severe disability [20, 21].  
It is thought that there are around 2.5 million people with MS worldwide, and around 
127,000 in the UK [20, 22]. Worldwide incidence is estimated at seven per 100,000 
per year, with a prevalence of roughly 120 per 100,000, which varies geographically. 
For reasons that remain unclear, Scotland has the highest incidence per capita 
worldwide (12/100,000 per year) [2, 23], and similarly high prevalence (203-
219/100,000) [23]. This creates a significant health care burden [24]. The global 
lifetime risk is estimated at 1 in 400, and peak age at diagnosis is 20-40 years, making 
it one of the most prevalent causes of neurological disability among young adults [1].  
MS is commoner in females (around 2-3:1), although the exact sex ratio can fluctuate 
in diverse regions around the globe [24, 25]. As compared to men, women are two 
and a half times more likely to develop an RRMS course. In PPMS the incidence rate 
ratio approaches 1:1 [24, 26].  
Research from Scotland suggests that MS tends to affect those of greater affluence 
[24, 27]. Systematic review evidence provides limited support for this finding, where 
in countries with high levels of socioeconomic inequality, such as the USA, Australia, 
and the UK, MS tends to affect more affluent people [28]. Speculative links have 
been drawn relating this to the so called ‘hygiene hypothesis’ (see section below).  
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2.3.2 Aetiology 
A large number of factors are implicated in the aetiology of MS, but an exact 
underlying cause remains uncertain [25, 29-32]. Several environmental factors are 
suggested [33]. Latitudinal distance from the equator appears to be relevant, perhaps 
relating to effects on Vitamin D [24, 34]. There is also a seasonal predominance [35], 
particularly in Scotland, where higher rates appear in May and lower levels in 
November. This seasonal variation may relate to ultraviolet light exposure [1, 24]. 
Lifestyle factors such as smoking may contribute to disease development by 
triggering pro-inflammatory mechanisms, but this hypothesis remains unproven [36]. 
Dietary factors such as fish and coffee are suggested as protective for RRMS [37].   
An underlying genetic susceptibility also seems highly likely in MS. Suspect factors 
include the gene coding for the endogenous inflammatory mediator Tumour Necrosis 
Factor-Alpha (TNF-α). The Major Histo-Compatibility (MHC) component on 
chromosome six, particularly genes encoding HLA-DRB*1501 and HLA-
DRB5*0101, is also implicated [20, 24, 38]. However, MS is generally believed to be 
polygenic. Much attention has focused on identifying a unique trigger-antigen such as 
an infectious agent, possibly contributing to a series of disease outbreaks in 
genetically susceptible individuals. So far this search has been inconclusive [38].  
Genetic precursors may combine with an environmental antigen trigger, for example 
Epstein-Barr Virus (EBV), which is present in over 99% of those with MS versus 
94% in age-matched controls. Such infection might lead to pathological alterations in 
Blood-Brain-Barrier (BBB) integrity, and an organ/tissue-specific autoimmune 
reaction. The ‘hygiene hypothesis’ suggests that higher socio-economic status (SES) 
may denote less exposure to childhood infections, including EBV, with subsequent, 
more aberrant reactions to the infection [28]. Genetic and environmental factors could 
be cumulative, and possibly even synergistic within an individual case [38].  
2.3.3 Inflammatory processes in MS 
All types of MS are thought to have an inflammatory component in their pathology 
[32]. Theoretical pathological processes involve both the cell-mediated and humoral 
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components of the immune system, and may largely be determined by activated ‘T’ 
cell ingress into the CNS [38]. Such activated ‘T’ cells are potentially directed 
towards Myelin Basic Protein (MBP) in the myelin sheaths surrounding nerve cells. T 
cells appear to traverse the BBB via complex mechanisms, including BBB cell 
junction disruption, alterations in brain solute barrier function, with enhanced 
leukocyte adhesion and migration. These mechanisms are more likely if the BBB has 
been exposed to generic inflammatory cytokines such as Interferon-Gamma [IFN-γ], 
TNF-α, and/or Interleukin-1-Beta [IL-1β]. Once activated, T cells arrive in the CNS 
and stimulate microglia, the CNS macrophage. These then re-present the myelin 
protein to the T cells, thus completing a toxic autoimmune, pro-inflammatory cycle 
targeting the myelin-oligodendrocyte complex [38]. The resultant CNS inflammatory 
response promotes further inflammation with proliferation of macrophages, feeding 
further release of inflammatory mediators [25, 38, 39].  
It is worth noting that demyelination is potentially reversible, and in some cases this 
will mean a move from relapse into remission, with potential recovery of function. 
However, when the myelin inflammatory process is unabated, leading to nerve axon 
transection, then permanent CNS damage ensues. CNS inflammation in MS may 
follow episodes of peripheral inflammation, with peripheral inflammatory mediators 
travelling into the CNS through a leaky, incompetent BBB. In MS relapses, the major 
cytokines suspected are IFN- γ, TNF-α, IL-1β, and Interleukin six (IL-6), both in 
terms of BBB breakdown and CNS inflammatory responses. These markers are 
notably elevated prior to the onset of and during disease activity, and decrease during 
periods of remission. Other factors that are implicated include Interleukins 17 and 23 
(IL-17, IL-23) [25, 38, 39] (Figure 2.1).  
The proposed inflammatory cascade in MS is non-linear and complex, with several 
components having multiple, sometimes paradoxical actions, which are context-
dependent [40]. For example, besides being potentially destructive to myelin and 
nerve cells, inflammation may also play an important role in re-myelination [20, 38-
40]. This can render targeted interventions i.e. pharmacological anti-inflammatory 
agents as both helpful and unhelpful, in that most are designed to either diminish 
inflammation, or hinder ingress of inflammatory mediators into the CNS [41]. 
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Figure  2.1 Complex, non-linear inflammatory pathways in MS 
 
Figure 2.1: Reproduced with permission from Shutterstock images; complex non-linear inflammatory 
pathways linking stress, inflammation, and disease activity in MS  
Breakdown of the BBB is a key step in the development of MS neuropathology, with 
a marked preponderance of neural inflammation noted at certain BBB locations [42]. 
Acute exacerbations in MS occur rapidly, within days, and correlate temporally with 
markers of acute inflammation. However, they can be short lived, with partial or 
complete recovery happening over weeks to months. Disease progression happens 
over years and probably represents either the cumulative result of repeated damage 
from numerous episodes of inflammation, or a continuous, lower-grade inflammatory 
process, with the end result being de-compensation in neural adaptive capacity [43].  
In people with MS, permanent functional deficits are believed to relate to scarring, or 
‘gliosed’ tissue, and diminished global functional reserve. However, during relapses, 
demyelinated axons do not conduct nerve action potentials as efficiently. This can 
result in cognitive impairment. The co-occurrence of other LTCs may compound this 
problem. For example, diabetes and cardiovascular diseases may also have 
cumulative detrimental effects on underlying CNS pathology. 
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2.4 MS signs and symptoms 
2.4.1 Vulnerability, declining neurological reserve, and how 
this relates to the symptoms and signs in MS 
There are a wide variety of symptoms and signs associated with MS including ataxia, 
bowel and bladder dysfunction, cognitive impairment, fatigue, mood disorders, pain, 
sensory disturbance, sexual dysfunction, spasticity and swallowing difficulties [20]. 
Even during periods of clinical quiescence, CNS tissues remain vulnerable in people 
with MS, where apparently innocuous stimuli can trigger problematic symptoms, such 
as pain or spasticity. Symptoms and signs are thought to result from a combination of 
localisable lesions, for example affecting the optic nerve, brainstem, cerebellum, or 
spinal cord, and the brain’s adaptive capacity being impaired by overall lesion load. 
This may manifest in different ways, one example being fatigue [20]. Demyelination 
can cause spontaneous neural discharges, some of which create obvious signs and 
symptoms, and others that are more subtle [20]. Symptom interpretation at this level 
can be difficult for the individual, with each experience potentially heralding a 
relapse, or disease progression. Demyelinated axons are more vulnerable to 
environmental stimuli, such as changes in temperature, or simple touch. Such stimuli 
can create enhanced ‘cross-talk’ with neighbouring demyelinated axons, creating 
paroxysmal symptoms, such as pain, in-coordination, and spasticity [20].  
2.5 Goals of treatment 
2.5.1 Beyond pharmacology 
Guidance from the UK National Institute for Health and Care Excellence (NICE) 
suggests that patient-centred care should be a priority for people with MS [44]. The 
guideline strongly emphasises the need for timely, co-ordinated, and evidence-based 
information and support. They promote well co-ordinated multidisciplinary care, with 
targeted symptom management and rehabilitation. The goal is for the individual to 
experience an integrated network of care [44]. Such integrated care, where all care 
sectors are working seamlessly for the individual, can be further enhanced with an 
aim for the individual patient also to experience ‘integration’, and the concept of ‘no 
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health without mental health’ emphasises the importance of treating the underlying 
person, not just the disease in LTCs, such as MS [45]. Compston and Coles [20] 
suggest that the goal of treatment is to decrease the frequency and detrimental effects 
of relapses, to ameliorate symptoms, offset disability, and to promote tissue repair.  
In the UK National Health Service (NHS), physical treatments for MS tend to be 
delivered by specialist Consultant-led multi-disciplinary teams (MDTs). In the early 
stages of disease this often involves the patient taking biologic disease modifying 
drugs (DMDs) that require close monitoring and have serious potential side effects, 
such as the re-activation of latent CNS infections that can (paradoxically) cause a 
neurodegenerative condition similar to MS [41]. Following periods of disease relapse 
or progression people with MS may require care in specialist rehabilitation centres 
over prolonged periods, and as disability becomes more advanced, then long term 
community care or care in a nursing home may be required. Specialist MS Nurses 
provide an enhanced service for patients and family members, and General 
Practitioners (GPs) may become involved at any stage [20, 46].  
A recent high quality systematic review (n=29 studies) concluded that in order to 
reduce the economic burden associated with MS, treatments with the potential to limit 
the frequency and severity of relapses, and ultimately disease progression should be 
prioritised. However, all of the studies came from countries with readily available 
economic data (Europe, North America, and Australia) making wider applicability of 
findings limited [46]. Rising DMDs costs were cited as a major concern, the authors 
suggesting an urgent need for cost-effectiveness and comparative-effectiveness 
studies for new treatments.   
2.6 Comorbidity in MS 
Comorbidity has been defined as the presence of one or more medical conditions in 
an individual, in addition to a specified ‘index’ condition [47]. First documented some 
40 years ago [48], it is a specialists’ concept. For example, a Diabetologist will 
consider a patient with diabetes, depression, and arthritis as being a diabetic (index 
condition) with comorbidities (depression and arthritis). Mulitmorbidity, a related 
concept, is defined as the occurrence of two or more medical conditions within the 
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same individual, without there being a single condition ordered as the ‘index’ [47]. 
This term is better suited to generalist doctors, such as GPs who deliver continuous 
care centred on the patient as a person. Thus, a patient with diabetes, depression, and 
arthritis would be classified as multimorbid, without assuming that any of the 
conditions is more important to the patient than another.  
Having multiple chronic conditions is believed to be stressful [49]. Recent 
epidemiological evidence from Denmark suggests that the co-existence of stress and 
multimorbidity is associated with excess mortality [50]. In a population-based cohort 
of 118,410 people, researchers found that after adjusting for SES, disease severities, 
and lifestyle factors, perceived stress impacted on mortality rates in a dose-dependent 
manner. High stress levels were associated with 69 excess deaths in those with one or 
less LTC, 128 in those with 2-3 LTCs, and 255 for those with four or more [50]. 
In this thesis, MS has been treated as the ‘index’, with other conditions being seen as 
comorbidities, including various other chronic conditions. The World Health 
Organisation (WHO) has defined chronic conditions as any: ‘health problems that 
require on-going management over a period of years, or decades’ [49]. People with 
MS may have many other co-morbid medical and/or psychiatric conditions as part of 
their ‘disease complex’. Mood disorders are common, anxiety and depression being 
particularly prevalent [51].  
2.7 MS and stress – psychological and physical 
perspectives 
2.7.1 Emotional turmoil, perceived stress, and quality of life 
Emotional regulation depends upon awareness, understanding, and the ability to 
influence one’s emotional state [52]. People with MS have difficulties in this area, 
where impaired emotional regulatory skills are implicated in diminished QOL [53]. 
There is evidence that emotional perception and processing of affective cues, such as 
social cognition, empathy, and theory-of-mind are abnormal from an early stage in the 
illness, even when age, sex, disease severity, underlying depression and cognitive 
dysfunction are controlled for [54, 55]. Such emotional difficulties can limit social 
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participation and correlate with impairment in psychological and social aspects of 
QOL [56]. There may be a neural basis for this in MS, such as damage or dysfunction 
in the insula and the ventrolateral prefrontal cortex (vlPFC), or impaired connectivity 
between the amygdala and the vlPFC and medial prefrontal cortex (mPFC) [5]. These 
altered neural dynamics may contribute directly to the enhanced vulnerability to 
depression in people with MS following stressful events [5].  
Further evidence supporting an organic cause for emotional dysfunction in people 
with MS is that difficulties can range from perceptual problems, to difficulties with 
cognitive loading, to outright emotional lability and pseudobulbar affect (PBA). PBA 
is an extreme form of emotional dysfunction occurring in those with neurological 
injury and impairment such as stroke, traumatic brain injury, and MS. PBA refers to 
uncontrollable laughing or crying, out of context with the social scenario, incongruent 
with the person’s inner emotional experience [57, 58]. 
However, it seems likely that emotional problems in people with MS are related to 
factors extending beyond damaged neural tissue, and in all likelihood have an 
important psychological and social basis too. Stress, mood and QOL are all intricately 
linked in people with MS. All have been shown to deteriorate from an early stage of 
the illness, in association with diminished ability for self-management [59]. 
Psychological stress has been shown to be an independent predictor of diminished 
QOL in people with MS [4] and perceived stress and depression both appear to play 
an important mediating role in diminishing QOL [60].  
Dennison et al. [3] note that MS patients can be subject to an unpredictable disease 
course, distressing symptoms (i.e. sexual dysfunction and incontinence), challenging 
pharmacological treatments/side effects, physical and cognitive impairment, and 
social stigma. All of these can be stressful. Qualitative studies suggest the main 
psychological challenges relate to event unpredictability, a sense of loss, isolation, 
and emotional distress [61]. Making sense of symptoms can be difficult for people 
with MS and subjectivity features strongly [62, 63]. New symptoms can take on a 
unique significance, heralding potential relapse and/or progression, and the presence 
of depression increases medical symptom reporting and perceived illness severity [4].  
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People with MS experience more pronounced psychological distress than people 
without, emotional distress being reported as three times as common compared with 
healthy controls [64]. This has been reported as independent of disability level, 
although stressors and responses are thought to change as the disease progresses, with 
physical disability being a greater source of stress early in the illness, and cognitive 
dysfunction a more prominent stressor as disability accumulates [4].  
In their operational model for stress appraisal and coping, Lazarus and Folkman [65] 
propose that individual cognitive appraisal is of central importance in determining 
each person’s unique response to stress. They suggest that distressing emotions 
emerge as a consequence of situations that the individual perceives/appraises as being 
stressful. This view fits with other pre-eminent contemporary models which likewise 
emphasise the importance of individual perception/appraisal on downstream stress 
responses, be these psychological or biological [66, 67].  
Folkman and Lazarus [68] suggest that coping can be seen as any patient behaviour(s) 
designed to alleviate, tolerate, or overcome the various demands, problems and 
burden that having chronic disease can bring forth. Individual psychological coping 
strategies can mediate the relationship between stress and coping in MS [69]. 
However, social/environmental context is also important for people with MS, where 
social support can protect against the deleterious impact of stress [69]. Loss of social 
function through MS appears to mediate between stress associated with the condition, 
and the development of depression [70]. Successful coping, or adaptation, depends 
upon how the individual appraises the situation and its salience, or meaning to them, 
but also how and to what extent the individual can access effective resources, such as 
social support or psychological interventions [68].  
The uncertain prognosis associated with MS [71] can pose problems for adaptation 
and coping, where new symptoms may represent an impending relapse, or may not. 
Subsequent high levels of contact with medical services, seeking out a diagnosis 
and/or treatment can lead to a perceived loss of control, and is reported as stressful for 
people with MS, especially when the emotional impact of their symptoms is not 
openly acknowledged by the healthcare provider [62]. Symptom uncertainty can 
predispose to anxiety and rumination. It is a strong predictor of depression in MS [5]. 
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The relationship between stress, emotions, and function in MS is complex. People 
with MS who are depressed, anxious, suffer from subjective or objective cognitive 
impairment, or have greater physical disability report lower QOL [72, 73]. Higher 
perceived stress is associated with a greater sense of impairment physically and 
socially, and worse adjustment amongst people with MS [70]. Higher levels of 
emotional distress also correspond with diminished functional capacity in ADLs [69]. 
Cognitive impairment is a common occurrence in people with MS [74], but separating 
out objective deficits from those that are more ‘functional’ is difficult, where 
depression and fatigue can complicate matters. Amongst these factors, depression and 
physical disability are reported as the strongest determinants of QOL [73, 75].  
Folkman and Lazarus [68] posit that controllable stressors promote coping that is 
‘problem-focused’, whilst those that are uncontrollable generate ‘emotion-focused’ 
strategies. Emotion-focused strategies in people with MS are linked to a greater risk 
of depression [5]. In contrast, problem-focussed coping is thought to enhance sense of 
control, and lessen sense of distress. Similarly, health locus-of-control is important in 
people with MS, where a higher sense of control over stressors confers better self-care 
and social functioning, better illness adjustment, and lowered relapse rate [76, 77].  
2.7.2 Emotions, behaviour and adjustment 
Systematic review evidence suggests that the commonest behavioural symptoms in 
people with MS are emotional lability (43%), emotional irritability (38%), 
psychological inflexibility (26%), aggression (23%), apathy (22%), and euphoria 
(12%) [78]. These symptoms are all more common in people with MS than in healthy 
controls, but are comparable with other LTCs [78]. It is unclear whether these 
symptoms are primarily reactive, how they relate to disability level, and to objective 
markers of disease activity [78]. However, they can impact negatively on QOL and 
how the individual deals with such symptoms seems important. For example, a recent 
cross-sectional study (n=157) showed that after adjusting for age, gender, SES, 
comorbidity, type and severity of MS, the tendency towards internalisation of anger 
significantly impaired QOL [79]; an effect stronger in women than men [79].  
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Irvine et al. [80] characterise psychosocial adjustment to MS as ‘the ability to foster a 
positive outlook on life, continuing to grow and develop in spite of MS’. Systematic 
narrative review evidence suggests that perceived stress, illness uncertainty, including 
ambiguity around diagnosis, symptoms, and treatments, and emotion-focused coping 
styles are associated with worse adjustment in people with MS [3]. A recent meta-
analysis reported adjustment disorder (a group of symptoms including stress, sadness, 
and hopelessness following stressful life events - SLEs [81]) as the commonest 
behavioural impairment in people with MS [78].  
Disease course in MS can affect psychological adjustment. For example, patients 
describe how a rapidly progressive course, or multiple relapses can be particularly 
stressful, and how adaptation and adjustment under such circumstances are 
challenging [62]. Certain psychological differences between patients serve as reliable 
predictors in this regard. Jopson and Moss-Morris [82] describe how a patient’s 
unique illness representation, or how she characterises her condition, can have 
significant impact on mental health, fatigue, self-esteem, and social function. They 
suggest that seeing the illness as being physical in nature, as opposed to a result of 
psychological factors, is associated with better adjustment. Further, Dennison et al. 
[3] stress the importance of co-operation with health professionals in addressing 
health behaviour, those who engage being more likely to have better adjustment. 
2.7.3 Psychological therapy in MS 
Cognitive Behavioural Therapy (CBT) techniques have the most evidence for 
effectiveness for treating psychological symptoms in people with MS, particularly 
depression [10, 11, 83]. However, effective psychological treatments for anxiety are 
very limited [10]. As in other chronic medical conditions, effect sizes for CBT in MS 
are typically medium in magnitude [10]. Evidence supporting the use of 
pharmacological interventions in MS such as anti-depressants is sparse, with the 
incidence of side effects high [10, 84]. From an academic perspective, reviews 
consistently suggest that a wider range of evidence-based and patient-centred 
treatments is needed [10-12, 85]. From a patient perspective, people with MS value 
new information and techniques for coping [62]. From a clinical perspective, 
psychological therapy is seen as an important part of integrated care for people with 
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MS, especially where anxiety or depression
 
exist [44]. Standard psychological input 
in the primary care setting is one potential treatment source, but is not always freely 
available, or accessible [86, 87], and in some cases specialist neuropsychological 
input is required [88]. Ideally, an intervention should be freely available, accessible, 
acceptable, tailored towards the needs of the individual, and highly effective [19]. 
2.7.4 Perceived stress and the immune system – conceptual 
overview, putative links, and potential relevance to 
people with MS 
A further consideration in people with RRMS is the possibility that stress may 
increase vulnerability to MS relapse. A putative link between psychological distress 
and disease activity has been suggested since MS was described in the late 19
th
 
century [89]. However, until recently, there was very little evidence to substantiate 
this hypothesis. One problem is the heterogenous nature of stress definitions [8, 90]. 
From a healthcare perspective, a widely accepted contemporary definition of stress is:  
‘A state in which homeostasis is actually threatened or perceived to be so’ 
[67] 
Put more simply, this definition suggests that the stress response systems (SRS) in the 
human body are in place to protect and sustain life. The process of homoeostasis 
maintains various vital bodily functions within a state of dynamic balance. Physical 
and environmental stressors can threaten this, an example being disruptions in blood 
pH, by triggering a host of compensatory physiological reactions. The same is also 
true for psychological stressors, even when the threat is illusory rather than ‘real’. 
Stress responses are protective in the short term, but may be damaging left unchecked 
[91]. With this in mind, Irwin and Cole [92] define the primary physiological role of 
the CNS as being:  
‘..to perceive external physical and social conditions (the environment, 
broadly speaking), assess their implications for organismal well-being 
(fitness) and modulate the activity of internal physiological processes to 
optimally adapt to those external conditions’.  
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They describe how this process of ‘macro-environmental sensing’ influences the 
‘decision-making’ i.e. pro-inflammatory or anti-inflammatory transcriptional activity 
in immune cells, such as leukocytes. Practically, this means whether/how to respond 
to threat in a complex, at times hostile environment, via the production of 
hormones/neurotransmitters, etc [92]. Put more simply, this model suggests that 
mental events can affect physical processes in the immune system, or physical body. 
Similarly, the reverse is also true, whereby immune system constituents i.e. cytokines, 
can exert profound effects on mental phenomena [93] and this may be particularly 
relevant where disordered interplay between the CNS and the immune system might 
contribute to disease states, such as in MS [32, 40, 94, 95].  
This model implies that how an individual appraises a stressor can mediate the 
physiological stress response. Importantly, stress can be a good thing under certain 
circumstances i.e. ‘eustress’ [96]. A similar view also applies in the case of ‘adaptive 
plasticity’, where in one scenario stress mediators can induce damage, but in another 
can drive forward beneficial change [97]. An illustrative example is the training 
effects from physical exercise, where ‘stress’, or exercise, leads to beneficial adaptive 
changes in the cardiovascular system, or ‘fitness’. Comparable adaptive processes are 
also known to take place in immune physiology [32]. The ability to adapt to stress 
like this can be linked with the concept of developing ‘resilience’, meaning that an 
organism can mount a ‘stress response’ to a given stressor, but remain able to return 
to a healthy state thereafter, without lasting damage [97].  
Stress is known to exacerbate CNS inflammation in general, and is implicated in the 
development of various neuropsychiatric/neurodegenerative conditions [98]. The 
development of inflammation via stress may trigger a process of excitotoxicity, 
acutely disordering calcium homeostasis and precipitating cell death. Excitotoxicity is 
one of many potential mechanisms/pathways for the neural damage seen in MS [98]. 
Acute stress has reasonably predictable neurobiological consequences, including 
activation of the hypothalamic-pituitary-adrenal axis (HPAA), and the sympathetic 
nervous system (SNS). Both have important short-term roles in homeostasis and 
immune competence, with protective and adaptive effects [99]. Both also have more 
problematic long-term roles in the pathogenesis of mental health conditions, such as 
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anxiety and depression, where SLEs are major risk factors for developing these 
conditions [100, 101]. Acute stress enhances immune system activity, with greater 
responses in both the Th1, pro-inflammatory, and the Th2, more anti-inflammatory, 
subdivisions [102]. Both Th1 pro-inflammatory effects and Th2 Mast cell-mediated 
BBB breakdown responses are implicated in MS pathology [98]. 
On the other hand, chronic stress is believed to be immunosuppressive, with 
associated HPAA dysfunction and peripheral resistance to glucocorticoids (GC) 
[102]. HPAA dysfunction is a common factor in both chronic stress and depression 
[101]. Of particular relevance to MS, chronic stress also appears to impair new nerve 
cell production, the protection of existing nerve cells, and nerve cell repair, although 
these effects may be reversible via early intervention [103]. 
2.7.5 Stress, resilience, and health 
Long term/incessant activation of the SRS has been associated with chronic ill health 
and ‘allostatic load’ (AL) [104]. AL is thought to contribute to various chronic 
conditions that are common in people with MS, including autonomic dysfunction, 
cognitive impairment, neurodegeneration, and depression [105]. Stress is widely 
regarded as a strong independent risk factor for depression [90, 101, 106], is 
implicated in the aetiology of other LTCs with inflammatory components i.e. 
cardiovascular diseases [107] and the metabolic syndrome [108] and is associated 
with increased mortality [50]. In those with LTCs, stress is frequently reported [109], 
and identifying stress resilience factors has been suggested as a research priority.  
Resilience as a construct is not well defined, and both psychological [109], and 
biological components [110, 111] have been proposed. In psychological terms, 
resilience has been defined as ‘the capacity of an individual to maintain/regain their 
mental health in the face of adversity/chronic illness’ [109]. A recent systematic 
review demonstrated the importance of accepting one’s illness, adopting a determined 
attitude, having an internal locus of control, hardiness, hope, mastery, and self-
efficacy, amongst psychological factors. Coping strategies that employed positive 
cognitive appraisal, spirituality, and active coping were beneficial, but having social 
support was the most important factor of all [109]. From a biological perspective, 
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resilience has been defined variously, in complex systems terminology [111] as how 
effectively a system returns to a healthy baseline, as depending on adaptive neural 
plasticity and allostatic regulatory systems [97], and also from the perspective of 
biological vulnerability, where certain genetic profiles may render an individual more 
or less resilient to SLEs [110]. It seems likely that both psychological and biological 
dimensions play a role in stress resilience. Stress resilience factors have not been 
systematically studied in MS, but two cross-sectional studies found that optimism and 
hardiness were predictive of coping and improved function [112, 113], whilst two 
qualitative studies suggested that a sense of spiritual purpose determines better 
adaptation to MS [114], as does benefit finding [115]. 
2.7.6 Can stress cause MS or make it worse? 
Stress has been putatively linked to increased rates of MS relapse, the return of old 
symptoms, and with disease onset/causation [8]. In 2004 Mohr et al. [6] carried out a 
meta-analysis of longitudinal and case-control studies to quantify the proposed link 
between global SLEs and disease exacerbation in MS. They reported a consistent 
association, with findings based upon 14 empirical studies. Study quality was noted 
only as ‘variable’. The weighted average effect size (ES) linking stress to relapses 
was modest (d=0.53), comparing favourably with treatment ESs for Interferon-β 
(d=0.30-0.36), an established pharmacological intervention for MS relapse [6].  
In 2011, Artemiadis et al. [8] systematically reviewed longitudinal observational and 
case-control studies to assess the quality of evidence for the relationship between 
SLEs with MS causation, and with MS relapse. The Cochrane Newcastle-Ottawa 
scale assessed quality. Seventeen studies were included, eight of which featured in the 
earlier meta-analysis by Mohr et al [6]. Artemiadis et al. [8] did not conduct a meta-
analysis due to heterogeneity in outcome measures of stress. The search criteria were 
limited (1980-2010), using only MEDLINE, and the search terms ‘stress and multiple 
sclerosis’. Study participant demographics and clinical characteristics were largely 
deemed as representative of the average MS population, with the majority being 
Caucasian females in their 30’s, but there was a tendency towards shorter disease 
durations (<10 years) and low levels of disability. Other potentially important 
confounders such as SES, disease stage/severity were only controlled for in four of 
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the studies. Most studies utilised an environmental approach to stress i.e. self-report 
diaries, as opposed to biological measures, such as brain imaging, or psychological 
constructs e.g. perceived stress. Selection bias was an issue in case-control studies, as 
was a risk of recall bias when reporting on SLEs. No studies directly assessed 
perceived stress, and the use of objective biological outcome measures was minimal.  
Findings from Artemiadis et al. [8] more strongly supported stress as a factor in 
relapse, where there were nine cohort and three case-controlled studies (n= 775), and 
10/12 reported a positive association between SLEs and relapse. Relaxation and 
distraction were identified as moderating the impact of stress, and greater reactivity to 
perceived stressors was associated with increased chance of relapse, even when 
disease duration and symptoms were controlled for. Overall, it was reported that 
stress factors contributed about 10% to the variance in relapse rate. The evidence for 
stress causing MS was less, with one cohort and five case-controlled studies (n= 245). 
In both instances common stressors were family and social conflict, and for stress 
being related to disease onset, the strongest association was for sudden loss of a child, 
based on a large retrospective Danish cohort (n with MS = 21,062 versus 293,745 
controls), where the hazard ratio was reported as 2.25 (95% CI: 1.32–3.81) [8].  
In 1999 the American Academy of Neurology (AAN) proposed that in order to test 
convincingly the complex, inconsistent, and poorly understood relationship between 
stress and disease activity in MS, future prospective research should include an 
objective biological outcome measure such as serial Gadolinium-enhanced Magnetic 
Resonance Imaging (Gd+MRI). Gd+MRI is a highly sensitive measure of BBB 
breakdown/ on-going disease activity in MS, correlating with clinical relapse [116]. In 
2012, Mohr et al. carried out a RCT using Gd+MRI to assess the impact of targeted 
stress management on disease activity [7]. Using a CBT-based Stress Management 
Therapy for MS (SMT-MS), they recruited individuals with RRMS (n=121) who 
were already established on pharmacological MS treatments, including individuals 
with a median Expanded Disability Status Scale (EDSS) score of 3.50 [range 0-6] 
[117]. Findings were of a 76.8% reduction in the development of new Gd+MRI 
lesions in the intervention group (n=60), with an odds ratio (OR) of 2.77 (95% CI 
1.17-6.55; p=0.02), with an absolute risk reduction of 22.2%, and a number needed to 
treat of five. These findings were correlated to significantly reduced stress levels in 
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the intervention group, as measured via the Brief Inventory of Perceived Stress, but 
clinical neurology outcomes were not significantly improved. 
In a secondary analysis of the Mohr et al. [7] study, Burns et al. [118] sought to 
clarify whether the value applied to stressors, i.e. negative/positive, major/moderate 
etc, impacted on clinical outcomes. Findings suggested that SLEs deemed by patients 
as ‘positive’ were associated with fewer new Gd+MRI lesions (OR 0.53; 95%CI 0.30-
0.91), and a diminished likelihood of new/increase in size of T2 lesions (which 
represent overall lesion load) in the following 29-62 days (OR 0.74; 95% CI 0.55-
0.99). In an earlier study, Mohr et al. [119] had found that ‘moderate’ stressful events, 
such as interpersonal conflict, disrupted routine, or reduced resources, predicted 
increased Gd+MRI enhancement. In the Burns et al. [118] secondary analysis, those 
events deemed as both ‘major’, such as physical threat/threat to family, and ‘negative’ 
were predictive for increased Gd+MRI lesions (OR 1.77; 95% CI 1.18-2.64), and 
new/increased size T2 lesions (1.57; 95% CI 1.11-2.23). However, ‘moderate’ SLEs 
did not correlate with disease activity and temporal measures ruled out brain lesions 
being related to subsequent positive, or major negative SLEs [118].  
At this stage, it is impossible to say whether psychological stress can precipitate MS 
disease activity, or not. However, it seems likely that psychological stress has a 
deleterious effect on relapse frequency in RRMS, possibly through the effects of 
stress on underlying inflammatory mechanisms, and that individual interpretation of 
SLEs might mediate outcomes.  
2.7.7 Patient report outcome studies of stress management 
interventions in MS 
A 2014 systematic review on the efficacy of stress management interventions in 
people with MS reported that the majority of existing studies (n=5/8) had used a CBT 
approach, alongside some form of relaxation training [120]. One study used 
meditation, and the remaining two taught only relaxation. Five of the eight studies 
measured perceived stress, but QOL was measured in only three. Overall, 
methodology was reported as poor, and quality varied widely [120].  
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Using the AAN criteria, Reynard et al. [120] reported that the best evidence, i.e. 
‘Class 1’, was for the SMT-MS used in the Mohr et al. [7] RCT described above. The 
grading was based upon rigorous trial methodology, and the fact that the outcome 
measurement was biological. Five studies were allocated AAN ‘Class 3’ evidence, 
less rigorous trial methodology and small sample sizes downgrading their quality.  
Smaller than the Mohr et al. [7] study, Artemiadis et al. [121] randomised participants 
(n=61) to receive either relaxation training CDs, or usual care over eight weeks. 
Those receiving the intervention reported significantly improved QOL (p<0.05) and 
depression scores (p<0.05), and a positive trend for anxiety (p=0.07). This approach 
was mirrored in another RCT (n=66) using relaxation training CDs versus usual care, 
with the intervention arm reporting significant improvements in QOL (p<0.05) [122].  
Another RCT (n=78) using mainly psycho-educational material and relaxation 
training on stress management found significant improvements in female MS patients 
on scores of mental health QOL (p<0.01) and perceived stress (p<0.05), but this was a 
heterogenous sample, not limited to MS [123]. The remaining two studies with ANA 
‘Class 3’ evidence used CBT, were non-randomised, using interventions that were 13 
[124], and six-weeks [125] in duration, respectively. They showed significantly 
improved anxiety (p<0.01) and depression (p<0.05) scores. The latter study sample in 
[125] was not confined to MS patients, limiting somewhat the relevance of results. 
The final two studies with ANA ‘Class 4’ evidence used very small, non-randomised, 
non-controlled samples. Welch [126] (n=7) used a five week CBT intervention. 
Participants reported significantly less stress (p<0.05). Pritchard et al. [127] (n=12), 
used a Yoga-nidra technique weekly over six-weeks, reporting significantly lowered 
perceived stress (p<0.001). However, the latter sample was heterogenous, including 
10 people with cancer, thus limiting its applicability.  
To summarise, there is some limited evidence that stress management interventions 
may be effective at improving patient-report outcomes for stress, stress-related mental 
health comorbidities, and QOL in people with MS. However, most studies have been 
hampered by small sample sizes (range 7-121), questionable research methods, and 
poor characterisation of participant demographic and phenotypic spread. The 
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interventions, although mostly CBT-based, have varied widely. None of the studies 
examined mindfulness as a potential stress management intervention and it seems 
clear that more research for potential treatment strategies in this area is merited [120]. 
2.8 Mindfulness – a means of managing stress in MS? 
Mindfulness is a Buddhist-derived insight meditation practice. The word is a 
translation of two Pali words ‘Sati’, meaning awareness, and ‘Samprajanya’, meaning 
clear-comprehension [128]. It has been defined in contemporary terms as applying an 
open, non-judgemental and non-elaborative quality of attention to awareness of the 
present moment [13]. A consensus definition in a health-care context remains elusive.  
In psychological terms, Bishop et al. [129] define mindfulness as involving regulation 
of attention to the present moment, and adopting an attitude of acceptance, curiosity 
and openness to whatever experiences may come. Shapiro et al. [130], on the other 
hand, suggest that there are three qualities that must be cultivated when fostering 
mindful-awareness, including Intention, Attention, and Attitude. Alternatively, Baer 
et al. [131] describe a five-facet construct of trait mindfulness, perhaps reflecting 
distinct neural components. These include 1) non-reactivity towards inner experience, 
2) observation of emotions, feelings and thoughts, 3) acting with awareness, 4) verbal 
description of experiences, and 5) non-judging of one’s inner experience.  
Drawing upon the models above, along with practitioner self-report and neuroimaging 
data, Holzel et al. [132] have proposed a working model for underlying neural 
mechanisms associated with mindfulness meditation, broken down into four 
components: 1) augmented attention regulation, 2) improved body awareness, 3) 
enhanced emotion regulation, and 4) change in perspective of the self (Table 2.1). 
In the Holzel et al. [132] model, attentional skills are honed through first fostering 
mindful awareness in the meditation exercises, paying close attention to the content 
and variation in one’s experiences, with a non-judgemental attitude. Body awareness 
is enhanced by ‘tuning-in’ to visceral sensations and emotions, for example, during 
mindful breath-awareness, mindful-movement, or ‘the body-scan’, which 
systematically trains the practitioner to shift attention from one body area to another. 
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Emotional regulatory skills are enhanced via adopting a non-directive, non-evaluative, 
and accepting approach to one’s experiences, whereby exposure takes place, and 
avoidance is discontinued. Through experiencing one’s self in this new way, implicit 
assumptions are brought to conscious awareness, which, it is asserted, can lead to a 
new perspective on the self, in terms of what does, and what does not constitute ‘self’.    
Table  2.1 Proposed neural mechanisms for mindfulness meditation (adapted from 
Holzel et al. [132]) 
 
Function Mechanisms Brain regions implicated 
1. Attention 
regulation 
The practitioner sustains their attention on a 
specified object of awareness, with any 
distractions being met simply with a return 
to the original focus of attention 
Anterior cingulate cortex 
(ACC) 
2. Bodily 
awareness 
The meditation practices encourage an 
enhanced viscero-somatic awareness 
through focusing attention on internal 
bodily processes, such as the breath, or on 
emotion 
Insular cortex (IC)  
Tempero-parietal junction 
(TPJ) 
3. Emotion 
regulation 
a) The practitioner attends to and adopts a 
non-judgemental attitude and acceptance 
towards their emotional experiences 
Dorsolateral prefrontal 
cortex (dlPFC) 
b) The practitioner exposes themself to 
whatever experience is present, avoiding 
suppressing or elaborating on cognitive and 
affective responses 
Ventromedial prefrontal 
cortex (vmPFC), 
Hippocampus, Amygdala 
4. Change in 
perspective of 
the self 
The practitioner detaches from their 
inherent and assumed identity with a fixed 
sense of self, thus diminishing its 
authority/validity  
Medial prefrontal cortex 
(mPFC), Posterior cingulate 
cortex (PCC), insula, TPJ 
 
Other authors broadly agree with the Holzel et al. [132] model and emphasise the key 
roles played in enhanced attention monitoring and emotion regulation by the 
prefrontal cortex (PFC), anterior cingulate cortex (ACC), and the insular cortex (IC) 
[128, 133, 134] (Figure 2.2).  
Manuello et al. [135] suggest these brain areas represent the ‘mindfulness-meditation 
network’, reflecting a move towards the study of distributed neural networks, beyond 
simply focusing on distinct brain locations. Tang et al. [134] concur with Holzel et al. 
[132] that mindfulness practices facilitate improved attentional control, better 
emotional regulation, and increased self-awareness, which together interact leading to 
a state of enhanced self-regulation. In the early stages, this is through the application 
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effortful practice, then later, by redirection of effort to reducing mind-wandering, and 
finally, in the more advanced stage, by being mindful with minimal effort.   
Figure  2.2 Key brain areas involved in mindfulness meditation 
 
 
Figure 2.2: Brain areas postulated to be of importance in mindfulness meditation. These cover 
attentional control (ACC and the striatum), self-awareness (mPFC, posterior cingulate cortex, 
precuneus, and the IC), and emotion regulation (prefrontal regions, striatum, and limbic regions). 
*Reproduced with permission from: Tang, Yi-Yuan, Britta K. Hölzel, and Michael I. Posner. "The neuroscience of 
mindfulness meditation." Nature Reviews Neuroscience 16.4 (2015): 213-225. 
Despite a rapid growth in the evidence base, neither the psychological nor neural 
mechanisms underlying mindfulness are entirely clear. In meta-analytic studies [136], 
the most effective emotion regulation strategies are ‘top-down’ cognitively-based i.e. 
problem solving and positive re-appraisal. These may apply in mindfulness-based 
cognitive therapy (MBCT) [137], but are less prominent in MBSR [13]. However, 
mechanistic models for mindfulness suggest that emotional regulation strategies may 
also stem from ‘bottom-up’ aspects of the training i.e. interoceptive practices, such as 
the body-scan, and somatoceptive practices such as mindful-movement, which recruit 
brain areas intricately linked to the PFC, the ACC, the IC, and the limbic system.  
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Whether mindfulness is distinct from more traditional cognitive concepts such as 
acceptance, emotional regulation, and/or selective attention is not known, but the 
models proposed by Holzel et al. [132], Tang et al. [134], and others [128, 133, 135] 
at least suggest some functional overlap [138]. In all of these models attention is a key 
feature, with skill postulated to grow with practice, facilitating a shift in awareness, 
described as a re-perceiving of, and potentially new relationship with ‘reality’ [132].  
Attention is thought to comprise three distinct neural processing units [139]: 1) 
alerting, 2) orienting, and 3) conflict monitoring. Functional overlap with those brain 
areas associated with mindfulness meditation is apparent (Table 2.2) 
Table  2.2 Attention: proposed subdivisions, functions and neural correlates 
 
Aspect of 
attention 
Function Associated neural structures 
1. ‘Alerting’ i.e. ‘readiness for an anticipated 
stimulus, including vigilance during 
prolonged tasks ‘sustained attention’ 
PFC, intraparietal sulcus, locus 
correuleus, regions of the 
thalamus 
2. ‘Orienting’ i.e. selecting out specific aspects of 
experience upon which to focus 
‘selective attention’ 
dlPFC, mPFC, ACC, parietal 
cortex 
3. ‘Conflict 
monitoring’ 
i.e. the monitoring of conflict and its 
resolution. Sometimes called 
‘executive attention’ 
ACC 
 
Research suggests that distinct components of the attentional system are active in 
expert meditators, and may be quite different to those in beginners, but Dickenson et 
al. [138] report that both complete beginners and experienced mindfulness meditators 
alike demonstrate improved emotion regulation. Expert meditators show increased 
acceptance towards distressing images, as compared with controls [140]. They also 
show evidence of enhanced executive attention and conflict monitoring, as compared 
to non-meditators, although stroop test results, which measure the ability to filter out 
irrelevant information, or interference, are not uniformly improved [132].  
The ACC is believed to regulate executive attention and exert ‘top-down’ control over 
lower neuroaxis brain structures – hence, perhaps, the purported importance of 
Intention and Attention in the Shapiro et al. model for mindfulness [130]. Together 
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with the IC, the ACC is also involved in switching of attention, via disparate neural 
networks. Switching of attention is a key skill in mindfulness, where the wandering 
mind is identified and returned to the chosen object of attention [132]. Mind-
wandering has been found to be positively associated with unhappiness [141]. 
ACC activity has been shown to be up-regulated both during and outwith regular 
meditation practice [142], with observed neuroplastic, i.e. structural and functional 
brain changes, also apparent. It has been suggested that enhanced ACC activity is an 
early phenomenon in meditation practice, diminishing as experience and skill grow 
[132]. Holzel et al. [132] suggest that changes in ACC activity are of potential clinical 
importance in conditions where executive control and function are impaired, such as 
Attention Deficit Hyperactivity Disorder (ADHD) and Bipolar Disorder (BPD).  
Expert meditators show an enhanced orientating response, as do individuals following 
an eight-week MBSR training course [143]. There have also been improvements 
noted in those completing a month-long mindful retreat, and a three month-long 
‘Samatha’ mindful breathing retreat. It remains debated as to how these reported 
benefits might manifest in the brain, but it seems likely that they act via ventral and 
dorsal sub-components of the attentional systems [132].  
Attentional blink, or impairment of the time-dependent capacity to detect a salient 
object from a series of sequential stimuli, has been shown to improve following a 
three-month mindfulness retreat [132]. Increasingly it appears that the type of 
meditation practised will determine which components of the attentional system are 
active [132]. This may be important where an intervention aims to improve cognitive 
skills that allow an individual to orient preferentially towards, attach significance to/ 
or not, or to respond/ or not to stressful stimuli.  
Tomasino et al. [144] have described how Buddhist and Hindu meditation styles 
utilise distinct neural systems. This may explain divergent, yet similar effects from 
the respective practices. Training these systems via mindful awareness, so that stress-
inducing experiences can be preferentially engaged/disengaged-with, may hold 
benefit for people with MS. Grecucci et al. [128], and others, [130] relate this to a re-
perceiving of the self, where prior ‘fusion’ of cognitive/ emotional states with an 
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enduring sense of self are prised apart and subsequently re-appraised in a more 
adaptive, and less stressful manner.  
However, Farb et al. [133] suggest that mindful emotion regulation does not work via 
cognitive re-appraisal, or through any attempt to control one’s emotional experience 
in a ‘top-down’ manner. Instead, they propose that it is through the preferential 
recruitment of non-conceptual, sensory/embodiment ‘bottom-up’ neural circuits, such 
as the thalamus, IC, and somatosensory cortex, that beneficial effects take place. 
Thus, a practitioner remains alert to the salience of present moment experience, 
without conceptual elaboration. This may limit cognitive elaboration of distressing 
experiences, and any associated negative evaluation of the self. When combined with 
an attitude of self-compassion, this approach might lead to increased tolerance for 
unpleasant emotions and a more adaptive response to moment-to-moment fluctuations 
in experience, translating into a distinct pattern of neural activity, with cumulative, 
and potentially lasting beneficial neuroplastic and functional effects [133].  
‘Trait’ mindfulness describes an enduring mindful quality of awareness, which is 
inversely related to trait rumination, a key feature in depression and anxiety [145]. 
The development of trait mindfulness might help with the problematic ‘negativity 
bias’ commonly observed in depression and seen as a behavioural marker of 
depression vulnerability [146]. How mindfulness might achieve such ends is unclear. 
Possible mechanisms may include a shift towards positive reappraisal of SLEs [147], 
or non-reactivity to negative stimuli [148]. Goldin et al. [149] have proposed that 
when utilising MBSR amongst those with social anxiety disorder (SAD), it is through 
adopting a state of meta-awareness that mindfulness exerts beneficial effects i.e. by 
developing the conscious ability to observe current mental phenomena from a 
detached perspective [150]. 
2.8.1 Mindfulness as a healthcare intervention 
Mindfulness was introduced into healthcare settings in the early 1980’s by Jon Kabat-
Zinn, primarily as a means of reducing stress in those with chronic illness. The first 
studies were among people with chronic pain and anxiety [151]. Over the last four 
decades, clinical research on the topic has risen exponentially (Figure 2.3).  
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Figure  2.3 Mindfulness journal publications by year, 1980-2015 [152].  
 
Blue line indicates results from a search of the term ‘mindfulness’ in the ISI Web of Science database. 
(Republished with permission from the American Mindfulness Research Association, 2015) 
MBIs derive mainly from the eight-week long, group-based MBSR, conceived by 
Kabat-Zinn. This model has served as a template for further derivations, such as 
MBCT, an intervention specifically aimed at preventing depressive relapse [13, 153]. 
MBIs have influenced the development of other composite interventions, such as 
Acceptance and Commitment Therapy (ACT), and Dialectical Behavioural Therapy 
(DBT), but mindfulness does not form the ‘core’ of such therapies, which are 
described as largely directive [154].  
In general, MBIs are considered ‘safe’ clinical interventions. Lustyk et al. [155] 
provide a helpful review of participant screening, safety, and researcher training. The 
authors point out that researchers should be aware of potential adverse effects, mental 
health concerns being foremost. Reported adverse events include enhanced feelings of 
anxiety and depression, and case reports of delusions, psychosis and mania. However, 
these have mostly been associated with intense, prolonged Vipassana retreats (an 
insight-orientated Buddhist meditation style [156]), which may also involve fasting, 
sensory deprivation, and altered sleep [155]. A physical health issue worth noting is a 
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potential for meditation to lower seizure threshold via decrease in serotonin, increase 
in glutamate, or via neuronal hypersynchrony, where large groups of neurones in the 
brain fire in synchrony. This effect has been reported with Transcendental Meditation 
(TM) [157], and is also seen in epilepsy [158]. This risk would be of primary concern 
in a known epileptic, but remains largely theoretical [155]  
There have been a number of recent systematic reviews and meta-analyses on the use 
of mindfulness as a healthcare intervention. In 2003 Baer [154] published a 
conceptual and empirical review of controlled and observational studies of MBIs as 
clinical interventions (n=21), reporting beneficial effects across a range of medical 
and psychiatric conditions, with a weighted mean post-treatment ES of 0.59 
(medium), which remained stable at follow-up. Clinically and statistically significant 
effects were largest for depression (ES 0.86), and lowest for pain (ES 0.31). 
In 2004 Grossman et al. [14] reported a meta-analysis of published and unpublished 
observational and controlled studies (n=20 studies/1,605 participants) on the health 
benefits of MBSR, amongst individuals who were ‘stressed’, or had specific clinical 
conditions, such as anxiety, cancer, chronic pain, depression, or heart disease. A 
limitation was that findings were based solely on pre- post- intervention change 
effects. Amongst the controlled studies (n=771 participants), the authors reported an 
overall ES of 0.54 for improvements in mental health, and an ES of 0.53 for 
improvements in physical health. In the observational studies (n=894 participants), 
the ES was 0.50 for mental health, and for physical health 0.42. Results were 
supportive of improvements across a range of validated measures for anxiety, 
depression, coping, QOL, pain, and physical impairment. 
In 2009 Mars and Abbey [17] carried out a systematic review on RCTs of MBIs as a 
healthcare intervention, including 22 studies in patients with medical and 
psychological conditions, such as depression, chronic pain, psoriasis, MS, cancer, 
heart disease, chronic fatigue syndrome (CFS), and substance misuse. They also 
included ‘stressed’ non-clinical populations. Findings highlighted positive health 
outcomes and decreases in psychological distress, with MBCT noted for effectiveness 
in recurrent depression. In the case of MS, the authors noted only methodological 
drawbacks and a small sample size limiting interpretation of findings in the single 
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study included. For other medical conditions, the authors found evidence of 
effectiveness for Mindfulness-Based Art Therapy (MB-ART) amongst female cancer 
patients, with reduced distress, improved vitality, social functioning, and QOL. They 
also found that in fibromyalgia patients, MBSR improved inner resilience, myalgic 
pain, and depression, whilst in heart disease, modified MBSR was associated with 
reduced respiratory rate, less anxiety, enhanced emotional expression and better 
coping. In psoriasis, MBSR was associated with faster skin healing. However, there 
were recurrent problems with methodological quality reported, such as small sample 
sizes, and a persistent lack of active control groups. Another consistent limitation was 
the widespread failure to include outcome measures for mindfulness, rendering 
inference somewhat problematical.  
In 2010 Bohlmeijer et al. [16] conducted a meta-analysis examining the role of 
MBSR in the mental health of adults with chronic medical disease (cancer, CFS, 
chronic pain, fibromyalgia, and rheumatoid arthritis). This included eight RCTs. The 
meta-analysis reported beneficial effects in depression (ES 0.26), anxiety (ES 0.47; an 
effect which diminished to 0.24 when including only the highest quality studies), and 
psychological distress (ES 0.32). Cochrane criteria were used to assess quality, and 
subsequent guidelines were set out for empirically supported therapies. The authors 
noted a preponderance of female participants, and a tendency to focus upon the 
middle-older age groups. The meta-analysis employed tighter inclusion/exclusion 
criteria than Baer [154] or Grossman et al. [14], possibly explaining the smaller ESs. 
Most recently in 2014, Goyal et al. [159] published a comprehensive and rigorous 
meta-analysis, examining the evidence for efficacy and comparative effectiveness of 
meditation programmes against active controls for improving psychological distress 
and wellbeing in adult clinical populations. MBIs were included. The authors assessed 
quality over four domains – consistency, directness, precision, and risk of bias. Forty-
seven RCTs were included (n=3,515), covering populations with anxiety, depression, 
stress, chronic worry, insomnia, substance misuse, cancer, diabetes, heart disease, 
HIV infection, and pulmonary disease. Goyal et al. [159] reported low evidence for 
improved distress and mental–health related QOL, and insufficient evidence for stress 
related behaviours, such as disordered sleep, or weight management. More robust 
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end-point results for MBIs were evident for anxiety (ES 0.22 at 3-6 month follow-up) 
and depression (ES 0.23 at 3-6 month follow-up). 
The MBI findings were across a diverse range of medical and psychiatric conditions. 
Goyal et al. [159] pointed out that meditation programmes in general were no better 
or worse than other active treatments, such as anti-depressants, exercise, or 
psychotherapy. They emphasise that such programmes are a viable and effective 
option against various aspects of psychological stress. The authors suggest that ESs 
for MBIs are comparable to antidepressants in primary care populations, with the ES 
for antidepressants quoted as 0.11 in mild-moderate depression, and 0.17 in those 
with severe depression. Limitations noted in the Goyal et al. [159] meta-analysis 
included that findings were limited to a primary care sample, with a potential floor 
effect, and thus small ESs. The methods used in the included studies were reported as 
inconsistent, with high levels of attrition, lack of blinding, and a lack of intention to 
treat (ITT) analyses. Interventions were diverse, varying in duration and instructor 
expertise. Although no study reported outright adverse events, potential harm 
reporting was generally poor, considered by only 9/47 studies.  
2.9 Summary 
This chapter has presented a background overview on MS epidemiology, aetiology, 
pathology, symptoms and comorbidity. Scotland has the highest incidence and 
prevalence of MS worldwide. MS is poorly understood. It is a stressful condition. 
Inflammation is a central feature in current models, but precise mechanisms remain 
unclear. Experimental evidence exists that stress can potentiate inflammation. 
Perceived stress is associated with increased mortality in multimorbid populations.  
Stress raises the risk of depression in MS and impairs QOL. Psychological stress 
management is linked with diminished MS disease activity, but current evidence to 
support this finding is limited. Psychosocial interventions improve common MS 
symptoms of anxiety and depression, and improve QOL. More research is required to 
determine the optimal treatment.  
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Mindfulness is an ancient Oriental meditation technique adapted to Western medical 
settings, especially for managing stress in LTCs. How MBIs work is not fully 
understood. They are thought to operate via improving attention and emotion 
regulation skills, and by decreasing stress reactivity. Their role in MS is unclear. 
Building upon this background, a rationale for studying MBIs in people with MS is: 
1. Perceived stress can impair QOL in MS, increase vulnerability to 
depression, and possibly the risk of relapse;  
2. Mental health comorbidity is likely to be high in MS;  
3. MBIs have been shown to be effective in helping manage stress, treating 
anxiety and depression, and improving QOL in other LTCs;  
4. People with MS value learning new skills to assist in stress management; 
5. Effective stress management interventions for people with MS are limited.  
The next chapter will outline and justify the general methods chosen to study the use 
of MBIs in people with MS in this thesis.
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Chapter 3 General methods 
3.1 Chapter overview 
This chapter provides an overview of the methods used in this thesis. It starts by 
introducing the MRC guidance [19] for developing and evaluating complex 
interventions to improve health. The chapter is then split into sections, describing the 
steps from the MRC guidance [19] through which the researcher worked in an 
iterative manner, in order to answer the research questions set out in Chapter 1. This 
follows a sequence of discussing the methods chosen for:  
1. Defining the population under study 
2. Setting-out to identify systematically the existing evidence for MBIs in 
people with MS 
3. Testing the feasibility of a standardised MBI in people with MS 
4. Thematically analysing participant experiences from the MBI  
5. Examining potential implementation issues 
6. Thinking about next steps. 
 
3.2 Developing and evaluating complex interventions 
in healthcare 
As described in Chapter 1, the overarching aim of this thesis was to focus on the 
needs of people with MS, and in particular whether MBIs may help, with specific 
research objectives being to: 
1. Measure comorbidity in people with MS in Scotland by characterising the 
number and type of conditions compared with the general population. 
2. Delineate the existing evidence for effectiveness of MBIs in people with MS 
by carrying out a systematic review. 
3. Test the feasibility and effects of conducting a RCT of a MBI for people with 
MS, and clarify whether a future definitive trial is currently merited. 
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4. Explore the perceptions and views of people with MS participating in a MBI 
(MBSR) 
5. Examine the potential barriers to and facilitators of implementing a MBI for 
people with MS  
 
The methods chosen for this task were based upon those suggested by the MRC 
guidance for developing and evaluating complex interventions to improve health [19, 
160]. The MRC guidance [19] recommends that researchers consider a series of 
iterative, complementary, and interconnected steps when undertaking such an 
evaluation (Figure 3.1). 
 
Figure ‎3.1 Developing and evaluating complex interventions to improve health 
 
 
In this thesis, the application of these methods included the following:  
1) Firstly, defining the population under study. This required developing 
an understanding of the epidemiology of multiple sclerosis, including 
the scope and extent of physical and mental health comorbidity in this 
population.  
Developing 
Piloting 
Evaluating Reporting 
Implementing 
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2) Secondly, defining the scope and extent to which MBIs have already 
been used in people with MS through carrying out a systematic review.  
3) Thirdly, testing the feasibility of delivering a MBI to people with MS 
under trial conditions and assessing likely effectiveness in a future 
definitive trial. 
4) Fourthly, determining stakeholder views on the accessibility and 
acceptability of a MBI for people with MS, by thematically analysing 
feedback from both course participants and course instructors.  
5) Fifthly, determining the likely implementability of a MBI for people 
with MS via the application of an implementation theory to the 
qualitative findings from the thematic analysis.  
6) Finally, thinking about the findings as a whole, what they show, and 
how this should be reported, but also in terms of what next steps may 
be necessary in order to create a MBI optimised for people with MS.  
The rationale for choosing these methods and working through the steps from the 
MRC guidance [19] in the above order is outlined below. 
The MRC guidance [19] suggests that in order to answer complex research questions, 
the use of multiple methodologies is likely to be required. In this context, diverse 
forms of data from various relevant sources can be compiled to generate a broader, 
more meaningful scope for an overall analysis. Complexity is increasingly seen as the 
norm in health services research. There is a general recognition of the need to look 
beyond simply measuring outcomes, and to link process evaluations, including 
delivery and organisation of health services, with clinical trial findings [161]. Such 
integrative mixed-methods approaches can increase confidence in the 
comprehensiveness and inclusiveness of findings [162]. ‘Mixed-methods’ research 
generally means taking into consideration both quantitative and qualitative research 
findings on a given topic. Including a variety of perspectives may intuitively make 
sense, but this approach is not entirely free from criticism. The main criticism is that 
quantitative and qualitative research approaches are based in different epistemological 
and ontological foundations, where epistemology refers to the nature of knowledge, 
where it comes from, and how it can be explored [163], and ontology refers to the 
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nature of the social world, what it comprises, and how its diverse aspects interact 
[163]. 
Traditionally, quantitative research is seen as having a ‘positivistic’ grounding, in that 
determinism (i.e. cause and effect) should be sought and identified as part of an 
‘objective’ reality [164]. A criticism of this method is that it can be seen as 
‘reductionist’; seeking to test ‘discrete’ ideas and assumptions about reality, 
ultimately in pursuit of uncovering ‘natural laws’. Thus, the use of numbers/ 
frequencies/ quantity i.e. statistics, is relied upon to determine ‘truth’ in the research 
hypothesis being tested [164]. A strength of this ‘deductive’ method is its inherent 
acknowledgement that any hypothesis should be modified in light of new information, 
and that the researcher remains ‘objective’ i.e. systematically seeks to remove sources 
of bias in his orientation and observation. A weakness with this approach is that it can 
actually by definition never ‘prove’ a hypothesis, only fail to reject it [164].  
Qualitative methods, on the other hand, are a more recent development in research 
[162]. The approach differs from quantitative methods by proposing that, contrary to 
the ‘positivist’ perspective, there is no objective reality; that in fact what we refer to 
as ‘reality’ is actually a mere social construct i.e. ‘constructivism’, resulting from 
individual, or societal interpretation i.e. ‘interpretivism’ [164]. Whereas quantitative 
measures set out to answer specific research hypotheses, qualitative research may 
generate a new theory or patterns, which may only emerge during the research 
process [164]. Central to this theory is the idea of deriving ‘meaning’ in reality, from 
the subjective point of view of the individual. This can lead to multiple ‘realities’, 
these being more likely to emerge when the individual faces open-ended questions 
posed by a researcher using an ‘inductive’ approach [164]. The researcher then aims 
to clarify and make meaning of key emergent themes from participant feedback, being 
careful not to marginalise any minority groups, and remaining cautious about the role 
that his own background and assumptions may play in his interpretation and analysis.  
Mixed methods are now commonly used in research [161], combing the strengths of 
both approaches. That is why they have been chosen to help address the complex 
questions posed in this thesis. 
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3.2.1 Defining the population to be studied and the rationale 
for the intervention. 
Scotland is known to have the highest MS prevalence rates worldwide (see Chapter 2 
for a more detailed discussion). However, at the time of starting this thesis, there were 
no existing population-based studies on comorbidity amongst people with MS in 
Scotland. The first part of the research in this thesis was thus based in epidemiology, 
and focused specifically on answering the question as to the level and extent of 
comorbidity in people with MS compared to the general population. 
In order to delineate the prevalence of comorbid diseases amongst people with MS in 
Scotland, a nationally representative primary care database from Scotland was 
accessed. This involved undertaking a secondary analysis of the database, which had 
been developed as part of a national programme for research into multimorbidity 
[165]. The database was cross-sectional, measuring the prevalence of comorbidities 
over a defined single time period, as a ‘snapshot’ [166]. Full details of this process are 
described in Chapter 4.  
Epidemiology can be defined as: ‘how often diseases occur in different groups of 
people and why’ [166]. It is mainly concerned with groups of people and can be used 
to measure outcomes in ‘at risk’ populations, where a person with the condition 
represents a ‘case’. It can be very useful in planning treatment strategies in people 
with specified medical conditions [166]. Most epidemiological studies are 
observational, comparing groups likely to differ in many ways, such as in age, sex, 
and SES. Such variables can act as confounding factors when appraising 
epidemiological data, in that certain conditions may be more likely to occur in older 
individuals, females versus males, or in the less affluent, and thus may potentially 
obscure relationships between exposure to certain conditions and the presence of a 
disease. However, such confounders can be statistically controlled for in quantitative 
analysis of such data in a number of ways, allowing closer scrutiny and focus on the 
variables of interest. For example, by isolating a ‘dependent’ variable, one can home 
in on the relative contributions other variables make to the prevalence of other 
comorbid conditions in people with MS. By controlling for age, sex, and SES, 
differences in the prevalence of depression can be sought between people with MS 
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and those unaffected, without these demographic variables exerting an otherwise 
‘hidden’ influence on the results generated [166].  
‘Prevalence’ is an epidemiological term referring to ‘the proportion of a population 
that are cases at a point in time’ and for rarer diseases like MS is thought to be a 
better measure than ‘incidence’, or ‘the rate at which new cases occur in a population 
during a specified period’, due to the relatively low numbers reported annually [166].  
Population-based studies tend to be most useful in epidemiology, giving a more stable 
risk estimate [166]. Population-based data is particularly useful as a means of 
controlling for random variability that may occur in small samples, and thus allows a 
greater degree of confidence that findings can be applied to research design and 
assumptions. A notable limitation is that cross-sectional data cannot be used to 
delineate definitive causal relationships, and observed associations thus require 
cautious interpretation [166]. 
In the cross-sectional database study described in Chapter 4, odds ratios (ORs) with 
95% confidence intervals (95% CI) were used as a means of describing the analysis of 
the data. These were adjusted for important potential confounders, including age, sex, 
and SES, and are reported for those with MS versus those without. ORs describe the 
odds of a defined event taking place in one group divided by the odds of it happening 
in another group [167]. ORs are useful when comparing individuals with a particular 
condition i.e. cases of people with MS, with MS-free ‘controls’. A ratio of 1 
represents no difference. A ratio greater than 1 indicates increased odds of an event 
taking place; and a value of less than 1 indicates decreased odds. ORs are usually 
accompanied by 95% confidence intervals, and if the range of values in the 
confidence interval does not cross zero then it implies a statistically significant result 
[167]. 95% CIs represent the range of values within which we can assume that 95% of 
the true population does in fact lie, thus boosting external validity. It has certain 
advantages over significance testing, i.e. ‘p’ values’, in that it allows us to see 
relationships between different variables, and also in that ‘p’ values can vary widely, 
making subsequent predictions regarding effects in complex scenarios very 
challenging [167, 168]. In epidemiology, ‘p’ values are used to determine if 
differences between two populations of interest differ in terms of distribution, and 
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allow a calculation of the probability as to whether a positive result occurred by 
chance. ‘P’ values are conventionally set as ‘significant’ if less than 0.05, or 5% i.e. 
there is less than a one in 20 probability of occurring by chance alone. Some critics 
argue that ‘p’ values are quite arbitrary, can vary widely on repeated testing, and are 
thus made more useful if combined with confidence intervals [167, 168].  
3.2.2 Defining the scope and extent to which MBIs have 
already been used in people with MS – is there existing 
evidence for effectiveness? 
In the Evidence-Based Medicine (EBM) paradigm of ‘Hierarchy of Evidence’, 
systematic reviews and meta-analyses of RCTs are seen as the ‘gold standard’, or 
representative of ‘Level 1a evidence’, meaning that results from such studies can be 
taken as the best available evidence on a given subject [169] (Figure 3.2).  
Figure  3.2 Oxford Centre for Evidence-Based Medicine ‘Hierarchy of Evidence’ [169] 
 
In this thesis, a systematic review was undertaken, setting out to delineate the scope 
and extent of evidence that exists for the effectiveness of MBIs amongst people with 
MS. The systematic review primarily examined for the effects of MBIs on perceived 
•Evidence from systematic reviews/meta-analyses of 
RCTs  Level 1a 
•Evidence from >/=1 RCT Level 1b 
•All or none case series Level 1c 
•Systematic review of cohort studies Level 2a 
•Individual cohort study Level 2b 
•Outcomes research/ Ecological studies Level 2c 
•Systematic review of case-control studies Level 3a 
•Individual case-control study Level 3b 
•Case series Level 4 
•Expert opinion Level 5 
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stress as the primary outcome, but also for a variety of other relevant secondary 
outcomes such as mental health, physical health, QOL, and cost-effectiveness in 
people with MS. The systematic review, given its rigour and depth of searching, also 
allowed the researcher to identify any important gaps in knowledge about the use of 
MBIs in people with MS. Full details of the systematic review process and findings 
are described in Chapter 5. 
A systematic review is a research method that allows the researcher to search the 
literature, both academic and ‘grey’, systematically and comprehensively. It is done in 
order to answer a specific research question, or set of questions where uncertainty 
exists, before distilling this information into a manageable and accessible format 
[170]. A systematic review starts by setting a focused clinical question in a specific 
population. In this case, the research question was focused on what evidence existed 
from RCTs and/or controlled trials for the effectiveness of MBIs at improving 
perceived stress in people with MS.  
In a systematic review, there are pre-defined inclusion criteria, and explicit research 
methods are employed throughout to identify and select appropriate studies before 
critically assessing the findings. This process includes scrutinising the study types, i.e. 
RCTs and/or controlled trials, the population characteristics/ demographics, the 
intervention designs i.e. ‘type’ of MBI, and the range of outcomes reported, including 
those of both primary and secondary importance for the purposes of the review [171].  
The review process is transparent and should be reproducible, being guided by a 
prospective, peer-reviewed protocol, designed partly to reduce any latent reviewer 
and/or publication bias [171]. The search is often aided by input from an information 
scientist, employing carefully selected bibliographic key words, along with Boolean 
operators, Medical Subject Heading (MeSH) descriptors, and predefined delimiters, 
such as language, publication dates, human subjects etc. These methods are applied in 
order to refine the search towards finding and retrieving relevant articles from major 
electronic databases, which are compiled and indexed around standard bibliographic 
convention [170]. This approach can then be further enhanced by hand searching and 
scrutiny of reference lists from identified studies [170].  
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Data extraction and quality assessment are done systematically [172], via a rigorous 
process involving crosschecking by a team of reviewers, looking specifically at such 
items as randomisation, blinding, and attrition. In this case, a pre-defined data-
extraction form was used, previously developed for a systematic review on the 
effectiveness of MBIs amongst people who had suffered from a stroke. The form was 
completed on all selected studies by two independent reviewers i.e. the researcher, 
and an experienced systematic reviewer. Findings were compared and adjudicated 
over by a further reviewer and senior academic, the researcher’s supervisor (Professor 
Stewart Mercer - SM). 
Systematic review results may subsequently be subject to further statistical scrutiny in 
a meta-analysis across studies, where heterogeneity can be assessed i.e. testing the 
probability as to whether differences between the study findings are likely due to 
chance alone [173]. Minimum reporting standards for systematic reviews of RCTs 
exist, for example the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA), an approach which has itself been shown via systematic review 
to improve evidence reporting [174]. For meta-analysis, results can only be combined 
where studies measure the same outcomes, and in the case where they do not, a 
narrative review may be a more appropriate method of reporting [171]. That proved to 
be the case in this present study.  
The reason for preferentially seeking out RCTs in systematic reviews is that 
randomisation of study participants reduces research bias by controlling for potential 
confounding by other variables, such as age, sex, SES. The randomisation process 
theoretically evens out the distribution of such variables between the groups into 
which participants are allocated in their respective studies [169]. However, RCTs do 
not provide much information on how interventions work on individuals or 
collectively and thus the MRC guidance [19] suggests that they should not be viewed 
in isolation, but interpreted in conjunction with other important sources of evidence. 
For the reasons outlined above, a systematic review is a persuasive tool to inform 
policy and practise in a climate of evidence-based decision-making [170]. 
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3.2.3 Testing the feasibility of delivering a MBI to people with 
MS under trial conditions. 
This research question related to the feasibility of being able to replicate and test the 
intervention of interest in the population of interest, which in this case was a MBI 
amongst people with MS. In this thesis, MBSR was tested in a pragmatic feasibility 
RCT. This process will be covered in full detail in Chapter 6.  
As discussed in Chapter 2, MBIs have been applied as a treatment strategy in a wide 
range of LTCs, and have demonstrated effectiveness in a number of these contexts. 
This did not automatically mean that these same effects would be observed in people 
with MS, but it did suggest that it would be worth investigating in a MS patient group 
and prudent to collect a range of outcomes measures of relevance to this particular 
population. Thus, feasibility work was required.  
Piloting and feasibility testing aims to reduce the number of studies undermined by 
issues that could have been anticipated by appropriate developmental work, such as 
poor recruitment, high attrition, and small ESs [19]. ‘Feasibility’ is about testing trial 
procedures and methods and may thus precede a ‘pilot study’, which is often 
characterised as a scale model for a definitive phase-3 trial, when the researchers are 
happy with the intervention and are not expecting any further modifications. It is 
worth noting, however, that this sequence and set of definitions are not uniformly 
followed in the literature, and another conceptualisation might be where research 
seeks first to ‘pilot’ and optimise an intervention, before then testing in a feasibility 
RCT [175]. 
A rigorously conducted RCT is widely regarded as the best method for evaluating 
interventions to improve healthcare [176]. Therefore, a RCT was chosen as the 
experimental method in this study, primarily for testing feasibility, but also for 
investigating likely treatment effects on relevant outcome measures. The MRC 
guidance [19] reminds researchers to remain aware that failure to demonstrate effect 
in this setting may occur for numerous reasons, that variation amongst individuals is 
likely, indeed the norm. At this stage the MRC guidance [19] recommends that any 
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control group should on balance receive ‘usual treatment’, since using an ‘active’ 
control at this point may serve to confuse/confound the interpretation of findings. 
The MRC guidance [19] suggests that researchers should ideally consider a RCT 
study design when testing a novel intervention, as this is the best method to guard 
against selection bias and sample variability. However, although randomisation is 
desirable, it is not essential. Arguably, when an intervention is not yet optimised for a 
specific population, a more suitable alternative can be to test feasibility in a pre- post- 
study. Potential advantages include greater flexibility to modify the intervention in 
real time and lower costs [19]. In this study, a RCT was chosen in favour of a pre- 
post- study because MBSR had previously been used successfully in ambulant people 
with MS [177], the timescale for the PhD project was limited, a wait-list control 
design might allow optimisation changes to a planned second iteration of MBSR to 
those initially allocated to ‘control’, it would allow the generation of effect estimates 
for a definitive study, and it was clear that RCT procedures would eventually require 
testing for feasibility and their acceptability to people with MS in this context. Patient 
and public involvement (PPI) through a grant application made to the UK Multiple 
Sclerosis Society (MSS) suggested that this decision was justifiable to people with 
MS, albeit from an admittedly small sample (n=3) (Appendix A). 
Fidelity is an important and often overlooked consideration when testing behavioural 
interventions [178]. The MRC guidance [19] suggests that assessing intervention 
variability is an important issue, particularly in the case of a study involving multiple 
sites. However, in this study, a single site was chosen for pragmatic reasons, and the 
MBI facilitators remained the same throughout. From a pragmatic perspective, 
although MBSR is a manualised MBI, minor modifications do occur in normal 
practice, based largely upon idiosyncrasies that may present with each new group of 
participants [13].  
Testing feasibility and performing piloting work was deemed necessary in this study 
when considering that the standard package of MBSR might not be optimal for people 
with MS. The main feasibility outcomes assessed how feasible it was to recruit, 
retain, and follow-up people with MS to take part in a MBSR intervention, as well as 
the likely effectiveness of the intervention. This comprehensive approach provided 
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insight into stakeholder interest, engagement, and sustained involvement i.e. whether 
people with MS were willing to attend the MBSR sessions or remain on a waiting list 
and continue to complete relevant outcome measures for the duration of the study. In 
addition to testing the feasibility of trial procedures, exploration of likely treatment 
effects provided useful data to help determine the required sample size for a phase-3 
definitive trial. Important elements included confidence about effect sizes and 
variability.  
The MRC guidance [19] suggests that questions of feasibility, accessibility, 
acceptability, adherence, and intervention delivery should ideally be addressed before 
ever proceeding to a phase-3 trial. If such elements are lacking, then it becomes 
questionable whether the intervention can actually be delivered as intended. In terms 
of replicability, the MRC guidance [19] emphasises the importance of being able to 
describe the intervention fully from the outset. In this regard, MBSR was a 
manualised and replicable MBI [13], previously having been widely used across a 
variety of other relevant LTCs [16, 17].  
MBSR was originally designed to help people with LTCs cope with stress and chronic 
pain [151]. It was not designed as a ‘cure’, but as a means of helping people to accept 
and live with their condition(s) in a more adaptive manner [13]. As noted in Chapter 
2, MS is a LTC with high levels of comorbidity, that comes with inherent uncertainty 
surrounding disease relapse and/or progression [20], and various social and role 
challenges, all of which can be stressful and can impair QOL [3, 179, 180]. The 
primary purpose of the intervention in this context was to provide a mindfulness-
based stress management programme to diminish perceived stress and improve QOL.  
The MRC guidance [19] suggests that when investigating a new intervention/context, 
a range of outcome measures should be sought, instead of focusing simply on one 
primary measure. Validated measures can give an indication of likely effects from the 
intervention, although causal pathways can remain very difficult to pick apart on this 
level [19]. In this study, qualitative semi-structured interviews from participants were 
also collected, detailing their experience of the intervention and its perceived effects, 
or lack thereof, being used to complement and augment quantitative measures – (this 
will be covered in more detail in section 4, below).  
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The MRC guidance suggests that quantitative outcome measures should be both 
‘valid’, and ‘reliable’ [19]. In quantitative research, ‘validity’ means the degree to 
which the tool actually measures the phenomenon or outcome of interest [181]. 
Similarly, ‘reliability’ refers to ‘precision’ and the extent to which repeated 
measurements of a phenomenon are consistent, dependable, and reproducible [181]. 
Thus, this programme of work selected a range outcome measures addressing 
perceived stress, QOL, common MS symptoms, and measures of mindfulness that 
have been shown to be both valid and reliable in MS populations, or related 
conditions. Chapter 6 reports the full details of the outcome measures chosen, 
including their basic psychometric properties. 
The justification for choosing perceived stress as a primary outcome measure was that 
stress is known to be common in people with MS, it can increase the likelihood of 
developing depression in MS, reduce QOL, and potentially exacerbate disease activity 
[6, 8, 182] (see Chapter 2 for a fuller discussion on these points). The Perceived 
Stress Scale-10 (PSS-10) was chosen as a widely used and validated measure that 
covers both negative and positive aspects of stress appraisal and coping [183-185], 
with the PSS-10 having the most favourable psychometric properties in people with 
MS compared with the shorter four-item or longer 14-item versions [186]. 
A generic QOL measure was chosen as a second primary outcome, based on 
recognition that QOL is often severely diminished in people with MS [59, 73]. The 
EQ-5D-5L was selected as a widely used and validated generic measure that has been 
recommended for people with MS [187]. It is a short measure, and was thus attractive 
in helping to keep participant measure completion burden to a minimum. The EQ-5D-
5L has been widely validated across the world, with weighted data available for UK 
populations, and can also contribute to an analysis of cost-effectiveness [188]. 
Cost-effectiveness is another important consideration when assessing novel 
interventions. Such information can be useful for health service commissioning, and 
is recommended by the MRC guidance [19]. An evaluation of economic value can 
contribute to decisions regarding implementation and sustainability, and whether an 
intervention is worth long-term investment. In practice, cost-effectiveness cannot be 
reliably determined in a small-scale study such as this [189], but it did make sense to 
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consider it at the feasibility stage [19]. Due to the small scale of this feasibility study 
and associated resource constraints, a decision was made by the researcher and his 
supervisors not to conduct a formal assessment of cost-effectiveness. 
Secondary outcome measures sought to assess the impact of mindfulness training on 
common MS symptoms and comorbid conditions. After considering of a range of 
options [187, 190], a MS-specific composite measure, the Multiple Sclerosis Quality 
of Life Inventory (MSQLI), was chosen as it covered several relevant domains 
including fatigue, mood, cognitive function, social support, vision, pain, bowel, 
bladder and sexual function [191]. Although it had not been used previously in UK 
populations, it had been validated in North American MS populations across a range 
of ages, including those with cognitive impairment [192, 193]. 
In addition, given the putative links between impaired emotion regulation, stress, 
depression, and diminished QOL in people with MS (covered in chapter 2), a measure 
of emotional lability was also included. At the time of designing the trial protocol, the 
researcher was unable to identify any validated MS-specific measure and thus the 
Emotional Lability Questionnaire (ELQ) was selected for use [194]. The ELQ is a 
validated measure [195] that was originally designed for people with Motor Neurone 
Disease (MND), a condition with similar cognitive and emotional symptoms to those 
commonly seen in people with MS [196]. 
Further secondary patient report outcomes included measures of mindfulness and self-
compassion. These measures were included as ‘process’ measures i.e. seeking to 
determine whether these constructs showed improved scores following mindfulness 
training versus controls. The development of mindfulness and self-compassion have 
both been described as key theoretical facets as to how/why MBIs exert beneficial 
effects in people with LTCs [13, 197]. A wide range of measures for mindfulness 
have been described, their psychometric properties recently examined via a systematic 
review [198]. Park et al. [198] conclude that those measures with the most supportive 
psychometric data include the Five-Facet Mindfulness Questionnaire (FFMQ) and the 
Mindful Attention Awareness Scale (MAAS). The FFMQ had previously been used 
to assess mindfulness in cross-sectional studies of people with MS [199, 200], but 
neither measure had been used in longitudinal studies. In this study, the MAAS was 
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chosen, as it was the most widely studied and validated measure, with supportive 
quality ratings for most psychometric measures, and in contrast to the FFMQ, 
measures mindfulness as a unified construct [198]. At the time of writing the protocol 
for the RCT the construct of self-compassion had never been studied in MS 
populations. The Self-Compassion Scale-short form (SCS-sf) was chosen as a 
concise, validated and responsive measure that has been used to assess the construct 
across a wide range of LTCs [201, 202].  
The quantitative evaluation in the feasibility RCT examined between-group 
differences on baseline and outcome measures i.e. those allocated to MBSR, versus 
those in a control group. In this scenario, ‘t’ tests were used to compare the means 
between the groups. T tests are a ‘parametric’ test, requiring normally distributed 
data, testing the probability for the ‘null hypothesis’ i.e. that two sample groups come 
from a population having the same value for the mean [167]. For non-normally 
distributed data, Chi squared (Χ2) tests were used instead. Χ2 is a ‘parametric’ 
hypothesis test of the association between two categorical variables i.e. different 
categories of the same thing, such as eye colour, gender etc, looking for differences 
between expected, and actual frequencies. If the null hypothesis is true, Χ2 will equal 
zero. However, if a difference between the groups does exist, then the bigger the 
difference, the greater the value for Χ2. A ‘p’ value usually accompanies a Χ2 as a 
means of demonstrating significance [167].  
In order to explore further the relationship between groups in the feasibility RCT, 
regression analyses were used as a means of defining the relationships between 
variables, one of which was ‘dependent’ upon the other i.e. precedes, or influences its 
value. Regression analyses can be either ‘linear’, where a ‘best fit’ line is drawn 
through a set of values in attempt to simplify the relationship between them, or it can 
be ‘logistic’, where the dependent variable is binary and only able to take one of two 
categories. Logistic regression can be used to predict binary outcomes, such as 
whether a patient has an outcome e.g. a disease, or not. Linear regression is used to 
assess how sets of data relate to one and other [167].  
As a feasibility study, the RCT in this thesis was not powered to detect effectiveness, 
but it was able to give an indication of likely effects across a range of outcome 
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measures. The RCT analyses reported ESs for outcome measures, which are a 
measure of the magnitude and practical significance of differences observed in 
treatment effects on outcome measures between the two groups [167, 203]. Over 40 
different methods are described for measuring effect sizes, but Vacha-Haase and 
Thompson [203] describe three major classes:  
1. The first class assess standardised difference in effect sizes, which has the 
advantage of allowing comparison across heterogeneous outcomes in a broad 
literature such as exists in medicine. These are calculated by subtracting post-
test mean of the control group from the experimental group and dividing by 
the entire population standard deviation (Cohen’s ‘d’). An alternative is to use 
the standard deviation from only the control group data (Glass’s ‘delta’), 
which may improve precision where a researcher can confidently determine 
that an intervention has not impacted on the control group’s standard 
deviation. Delta may also be preferable when there is a large control group 
sample size, so that combining the intervention and control group data does 
little to improve precision, or when the intervention and control groups are 
very different from one and other [203].  
2. The second class of techniques are termed ‘variance-accounted-for indices’, 
are associated with general linear statistical models, rely on correlations, and 
can allow sophisticated statistical calculations with ‘weight’ applied to 
variables and partitioning to determine which variables contributed what to the 
outcome effect size. However, effect sizes from such models can be difficult 
to interpret regarding their practical significance [203]. 
3. The third class are termed ‘corrected effect sizes’, so named as they ‘correct’ 
for sampling error variance in the sample data, such as effect characteristics 
unique to the given sample, thus preventing erroneously inflated effect 
estimates due to small sample size, or a large number of measured variables. 
Theoretically, corrected effect sizes may be most accurate, but debate exists as 
to at what levels sample size, variable number, and population effect sizes 
should be corrected [203]. 
Vacha-Haase and Thompson [203] suggest that when reporting effect sizes, 
researchers should consider: 
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1. Which types of effect size are being reported? This matters, as different 
expressions exist that are not directly reciprocal, although conversion 
formulae can be used in most cases. 
2. What assumptions and limitations does each method have? 
3. Confidence intervals should also be reported, which allow an estimate of 
precision, and aid in comparison across a study or across multiple studies, 
such as in meta-analysis. 
In this study, standardised effect sizes using Cohen’s ‘d’ were chosen to allow 
practical comparison with findings in the related literature where they are commonly 
reported. The use of Delta was not felt to be required, given that baseline differences 
between the groups were minimal, and thus this technique was unlikely to improve 
precision. Cohen’s ‘d’ scores were thus calculated by dividing the observed treatment 
effects for a given variable i.e. differences between the treatment and control groups, 
by the standard deviation for the variable of interest for the group as a whole [204]. 
Effect sizes with confidence intervals have the advantage over significance testing, 
which cannot evaluate replicability. Instead, by using effect sizes and confidence 
intervals, results from multiple studies can be compared to determine whether results 
are consistent with other published data in the field, or stand out as anomalous [203]. 
Where beneficial effects were observed, their values may be used later to inform 
‘power’, meaning the probability that a future study will observe a statistically 
significant difference between treatment groups, when one truly exists. Where the 
study failed to show effects, further exploration as to how/why this occurred could be 
undertaken through the linked process evaluation (covered in more detail in section 4, 
below). Assessing the magnitude and variability of effects in this feasibility study 
meant that this data would be available to guide sample size likely to be required for a 
future phase-3 trial.  
The Consolidated Criteria of Reporting Trials (CONSORT) guidance is widely 
acknowledged and accepted as a ‘gold-standard’ method of reporting on RCTs [176], 
and was utilised in this study (see Chapter 6 for the CONSORT reporting checklist 
and diagram applied to this study). The CONSORT group suggest that poor reporting 
can seriously hamper interpretation of study findings, and the checklist is designed to 
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guard against this [176]. The guidance seeks to standardise reporting, to include clear 
and structured information in RCTs, with: 
 A title that clearly identifies the study as a RCT, with an accompanying 
abstract delineating design, methods, results and conclusions 
 An introduction highlighting scientific rationale, with specific aims and 
objectives for the trial 
 Clearly described methods about study design, participants, the 
intervention, outcomes, sample size, randomisation, blinding, and 
statistical methods 
 Results highlighting participant flow, recruitment, baseline data, 
numbers analysed, outcomes and estimation, ancillary analyses, and 
harms 
 Discussion of limitations, interpretation of findings and consideration of 
their generalisability  
 Details regarding registration of the trial in a recognised registry, along 
with pre-defined protocol, and funding source(s). 
The MRC guidance [19] recommends that statistical advice be sought early in the 
course of developing and evaluating complex interventions, and this was the case in 
this current study, both for analyses and results reporting, with input and supervision 
from staff in the Robertson Centre for Biostatistics (RCB), University of Glasgow 
(Miss Suzanne Llyod and Dr. Alex McConnachie).  
3.2.4 Determining stakeholder views on the accessibility and 
acceptability of a MBI for people with MS 
In mixed-methods research, quantitative outcome measures can be supplemented 
through the addition of qualitative data. In the RCT in this study, a parallel process 
evaluation was carried out involving semi-structured stakeholder interviews. An 
advantage of including a process evaluation was that it could provide valuable 
information to test assumptions about the research hypotheses, the intervention, or the 
outcome measures chosen [205]. 
Mindfulness-based interventions for people with MS 
 
 75 
The intention in this study was to examine participant views on their experiences of 
MBSR. The MRC guidance [19] suggests that this process should be theory-informed. 
In this study, a thematic analysis was employed first to capture emergent, unabridged 
participant views. Following this, Normalisation Process Theory (NPT) [206, 207], 
was used as a theoretical ‘lens’ for scrutinising the themes arising from the thematic 
analysis. These methods are explained in more detail below and Section 5 will cover 
the use of NPT. Chapter 7 then gives full details of the qualitative research process. 
3.2.4.1 Measuring quality in qualitative research  
The scope of qualitative research methodology is extensive and varied. When 
selecting methods for a study such as this, quality assurance should feature as a 
distinct consideration from an early stage. Mays and Pope (2000) suggest that in order 
to demonstrate rigour, qualitative research should be subject to an assessment of its 
quality via two broad criteria, namely relevance and validity. The approach used 
should be systematic, but also reflexive in its design, data collection, interpretation, 
and dissemination [208]. Hammersley [209] has suggested that any theoretical claims 
coming from a qualitative research study must be consistent with the data, that the 
data source from which it originates should be credible and valid, that an analysis 
should consider the external validity of the findings, that the research process should 
be transparent and reproducible, and that its interpretation should be reflexive. 
However, Mays and Pope [208] also suggest that qualitative research methods should 
be malleable, when considering the distinctive goals in each study.  
Validity can be assessed via [208]:  
1) Triangulation, where findings from a qualitative analysis may be 
compared against other sources, such as those from the RCT;  
2) Respondent validation, where respondents’ review the researcher’s 
account;  
3) Provision of a clear account of the research process;  
4) Reflexivity, where the researcher reflects on how, during the research 
process, the researcher may himself influence interpretation and 
analysis of the data;   
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5) Attention to negative cases or ‘deviant case analysis’, where emergent 
themes and/or theories are tested against the original data; and  
6) ‘Fair-dealing’, where a clear attempt is made to include as broad a 
range of participant views as possible, not focusing explicitly on single 
viewpoints as representative of the group as a whole. 
Relevance can be assessed by whether/how findings add to existing knowledge, 
including the generalisability of findings. The amount of detail included in the 
account can serve as a means whereby a reader can make a critical assessment 
regarding wider relevance – thus the sample from which data is drawn should be as 
broad, and as representative as possible [208]. 
Smith and Firth [210] describe three broad approaches to qualitative data analysis: 
1) Models which examine the use and meaning of language – ‘socio-
linguistic methods’ – such as Discourse Analysis 
2) Models concerned with developing new theories, such as Grounded 
Theory 
3) Models that set out to delineate and interpret participant views, such as 
Thematic Analysis. 
Whichever method is chosen, the researcher is encouraged to make every attempt to 
adopt a rigorous, unbiased, and ‘open’ approach to data analysis.  
In this study, qualitative data was gathered from semi-structured interviews with 
MBSR participants and instructors. Smith and Firth [210] suggest that analysis of any 
qualitative research interview data should involve the following steps: 
 Interview transcription 
 Becoming immersed in the data 
 Developing a coding system 
 Linking codes into higher order categories, which may or may not lead to the 
subsequent development of new theory 
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Thematic analysis is an interpretative technique that can bring to light unabridged 
participant descriptions of their experience of MBSR, the analysis seeking to elicit 
and describe the nature of any underlying patterns that exist in the data. Thematic 
analysis allows for rich accounts from research participants to emerge via an iterative 
process of data coverage and analysis. In thematic analysis, no explicit attempt is 
made to interpret findings in their element, but the accumulation of recurrent patterns 
and themes can become obvious via the wide coverage of the data that this technique 
allows [210]. No attempt need be made to generate new theory, and phenomena 
unearthed can be applied across varied epistemological and ontological perspectives.  
The thematic analysis in this thesis was also guided by the Framework Approach 
[211]. The framework approach augmented and bolstered the rigour of the thematic 
analysis, by ensuring the iterative, yet non-linear process was systematic, transparent, 
and open to audit, whereby the linkages between different stages of the process and 
the emergent themes generated could subsequently be ‘laid bare’ and open to critical 
scrutiny [211] (see Chapter 7 for full details of the thematic analysis).  
3.2.5 Determining the implementability of a MBI for people 
with MS. 
The MRC guidance [19] recommends that implementation should feature in the 
researcher’s thoughts from an early stage, considering potential barriers and 
facilitators to the uptake and engagement with the intervention, before moving on to a 
definitive phase-3 study. The MRC guidance [19] suggests that this should take 
account of views from the broad range of stakeholders likely to be involved in any 
eventual use of the intervention. 
The MRC guidance [19] suggests that implementation may include, amongst other 
things, dissemination, or publication of findings, surveillance, monitoring, and long-
term follow-up. Implementation necessarily involves decision makers, and as such, 
study findings and results have to be easily accessible and interpretable, with coherent 
recommendations presented in sufficient detail. The MRC guidance [19] suggests that 
costs, benefits, and harms are all necessary pieces of information and that policy 
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makers should have easy access to these when making more general 
recommendations for implementation.  
Moving the study from the research setting into more general implementation in 
routine clinical practice is unlikely to be a straightforward process. The MRC 
guidance [19] suggests that an understanding and description of any necessary 
behavioral changes may be required. Furthermore, the guidance suggests that even if 
an intervention becomes established in routine practice i.e. ‘normalised’, evaluation 
should continue at that point and beyond, with care being taken to assess for any 
longer-term effects that may not have been identifiable earlier in the evaluation. This 
highlights again the benefits associated with the iterative nature of the process, and 
the importance of good planning. 
Nilson [212] defines implementation science as: ‘the scientific study of methods to 
promote the systematic uptake of research findings and other evidence-based 
practices into routine practice to improve the quality and effectiveness of health 
services and care’. In this context, implementation is seen as part of a continuum of 
‘diffusion-dissemination-implementation’, where diffusion is the passive spread of 
innovative practices, dissemination active, and implementation about how new 
practices become integrated in novel contexts/settings.  
The MRC guidance [19] suggests that implementation should be theory-based, and 
Nilsen [212] warns that when implementation research has a poor theoretical basis, 
understanding how/why processes succeed or fail is hampered. Having limited insight 
into what factors impede, or promote successful implementation limits the likelihood 
of future success [212]. Theories can have an advantage over the simple application 
of ‘common-sense’ or an ‘educated guess’, in that theories are explicit, can be openly 
scrutinised, used/not depending on applicability to the research question(s) at hand, 
and provide a context for findings. On the other hand, care has to be taken not to 
apply theory blindly, to ‘shoe-horn’ data to fit where really it does not, and rigid 
application of theory may serve to hinder the development of new knowledge [212]. 
Nilsen [212] suggests that implementation theories cover three broad domains:  
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1) Process models – guiding the translation of research into practice 
2) Implementation theories, classic theories, and determinant frameworks 
– which aim to understand and/or explain what variables impact on 
implementation outcomes 
3) Evaluation frameworks – which are designed to assess implementation. 
In this thesis, NPT was chosen for the parallel process evaluation as a means of 
assessing implementability. The reasons for choosing NPT were that it was a research 
tool designed for studying the implementation of complex interventions in healthcare 
settings [213], it was suggested by the MRC guidance [19] as an appropriate 
implementation tool in this context, it had been widely studied in this context, and one 
of the researcher’s supervisors (Professor Frances Mair) was an expert in its use.  
NPT is a sociologically-derived action theory for analysing how social processes i.e. 
complex interventions are enacted by people implementing new practices [206]. It can 
be used in feasibility work, mapping the individual, collective, and resource 
challenges that may be encountered introducing novel complex interventions [206].  
For any new complex intervention, May [214] suggests that health service decision 
makers require to appraise and assess its ‘workability, clinical- and cost-
effectiveness’, and also its ability to ‘integrate’ into existing/new paradigms and 
professional practice, such as service delivery, organisation, and quality improvement. 
NPT sets out to delineate facilitators and barriers to the process of implementation, 
and also allows for estimations regarding likely incorporation into routine practice 
(see Chapter 7 for full details of the NPT analysis). 
NPT proposes that four key domains of behavior should be assessed [214]:  
1) Coherence - This refers to sense-making amongst stakeholders, 
individually and collectively, when charged with operationalising a new 
set of practices 
2) Cognitive participation - This assesses the relational work that 
stakeholders undertake to create and sustain a community of practice 
around a new intervention  
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3) Collective action – This refers to the operational work that stakeholders 
have to do in order to enact the practices of the new intervention 
4) Reflexive monitoring – This refers to ongoing appraisal and assessment of 
how the new practices impact on the stakeholders, and those around them. 
Combining a NPT analysis with findings from the thematic analysis had advantages 
[206], as the two approaches addressed different aspects of the qualitative data. Using 
NPT was about making sense of collective and distributed patterns of work, and 
specifically not about individual intentions and perceptions [206]. In contrast, 
thematic analysis was about exploring individual perspectives [210]. Further, thematic 
analysis was seen as a means to extract participant views directly from participants in 
a format minimally removed from their raw expression, whilst NPT was applied as an 
integrative theoretical framework to inform conceptualisation of the thematically 
analysed data [206]. 
NPT can be applied flexibly to managing qualitative data, or modified in vivo, to suit 
the ecology of the data and context of the intervention setting [206]. It is not a 
prescriptive protocol, and can be used in both ‘positivist’ and ‘constructivist’ 
paradigms, which is useful in mixed-methods research [206]. NPT can be used at 
various points in the research process. In this thesis, NPT was used initially to inform 
the design of the semi-structured interview questions, then again at a later stage, as a 
theoretical ‘lens’ through which to conceptualise the emergent themes. During this 
process the researcher had to keep in mind the possibility that the data might not fit 
neatly under a NPT ‘lens’. To guard against this, the thematic analysis was conducted 
first, and then the initial analysis was conceptualised using NPT. In this way 
inappropriate ‘shoehorning’ of qualitative data was avoided and the researcher could 
incorporate data that might not fall within the NPT framework.  
NPT suggests that successful implementation depends upon coherent and organised, 
dynamic and contingent interactions between stakeholders, over time [215]. The term 
‘interactional workability’ describes how well individuals come together to make the 
intervention work. ‘Relational integration’ describes how a complex intervention 
becomes translated from theory into practice, through individual and collective 
responsibility being assumed by stakeholders to drive forward its successful 
integration. ‘Skill-set workability’ assesses how the necessary work required to 
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implement the intervention is divided up amongst the stakeholders, and can thus be 
useful for identifying gaps in the skill set. ‘Contextual integration’ describes how well 
the intervention fits into the context in which it is being implemented, and includes 
consideration of resourcing and on-going evaluation.  
3.2.6 Interpreting and reporting findings, and thinking about 
next steps 
The MRC guidance [19] suggests that optimising an intervention is an iterative 
process of testing an approach, reviewing process outcomes, and modifying on the 
basis of these (see Chapter 8 for full details of how findings from the five previous 
research steps could be used to optimise MBSR for people with MS).  
Campbell et al. [216] suggest the following as key tasks in optimisation work: 
 Identification of the key processes and outcomes 
 Identification of mechanisms that lead to improved outcomes 
 Identification of possible rate-limiting steps/barriers preventing 
intervention 
 Quantification of potential benefit and estimated likely ESs 
 Refining the target group, based on the likelihood of responding 
 Defining the optimum combination of intervention content and dose. 
Important pragmatic considerations in optimisation work relate to ‘internal validity’. 
For example, making necessary modifications to an intervention, even if ‘minor’, can 
raise important questions about whether the intervention is still a MBI. Similarly, 
from the perspective of ‘external validity’, important questions have to be asked about 
reproducibility e.g. do the same modifications made in this study need to be made in 
all subsequent settings to make the intervention externally valid? These questions can 
be difficult to answer with much certainty, and serve to highlight once again the 
importance of the iterative nature of the development and evaluation process [19].  
When considering treatment fidelity in behavioural interventions, unplanned variation 
should ideally be limited [178]. In this study, the MBSR instructors were experienced 
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physicians and appropriately qualified mindfulness facilitators [217], but had never 
delivered the intervention to people exclusively with MS. Further, there was a high 
chance that many of the participants in the study would be quite disabled. Collecting 
qualitative data in these circumstances served to illuminate how such factors could 
impact on intervention delivery, and thus inform design and delivery of future courses 
in this context.  
Another important consideration in optimisation work is optimising outcome 
measurement. For example, in feasibility testing it may become clear that there are 
too many measures, too few, that those chosen do not adequately capture the type of 
data which the research questions are seeking, or do not measure other important 
outcomes that only become apparent from qualitative participant feedback. Even with 
meticulous planning, this type of information may become apparent only through 
‘trial and error’ [19].  
3.3 Summary 
This chapter has outlined the methods chosen for this thesis and the rationale for this 
choice. Methods are based on the suggestions of the MRC guidance [19] for 
developing and evaluating complex interventions to improve health. The next five 
chapters will describe the research process for each of these areas in detail, discuss the 
research findings, their implications, and suggest further steps for future research.
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Chapter 4 Comorbidity in multiple sclerosis 
4.1 Summary 
This chapter describes the prevalence of comorbidity in people with MS from a 
nationally representative cross-sectional primary care database from Scotland. It starts 
by introducing what is known about comorbidity in MS, and describes key existing 
published studies on this topic. It then describes the methods used for the database 
analysis. Results are presented for people with MS versus age, sex, and deprivation 
matched controls. Following this, results are discussed in the context of the existing 
literature and knowledge gaps, before finishing with suggestions for future research. 
4.2 Background 
Research suggests that people with MS have reduced health-related QOL, and that in 
those with comorbidities this may be considerably worse [218, 219], with conditions 
such as fatigue, anxiety, and depression potentially synergistic in reducing QOL [9, 
73]. Scores for QOL are lower in people with MS than in other LTCs, such as 
inflammatory bowel, musculoskeletal, and respiratory diseases [73, 220]. In people 
with MS, the impact of comorbidity on physical health-related QOL seems to impact 
more strongly on those who are more disabled. There appears to be a dose-response 
relationship, where greater number of comorbidities is associated with a progressive 
decline in QOL [220], although this has not been a uniform finding [180]. It has been 
suggested that some of the emerging MS pharmacological treatments may increase 
the risk of developing comorbidities, and that new therapies targeting improved QOL 
in people with MS should routinely take into account comorbidities as a matter-of-
course, with a view to diminishing their deleterious impact [221]. 
Comorbidity is known to be associated with diminished functional ability in chronic 
diseases, being associated with a more rapid deterioration in Alzheimer’s Disease 
[222], and with higher levels of mortality in many chronic conditions, including 
Parkinson’s Disease [223]. In people with MS, comorbidity may adversely affect time 
to primary diagnosis, potentially by ‘obscuring’ the underlying pathology, where 
symptoms are attributed in error to another condition [224]. Such diagnostic delay is 
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particularly likely amongst male patients, smokers, those with comorbid mental health 
conditions, and in those with comorbid physical health conditions (vascular, auto-
immune, musculoskeletal, gastrointestinal, visual, and obesity) [224]. The presence of 
comorbidity at the time of initial diagnosis is also associated with increased disability 
levels [224]. Comorbidity in MS is linked with increased hospital admissions [225], a 
higher number of CNS lesions on MRI measurement [226], and an increased 
mortality risk, particularly in those with comorbid depression [227]. 
4.2.1 Studies of comorbidity in MS 
Marrie et al. [9, 228] reported findings from a national database in the USA, covering 
8,983 individuals with MS, 34 conditions, and socio-demographic data. This included 
30 physical comorbidities, and four mental comorbidities [9, 228]. Mental health 
problems were common in this study (48%, n=4,264) in all age groups and at all 
stages of disease progression. This ranged from 48.1% in those with a classification of 
‘mild’ disability, to 56.4% in those with ‘moderate’ disability, and 46% in those with 
‘severe’ disability levels [9]. Anxiety and depression were the most prevalent (19.5% 
and 43.9%, respectively, as compared to 16.6% and 16.2% in the US population in 
general). Women were 1.5 times more likely to be affected by depression than men, 
patients in their mid-forties were 1.5 times more likely to be diagnosed with 
depression than those over sixty, and those in the lowest income bracket were twice as 
likely to have depression than those in the highest. Overall, reporting a mental health 
comorbidity was more common amongst those of lower SES, in keeping with 
previous findings for the general population in the USA, although this trend did not 
reach statistical significance [9, 229]. 
The same study [228] found that physical comorbidities were more prevalent in male 
patients, African Americans, those of increasing age (over sixty years), and those of 
lower SES. Overall, 77.1% of respondents (of both genders) reported having one or 
more physical comorbidities, of which 25.6% had two, and 44.1% had three. The 
most frequent physical comorbidities were hypercholesterolaemia, hypertension, 
arthritis, irritable bowel, and lung disease. Half of the respondents were overweight, 
and of them, half were obese. Vascular comorbidities i.e. hypercholesterolaemia, 
hypertension, heart disease, diabetes, and peripheral vascular disease were common 
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(>50%). Almost 16% of all respondents had two or more vascular diagnoses, 4% had 
three, and 1% had four or more [228]. Such conditions have since been shown to 
increase disability progression greatly [230].  
In Canada, Warren et al. [180] studied data from the Canadian Community Health 
Survey, reporting on 21 self-report comorbidities amongst a sample of 335 people 
with MS, described as nationally representative, though this seems unlikely on such a 
small sample. The mean number of comorbidities was 1.6, with up to 10% reporting 
in excess of eight other chronic conditions. This study reinforced the relationship 
between comorbidity and impaired health-related QOL, and also demonstrated that 
lower SES was an important compounding variable, with lower levels of education, 
and being in receipt of social support contributing significantly to reduced QOL. 
In Taiwan, Kang et al. [231] described prevalence of comorbidity in MS from 30 
conditions, derived from 989 patients who were compared against 4,490 non-MS 
controls. Data were taken from a national health insurance administrative research 
database. They described higher levels of various medical (autoimmune, endocrine, 
gastrointestinal, haematological, infectious, neurological, oncological, pulmonary, 
and renal) and psychiatric conditions (dementia, depression, psychoses) in people 
with MS.  
Aside from the three studies listed above, the majority of studies of comorbidity in 
MS focus on small numbers of conditions, often with a particular disease focus (such 
as cardiovascular or autoimmune conditions), and originate mainly from Caucasian 
populations in Europe and in North America [232-236].  
Scotland has the highest prevalence rates for MS worldwide [24], yet no previous 
studies exist focusing explicitly on the subject of comorbidity. In the UK, MS care is 
delivered via a MDT approach, although it remains a ‘specialist’ condition with a 
Consultant Neurologist usually taking the lead in patient care [44]. The primary role 
of the specialist is to manage the individual condition, but the GP also has a very 
important role, and holds a comprehensive electronic medical record. Data such as 
this can be used as a means of studying comorbidity in people with MS. 
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4.3 Methods 
The aim of this study was to measure comorbidity in people with MS in Scotland by 
characterising the number and type of conditions compared with the general 
population. 
The study used a dataset supplied by the Primary Care Clinical Informatics Unit, 
University of Aberdeen, UK. The dataset was created as part of national programme 
of research into multimorbidity, and anonymysed use has been approved by the UK 
NHS National Research Ethics Service [165]. The dataset contains information that 
was extracted in April 2007 on a total of 1,751,841 individual patients (around 1/3 of 
the Scottish population) from 314 general practices around Scotland. It is nationally 
representative in terms of age, sex, and deprivation [165]. All general practices in 
Scotland use electronic patient records, and have done so since the early 1990s. 
Electronic records are used for practice list management, recording of prescribing, 
recording of morbidities via a standard system of Read Codes by the Health and 
Social Care Information Centre (HSCIC - 
http://systems.hscic.gov.uk/data/uktc/readcodes/) and by the NHS Information 
Services Division (ISD) http://www.isdscotland.org/Health-Topics/General-
Practice/GP-Consultations/Grouping-clinical-codes.asp ). 
The dataset holds information on 40 comorbidities, which were chosen for use based 
upon recent systematic review guidance on multimorbidity (n=11), conditions 
included in the UK GP Quality and Outcomes Framework (QOF) (n=16), and those 
specified as important for health services planning by NHS Scotland (n=26) [165]. In 
this dataset, MS has been defined as the presence of a Read Code ever being recorded 
for the condition. The code set was designed by the NHS ISD for Scotland. Of the 
remaining 39 morbidities, eight are mental health conditions and 31 are physical 
health conditions, and are based on Read Code recording by a clinician in the 
electronic patient record, or have been derived from prescribing data [165] – for more 
details regarding Read Code definitions see Appendix B.  
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For the purposes of this present study, the analysis was restricted to those aged over 
25 years (n=1,268,859), as the number of individuals with a diagnosis of MS who are 
under 25 years of age was extremely low. 
4.3.1 Statistical analysis 
The main focus of the analysis was descriptive, comparing comorbidity in people with 
MS against those without. ‘T’ tests were employed as a means of examining 
differences between the mean numbers of morbidities, whilst Chi-squared tests 
examined for differences in percentages of individuals with comorbidities across 
variables [167]. 
Binary multivariate logistic regression was employed to examine for associations 
between comorbidities in those with MS versus those without, controlling for age, 
sex, and SES (measured by Carstairs score – [237]).  
4.4 Results 
Amongst the 1,268,859 individuals included in the analysis, 3,826 (0.3%; 95%CI 
0.29-0.31) had a diagnosis of MS, and of these 2,767 (72.3%) were of female sex. 
Those with MS were slightly older on average, when compared to the general 
population (mean age 53.4 years, versus 51.2 years; p<0.001). Those with MS were 
slightly less deprived than the general population (mean -0.64 against -0.22; p<0.001) 
(Table 4.1).  
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Table  4.1 General sample characteristics, people with MS versus controls 
 
 MS (>25yrs) 
n (%) 
Non-MS (>25yrs) 
n (%) 
Significance p 
Total 3,826 1,268,859  
Gender (% female) 2,767 (72.3) 647,836 (51.1) p<0.0001* 
Mean age (SD) 53.4 (12.8) 51.2 (16.6) p<0.0001* 
Mean deprivation 
(SD) 
-0.64 (3.0) -0.2 (3.3) p<0.0001* 
Age group    
25-44 1018 (26.6) 507371 (40.0) p<0.0001* 
45-64 2083 (54.4) 471044 (37.1) p<0.0001* 
65-84 685 (17.9) 253915 (20.0) p<0.001* 
85+ 40 (1.0) 36529 (2.9) p<0.0001* 
Deprivation 
Quintile  
   
Q1 least deprived 813 (21.2) 243545 (19.2) p<0.001* 
Q2 889 (23.2) 274878 (21.7) p<0.01* 
Q3 913 (23.9) 289037 (22.8) p=0.06 
Q4 687 (18.0) 241207 (19.0) P<0.05* 
Q5 most deprived 524 (13.7) 220192 (17.4) p<0.0001* 
* Statistically significant ‘p’ value 
People with MS were significantly more likely to have more than one other chronic 
condition, following adjustment for age, sex, and deprivation (OR 2.44; 95% CI 2.26-
2.64) (Table 4.2). 
Table  4.2 Comorbidity prevalence and type in people with and without MS 
*Odds Ratios adjusted for Age, Sex and Deprivation Scores. 
 MS n (%) Non-MS n (%) OR* (95% CI)  
Significance p 
No comorbidity 1,027 (26.8) 597,363 (47.1) 0.20 (0.18-0.22) 
p<0.001* 
One  2,799 (73.2) 671,496 (52.9) 2.44 (2.26-2.64) 
p<0.0001* 
Two 714 (18.7) 159,293 (12.6) 1.49 (1.38-1.62) 
p<0.0001* 
Three 546 (14.3) 97,368 (7.7) 1.86 (1.69-2.04) 
p<0.0001* 
Four or more 669 (17.5) 136,847 (10.8) 1.61 (1.47-1.77) 
p<0.0001* 
Any physical 
comorbidity 
2,475 (64.7) 600,669 (47.3) 2.05 (1.90-2.21) 
p<0.0001* 
Any mental health 
comorbidity 
1,541 (40.3) 227,361 (17.9) 2.94 (2.75-3.14) 
p<0.0001* 
* Statistically significant ‘p’ value 
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No differences were found between males and females with MS when considering 
age, deprivation, or total comorbidity count. However, mental comorbidity was 
significantly more likely amongst women with MS (OR 1.26; 95% CI 1.09-1.46) 
(Table 4.3). 
Table  4.3 Gender differences in co-morbidity in people with MS 
*Odds ratios adjusted for Age and Deprivation scores 
Physical Conditions 
(Including MS) 
MS Population Characteristics 
Female 
n (%) 
Male 
n (%) 
OR* (95%CI) 
Significance p 
2+ 1801(64.6) 678 (63.7) 1.07 (0.91 1.25) 
p=0.37 
3+ 1021 (36.6) 401 (37.7) 0.98 (0.84 1.14) 
p=0.55 
Mental Conditions    
At least 1 1156 (41.8) 385 (36.4) 1.26 (1.09 1.46) 
p<0.05* 
2+ 112 (4.0) 55 (5.2) 1.02 (0.91 1.13) 
p=0.69 
* Statistically significant ‘p’ value 
Higher levels of chronic conditions were recorded for people with MS, after 
controlling for age, sex and deprivation (OR 2.44; 95%CI 2.26-2.64), and in particular 
for mental health comorbidity (OR 2.94; 95%CI 2.75-3.14). Those with MS were 
more likely to have one other (OR 2.44; 95%CI 2.26-2.64), two others (OR 1.49; 
95%CI 1.38-1.62), three others (OR 1.86; 95% CI 1.69-2.04), or four or more other 
non-MS conditions than those unaffected by MS (OR 1.61; 95%CI 1.47-1.77) (Table 
4.2). As the number of physical morbidities rose, both males and females with MS 
had consistently higher levels of mental health comorbidity than the general 
population (Figure 4.1) 
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Figure  4.1 Association between number of physical conditions and presence of any 
mental health condition 
 
 
4.4.1 Mental health comorbidity in people with MS 
After adjustment for age, sex, and deprivation, prevalence was higher for four of the 
eight mental conditions examined for amongst those with MS (Figure 4.2); the highest 
being depression (OR 3.33; 95%CI 3.10-3.57), then anxiety (OR 3.18; 95%CI 2.89-
3.50), and then drug misuse (OR 2.03; 95%CI 1.77-2.32). Prevalence was also higher 
for a diagnosis of an eating disorder (OR 1.72; 95%CI 1.20-2.45), but the numbers 
included in this group were small (n=31). Schizophrenia/bipolar (OR 1.07; 95%CI 
0.78-1.47) and learning disability (OR 0.66; 95%CI 0.33-1.32) were not significantly 
different between those with MS and controls, but dementia (OR 0.66; 95%CI 0.47-
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0.94) and alcohol misuse (OR 0.68; 95%CI 0.54-0.87) were both significantly less 
common in those with MS as compared to the general population. 
Figure  4.2 Odds ratios for individual mental health conditions: people with MS versus 
controls 
 
Note on abbreviations [12]: Depression = Read code recorded in last 12 months OR ≥4 anti-depressant 
prescriptions (excluding low dose tricyclics) in last 12 months; Anxiety = Anxiety & other neurotic, stress related 
& somatoform disorders, Read code in last 12 months OR ≥ 4 anxiolytic/hypnotic prescriptions in last 12 months 
OR ≥4 10/25mg amitriptyline in last 12 months & do not meet the criteria for .‘Pain.’; Drugs Misuse = Other 
psychoactive substance misuse; Eating Disorder = Anorexia or Bulimia; Bipolar/Schizo = Schizophrenia (and 
related non-organic psychosis) or bipolar disorder, Read code ever recorded/recorded in last 12 months (code 
dependent) OR Lithium prescribed in last 168 days.  
4.4.2 Physical health comorbidity in people with MS 
Of the thirty other physical conditions included in the analysis, the prevalence was 
higher amongst those with MS for 10 conditions, no different for nine, but lower for 
11 (Figure 4.3). 
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Figure  4.3 Odds ratios for individual physical health conditions: people with MS versus 
controls 
 
 
Note on abbreviations [12]: Constipation = ≥4 laxative prescriptions in last year; Pain = ≥4 prescription only 
medicine analgesic prescriptions in last 12 months OR ≥4 specified anti-epileptics in the absence of an epilepsy 
Read code in last 12 months; Migraine = ≥4 prescription only medicine anti-migraine prescriptions in last year; 
Epilepsy = Read code ever recorded AND antiepileptic prescription in last 12 months; IBS = Read code ever 
recorded OR ≥ 4 prescription only medicine antispasmodic prescription in last 12 months; Parkinson’s Disease= 
Parkinson’s Disease and Parkinsonism; Psoriasis or Eczema = Read code ever recorded AND ≥ 4 related 
prescriptions in last 12 months (excluding simple emollients) Dyspepsia = ≥ 4 prescriptions in last 12 months 
excluding antacids AND NOT (≥4 NSAIDS OR ≥4 aspirin/clopidogrel) IBD = inflammatory bowel disease; PVD = 
Peripheral vascular disease;  Stroke = Stroke and Transient ischaemic attack; COPD = Chronic obstructive 
pulmonary disease;  CKD = Chronic kidney disease;  Inflammatory Arthritis = Rheumatoid arthritis, other 
inflammatory polyarthropathies & systematic connective tissue disorders;  Asthma = Read code ever recorded 
AND any prescription in last 12 months 
The highest prevalence was recorded in those with MS (versus controls) for 
constipation (OR 6.61; 95%CI 6.00-7.27), followed by visual impairment (OR 4.06; 
95%CI 3.33-4.96), chronic pain (OR 3.43; 95%CI 3.18-3.70), migraine (OR 2.38; 
95%CI 1.91-2.97), and then epilepsy (OR 2.20; 95%CI 1.74-2.77). On the other hand, 
prevalence was significantly lower amongst those with MS for most of the 
cardiovascular conditions, including atrial fibrillation (OR 0.49; 95%CI 0.36-0.67), 
chronic kidney disease (OR 0.51; 95%CI 0.40-0.65), heart failure (OR 0.62; 95%CI 
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0.45-0.85), coronary heart disease (OR 0.64; 95%CI 0.52-0.71), and hypertension 
(OR 0.65; 95%CI 0.59-0.72). 
4.5 Discussion 
4.5.1 Key findings 
The present study examined physical and mental health comorbidity in people with 
MS in a large primary care clinical dataset, and has shown that having additional 
LTCs is commonplace amongst this group. Mental health comorbidity was 
particularly common and this association increased in a linear fashion as the number 
of physical comorbidities increased. Females were statistically significantly more 
likely to have mental health comorbidity that men with MS. Cardiovascular 
comorbidities were notably low in prevalence. 
4.5.2 Comparison with literature 
This present study demonstrated that mental health comorbidities (anxiety and 
depression in particular) were almost three times more common in those with MS, as 
compared to the general population. These levels are comparable to those reported by 
other researchers in the USA and Ireland [9, 238], and to findings from a recent 
systematic review examining global prevalence rates [51]. This current study found a 
higher prevalence of mental health comorbidities in women with MS. Recently, 
another UK-based study, which examined a cross-sectional web-based self-report 
database (n with MS = 7,786) [239], reported significantly higher anxiety scores on 
the Hospital Anxiety and Depression Scale (HADS) for women with RRMS versus 
men with the same phenotype. Similarly, a recent retrospective database analysis of 
North American patients with MS (n with MS = 711) found that anxiety was more 
prevalent in female patients, but depression was not significantly different between 
the sexes [240]. However, an older population-based survey from Canada (n with MS 
= 322) suggested a higher prevalence of depression in females [241], whilst a 
Portuguese cross-sectional study (n with MS = 325) found that female MS patients 
scored higher than male patients on both anxiety and depression scales on the HADS 
[242]. Other studies have not found any significant differences in mental health 
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comorbidities between the sexes in MS patients [243, 244]. In the general Scottish 
population, however, mixed physical-mental comorbidity is known to be more 
prevalent in women [245]. 
Both anxiety and depression are associated with greater levels of suicidality in those 
with MS, whilst depression is linked to reduced health-related QOL and is in itself a 
noted predictor of increased morbidity and mortality [5, 57]. Amongst those with MS, 
anxiety is known to increase following initial diagnosis. It may be particularly 
problematic and is more prevalent in females [57, 240]. Anxiety can predispose to 
increased social difficulties, higher levels of somatic complaints [246], and higher 
usage of alcohol [57]. Depression is poorly understood in MS. The suggestion has 
been made that depression could relate to the underlying neuro-inflammatory process 
[247, 248]. This could fit with the proposed auto-immune aetiology in MS [248], but 
it is important to note that depression is a common finding in many physical diseases 
[249], and it remains likely that multiple factors contribute to depression in those with 
MS.  
The prevalence of bipolar disorder (BPD) was not significantly different between 
those with MS and controls in this study. Recent research suggests an increased 
prevalence of the condition amongst those with MS [250]. A growing literature 
around the world suggests that BPD may in fact be frequently misdiagnosed in the 
primary care setting as major depressive disorder (MDD) [251, 252], which has 
implications for treatment, as antidepressants, which are a key treatment in MDD, can 
actually make BPD worse, and untreated BPD is associated with high rates of suicide 
[250]. 
Comorbidity of physical health conditions was present in almost two thirds of those 
with MS in this study, being twice as likely when compared to the general population 
(after controlling for age, sex, and deprivation). Nervous system comorbidities were 
notably prevalent, with chronic pain, migraine, and epilepsy all being over two times 
as likely amongst those with MS. These findings are in accord with those in the 
existing literature, with Koch et al. [253] reporting seizures being present in up to 
8.3% of those with MS, and Marrie et al. [254] reporting global prevalence estimates 
for epilepsy in MS at 3.1% (versus 1.9% in the present study). Kratz et al. [255] 
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reported rates for chronic pain of up to 50% in people with MS. Chronic pain can 
directly impact levels of psychological morbidity, diminish health-related QOL, 
increase disability, and drive up health service utilisation [255]. Migraine has also 
been reported as more prevalent amongst those with MS [256], although it is 
important to note that there may be some overlap in terms of pathology between the 
conditions, with cortical spreading depression (a putative pathological mechanism 
underlying migraine –[257]) thought to be enhanced by cortical demyelination [256]. 
Visual impairment was more than four times as likely in those with MS in this present 
study, in keeping with similar studies in this area [258]. This probably represents 
optic neuritis, a common problem amongst those with MS, and a condition with 
implications for lasting visual function and health-related QOL [258]. Indeed, 
qualitative studies have found that from the range of possible disabilities ensuing as 
MS progresses, patients tend to report that loss of visual function and diminished 
ambulatory ability matter most [21]. 
This present study also found that certain gastrointestinal conditions (constipation, 
dyspepsia, irritable bowel syndrome - IBS) stand out as more common amongst those 
with MS. Similarly high levels of IBS were reported in a recent systematic review by 
Marrie et al. [259]. It is possible that these findings may relate to neurogenic bowel 
dysfunction, known to be common in people with MS [260], raising the question 
whether such comorbidities are distinct disease entities, or whether they in fact relate 
directly to MS disease activity. 
An unexpected finding in this current study was that of lower recorded cardiovascular 
conditions amongst the MS population, when compared to controls, particularly 
surprising given that the sample is nationally representative for the Scottish 
population. As previously noted, cardiovascular pathologies represent a potentially 
important group of comorbidities in people with MS. Cardiovascular disease can 
increase disability and mortality in this group [227, 230] and, as in non-MS patients, 
may have detrimental effects on brain mass and function [261, 262]. Recent 
systematic review evidence suggests that those with MS are more likely to be 
diagnosed with cardiovascular comorbidities [263]. The exact reasons remain unclear 
at present, and the review authors point out that traditional cardiovascular risk factors 
(diabetes, dyslipidaemia, hypertension, obesity) are not so easily identifiable as 
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causative amongst those with MS. Inflammation may play a pathological role in both 
MS and these cardiovascular conditions [263], but the immune profile in MS is very 
complex, limiting comparisons [38, 94]. 
As noted above, certain physical conditions were found to be particularly prevalent in 
the present study, and whether this relates to the direct consequences of MS disease 
activity, its treatment, or other mechanisms remains unclear. It is possible that 
common pathologies may co-exist in MS and other chronic conditions, such as 
chronic inflammation [264]. The low level of cardiovascular conditions is also 
notable, but resonates with findings from Smith et al. [265], who used the same 
database, and reported similar findings amongst those affected with schizophrenia and 
BPD. This might suggest that there is under-diagnosis of cardiovascular comorbidities 
in the primary care setting in such chronic conditions. With respect to MS, it is not 
clear why this is the case. It seems unlikely to result from less contact with primary 
care [87, 266]. Another explanation may relate to the diagnostic and prognostic 
difficulty associated with the condition, where the significance of new symptoms can 
be challenging for clinicians [87]. MS patients may be at various stages of disease 
progression, and early in the condition there may be little perceived need for contact 
with primary care, or a neurologist [87]. Very little is known about whether 
cardiovascular comorbidities might present differently in people with MS, but in 
general, comorbidity in this population is associated with diagnostic delay, and 
reduced treatment adherence [267]. As intervention is likely to be beneficial, it seems 
important that clinicians adopt a vigilant approach to cardiovascular risk factors when 
caring for patients with MS. 
4.5.3 Strengths and limitations 
A strength of the current study is the large, nationally representative dataset used, 
from the country with the highest prevalence of MS worldwide. It included a wide 
range of conditions, including both mental and physical, with data on age, gender, and 
deprivation (as estimated from postcode). 
Weaknesses included the fact that the dataset was not designed specifically for MS 
research. It did not have information on disease duration and also did not specify 
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whether comorbidities pre-dated the diagnosis of MS, or whether comorbidity 
diagnoses increased/decreased after MS diagnosis. The cross-sectional nature of the 
dataset meant that associations could be drawn, but causal inferences could not. 
Further work using prospective cohort data would be important in trying to seek 
temporal relationships. As per other routine data analyses, the dataset is dependent on 
the recording quality by front-line clinicians, which may vary. Data recording in 
General Practice in the UK is thought to be good, but as Khan et al. [268] note in a 
recent systematic review, the positive predictive value (PPV) for a MS Read Code is 
limited to around 0.60, meaning that there is a distinct possibility that some of the 
people included in this analysis may not actually have MS. A further limitation is that 
recorded rates for anxiety and depression in the database used in this study may be an 
underestimate of true prevalence, given that only around a third of community 
populations seek help for these conditions in primary care [269] and a recent trend has 
been noted for UK GPs increasingly to record symptom codes rather than diagnostic 
codes [270, 271]. In this study, coding for anxiety and depression were based on Read 
Code recording plus prescribing data (Appendix B). Reasons for not recording 
diagnostic codes in primary care are known to include spontaneous symptom 
resolution, patients presenting with primarily physical symptoms, and stigma [272]. 
John et al. [273] recently assessed sensitivity, specificity and PPV for common mental 
disorders in the General Practice Research Database (GPRD) using various 
algorithms and the Mental Health Inventory-5 (MHI-5) as a ‘gold-standard’ 
diagnostic tool. They found that a Read Code indicating a historical diagnosis of 
depression or anxiety (over a ten year period) plus a current diagnosis (treated or 
untreated) had a specificity of 0.96, a sensitivity of 0.29, and a PPV of 0.76, and that 
adding in current symptoms codes rendered little change to specificity (0.95) and PPV 
(0.74), but facilitated a slight increase in sensitivity to 0.32. Nine percent of false 
negatives had current symptom codes, and in general were more likely to have 
chronic pain (71%) or other chronic comorbid conditions (50%). Read codes are 
generally more accurate in chronic conditions, and largely considered as being well 
recorded in practice, but in some cases may reflect ‘activity’ with a patient, rather 
than application of a diagnosis per se [268]. The fact that prescribing data was used 
for the generation of certain comorbidities is also a limitation, in that some drugs have 
unlicensed, or non-standard uses that may well feature amongst those with MS – for 
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example the use of analgesics or anti-convulsant medication for spasticity 
management, and this may have led to some misclassification. 
The comorbidities included in the database come from General Practice and 
prescribing data, and in the specific case of MS, some of these may actually represent 
so-called ‘concordant conditions’ i.e. may represent aspects of the same pathological 
risk profile, and possibly the same disease management schedule [274]. This concept 
is not well described in the research literature for MS, and may form an important 
avenue for future enquiry. For example, differentiating whether a condition is an 
entity distinct from MS, or is a complication of MS can influence treatment decisions. 
If a comorbid condition unrelated to MS pathology leads to worse outcomes, then 
treatment may focus on the comorbidity, but if the condition is a result of MS disease 
activity, then focusing treatment on the underlying disorder (MS), as well as the 
condition makes sense.  
4.5.4 Implications for practice/policy/future research 
Clinicians and researchers alike should be aware that comorbidity is common in 
people with MS. This is particularly true for mental health comorbidity, where an 
association increases in line with the number of physical conditions present. Treating 
MS in isolation may fail to address this burden, which can be a stressful experience 
for people with the condition. Future research could focus on the development of 
integrative treatment strategies that acknowledge this difficulty and contribute to 
enhanced stress- and self-management skills.   
4.6 Conclusions 
This current study has confirmed that people with MS in Scotland commonly 
experience comorbidity, at much higher levels than amongst those in the general 
population. Certain conditions were found to be much more likely to be present in 
those with MS. Among mental health conditions, anxiety and depression were 
particularly common. Amongst physical conditions, nervous system and 
gastrointestinal comorbidities predominated. Cardiovascular conditions were less 
common in those with MS, but this could be due to decreased case finding in those 
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with MS and further research in this area is required. As per the general population, 
increasing numbers of physical conditions was associated with higher levels of mental 
health comorbidity, and this was more marked in those with MS. The consequences of 
mental health comorbidity in MS are largely unknown. This too deserves further 
scrutiny. Effective mental health treatments in MS seem necessary, and may require 
to be tailored to meet the specific needs of this group [275, 276]. 
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Chapter 5 A systematic review of mindfulness 
based interventions for people with multiple 
sclerosis 
5.1 Summary 
This chapter describes the findings from a systematic review of the evidence for 
effectiveness of MBIs in people with MS. A brief background summary focuses the 
reader on why this review was necessary, and then the methods used to perform the 
review are described. Following this, the results section presents data synthesised 
from randomised and controlled studies on the use of MBIs in people with MS. The 
main findings are then summarised, compared with the relevant literature, including 
those developments taking place since the review was completed. Finally, 
implications and suggestions for future research and practice are suggested.     
5.2 Background 
Self-management forms an important component of living with a diagnosis of MS, 
which can mean developing resilience towards distressing events, or adopting a 
flexible approach towards both symptoms and the trials and tribulations of daily life 
[277, 278]. Such adaptive changes may not come naturally to an individual, and as 
such a form of psycho-education may be required [3]. Traditional approaches in this 
regard often involve some form of CBT [11], or a more general composite of ‘advice’ 
from experienced clinicians, fellow patients, or support groups [44]. However, a 
standardised form of stress management designed to build distress tolerance and 
psychological flexibility is not routinely available to people with MS in the UK NHS. 
Mindfulness training for people with MS has been suggested as a means to ‘..enhance 
general features of coping with distress and disability in everyday life, as well as 
under more extraordinary conditions of serious disorder or stress.’ [279]. In certain 
adult populations living with LTCs, and also amongst healthy individuals, MBIs have 
shown promise for improving cognitive abilities, such as selective and executive 
attention, unfocussed sustained attention, memory and other executive functions [15, 
280]. As a health care intervention, mindfulness has been studied in a variety of 
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settings and in several different medical conditions [14, 16, 17, 154]. These studies 
have generally reported beneficial effects in relation to both physical and 
psychological symptoms (including stress), although quality issues are commonplace. 
Most studies have not been well designed, did not compare a MBI against an active 
control group, and did not report findings in line with suggested CONSORT criteria 
[159]. Where MBIs have been compared against active controls, findings suggest that 
MBIs are effective, but with effects comparable to other active interventions (such as 
CBT or antidepressants) [159]. A widespread consensus on the applicability and 
utility of MBIs in managing stress associated with LTCs has not been established.  
Systematic reviews and meta-analyses have shown MBIs to be efficacious in treating 
anxiety and recurrent depression [18, 281]; in people who have had a stroke – 
improving anxiety, depression, fatigue, and QOL [282]; and in somatisation disorders 
(such as fibromyalgia, CFS, IBS) for improving subjective fatigue, anxiety, 
depression, QOL and physical functioning [283]. MBIs have weaker benefits in 
people with chronic pain
 
[159, 284] and in people who are ‘stressed’ [159]. Despite 
many of these LTCs being relevant and/or sharing common features with symptoms 
experienced by people with MS, the use of MBIs in the MS population has not been 
widely studied.  
5.2.1 Why undertake a systematic review on mindfulness-
based interventions in people with MS? 
As described in Chapter 2, MS is thought to be a very stressful condition. As 
described in Chapter 4, MS is associated with high levels of comorbidity, which is 
believed to be stressful [49], and high levels of stress in the context of multimorbidity 
is associated with excess mortality [50]. People with MS value learning effective 
stress management techniques, but report that they are not always available [62]. 
Amongst psychological interventions for people with MS, CBT has the most evidence 
for effectiveness [10, 11, 120], but questions remain regarding lasting efficacy. This 
may be related to mechanisms of action [285], where CBT is thought to operate via 
predominantly ‘top-down’ mechanisms, with cognitive restructuring exerting an 
increase in inhibitory executive control over lower axis brain structures [286]. MBIs 
are proposed to work differently, with both ‘top-down’ cognitive and ‘bottom-up’ 
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somatic mechanisms suggested, alongside the added component of ‘meta-awareness’ 
[132], which may make them more effective than established CBT therapies (see 
Chapter 2 for more details regarding proposed mechanisms of action for MBIs).  
At the time of conducting this review, there were no published systematic reviews on 
the use of MBIs for people with MS. The aim of this study was to delineate the 
existing evidence for effectiveness of MBIs in people with MS by carrying out a 
systematic review. The specific research questions addressed in the review were: 
1) What effects, if any, do MBIs have on perceived stress in people with MS? 
2) What effects, if any, do MBIs have on mental and physical health in 
people with MS? 
3) What effects, if any, do MBIs have on QOL in people with MS? 
4) What evidence, if any, is there that MBIs are cost-effective in people with 
MS? 
5) What gaps are there in the literature concerning the effectiveness of MBIs 
in people with MS, across variables such as differing age, gender, 
ethnicity, SES, level and type of comorbidity?  
 
5.3 Methods 
5.3.1 Search strategy 
In May of 2013 a systematic search of both the published and unpublished empirical 
literature was undertaken via six key electronic bibliographic databases, including 
Allied and Complementary Medicine Database (AMED), CINAHL, Cochrane 
Register of Controlled Trials, EMBASE, MEDLINE, and PSYCHinfo. ProQuest 
Dissertation and Thesis Database was also searched and MS/mindfulness researchers 
were contacted, in order to identify any additional published/unpublished trials. 
Medical subject headings were selected and combined with key words pertaining to 
MS and mindfulness (Figure 5.1) to create a search strategy to be finalised for use in 
MEDLINE (being amended as required for use in the other databases). The search 
strategy employed appropriate controlled vocabulary, search symbols and Boolean 
operators. Dates searched (1980-2013), Language of reporting (English), and 
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Research Subjects (Human) served as delimiters. The search also extended to the 
Grey Literature, accessing the Science Citation Index, reference lists and citation 
searching from relevant published trials and reviews, and included making contact 
with experts in the field. All results were stored and managed via Endnote. 
Figure  5.1 Search history: OVIDsp - MEDLINE with Full Text 3/5/13 
 
S1. exp multiple sclerosis/ or exp multiple sclerosis, chronic progressive/ or exp multiple sclerosis, 
relapsing-remitting/ or exp neuromyelitis optica/ 
S2. limit S1 to (english language and humans and yr=”1980-current” 
S3. ("disseminated sclerosis" or "demyelinating disease" or devic or "acute disseminated 
encephalomyelitis" or "multiple sclerosis" or "neuromyelitis optica" or "optic neuritis" or "transverse 
myelitis").mp. [mp=title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept, rare disease supplementary concept, unique 
identifier] 
S4. limit S3 to (english language and humans and yr="1980 -Current")  
S5. exp Meditation/  
S6. limit S5 to (english language and humans and yr="1980 -Current") 
S7. ("breathing exercise$" or "breathing technique$" or mindful$ or meditat$ or relaxation or vipassana 
or yog$).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept, rare disease supplementary concept, unique identifier] 
S8. limit S7 to (english language and humans and yr="1980 -Current")  
S9. S2 or S4  
S10. S6 or S8  
S11. S9 and S10 
Articles: 278 
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5.3.2 Selection criteria 
Studies for inclusion were selected on the basis of the SPIO model (Study design, 
Participants, Interventions, and Outcomes), which is adapted from the PICOs model 
(Population, Interventions, Comparison, Outcomes) [287] (Table 5.1).  
Table  5.1 SPIO narrow screen inclusion/exclusion criteria 
 
 Inclusion criteria Exclusion criteria 
Study design Randomised controlled 
trial  
Controlled trial 
Qualitative studies  
Single case study 
Systematic reviews 
Literature reviews  
Guidelines  
Audit 
Population Age >18 years 
Any diagnosis of MS 
<18years old  
Diseases other than (and not 
including) MS 
Intervention Any MBI Psychotherapy 
Drug treatments 
Manual therapy (i.e. massage) 
Outcomes Perceived stress  
Anxiety  
Depression  
Health-related QOL  
Pain  
Personal wellbeing  
Social participation 
 
 
Studies included RCTs and controlled trials (CTs) only. A definite MS diagnosis in an 
adult patient (>18years of age) was set as acceptable for inclusion in the review. As 
MBIs can vary in content, core ingredients including body awareness, breath 
awareness, and mindful movement (as per the standard MBSR components) were 
identified as pre-requisite for inclusion. MBSR was selected as it was the first MBI to 
be introduced as a health care intervention, inaugurated in the nineteen-eighties in 
North America [151]. The primary outcome measure for the purposes of this study 
was perceived stress. Other secondary outcomes were mental health measures, 
physical health measures, psychosocial measures, and health care utilisation. 
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Bibliographic records identified through the searches were assessed for relevance via 
broad inclusion criteria (i.e. ‘multiple sclerosis’ and ‘mindfulness’) and all papers 
deemed relevant were then subject to screening via the SPIO model to determine 
eligibility. Those selected papers were then methodologically appraised. The low 
number of studies yielded from the search led to a decision not to exclude any papers 
on the sole basis of poor methodological quality. The methodological issues identified 
are discussed in the text below. 
5.3.3 Quality appraisal 
The risk of bias was determined via the assessment tool suggested by the Cochrane 
Collaboration [288], summarising the potential risk of bias for major outcomes. Each 
outcome was graded individually as high, unclear, or low risk. Data was sought to 
determine whether adequate evidence was present for sequence generation, 
concealment of allocation, participant, personnel and outcome-assessor blinding, 
completeness of outcome data, selective reporting of outcomes, or any other sources 
of bias. 
5.3.4 Data extraction 
In conjunction with supervisors and other colleagues involved in the review (Dr 
Maggie Lawrence - ML; Dr Joanne Booth - JB), a data extraction tool was developed, 
which was adapted from one used in a recent systematic review examining the role of 
MBIs amongst those having suffered a transient ischaemic attack or stroke [282] 
(Appendix C). Data extraction included information on the study methodology and 
design, the population being reviewed, the interventions employed, and the study 
outcomes. Two independent reviewers screened the studies and extracted data 
separately. The broad screen was carried out by the researcher (RS) and a research 
assistant – Miss Sharon Byrne (SB), whilst RS and JB subsequently completed the 
narrow screen. Any discrepancy was subject to a third party opinion by a senior 
reviewer i.e. the researcher’s supervisor (Professor Stewart Mercer - SM). 
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5.3.5 Data synthesis 
The heterogeneous nature of the results from the search and review rendered meta-
analysis impossible, and findings are thus presented in a narrative format. 
5.4 Results 
Searching of the databases identified a total of 1,049 studies. After broad and narrow 
screens (Figure 5.2), only three papers were judged appropriate for inclusion. These 
were Mills and Allen [289], Grossman et al. [177], and Tavee et al. [290] (Table 5.2). 
Excluded papers at the narrow screen stage are detailed in Table 5.3. Several attempts 
(three) were made to contact Authors Mills and Allen [289] and Tavee et al. [290] for 
further information via listed email addresses, but no replies were ever received. 
Figure  5.2 Search results flow diagram 
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Table  5.2 Study characteristics 
Study (Country) Study design (Setting) Sample size 
(Attrition%) 
Type of intervention 
(duration) 
Outcome measures Data collection 
Mills and Allen [289] 
(Wales) 
RCT (Patients home) n = 16 (12.5%) Mindful breathing  
Mindful movement (Tai 
Chi) Self compassion  
Home study material  
(6/52 duration) 
POMS  
Standing balance 
Symptom rating 
questionnaire 
Baseline 
Post intervention 
3 months post intervention 
Grossman et al.  [177] 
(Switzerland) 
RCT (University 
hospital) 
n = 150 (5%) Mindful breathing  
Mindful movement 
(Yoga)  
Body scan  
Home study material  
(8/52 duration) 
CES-D 
STAI  
MFIS  
HAQUAMS  
PQOLC Neuropsych 
Baseline 
Post intervention 
6 months post intervention 
Tavee et al. [290] 
(United States) 
CT (University hospital) n = 17 (43%) Mindful breathing 
(Samatha) Mindful 
movement (Tai Chi) 
Walking meditation  
(8/52 duration) 
SF-36  
MFIS  
VAS  
Physical role Vitality  
PDDS 
Baseline 
Post intervention 
NR 
1.RCT - Randomised controlled trial; 2.CT - Controlled trial; 3.CES-D Center for Epidemiological Studies Depression scale; 4.HAQUAMS - Hamburg Quality of Life Questionnaire in Multiple 
Sclerosis (German); 5.MFIS - Modified Fatigue Impact Scale; 6.POMS - Profile of Mood States; 7.PQOLC - Profile of health related Quality Of Life in Chronic disorders (German); 8.SF-36 - 
Short Form-36; 9.STAI - Spielberger Trait Anxiety Inventory; 10.VAS - Visual Analogue Scale for bodily pain; 11.PDDS - Patient Determined Disease Steps; 12. Neuropsych. – 
Neuropsychological assessment; 13. NR - Not recorded.
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 Table  5.3 Excluded studies 
Author 
(Study title) 
Factors necessitating 
exclusion 
Ahmadi et al. [291] 
The Effects of a Yoga Intervention on Balance, Speed and 
Endurance of Walking, Fatigue and Quality of Life in 
People with Multiple Sclerosis 
Yoga intervention. No 
emphasis on mindfulness 
described. 
Doulatabad et al. [292] 
The effects of pranayama, hatha and raja yoga on physical 
pain and the quality of life of women with multiple 
sclerosis  
Yoga intervention. No full 
text available. 
Garrett et al. [293] 
Exercise in the community for people with multiple 
sclerosis—a follow-up of people with minimal gait 
impairment 
Yoga intervention. No 
emphasis on mindfulness 
described. 
Garrett et al. [294] 
Exercise in the community for people with minimal gait 
impairment due to MS: an assessor-blind randomized 
controlled trial 
As Garrett et al. study above 
– elaboration on prior 
findings. 
Granmayeh et al. [295] 
The effects of Mindfulness-Based Stress Reduction 
programme on physical symptoms, quality of life, and 
mental health in patients with multiple sclerosis 
Full paper unavailable in 
English. 
Hankin [296] 
Mindfulness-Based Stress Reduction in couples facing 
multiple sclerosis: Impact on self reported anxiety and 
uncertainty 
Uncontrolled trial. 
Jajvandian et al. [297] 
Influence of 6-week yoga on depression and fatigue in 
patients with multiple sclerosis, North Khorasan, 
northeastern Iran 
Full paper unavailable in 
English. 
Nordin et al. [298] 
Cognitive behavioural therapy in multiple sclerosis: a 
randomized controlled pilot study of acceptance and 
commitment therapy 
Acceptance and 
Commitment Therapy 
intervention. 
Oken et al. [299] 
Randomized controlled trial of yoga and exercise in 
multiple sclerosis 
Yoga intervention. No 
emphasis on mindfulness 
described. 
Pritchard et al. [127] 
Impact of Integrative Restoration (iRest) Meditation on 
Perceived Stress Levels in Multiple Sclerosis and Cancer 
Outpatients 
Yoga intervention. No 
emphasis on mindfulness 
described. 
Velikonja et al. [300] 
Influence of sports climbing and yoga on spasticity, 
cognitive function, mood and fatigue in patients with 
multiple sclerosis 
Yoga intervention. No 
emphasis on mindfulness 
described. 
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5.4.1 Study characteristics 
The studies included were derived from Wales [289], Switzerland [177], and the 
United States [290]. Mills and Allen [289] and Grossman et al. [177] undertook 
RCTs, whereas Tavee et al. [290] opted for a non-randomised CT. None of the studies 
employed an active control for comparison with the MBI. In the Grossman et al. [177] 
trial, participants were recruited from outpatient Neurology clinics, and the trial was 
carried out in a university hospital location, as was the case in the Tavee et al. [290] 
study. In the Mills and Allen [289] trial, recruitment was from either the participants 
General Practitioner or by a Physiotherapist. 
There were 183 participants in total across the three studies. Attrition rates varied, 
with Grossman et al. [177] reporting very low rates (5%), and notably high overall 
attendance (92%). Mills and Allen [289] described attrition rates of 12.5%, noting that 
bereavement, and dislike of the Tai Chi-based mindful movement component, 
accounted for their dropouts. The highest attrition rates (43%) were described by 
Tavee et al. [290], who described transportation issues, or lack of enthusiasm for the 
intervention as reasons accounting for this finding. 
A complicating factor in the Tavee et al. [290] study was that the authors presented 
findings for a heterogeneous participant group, in that the results for people with MS 
were in some cases mixed together with individuals with peripheral neuropathy. This 
limited interpretation of some of their findings.  
Data collection was most comprehensive in the Grossman et al. [177] study (baseline, 
post-intervention, and six-month follow up), although Mills and Allen [289] also 
collected at three time points (baseline, post-intervention, and three-month follow up). 
Tavee et al. [290] collected data at baseline and at the completion of the intervention 
only (Table 5.2). 
5.4.2 Intervention characteristics 
The Grossman et al. [177] study intervention closely resembled MBSR. The Mills and 
Allen [289] and the Tavee et al. [290] studies employed non-standard components, 
with Tai Chi and Qi Gong exercises. Nevertheless, all of the three studies had broadly 
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comparable ingredients, with emphasis on mindful-movement, mindful-body 
awareness, and mindful-breath awareness. Grossman et al. [177] and Tavee et al. 
[290] both undertook group interventions, whilst Mills and Allen [289] delivered an 
intervention on a one-to-one basis.   
In the Grossman et al. [177] study, experienced and certified trainers delivered the 
eight week, 2.5 hour session intervention weekly, and included a seven-hour session 
at the sixth week. Mindfulness practices were emphasised sitting, lying, and in the 
yoga asana postures. Home practice of up to 40 minutes per day was also encouraged, 
and was recorded (with Grossman et al. [177] also being the only researchers to 
record home practice times). Tavee et al. [290] started their intervention with a four 
hour introductory session, which was followed by eight weekly 1.5 hour sessions, all 
being facilitated/taught by a Buddhist Monk. Sessions in the Tavee et al. [290] study 
included a Samatha meditation (a sitting practice where the goal was simply to 
observe the breath), and mindful-movement (Tai Chi/Qi Qong/walking meditation). 
Home practice was encouraged, but not recorded. Alternatively, Mills and Allen [289] 
opted for six sessions, which were individualised to the participants, but included 
mindful-movement (Tai Chi/Qi Gong), breath and posture awareness, and the 
cultivation of self-compassion. Mills and Allen [289] included self-study material, but 
further details on its uptake/usage were absent. Details pertaining to their course 
facilitators were not specified (Table 5.2).  
5.4.3 Participant characteristics 
Ethnicity of participants was not made explicit in any of the studies. Out of the total 
183 participants included in all three studies, 146 (80%) were female, with the mean 
(SD) age of the total sample (n=183) being 48.6 (9.4) years. No data was available on 
the range of participant ages in any of the studies, but none reported excluding 
participants on the basis of age. SES data was not well reported in any of the studies 
(Mills and Allen [289] described data on only half of their participants, of which half 
were in employment). The number of years in education was reported by Grossman et 
al. [177]. MS phenotype was outlined in two of the studies (Grossman et al. [177], 
and Mills and Allen [289]), with Tavee et al. [290] simply describing participants as 
having MS. Of the 166 participants in the Grossman et al. [177] and the Mills and 
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Allen [289] studies, 123 (or 67% of the total n 183) had RRMS, whilst 43 (or 25% of 
the total n 183) had SPMS. Excluded from all studies were those with 
dementia/severe cognitive impairment, those with severe physical disability (EDSS 
>6.0 i.e. maximally requiring two walking aids in order to walk 20 metres without 
rest), and more generally in the Mills and Allen [289] study if they could not make 
their own way to the hospital (Table 5.4). 
Table  5.4 Participant characteristics  
 Mills and Allen [289] Grossman et al. 
[177] 
Tavee et al. [290] 
Ethnicity NR NR NR 
Number of 
participants (% 
female) 
16 (80%) 150 (80%) 17 (78%) 
Mean age (SD) 49.8 (6.8) 47.3 (10.3) 48.7 (11.2) 
Socio-economic status NR NR NR 
Employment status 4 employed (25%) NR NR 
Mean years of 
education (SD) 
NR 14.1 (1.9) NR 
Disease phenotype SP 16 (100%) RRMS 123 (82%)  
SPMS 27 (18%) 
NR 
EDSS score NR Mean (SD) 3.0 (1.1) Mean (SD) 3.0 
(2.5) 
Comorbidities NR NR NR 
Number taking disease 
modifying medication 
NR 91 (60.1%) NR 
Number taking 
psychotropic 
medication 
NR 30 (20%) NR 
1. SPMS - Secondary Progressive MS; 2. RRMS - Relapsing Remitting MS; 3. EDSS - Expanded disability status 
scale; 4. NR - Not recorded. 
5.4.4 Outcomes 
Perceived stress (the primary outcome of this review) did not feature in any of the 
included studies. Nevertheless, other secondary outcomes did, including anxiety, 
depression, fatigue, health-related QOL, and standing balance. There were no 
definitive data available for cost/benefit parameters or health service use (Table 5.2) 
5.4.4.1 Mental health outcomes 
5.4.4.1.1 Anxiety 
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Grossman et al. [177] used the Spielberger Trait Anxiety Index (STAI) to determine 
levels of anxiety. They demonstrated a significant reduction immediately following 
MBSR, both in the whole group, and in a sub-group analysis of those with levels 
indicating impairment pre-intervention. These findings remained significant at six-
month follow up in both groups. However, in the Mills and Allen [289] study, anxiety 
as measured by a general MS symptom checklist and the Profile of Mood States 
(POMS), showed non-significant change over the period of study (Table 5.5). 
5.4.4.1.2: Depression 
The effect of MBIs on depression was assessed in the Grossman et al. [177] and the 
Mills and Allen [289] studies. In the Grossman et al. [177] trial the Centre for 
Epidemiological Studies - Depression scale (CES-D) demonstrated significant 
reductions in scores at post intervention in both the whole group, as well as in sub-
group analysis of those with pre-intervention impairment. In both cases, this effect 
was maintained at six-month follow up. Similarly, Mills and Allen [289] reported a 
significant change in depression scores using the POMS (Table 5.5) 
Table  5.5 Mental health outcomes 
Study Outcome 
(Measure) 
Post intervention 
effect size (p) 
Follow up effect size (p) 
and time point 
Grossman et al. 
[177] 
Full 
intervention 
group 
Anxiety 
(STAI) 
0.39 (0.0006) 0.36 (0.02) at six months 
Sub-group 
analysis 
1.00 (0.002) 0.64 (0.05) at six months 
Full 
intervention 
group 
Depression 
(CES-D) 
0.65 (0.00001) 0.36 (0.03) at six months 
Sub-group 
analysis 
1.06 (0.0002) 0.66 (0.03) at six months 
Mills and Allen [289] Anxiety 
(POMS) 
p > 0.05* p > 0.05* 
Depression 
(POMS) 
p < 0.01* NR 
1.STAI - Spielberger Trait Anxiety Index; 2. CES-D - Centre for Epidemiological Studies Depression scale; 
3.POMS - Profile of Mood States. * Effect size not recorded. 
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5.4.4.2 Physical outcomes 
5.4.4.2.1 Standing balance 
Mills and Allen [289] examined for change in scores for single leg standing balance. 
They noted improvements at study completion, and at three-month follow up, with 
only one individual’s data missing (Table 5.6). 
5.4.4.2.2 Pain 
Tavee et al. [290] reported significant improvements in pain at the completion of their 
intervention, which used the Visual Analogue Scale (VAS) (Table 5.6). 
5.4.4.2.3 Fatigue 
Fatigue was measured in all three studies. Scores from the Modified Fatigue Impact 
Scale (MFIS) improved significantly after receiving MBSR training in the Grossman 
et al. [177] study, more so in those who had pre-intervention impairment. These 
effects were maintained at six-month follow up. In the Tavee et al, [290] trial 
significant pre-post beneficial changes on MFIS scores were also noted. However, in 
the Mills and Allen [289] study, fatigue was non-significantly improved, going by the 
POMS change scores (Table 5.6). 
Table  5.6 Physical health outcomes 
Study Outcome 
(Measure) 
Post intervention 
effect size (p) 
Follow up effect size (p) 
and time point 
Grossman et 
al. [177] 
Full 
intervention 
group 
Fatigue (MFIS) 0.41 (0.0001) 0.38 (0.001) at six months 
Sub-group 
analysis 
1.27 (0.0005) 1.09 (0.02) at six months 
Mills and Allen [289] Fatigue (POMS) p > 0.05* NR 
Single leg 
standing balance 
p < 0.05* p < 0.05* at three months 
Tavee et al. [290] Fatigue (MFIS) p = 0.035* NR 
Pain (VAS) p = 0.031* NR 
PDDS p > 0.05* NR 
1.MFIS - Modified Fatigue Impact Scale; 2.POMS - Profile of Mood States; 3.VAS - Visual Analogue Scale for 
pain; 4.PDDS - Patient Determined Disease Steps; 5.NR - Not recorded;  *Effect size not recorded. 
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5.4.4.3 Psychosocial outcomes 
In the Grossman et al. [177] study, both generic (Profile of health-related Quality of 
Life in Chronic disorders – PQOLC) and MS-specific (Hamburg Quality of life 
questionnaire in Multiple Sclerosis – HAQUAMS) QOL scores improved 
significantly, both in the group overall, and in those with levels indicating pre-
intervention impairment. These effects persisted at six-month follow up. Mills and 
Allen [289] reported symptoms in general trending towards improvement (but without 
any statistical ratification), whilst Tavee et al. [290] did not report interpretable data 
for QOL from the Short From-36 (SF-36), with their results for people with MS being 
pooled with individuals with peripheral neuropathy (Table 5.7). 
Table  5.7 Quality of life outcomes 
Study Measure Post intervention 
effect size (p) 
Follow up effect size 
(p) and time point 
Grossman et al. 
[177] 
Full intervention 
group 
HAQUAMS 0.43 (0.0002) 0.28 (0.04) at six 
months 
PQOLC 0.86 (0.00000001) 0.51 (0.03) at six 
months 
Sub-group 
analysis 
HAQUAMS 1.01 (0.0001) 0.58 (0.04) at six 
months 
PQOLC 1.71 (0.00000001) 0.51 (0.003) at six 
months 
1.HAQUAMS - Hamburg Quality of Life Questionnaire in Multiple Sclerosis (German); 2.PQOLC - Profile of 
Health-related Quality of Life in chronic disorders (German). 
5.4.5 Methodological quality 
The Cochrane Collaboration tool for assessing Risk of Bias was employed to appraise 
study quality. Out of the included studies, Grossman et al. [177] were the only 
researchers to describe adequate sequence generation at the time of randomisation. 
They also most convincingly described allocation concealment, with the investigator 
blinded to participant information, whilst Mills and Allen [289] did not describe this 
clearly, and Tavee et al. [290] appear to have constructed a control group separately 
from those making up the intervention group (which comprised only those expressing 
a desire to be included in the intervention group). There was minimal suggestion of 
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incomplete outcome data reporting (to include attrition data), being described in all of 
the studies. However, only Grossman et al. [177] used attrition data and intention to 
treat (ITT) in the statistical analysis. Selective outcome reporting was not apparent in 
any of the studies. Using the Cochrane Collaboration guidance, only the study by 
Grossman et al. [177] can be considered of high methodological quality (Table 5.8). 
Table  5.8 Risk of bias summary 
 Grossmann et al. 
[177] 
Mills and 
Allen [289] 
Tavee et al. 
[290] 
Random sequence generation (selection 
bias) 
Low Unclear NA 
Allocation concealment (selection bias) Low Unclear NA 
Blinding of assessors (performance bias) Low Unclear High 
Blinding of outcome assessment (detection 
bias) (patient reported outcomes) 
High High High 
Incomplete outcome data addressed 
(attrition bias) 
Low Unclear High 
Selective outcome reporting (reporting bias) Low High Unclear 
Other sources of bias (ie baseline bias) Low Unclear Unclear 
1.Low = Low risk of bias; 2.Unclear = Unclear risk of bias; 3.High = High risk of bias; 4.NA = Not available. 
5.5 Discussion 
This systematic review has examined the use of MBIs in people with MS, identifying 
only three eligible studies, which were heterogeneous in nature, only one study 
having the required statistical power to generate meaningful effect sizes. Rates of 
attrition were variable, with clear reasons seldom cited. The interventions did not all 
use the same methodology, two of the studies deviating from the standard MBSR 
protocol by including Tai Chi and Qi Gong as part of the mindful-movement 
elements. Furthermore, only two of the studies delivered the MBI in a group setting, 
whilst the remaining study administered the intervention on a one-to-one basis. The 
primary outcome in this current review was perceived stress, and it was not recorded 
Mindfulness-based interventions for people with MS 
 
 116 
in any of the included studies, although other secondary outcomes of relevance, such 
as anxiety, depression, fatigue, standing balance, and QOL were. 
Taken together these studies give encouraging results, in terms of mental health and 
health-related QOL effects. These beneficial effects (anxiety, depression, fatigue, 
health-related QOL) persisted for up to six months in the Grossman et al. [177] study, 
although effect sizes had diminished somewhat by that time. In the Mills and Allen 
[289] study, standing balance remained significantly improved by three-month follow 
up. No adverse events were reported in any of the studies.  
5.5.1 Strengths and limitations of the review 
A rigorous methodological approach was employed to undertake both the searching 
and appraisal of the literature examining the use of MBIs in people with MS. All 
screening and quality appraisal was undertaken by two independent reviewers, and a 
well-recognised and accepted tool was used (Cochrane Collaboration appraisal tool). 
Given that MBIs originate from ancient Oriental roots, the fact that the review was 
necessarily (via budgetary constraints) limited to studies published in English may 
have introduced some bias. Meta-analysis was not deemed possible, given the 
heterogeneous nature of the studies, and the low methodological quality of two of the 
included studies compounded this situation further. 
5.5.2 Strengths and limitations of included studies 
The Grossman et al. [177] trial represents a well-designed RCT, which included a 
sufficient sample size (based on prior studies [14, 301]) to allow statistical power 
calculations and meaningful effect sizes. The authors’ clear inclusion/exclusion 
criteria, and delivery of a standard manualised MBI, facilitated by certified and 
experienced trainers, with pre-,post-, and six-month follow-up measures, allows some 
confident inferences to be drawn from their findings. The Mills and Allen [289] and 
Tavee et al. [290] studies were not of such high quality, including smaller sample 
sizes, and opting for non-standard MBIs. Tavee et al. [290] did not randomise and 
employed a questionable control group.  
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Populations, interventions, and outcomes across the studies varied considerably. The 
effects of MBIs on different age groups in MS remains unclear, and how these might 
differ with respect to varied SES was not covered at all. Furthermore, information 
regarding MS phenotype, stage/severity of illness, the presence/absence of 
comorbidity was poorly characterised. Lastly, the dearth of data on economic 
costs/benefits precludes the drawing of any conclusions about the cost-effectiveness 
of MBIs amongst those with MS. Therefore, the results of this review should be 
treated with caution. 
5.5.3 Implications for future research 
From this review, it seems clear that future studies of MBIs for people with MS are 
needed to clarify a variety of unanswered questions. Studies might usefully seek 
information on a mix of physical and psychological measures pertinent to the MS 
population, and also more meaningful information on how MBI effects may differ 
with respect to different disease phenotypes, different stages of MS, amongst those 
with greater levels of disability, and across all relevant age groups. Important 
practical questions concerning feasibility, accessibility, and acceptability also need to 
be asked. Attrition rates varied widely in the above studies and it remains largely 
unclear why this might be. Qualitative research could seek specifically to provide 
answers to questions about accessibility, acceptability, and sustainability of MBIs for 
people with MS. Furthermore, it remains unclear as to how MBIs might fare amongst 
different ethnic groups, and ultimately if the intervention is cost-effective in those 
with MS. A final point to consider is whether MBIs need to be tailored for people 
with MS, given that levels of disability can vary considerably, as can disease activity, 
which is unpredictable, and disruptive [3, 62]. With this in mind, MBI trainers might 
themselves require enhanced training, and this too could be studied [217]. 
It would also be sensible for researchers to attempt to define the construct of 
mindfulness in any future studies in this area, and employ a validated measure in this 
regard. A range of measures is available [198], reflecting different definitions of the 
construct, such as the Mindful Attention Awareness Scale (MAAS) (measuring an 
integrated conceptual model [145]) or the Five-Facet Mindfulness Questionnaire 
(FFMQ) (reflecting proposed subcomponents of being mindful [131]).  
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Given that there may be a link between stress and MS exacerbation [8], future studies 
might examine for changes in perceived stress alongside specific biomarkers of 
inflammation. Using a contemporary biomedical model of stress [67], and correlating 
functional outcomes with disease biomarkers, such as via clinical imaging, could 
prove to be very useful in clarifying potential mechanism of action of MBIs in this 
group [302, 303].  
5.5.4 Literature developments since completing the 
systematic review 
Since this systematic review was completed, three further studies have been published 
examining the role of MBIs in people with MS. These will be briefly discussed here, 
but will be covered in full detail, in the same manner as those studies outlined in the 
present systematic review, in Appendix D. 
In Germany, Burschka et al. [304] carried out a controlled trial, analysing data from 
32 participants who took part in a MBI that focused mainly on mindful-movement, 
via Tai Chi. Participants were mainly RRMS patients (85%), and all had an 
EDSS<5.0. Outcomes focused primarily on balance, with secondary measures on 
QOL, fatigue and depression. Mindfulness was not measured. Amongst those 
receiving the intervention, significant improvements were noted for balance (p<0.05), 
co-ordination (p<0.05), depression (p<0.05), and QOL (p<0.05). Overall, this was a 
poor quality study, with multiple potential sources for bias. 
In England, Bogosian et al. [305] undertook a RCT, randomising 40 people with 
progressive MS to receive a MBI based on MBCT for depression, but without 
mindful-movement, which was delivered ‘remotely’, via Skype. All levels of 
disability were eligible for participation, with the mean EDSS amongst participants 
6.5. The primary outcome was distress, measured via the General Health 
Questionnaire (GHQ), and secondary outcomes measured mental health, fatigue, pain, 
the impact of MS symptoms, and likely cost-effectiveness. Mindfulness was not 
measured. Those who received mindfulness training had significant improvements in 
distress (p<0.05), anxiety (p<0.05), depression (p<0.05), the psychological impact of 
MS (p<0.05), fatigue (p<0.05), and the physical impact from MS symptoms (p<0.05). 
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In addition, a health economic analysis demonstrated likely effectiveness of the MBI, 
at a threshold of £20,000. Overall, for a pilot study this was of high quality, and adds 
important information on the potential use of MBIs in more disabled groups with MS. 
In Iran, Kolahkaj and Zargar [306] carried out a RCT testing a MBI based on MBSR 
and MBCT in women with MS. Eligibility criteria were female sex and having any 
type of MS. Phenotype and disability level were not reported. Forty-eight women 
were randomised to receive the MBI or usual care. The primary and only outcome 
measure was the Depression, Anxiety, and Stress Scale-21 (DASS-21). Those 
completing the MBI demonstrated significant improvements in depression (p<0.001), 
anxiety (p<0.001), and stress (p<0.001) at post-intervention, and two months later. 
Reporting in this study was vague and overall methodological quality was low. The 
study does add useful information about the use of MBIs in another ethnic group. 
5.5.5 Implications for clinical practice 
This systematic review has reported findings that suggest that MBIs may have utility 
in people with MS, especially for mental health, for some physical aspects of MS, and 
for QOL. Developments since the review also suggest the potential for MBIs to be 
cost-effective in people with progressive MS. From the limited literature available, no 
overt evidence of harm from MBIs is apparent in this population. 
5.6 Conclusions 
The limited evidence that exists for the use of MBIs in people with MS suggests that 
they can be of benefit, especially in terms of mental health, some physical health 
measures, QOL, and possibly from a health economic perspective. Generalising these 
results to different ethnic groups, to include both sexes, diverse age groups, disparate 
disease phenotypes, and differing socioeconomic groups should be done with caution 
at this time. Whether MBIs might also benefit those with comorbidities and/or more 
severe disabilities is at present less clear. The next round of research needs to be of 
high methodological quality and may best employ a mixed-methods approach, in 
order to increase our understanding of barriers and facilitators to uptake, utilisation, 
and sustainability of such services.
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Chapter 6 Randomised controlled trial – 
Mindfulness-Based Stress Reduction for 
people with multiple sclerosis versus wait list 
control 
6.1 Summary 
This chapter describes the research process and findings from a RCT of a MBSR 
intervention against wait-list control. The outline of the chapter is based on the 
CONSORT criteria for reporting RCTs [176]. The trial design and methods are 
described, followed by results, strengths and limitations, and interpretation of the 
findings in the context of the existing evidence for the use of MBIs in people with 
MS. Suggestions are then made for future research priorities, and how such questions 
might best be addressed.  
6.2 Aims and objectives 
The aim of this study was to test the feasibility and effects of conducting a RCT of a 
MBI for people with MS, and clarify whether a future definitive trial is currently 
merited. Specific objectives included: 
 Assessing the feasibility of recruiting participants with MS to take part in a 
RCT of an eight-week MBSR course versus usual care 
 To provide estimates of engagement (recruitment, retention, adherence)  
 To assess the suitability of selected patient report outcomes and the feasibility 
of collecting these at baseline, immediately following MBSR, and three 
months later  
 To evaluate the evidence of likely effectiveness of MBSR and determine 
variability estimates for selected outcome measures to inform power 
calculations for a definitive trial 
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6.3 Introduction 
As discussed in Chapter 5, there are only a small number of studies from around the 
world (n=6) examining the use of MBIs in people with MS and these have left several 
questions unanswered. Such studies have, with the exception of Grossman et al. [177] 
(n=150), mostly included small sample sizes, with limited information provided about 
participant demographics, offering few details regarding ethnicity, SES, and other 
potentially important confounders such as the presence of comorbidities, on-going 
pharmacologic therapies, or previous exposure to meditation practices (see Chapter 5 
and Appendix D). With one exception [305], trials have largely focused on 
participants who remain ambulant, and have not included more disabled people. 
Disability is common in MS, and thus there is a need to know whether or not more 
disabled individuals can engage with a MBI.  
6.4 Materials and methods 
6.4.1 Trial design and participants 
This was a phase-2 RCT, designed to assess the feasibility (engagement and retention) 
and likely effects, if any, of MBSR on patient-reported outcomes in people with MS 
to inform decision making regarding the evidence to support a phase-3 trial. The trial 
employed a wait-list control design, in order to allow all study participants eventually 
to receive MBSR. The study was registered with Clinicaltrials.gov 
(https://clinicaltrials.gov/ct2/show/NCT02136485), prior to any trial recruitment 
having taken place. Full ethical approval was prospectively granted via the NHS 
Lothian Research Ethics Council (REC reference number: 14/SS/0091) and NHS 
Greater Glasgow and Clyde (NHS GGC) acted as the host health board throughout 
(study ID number: GN14CH078). The protocol for this trial was made publicly 
available, prior to its commencement 
(http://www.gla.ac.uk/researchinstitutes/healthwellbeing/research/generalpractice/rese
arch/mbsr-ms/). The trial took place at the NHS Centre for Integrative Care (NHS 
CIC), Glasgow, a tertiary referral centre for Integrative Care services in Scotland.  
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Recruitment for the trial took place across Greater Glasgow NHS sites over a pre-
specified three-month period during June – August 2014. Within this area, the 
Institute for Neurosciences (INS), the regional centre for MS care in the West of 
Scotland, formed the primary recruitment site, with the researcher (RS) attending 
weekly MS outpatient clinics. This was arranged following a meeting between the 
researcher and the Lead Clinician for MS services in the INS (Dr Stewart Webb). 
During their clinic reviews, the MS Specialist Nurses identified potential participants 
who were interested and eligible. These individuals were then further assessed by the 
researcher on-site, or at a later date, depending on patient preference. Secondary 
recruitment sites included the NHS CIC, MS Revive, and GPs in Greater Glasgow - 
all GP Practice Managers in Glasgow were contacted via e-mail and asked to 
distribute study flyer/clinician information sheets to GPs. Across these sites, all 
participants were recruited via NHS clinicians, including MS Specialist Nurses, 
Clinical Psychologists, Specialists in Rehabilitation Medicine, General Practitioners, 
and Specialists in Integrative Care (see Appendix E for an example of a Clinician 
Information Pack). Extended recruitment strategies also allowed for interested parties 
to get in touch with the researcher directly, for example if they had seen a study flyer, 
or heard about the study via word-of-mouth. Study flyers were posted at various NHS 
sites (INS, NHS CIC, Revive MS). Finally, the study was advertised online via 
University of Glasgow social media outlets on Facebook and Twitter, and also via the 
UK Multiple Sclerosis Society (MSS) website (http://www.mssociety.org.uk/). 
As this was a feasibility study, no formal calculation for sample size was conducted. 
Browne [307] has demonstrated that a total sample size of 30 is sufficient to allow 
standard deviation (SD) estimates for outcome variables to determine sample size for 
an efficacy trial. Thus, sample size was determined based on this, but was also 
influenced by pragmatic reasoning; namely that the maximum group size which the 
NHS CIC could accommodate was 25 participants per class. Thus, a recruitment 
target of 50 people i.e. two groups of 25 was set. Box 6.1 delineates eligibility 
criteria. 
Initial screening for eligibility of potential participants took place through NHS 
clinicians, but also by the researcher in every case. Prior to meeting, potential 
participants were sent out detailed information regarding the study aims and 
Mindfulness-based interventions for people with MS 
 
 123 
objectives, and scientific rationale – see Appendix F. In all cases it was made clear 
that this was a feasibility study. The face-to-face meeting between the researcher and 
potential participants allowed the following to be completed: 
1) Addressing any remaining doubt about eligibility  
2) Collection of informed consent 
3) Baseline measures on the participant questionnaire, including assessment 
of disability level using the EDSS score [117]. 
Box  6.1 Eligibility criteria 
 
Inclusion criteria Exclusion criteria 
1) Over 18 years of age; 
 
2) Neurologist confirmed diagnosis of MS; 
 
3) Able to understand spoken and written 
English; 
 
4) A score of less than or equal to 7.0 on the 
EDSS* to allow for active participation in the 
Hatha Yoga asana postures 
1) Life-threatening physical or mental health 
conditions, such as suicidal ideation, active 
psychosis, or terminal/life threatening inter-
current medical illness, or such conditions 
expected to limit significantly participation 
and adherence, including dementia, 
pregnancy, ongoing substance abuse; 
 
2) Those currently receiving another form of 
psychological intervention (non-
pharmacological). 
 
 
* EDSS = Expanded Disability Status Scale [117]. Score of 7.0 = ‘Unable to walk beyond approximately 5 metres, 
even with aid. Essentially restricted to wheelchair; though wheels self in standard wheelchair and transfers alone. 
Up and about in wheelchair some 12 hours a day’ 
A priori stopping criteria were for trial discontinuation in the occurrence of any 
adverse event(s) strongly suggesting harm derived from the intervention. 
Recruited participants had baseline measures and informed consent collected face-to-
face with the researcher, prior to randomisation. Follow-up measures were collected 
by post, at intervention completion (i.e. two months) and then again three months 
later (i.e. at the five-month point). Those who did not return postal measures within 
14 days were telephoned to confirm their on-going participation and encourage their 
self-completion of the questionnaire. Participants received a £5 gift voucher as a 
gesture of appreciation for their completing each cycle of the questionnaire.  
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6.4.2 Randomisation 
A member of staff who was not involved in recruitment (Suzanne Lloyd - SL) at the 
RCB, University of Glasgow, undertook a random sequence generation procedure. 
The statistician generated a list in blocks of two, so as to minimise the risk of over-
allocation into the two groups, where a maximum of 25 participants could not be 
exceeded due to space constraints. SL had no prior knowledge or way of identifying 
any of the individuals in the trial and simply allocated a random number to each 
participant. The numbered list was then passed to a blinded member of administrative 
staff (John McLeod – JM) in General Practice and Primary Care (GPPC) at the 
University, who otherwise had no part in the trial or PhD project. JM then contacted 
all participants to inform them of their group allocation. JM also fielded calls from 
participants relating to attendance and attrition. Follow-up measures were all 
identified according to participant number. Blinding of participants and care providers 
was not possible, given the nature of the intervention. The researcher remained 
blinded to allocation and undertook data entry for the first and subsequent iterations 
of the questionnaires. All forms were anonymous, and were returned to the researcher 
with only a unique numerical identifier on their outer cover.  
6.4.3 Statistical analysis 
In association with RCB staff (SL), an a priori statistical analysis plan was developed 
and made publicly available in advance of all data being collected: 
http://www.gla.ac.uk/researchinstitutes/healthwellbeing/research/generalpractice/rese
arch/mbsr-ms/ 
To assess the feasibility, acceptability and accessibility to patients with MS, key 
outcomes included recruitment and retention. These were calculated by descriptive 
statistics reporting frequencies and percentages. 
Baseline characteristics were summarised according to intervention arm.  
Differences between the arms were tested using two-sample ‘t’-tests for normally 
distributed variables, and chi-square tests for categorical variables. 
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Questionnaire outcome data were analysed in relation to change from baseline using 
an Analysis of Covariance approach (ANCOVA), adjusting for the baseline score, as 
appropriate. ANCOVA is an extension of analysis of variance (ANOVA), measuring 
spread of data points away from the mean – the square of the SD. It compares two 
means amongst two or more groups to assess whether they derive from the same 
population. ANCOVA permits the model to include continuous variables, for 
example, any variable which can fall anywhere within a range of values e.g. weight, 
height etc [167]. Models were adjusted for age, sex, and deprivation, as well as any 
characteristics found to differ between the intervention arms at baseline. Based on 
advice from the statistician (SL), no plans were made to impute missing values, 
although these would be subject to scrutiny later on in the analysis, and reported as 
part of the overall assessment of feasibility. No interim analyses were undertaken. All 
statistical analyses were carried out using SPSS v21. 
For questionnaire data, study results are reported for between group mean (SD) 
baseline scores, change scores, treatment effects (β), 95% confidence intervals, 
significance levels, and effect sizes (ES - Cohen’s ‘d’).  
 
6.4.4 Intervention 
Two experienced physician instructors delivered the intervention:  
1. Dr Leonora Coll had a clinical background in General Practice since 1983 and 
at the time of the RCT worked full time as a Specialty Doctor in Integrative 
Care at the NHS CIC. Dr Coll had completed teacher training in MBCT in 
2005, via the University of Bangor, and had been teaching mindfulness since 
then. In addition, she had completed residential MBSR training in with Jon-
Kabat-Zinn, in the USA in 2011, along with regular attendance at training 
retreats in MBCT and Vipasana meditation around the world. She had a 
teaching qualification in Iyengar Yoga and in Pranayama. She regularly 
attended one-to-one clinical supervision for her mindfulness teaching and had 
a longstanding daily practice.  
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2. Dr Bridie O’Dowd also had a background in General Practice, completing her 
training in 1994. She qualified as a mindfulness teacher in 2011, again via the 
University of Bangor. At the time of the RCT, she was halfway through 
completing an MSc qualification in teaching MBIs via the University of 
Bangor. She also had a longstanding daily mindfulness practice and undertook 
regular clinical supervision. 
The mindfulness teachers had been working together to deliver courses at the NHS 
CIC for three years. Both took time to prepare for delivering the course in this study. 
Their preparations included meeting with the researcher to discuss the RCT, liaising 
with nursing, physiotherapy, administrative, and management staff at the NHS CIC, 
arranging room booking for the course, and meeting with each other to discuss the 
course in general prior to its commencement, and then prior to each mindfulness 
session to prepare, including reviewing comments made on participant home practice 
sheets that had been returned the week previously. In addition, both instructors met at 
the end of each mindfulness session to debrief with one and other. 
The intervention was based on the most widely used, manualised form of MBSR [13] 
(Appendix G). The only ‘modification’ was omission of the full day-retreat at week 
six. The decision to exclude this component was based mainly on resource 
constraints, namely that the NHS CIC operates at near to full capacity throughout the 
week, and is not open at the weekends, but was also supported by the fact that very 
little evidence exists to suggest that the day retreat is an essential component [308].  
The control group received whatever they normally would do via standard NHS 
patient contacts, such as making appointments with their GP, MS Specialist Nurse, or 
Consultant in Rehabilitation or Neurology, as required. However, no attempt was 
made to characterise this further during the trial. At the time of recruitment into the 
trial, all participants (regardless of eventual assignment to intervention or control) had 
received a participant information pack that described trial procedures, including the 
purpose of the study, why they had been chosen to take part, what would happen if 
they took part, what mindfulness was, including core components, session lengths, 
expectations regarding attendance on the course, home practice requirements, 
questionnaire length and estimated completion time, the likelihood of being invited 
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for a qualitative interview following MBSR. All were made aware that everyone 
would eventually receive MBSR (Appendix F).  
Relatively high levels of disability were considered a strong possibility from the 
outset, given that this trial sought to include participants with higher EDSS 
(disability) scores than those in previous studies that had been identified via the 
systematic review (Chapter 5 and Appendix D). Despite this, there were no initial 
changes made to any of the core MBSR practices of mindful-breath-awareness, 
mindful-body-awareness, or mindful-movement. However, the importance of 
flexibility in application of the practices was agreed in advance with the MBSR 
instructors, with provisions made for the possibility of recruiting skilled NHS CIC 
moving-and-handling trained nursing staff into the group setting, should their 
expertise be required.  
6.4.4.1 Intervention fidelity 
No explicit measures were put in place to measure intervention fidelity during the 
study, such as video recording of sessions, or having an independent reviewer ‘sit-in’ 
on MBSR classes etc [178]. The decision not to do so was made based on the MRC 
guidance [19], which suggests that this may be impractical in a feasibility trial, more 
so when it was limited to a single study site, with the same MBSR instructors 
delivering the intervention throughout, both of whom were used to working with each 
other in this capacity. The decision was also based on the anticipation that, as this was 
a feasibility study, protocol deviation might be necessary i.e. to accommodate a more 
disabled group. It was also influenced by practical, time, and resource constraints 
associated with the PhD. However, if the guidance suggested by Bellg et al. [178] for 
measuring fidelity in behavioural interventions is considered, then fidelity was 
indirectly measured in a number of other ways during this study - see Table 6.1 
below. 
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Table  6.1 MBSR treatment fidelity 
Fidelity 
domain 
How it was met 
1. Study 
design 
Use of an a priori study protocol; a fixed number and length of MBSR 
classes; protocol deviations recorded; manual for course scripted (MBSR); 
external monitoring from research team and another MBSR instructor who 
was not part of the research project; home practice monitoring 
2. Provider 
training 
By using qualified and experienced mindfulness instructors; instructors 
trained together using scripted MBSR treatment manuals; use of the same 
instructors throughout; external provider debriefing and supervision for 
instructors on a regular basis; access to senior research staff (SM) freely 
available; exit interviews for participants enquiring about the course content  
3. Improving 
delivery of 
MBSR 
Qualitative assessments from participants undertaken regarding provider 
‘warmth/credibility’, complaint monitoring in situ; course reading provided 
to all participants (‘Full Catastrophe Living’);  
4. Improving 
receipt of 
MBSR 
Weekly participant feedback encouraged by instructors, both in writing 
(embedded questionnaire – not part of study data), and verbally; regular 
activity logs completed by participants; feedback from participant and 
providers on MBSR exercises during classes; follow-up with drop-outs via 
telephoning by instructors 
5. Improving 
MBSR skill 
enactment 
Semi-structured participant interviews on completion of MBSR; home 
practice and materials provided regularly along with a diary for adherence 
measurement; in class discussion and post-MBSR interview discussion on 
on-going use of MBSR skills in their daily life  
 
The MRC guidance [19] helped the researcher to consider how best to minimise 
deviation from the standard MBSR package. For example, both instructors were 
trained and competent to deliver MBSR specifically. The researcher met with both 
instructors on a number of occasions prior to the study taking place, in order to gain 
consensus on course content, which was based on the MBSR manual produced by the 
University of Massachusetts Center for Mindfulness. It was also agreed with the 
researcher’s supervisors (SM, FM), that any deviations in the protocol, intended, or 
otherwise, would be recorded as part of the evaluation process. Lastly, it was 
anticipated that the parallel process evaluation using qualitative semi-structured 
interviews from participants and instructors, and an implementation analysis would 
likely yield useful information pertaining to intervention fidelity, in terms of course 
structure and components. 
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6.4.5 Study outcomes 
6.4.5.1 Primary feasibility outcomes 
With respect to primary outcomes, there were three main objectives: 
1) To see if MBSR was feasible i.e. was it possible to recruit, to randomise, 
to deliver the intervention, and to retain participants in the study? 
2) To determine the suitability of the outcome measures chosen 
3) To establish whether it was possible to collect outcomes measures at 
baseline, post-intervention, and at three-month follow-up? 
Feasibility outcomes were considered for the following: 
 Reaching the recruitment target of 50 participants 
 Consent rates 
 Refusal rates 
 Study questionnaire length, content, and missing-ness 
 Adherence rates to course sessions and home practices 
 Course completion rates 
The main outcome measures were self-report, and reflected the interest in the 
relationships between stress, MS, and QOL.  
6.4.5.2 Primary patient outcomes  
The main objectives for primary patient outcomes were to assess the likely 
effectiveness of MBSR training for reducing scores of perceived stress and for 
increasing scores for QOL. Perceived stress was assessed via the ten-item Perceived 
Stress Scale (PSS-10) [185]. QOL was measured via the EQ-5D-5L. Both of these 
measures have been used previously in studies examining the stress-modulatory 
effects of meditation amongst people with MS, Pritchard et al. [127] using the PSS-
10; Bogosian et al. [305] using the EQ-5D-5L 
 The PSS-10 is a measure of the individual’s perception of how stressful life 
events have been over the past four weeks. The PSS-10 has the best 
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psychometric properties (internal consistency) in patients with MS, as 
compared to the longer (14-item) or shorter (four-item) versions [186]. 
Originally designed as a single construct measure [184], recent evidence 
suggests that a two-dimensional construct is more likely for the PSS-10; one 
relating to perceived stress (assessed via items 1,2,3,6,9,10 on the scale), and 
one to stress resilience (items 4,5,7,8, which are reverse-scored) [183]. The 
author of the scale [185] describes it as being designed to ascertain how 
overloaded, uncontrollable, and unpredictable respondents find their lives. The 
range of scores that a respondent may return vary between 0-40, with higher 
scores indicative of higher perceived stress. Higher scores have been 
associated with a greater vulnerability to depressive symptoms and/or viral 
infections following SLEs. In general, it is recognised as having good 
psychometric properties, with a Chronbach’s-α reliability co-efficient of 0.89, 
and it also has supportive convergent/divergent validity [309]. A limitation is 
that it does not have a cut-off score indicative of clinical significance, but 
normative values in US populations are described as mean (SD) scores of 12.1 
(5.9) for males, and 13.7 (6.6) for females [184]. In Danish samples, a level 
over 18.0 is considered to indicate abnormally high stress [50]. 
 
 The EQ-5D-5L is a generic two part self-report measure of QOL, which aims 
to capture data on physical, mental, and social functioning [188]. The first part 
relates to mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression. These can be scored as having no problems, slight 
problems, moderate problems, severe problems, and extreme problems. The 
second part is a scale 0-100, asking the respondent to rate their state of health. 
The EQ-5D-5L has been validated in diverse patient populations with chronic 
conditions in many different countries around the world, and has been shown 
to have good test-retest reliability in UK populations [188]. Participant 
responses are converted into a numerical score that has been weighted for 
diverse populations around the world based on population norms so that it can 
be calculated as a single utility score. The utility score can then be used as part 
of a health economic analysis. In this study, scores were converted to UK 
weighted values: http://www.euroqol.org/about-eq-5d/valuation-of-eq-5d/eq-
5d-5l-value-sets.html 
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6.4.5.3 Secondary patient report outcomes 
Secondary patient report outcomes were chosen to cover the impact of common MS 
symptoms, the putative mechanisms of action for MBSR, and emotional lability. 
The Multiple Sclerosis Quality of Life Inventory [191] (MSQLI) was chosen as a 
composite measure to represent the variety of symptoms and issues known to be 
prevalent in people with MS i.e. physical, mental, and social problems. This measure 
was specifically designed for and validated in people with MS, across a range of ages, 
and including those with cognitive impairment [191-193]. Prior to this study, the 
MSQLI had been used almost exclusively in North American populations, and never 
within Scotland. Construct validity, internal consistency and reliability have been 
reported as adequate, with only the vision scale being less reliable in those with 
cognitive impairment [191, 192].  
The MSQLI includes the option of using another generic QOL score, the Health 
Status Questionnaire, Short-Form 36 (SF-36). The SF-36 was not used in this present 
study for three reasons: a) the EQ-5D-5L was already being used as a generic QOL 
measure b) the questionnaire was already 27 pages long, with an estimated toil time of 
45-60 minutes, and c) the SF-36 came with a copyright, requiring payment for usage. 
Thus, the SF-36 component of the MSQLI was omitted from the participant 
questionnaire. 
The MSQLI measures scores for items over the last four weeks, covering: 
 Fatigue – The Modified Fatigue Impact Scale (MFIS) has 21 separate items, 
designed to measure how much cognitive (items 1,2,3,5,11,12,15,16,18,19), 
physical (items 4,6,7,10,13,14,17,20,21), and psychosocial (items 8,9) aspects 
of fatigue have impacted on daily activities. It has an internal consistency 
reliability Chronbach-α of 0.96. Higher scores indicate a greater impact of 
fatigue [191] 
 Mental health – The Mental Health Inventory (MHI) is an 18-item 
questionnaire, measuring four separate domains, covering anxiety (items 
4,6,10,11,18), depression (items 2,9,12,14), behavioural and emotional control 
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(items 5,8), and positive affect (1,7,13,15). These four facets are different 
factors and are scored separately [191]. Items 1,3,5,7,8,10,13,15 are reverse 
scored, and higher scores are indicative of better mental health. 
 Cognitive function – Impact of subjective cognitive dysfunction is measured 
by the 20-item Perceived Deficits Questionnaire (PDQ), which assesses 
aspects of attention/concentration (items 1,5,9,13,17), retrospective memory 
(items 2,6,10,14,18), prospective memory (items 3,7,11,15,19), and 
planning/organisation (items 4,8,12,16,20). Higher scores indicate a greater 
subjective cognitive deficit. It has an internal consistency reliability 
Chronbach-α of 0.93 [191]. 
 Social support – The Modified Social Support Survey (MSSS) is an 18-item 
questionnaire assessing tangible support (items 1,4,11,13), emotional support 
(items 2,3,7,8,12,14,15,17), affective support (items 5,9,18), and positive 
social interaction (items 6,10,16). It measures patient-perceived social support. 
Higher scores indicate higher perceived social support. It has an internal 
consistency reliability Chronbach-α of 0.97 [191]. 
 Pain – This is assessed via a six-item, modified version of the Medical 
Outcomes Study Pain Effects Scale (PES). Pain is defined as ‘any unpleasant 
sensory symptom related to MS’. It is designed to assess the effects of pain on 
mood and behavior, with higher scores reflecting higher impact. It has an 
internal consistency reliability Chronbach-α of 0.89 [191].  
 Visual function – The five-item Impact of Visual Impairment Scale (IVIS) 
assesses how much vision-dependent activities that are not correctable with 
visual aids are affected by MS-related visual dysfunction. It has an internal 
consistency reliability Chronbach-α of 0.87 [191]. Higher scores represent 
greater visual dysfunction affecting daily activities. 
 Bladder function – This is examined via the four-item Bladder Control Scale 
(BCS). It has an internal consistency reliability Chronbach-α of 0.84 [191]. 
Higher scores indicate greater dysfunction.  
 Bowel function – This is assessed via the five-item Bowel Control Scale 
(BWCS). This scale has an internal consistency reliability Chronbach-α of 
0.76 [191]. Higher scores indicate greater dysfunction.  
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 Sexual functioning and sexual relationships – This is assessed via the four-
item Sexual Satisfaction Scale (SSS), which has an internal consistency 
reliability Chronbach-α of 0.92 [191]. Higher scores indicate less 
satisfaction/more problems in this area. 
The next set of secondary patient report outcome measures focused on the putative 
processes of mindfulness. They included the Mindful Attention Awareness Scale 
(MAAS) [145] and the Self-Compassion Scale-short Form (SCS-sf) [201]. 
 The MAAS is a generic single construct measure of mindfulness, designed to 
capture data on present-centred awareness, or the ‘presence/absence’ from 
everyday experiences. It has 15 items, and can be used by the novice or 
experienced practitioner alike. The MAAS has been reported as having good 
internal consistency (with a Chronbach-α of 0.78-0.92), test-retest reliability, 
and construct validity, with weak-moderate correlations with other commonly 
used measures of mindfulness [198]. Higher scores indicate higher levels of 
mindfulness, and more experienced meditators have been found to score more 
highly than novice counterparts [198]. Normative levels in community adults 
have a mean value of 4.20 (SD 0.69) [145]. 
 Neff [202] describes the construct of self-compassion as ‘..the ability to hold 
one’s feelings of suffering with a sense of warmth, connection, and concern.’, 
with the construct having three key components: 1) kindness – treating oneself 
with care, 2) common humanity – recognising the universality of imperfection 
in human experiencing, and 3) mindfulness – a balanced perspective. Six 
second-order components are assessed via the questions in the SCS-sf (I. 
common humanity – items 5,10; vs. II. isolation – items 4,8; III. mindfulness – 
items 3,7; vs. IV. over identification – items 1,9; and V. self-judgement – 
items 11,12; VI. vs. self-kindness – items 2,6) [201]. The SCS-sf is a 12-item 
scale that asks participants to score their experiences from 1-5, with items 
covering self-judgement, isolation, and over-identification being reverse 
scored. Higher overall scores indicate being more compassionate towards 
one’s self. Originating from the Netherlands, it has been validated in English, 
with adequate internal consistency and reliability, having a Chronbach-α of 
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0.86. Mean (SD) normative values in clinical populations are quoted as 2.80 
(0.74) [201].  
Finally, given that difficulties with emotional regulation are commonly described 
amongst people with MS, a measure of emotional lability was also included. At the 
time of protocol development, the researcher was not aware of any validated scale for 
measuring emotional lability in people with MS. Following a combination of 
literature searching and discussion with expert neuropsychology clinicians in the field 
(Dr. Niall Broomfield, NHS GGC), the Emotional Lability Questionnaire (ELQ) 
[194] was chosen.  
 The ELQ was originally designed for use in people with Motor Neurone 
Disease (MND), another neurodegenerative condition with some features 
similar to MS, including high levels of emotional lability [194]. Adapting this 
scale for people with MS involved discussing its use with the scale authors’, 
who suggested simply substituting in the term ‘MS’ to replace MND in scale 
items numbered: 11, 22, and 33. The ELQ has 33-items, and is described by 
its authors as having confirmed internal consistency, particularly in cases of 
pathological emotional lability [194]. There was very little psychometric data 
on the ELQ in the literature, aside from one validation study in Italian MND 
patients [195].  
Data was also collected on a range of demographics including age, sex, education, 
SES, disease duration, level of disability (EDSS), comorbidities, drug usage including 
DMDs, analgesics, and psychotropics, and previous exposure to meditation and/or 
yoga. All participants completed the initial questionnaire with the researcher in 
attendance, in order that any practical problems, or difficulties interpreting the 
questions were identified and addressed at this early stage. Subsequent follow-up 
questionnaires were posted out to participants to complete on their own immediately 
post-intervention, and then again three-months following completion of the 
intervention. 
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6.5 Results 
6.5.1 Baseline data 
Table 6.2 (below) summarises baseline data for participants allocated to MBSR 
versus the control group. At baseline, mean age (SD) for the total sample was 44.96 
(10.90). Participants were predominantly female (n=46, 92%), most being White 
Scottish (n=49, 98%). Phenotypic breakdown included 40 people with RRMS (80%), 
eight (16%) with SPMS, and two (4%) with PPMS. Intervention and control groups 
were similar at baseline, with respect to age, sex, and SES, and the only significant 
difference between the groups related to previous exposure to meditation and/or yoga 
practice. For this reason, previous meditation/yoga experience was also controlled for 
in the adjusted analyses. 
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Table  6.2 Baseline characteristics 
 Intervention Control Significance p  
Mean age in years (standard deviation - SD) 43.6 (10.7) 46.3 (11.1) 0.37 
Sex Female 23 (92%) Female 22 (88%) 1.00 
Ethnicity White British 25 (100%) White British 25 (100%) 1.00 
MS phenotype 
RRMS – relapsing remitting; SPMS – secondary 
progressive; PPMS – primary progressive 
RRMS 22 (88%) 
SPMS 1 (4%) 
PPMS 2 (8%) 
RRMS 18 (72%) 
SPMS 7 (28%) 
 
0.74 
Deprivation decile 5.0 (2.8) 5.4 (2.6) 0.64 
Education – highest level Secondary school 3 (12%) 
College 7 (28%) 
University 15 (60%) 
Secondary school 5 (20%) 
College 7 (28%) 
University 13 (52%) 
0.73 
Employment Full time 4 (16%) 
Part time 3 (12%) 
Unemployed 6 (24 %) 
Retired 5 (20%) 
Other 7 (28%) 
Full time 7 (28%) 
Part time 6 (24%) 
Unemployed 7 (28%) 
Retired 3 (12%) 
Other 2 (8%) 
0.39 
Living arrangement Lives alone 6 (24%) 
With partner 9 (36%) 
With family/friends 10 (40%) 
Lives alone 3 (12%) 
With partner 10 (40%) 
With family/friends 12 (48%) 
0.54 
EDSS 4.5 (1.8) 4.3 (1.7) 0.64 
Mean disease duration in years (SD) 8.9 (8.5) 9.6 (9.4) 0.79 
Mean total comorbidity count (SD) 2.5 (2.2) 2.3 (1.9) 0.68 
Mean mental health comorbidity count (SD) 0.8 (0.83) 0.7 (0.8) 0.73 
Mean physical health comorbidity count (SD) 1.8 (1.5) 1.6 (1.5) 0.71 
Using analgesic drugs 19 (76%) 17 (68%) 0.75 
Using disease modifying drugs 14 (56%) 12 (48%) 0.78 
Using psychotropic drugs 12 (48%) 11 (44%) 1.00 
Previous meditation/yoga experience 17 (68%) 10 (40%) 0.04 
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6.5.2 Primary feasibility outcomes 
6.5.2.1 Patient recruitment and retention in the trial 
In total 101 patients were approached via the different recruitment sites. From this 
overall number, 66 (65%) contacted the researcher (RS) and were screened. After 
screening, three people were deemed ineligible (EDSS>7.0), whilst 13 decided at that 
stage not to take part for the following reasons: difficulties securing transport (n=7), 
difficulties getting time off work (n=4), perception the course would be too tiring 
(n=1), and for unclear reasons in the remaining person. The consent rate was thus 
50/66, or 76%. Thus the original recruitment target of 50 people was met. These 
individuals were recruited and completed baseline measures, before being randomised 
to receive either the MBSR intervention, or to go on to a wait list control group, 
where they would continue to complete measures at the same time points as those 
receiving MBSR. 
Recruitment to the target n of 50 was completed by week 10, out of the pre-specified 
12 weeks (Table 6.3). 
No index entries found.Table  6.3 Sources of trial recruitment  
Source of engagement/ 
recruitment 
Numbers known 
to have been 
approached 
Numbers 
(known) 
expressing 
interest 
Numbers 
recruited 
into trial 
(n/50) 
Percentage of 
recruitment 
overall 
MS Specialist Nurses 75 52 34 68% 
MS Revive Nurse 6 6 6 12% 
Integrative Medicine 
Specialists 
9 9 5 10% 
General practitioners 11 11 5 10% 
Via MS Society 
advertisement 
Freely available 
online 
2 0 0% 
Via University web 
(Twitter/ Facebook) 
Freely available 
online 
0 0 0% 
Via protocol (clinical 
trials.gov) 
Freely available 
online 
5 0 0% 
Total 101(+) 85 50 N/A 
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6.5.3 Participant flow 
The flow of participants throughout this study is detailed in the following CONSORT 
flow diagram (Figure 6.1) 
Figure  6.1 CONSORT flow diagram 
 
For all participants, measures were taken at baseline during the three-month 
recruitment window prior to the first MBSR course commencing, at the end of the 
first MBSR course at two-months, and then at follow-up, a further three months later. 
All 50 participants completed baseline questionnaire measures with the researcher 
present, requiring minimal assistance. Despite initial concerns that the length of the 
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questionnaire might be too long for participants, a pilot sample of the first five 
participants completing it identified no such issue, so the decision was made to stick 
with the full-length version throughout the study. At the post-intervention time point, 
45/50 (90%) participants returned the questionnaire measures by post. In two cases, 
measures had to be re-sent, having become lost in transit. At follow-up (three months 
following the completion of the MBSR course) the number of participants returning 
measures had only dropped slightly to 44/50 (88%). Facilitating this high level of 
return necessitated several telephone reminders to participants, with an average 
number of 4.4 telephone calls per person, and 222 in total. Retention rate in the study 
varied from 90% immediately post-intervention, to 88% three months following 
MBSR.  
Missing values varied considerably across the measures and time points. Twelve of 
the 14 measures accrued levels for missing values below 20%, with the lowest levels 
being for the EQ-5D-5L (0-12%), and the highest levels being seen for the SCS-sf (2-
22%). For full details regarding missing values, see Appendix H. 
6.5.3.1 Treatment adherence 
Adherence to treatment was defined by how closely participants followed their 
prescribed practices for the MBSR treatment [310]. In this study, this was measured 
via MBSR session attendance and self-reported home practice completion rates. 
Of those allocated to the intervention, only 21 out of 25 (88%) were able to attend any 
of the MBSR classes. From the four who did not attend any of the classes, reasons 
reported for not taking part included: not wishing to be allocated to MBSR at the first 
iteration, where the later course dates suited better; becoming involved in another MS 
trial with a pharmacological intervention; becoming too unwell to participate; and 
experiencing family conflict. Four people (16%) only attended one session, with 
reasons cited for not coming back as: having expected the course to be one-to-one 
therapy (n=1), or not liking the mindfulness approach (n=2). One participant could 
not be contacted following his departure from the course, but feedback from his MS 
Specialist Nurse suggested his leaving was due to social anxiety. Reasons accounting 
for non-attendance are highlighted in Figure 6.1. 
Mindfulness-based interventions for people with MS 
 
 140 
For those continuing to attend the classes, reasons cited for non-attendance at 
individual MBSR sessions varied, from difficulty getting up on time; transport 
difficulties; problems arranging childcare; work commitments; inter-current illness 
including MS relapses, or having a cold; to being on holiday. For a detailed 
breakdown of MBSR attendance, see Table 6.4 below: 
Table  6.4 MBSR session completion rate 
MBSR sessions completed Number of participants Percentage (%) 
All 3 12% 
7 8 32% 
6 3 12% 
5 1 4% 
4 0 0% 
3 1 4% 
2 1 4% 
1 4 16% 
0 4 16% 
 
From the 25 participants allocated to MBSR there was a completion rate of 60% 
(15/25). This is adjudged via a cut-off value of four or more MBSR sessions being 
taken as a minimum attendance for ‘completion’ of the course [197, 311, 312]. 
From those 25 participants initially allocated to the control arm, four dropped-out of 
the course altogether, one citing family bereavement, and the remaining three not 
being able to get time off work. 
In terms of home practice adherence, all MBSR participants were routinely asked to 
do this for the duration of the course. However, only 16 participants returned figures 
in this regard, and from their responses this generated an average practice time of 32.5 
minutes/day.  
6.5.3.2 Protocol deviations 
The only deviation that was necessary related to mindful-movement, which had been 
anticipated as a possibility during the pre-trial development stage in discussions with 
the MBSR instructors. In the event, the MBSR instructors responded reflexively to 
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the perceived needs of the group, in terms of their level of physical disability and how 
they were responding to the practices during the course. This was in keeping with 
their usual practice for delivering mindfulness courses. However, despite this, the 
level of disability encountered by the MBSR instructors, along with participant 
responses to the practices, led to the instructors having to adapt more extensively than 
they had anticipated, in order that they meet the needs of the group. Thus, following 
the first few MBSR sessions, discussion took place with an experienced 
physiotherapist/ mindfulness teacher at the NHS CIC, and based on this a simplified 
version of the movement practice was administered subsequently that allowed 
engagement from a seated position, to include head movements, hand movements, 
wrist rotations, shoulder rolls, shoulder circles, arm movements, and foot slides.  
6.5.3.3 Adverse events 
One participant allocated to the intervention group reported an exacerbation in her 
symptoms of neuropathic pain following her first, and only class. This is reported in 
greater detail in the qualitative research chapter. 
6.5.4 Outcomes and Estimation 
There were no significant differences between the groups on any of the baseline 
outcome measures. The models presented below are adjusted for 
age/sex/deprivation/previous yoga/meditation experience. For unadjusted models, see 
Appendix I. Overall, in the models adjusted for age, sex, SES, and previous 
meditation/yoga experience, at the immediate post-intervention point, 14 out of 15 
patient outcomes showed a positive trend for treatment effects from MBSR (Figure 
6.2). At follow-up (three-months after the end of the course), 14 out of the 15 patient 
report outcomes showed a trend towards improvement (Figure 6.3). These findings 
are explained further below in terms of primary and secondary outcomes. 
6.5.4.1 Primary patient outcomes 
6.5.4.1.1 Post-intervention 
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Immediately post-MBSR, scores on the Perceived Stress Scale-10 (PSS-10) were 
improved in the treatment group with a large effect size (ES 0.93; 95%CI 0.41 – 1.44; 
p<0.01). These improvements post-MBSR were large for both the items on the PSS-
10 representing a decrease in the negative aspects of perceived stress (ES 0.82; 
95%CI 0.29 – 1.34; p<0.05); and for those items measuring stress resilience (ES 0.92 
95%CI 0.40 – 1.45; p<0.05) (Table 6.5). From the overall PSS-10 baseline scores, the 
changes noted in the treatment group are likely to be clinically significant, with a 
reduction from abnormally high stress scores (>18) to those approximating normative 
levels (12-13). 
Effect sizes for QOL on the EQ-5D-5L scores were very small at post-MBSR in both 
un-weighted (ES 0.13; 95%CI -0.48 – 0.74; p=0.66), and weighted scores (ES 0.17; 
95%CI -0.3 – 0.61; p=0.48), and negligible on the Area-Under-the-Curve (AUC) 
analysis (ES 0.00; 95%CI -0.50 – 0.75; p=0.80). On the EQ-5D-5L subscales, the 
largest effect size was found on the subscale for anxiety/depression (ES 0.41; 95%CI 
-0.16 – 0.90; p=0.16), with negligible effect sizes found on subscales for mobility (ES 
0.07; 95%CI -0.60 – 0.73; p=0.85), pain/discomfort (ES 0.05; 95%CI -0.63 – 0.52; 
p=0.86), self-care (ES 0.03; 95%CI -0.65 – 0.58; p=0.92), and usual activities (ES 
0.01; 95%CI -0.59 – 0.57; p=0.97) (Table 6.6). 
6.5.4.1.2 Three-month follow up 
At three-month follow-up, the effect size favouring MBSR for overall PSS-10 scores  
was small (ES 0.26; 95%CI 0.26 -0.37 – 0.85; p=0.39). The effect size in favour of 
MBSR was very small for items measuring the negative aspects of stress (ES 0.12; 
95%CI -0.52 - 0.77; p=0.71), but was somewhat higher for items measuring stress 
resilience (ES 0.46; 95%CI -0.01 – 0.91; p=0.05) (Table 6.5).  
Effect sizes for improvements in EQ-5D-5L QOL favouring MBSR were small for 
un-weighted values (ES 0.23; 95%CI -0.43 – 0.89; p=0.48), and very small for 
weighted values (ES 0.08; 95%CI 0.35 – 0.50; p=0.71), and on the AUC analysis (ES 
0.10; 95%CI -0.50 – 0.80; p=0.71). Once again, on the EQ-5D-5L subscales the 
largest effect size favouring MBSR was on the anxiety/depression subscale (ES 0.26; 
95%CI -0.38 – 0.90; p=0.42), with very small effect sizes evident on scores for usual 
activities (ES 0.12; 95%CI -0.51 – 0.74; p=0.69), mobility (ES 0.11; 95%CI -0.78 – 
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0.53; p=0.70), self-care (ES 0.10; 95%CI -0.52 – 0.70; p=0.77), and pain/discomfort 
(ES 0.06; 95%CI -0.57 – 0.69; p=0.85) (Table 6.6) 
6.5.4.2 Secondary patient outcomes 
6.5.4.2.1 Post intervention 
At the post-MBSR time point, improved scores favouring the intervention were 
evident on a number of the MSQLI measures (Table 6.7). Medium magnitude effect 
sizes were evident for the Sexual Satisfaction Scale (SSS) (ES 0.70; 95%CI -0.20 – 
1.60; p=0.12), the Modified Fatigue Impact Scale (MFIS) (ES 0.63; 95%CI -0.02 – 
1.12; p=0.06), and the Mental Health Inventory (MHI) (ES 0.54; 95%CI -0.03 – 1.10; 
p=0.06). Smaller effect sizes were evident on the Pain Effects Scale (PES) (ES 0.44; 
95%CI -0.14 – 1.01; p=0.13), the Perceived Deficits Questionnaire (PDQ) (ES 0.43; 
95%CI -0.15 – 1.02; p=0.14), and the Impact of Visual Impairment Scale (IVIS) (ES 
0.30; 95%CI -0.23 – 0.82; p=0.26). Very small effect sizes for improvement were also 
discernable on scores for the Bowel Control Scale (BWCS) (ES 0.16; 95%CI -0.41 – 
0.72; p=0.58) and the Bladder Control Scale (BCS), (ES 0.13; 95%CI -0.41 – 0.68; 
p=0.62), with negligible effect size improvements on the Modified Social Support 
Survey (MSSS) (ES 0.03; 95%CI -0.59 – 0.66; p=0.91).  
Analysis of the MSQLI subscales demonstrated that on the MFIS, the largest effect 
size for improvement was on the subscale for cognitive fatigue (ES 0.57; 95%CI -0.04 
– 1.19; p=0.07), followed by psychosocial fatigue (ES 0.49; 95%CI -0.07 – 1.07; 
p=0.09), and then physical fatigue (ES 0.45; 95%CI -0.08 – 0.99; p=0.10) (Table 6.8). 
On the MHI, improvements in depression scores had a large effect size (ES 1.35; 
95%CI 0.11 – 2.59; p<0.05), as did those for positive affect (ES 0.87; 95%CI -0.27 – 
2.00; p=0.13), and anxiety (ES 0.85; 95%CI -0.01 – 1.69; p=0.05) (Table 6.9). Scores 
for behavioural control had a medium effect size (ES 0.51; 95%CI -0.32 – 1.33; 
p=0.22) (Table 6.9). Further, cognitive function scores from the PDQ demonstrated 
improvements on subscales for attention/concentration (ES 0.62; 95%CI 0.05 – 1.19; 
p<0.05), and prospective memory (ES 0.56; 95%CI -0.01 – 1.14; p=0.05), both of 
which had medium effect sizes, whilst those on the retrospective memory subscale 
(ES 0.37; 95%CI -0.16 – 0.91; p=0.17), and the planning/organisation subscale (ES 
0.29; 95%CI -0.24 – 0.85; p=0.27) were small (Table 6.10). On the MSSS subscales, 
Mindfulness-based interventions for people with MS 
 
 144 
improvements were evident for tangible support with a small effect size (ES 0.26; 
95%CI -0.38 – 0.89; p=0.42), whilst those for affectionate support were very small 
(ES 0.13; 95%CI -0.45 – 0.55; p=0.88), and negligible for positive interactions (ES 
0.04; 95%CI -0.48 – 0.55; p=) and emotional support (ES 0.01; 95%CI -0.63 – 0.64; 
p=0.85) (Table 6.11). 
With respect to measures of self-compassion and mindfulness, scores on the Self-
Compassion Scale-short form (SCS-sf) (ES 0.78; 95%CI 0.23 – 1.32; p<0.01) and the 
Mindful-Attention Awareness Scale (MAAS) (ES 0.50; 95%CI -0.08 – 1.09; p=0.09) 
both improved in the treatment group with a medium effect size (Table 6.12) (Table 
6.13). On closer scrutiny of the SCS-sf subscales, improvements noted in the 
treatment group were largest for common humanity (ES 1.01; 95%CI -0.06 – 1.06; 
p=0.08) and isolation (ES 0.80; 95%CI 0.26 – 1.40; p<0.01) subscales, with small 
effect sizes also seen on self-judgement (ES 0.58; 95%CI 0.05 – 1.12; p<0.05), over-
identified (ES 0.55; 95%CI 0.02 – 1.07; p<0.05), mindfulness (ES 0.48; 95%CI -0.12 
– 1.08; p=0.11), and self-kindness (ES 0.44; 95%CI -0.05 – 0.92; p=0.08) (Table 
6.13). 
Effect sizes for improved Emotional Lability Questionnaire (ELQ) scores favouring 
MBSR were negligible at the immediate post-intervention point (ES 0.06; 95%CI -
0.42 – 0.51; p=0.85) (Table 6.14) 
6.5.4.2.2 Three-month follow-up 
At the three-month follow-up point, improvements for MSQLI scores were most 
evident for the SSS (ES 0.57; 95%CI -0.25 – 1.38; p=0.16) with a medium effect size. 
Improvements with small effect sizes were also seen on the MFIS (ES 0.33; 95%CI -
0.29 – 0.94; p=0.29), the PES (ES 0.32; 95%CI -0.25 – 0.88; p=0.27), the PDQ (ES 
0.29; 95%CI -0.41 – 1.00; p=0.41), and the BWCS (ES 0.28; 95%CI -0.27 – 1.60; 
p=0.31). Improvements for the MHI (ES 0.12; 95%CI -0.52 – 0.81; p=0.66) were 
very small, and negligible for the BCS (ES 0.05; 95%CI -0.50 – 0.62; p=0.85), and 
the IVIS (ES 0.04; 95%CI -0.48 – 0.56; p=0.91). Scores for the MSSS showed 
evidence of deterioration with a small effect size (ES -0.39; 95%CI -0.99 – 0.22; 
p=0.20) (Table 6.7).  
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At the three-month follow-up point, analysis of the MSQLI subscales revealed 
improvements favouring MBSR on the MFIS subscales with small effect sizes for 
cognitive (ES 0.27; 95%CI -0.34 – 0.88; p=0.38), and psychosocial fatigue (ES 0.23; 
95%CI -0.30 – 0.87; p=0.32), and a very small effect size for physical fatigue (ES 
0.17; 95%CI -0.33 – 0.67; p=0.49) (Table 6.8). Analysis of the MHI subscales 
showed persistent reductions in positive affect (ES 0.90; 95%CI -1.88 – 3.89; 
p=0.54), and anxiety (ES 0.82; 95%CI -0.29 – 1.93; p=0.15), both with large effect 
sizes. Scores for behavioural control (ES 0.16; 95%CI -1.25 – 0.94; p=0.77) also 
showed improvement with a small effect size favouring MBSR, but those for 
depression (ES 0.01; 95%CI -2.60 – 2.59; p=1.00) were negligible (Table 6.9). PDQ 
subscale scores revealed improvements favouring MBSR with a large effect size for 
prospective memory (ES 0.81; 95%CI 0.18 – 1.45; p<0.05), and small effect size 
improvements for retrospective memory (ES 0.35; 95%CI -0.29 – 0.99; p=0.28), 
planning/organisation (ES 0.31; 95%CI -0.29 – 0.92; p=0.30), and attention (ES 0.23; 
95%CI -0.37 – 0.91; p=0.40) (Table 6.10). On the MSSS subscales effect sizes for 
improved scores favouring MBSR were very small for positive interactions (ES 0.11; 
95%CI -0.45 – 0.69; p=0.69), and negligible for affectionate support (ES 0.06; 95%CI 
-0.53 – 0.64; p=0.85), and tangible support (ES 0.05; 95%CI -0.58 – 0.67; p=0.88). 
Those for emotional support suggested a deterioration in scores following MBSR, 
with a small effect (ES -0.22; 95%CI -0.83 – 0.39; p=0.47) (Table 6.11).  
At three-month follow-up, improvements with large effect sizes favouring MBSR 
were evident for mindfulness (MAAS scores) (ES 1.21; 95%CI 0.67 – 1.75; p<0.001) 
(Table 6.12), and for self-compassion (ES 0.80; 95%CI 0.18 – 1.43; p<0.05) (Table 
6.13). Analysis of the SCS-sf subscales revealed improvements favouring MBSR with 
a large effect size for common-humanity (ES 1.01; 95%CI 0.45 – 1.57; p<0.01), 
medium effect sizes for self-kindness (ES 0.72; 95%CI 0.13 – 1.22; p<0.05), over-
identification (ES 0.68; 95%CI 0.05 – 1.31; p<0.05), and isolation (ES 0.50; 95%CI -
0.06 – 1.06; p=0.08), but smaller effect sizes for self-judgement (ES 0.34; 95%CI -
0.23 – 0.90; p=0.24), and mindfulness (ES 0.32; 95%CI -0.30 – 0.94; p=0.30) (Table 
6.13). 
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At the three-month follow-up point, effect size for improvements in ELQ scores 
favouring MBSR were negligible (ES 0.07; 95%CI -0.39 – 0.30; p=0.79) (Table 
6.14). 
See Figure 6.2 and Figure 6.3 for a graphical summary of overall treatment effects 
(effect sizes - ESs) for the adjusted models. Also, see Table 6.5 – Table 6.14 for 
results adjusted for age/sex/SES/previous meditation/yoga experience. 
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Figure  6.2 Adjusted overall treatment effects with confidence intervals for MBSR at two 
months (adjusted for age/sex/SES/meditation/yoga) 
EQ5D – EuroQol QOL measure adjusted for age/sex/SES/meditation/yoga; AUC – EuroQol Area Under the Curve 
adjusted for age/sex/SES/meditation/yoga; PSS – Perceived Stress Scale-10 adjusted for 
age/sex/SES/meditation/yoga; MFIS – Modified Fatigue Impact Scale adjusted for age/sex/SES/meditation/yoga; 
MHI – Mental Health Inventory adjusted for age/sex/SES/meditation/yoga; PDQ – Perceived Deficits 
Questionnaire adjusted for age/sex/SES/meditation/yoga; MSSS – Modified Social Support Survey adjusted for 
age/sex/SES/meditation/yoga; PES – Pain Effects Scale adjusted for age/sex/SES/meditation/yoga; IVIS – Impact 
of Visual Impairment Scale adjusted for age/sex/SES/meditation/yoga; BCS – Bladder Control Scale adjusted for 
age/sex/SES/meditation/yoga; BWCS – Bowel Control Scale adjusted for age/sex/SES/meditation/yoga; SSS – 
Sexual Satisfaction Scale adjusted for age/sex/SES/meditation/yoga; MAAS – Mindful Attention Awareness Scale 
adjusted for age/sex/SES/meditation/yoga; SCS-sf – Self-Compassion Scale – short form adjusted for 
age/sex/SES/meditation/yoga; ELQ – Emotional Lability Questionnaire adjusted for age/sex/SES/meditation/yoga   
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Figure  6.3 Adjusted overall treatment effects with confidence intervals for MBSR at five 
months (adjusted for age/sex/SES/meditation/yoga) 
EQ5D – EuroQol QOL measure adjusted for age/sex/SES/meditation/yoga; AUC – EuroQol Area Under the Curve 
adjusted for age/sex/SES/meditation/yoga; PSS – Perceived Stress Scale-10 adjusted for 
age/sex/SES/meditation/yoga; MFIS – Modified Fatigue Impact Scale adjusted for age/sex/SES/meditation/yoga; 
MHI – Mental Health Inventory adjusted for age/sex/SES/meditation/yoga; PDQ – Perceived Deficits 
Questionnaire adjusted for age/sex/SES/meditation/yoga; MSSS – Modified Social Support Survey adjusted for 
age/sex/SES/meditation/yoga; PES – Pain Effects Scale adjusted for age/sex/SES/meditation/yoga; IVIS – Impact 
of Visual Impairment Scale adjusted for age/sex/SES/meditation/yoga; BCS – Bladder Control Scale adjusted for 
age/sex/SES/meditation/yoga; BWCS – Bowel Control Scale adjusted for age/sex/SES/meditation/yoga; SSS – 
Sexual Satisfaction Scale adjusted for age/sex/SES/meditation/yoga; MAAS – Mindful Attention Awareness Scale 
adjusted for age/sex/SES/meditation/yoga; SCS-sf – Self-Compassion Scale – short form adjusted for 
age/sex/SES/meditation/yoga; ELQ – Emotional Lability Questionnaire adjusted for age/sex/SES/meditation/yoga   
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Table  6.5 Adjusted scores (Age, sex, deprivation, previous meditation/yoga experience) for primary stress outcome measure – Perceived Stress 
Scale-10 
 Mean (SD) Change from baseline Treatment effect* (95% 
CI), Significance 
(*Intervention-control) 
Effect size 
(Cohen’s ‘d’) 
(95% CI) 
Measure Time Intervention Control Intervention Control   
Perceived 
stress scale - 
overall 
Baseline 21.08 (1.72) 21.96 (1.34) N/A N/A N/A N/A 
Post 13.50 (7.62) 21.77 (8.01) -7.50 (-8.00)
  
-0.32 (-6.27) -7.34 (-11.44 - -3.23), 
p=<0.01 
0.93 (0.41 – 
1.44) 
F/u 16.05 (7.94) 18.83 (5.93) -4.40 (7.16) -2.87 (4.60) -1.51 (-5.04 – 2.20), p=0.39 0.26 (-0.37 – 
0.85) 
Perceived 
stress scale – 
negative 
stressors 
Baseline 14.56 (6.09) 14.60 (4.97) N/A N/A N/A N/A 
Post 9.10 (5.26) 14.23 (5.80) -5.00 (5.96) -0.27 (4.76) -4.75 (-7.81 - -1.69), 
p<0.05 
0.82 (0.29 – 
1.34) 
F/u 10.15 (6.55) 11.48 (5.30) -3.75 (5.81) -3.13 (3.60) -0.56 (-3.61 – 2.49), p=0.71 0.12 (-0.52 - 
0.77) 
Perceived 
stress scale – 
stress 
resilience 
Baseline 6.79 (2.82) 7.36 (2.72) N/A N/A N/A N/A 
Post 4.40 (2.58) 7.54 (2.91) -2.50 (2.48) 0.04 (2.64) -2.60 (-4.08 - -1.12), 
p<0.05 
0.92 (0.40 – 
1.45) 
F/u 5.90 (1.92) 7.34 (1.72) -0.65 (2.28) 0.26 (2.78) -1.17 (-2.34 - -0.02), 
p=0.05 
0.46 (-0.01 – 
0.91) 
F/u – Follow up; N/A – Not applicable 
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Table  6.6 Adjusted scores (Age, sex, deprivation, previous meditation/yoga experience) for primary QOL outcome measures – EQ-5D-5L and Area 
under the curve analysis 
 Mean (SD) Change from baseline Treatment effect* (95% 
CI), Significance 
(*Intervention-control) 
Effect size 
(Cohen’s ‘d’) 
(95% CI) 
Measure Time Intervention Control Intervention Control   
EQ-5D un-
weighted 
Baseline 12.20 (3.21) 11.36 (4.20) N/A N/A N/A N/A 
Post 11.62 (3.22) 11.43 (3.88) -0.71 (2.00) -0.13 (2.94) -0.34 (-1.88 – 1.21), p=0.66 0.13 (-0.48 – 
0.74) 
F/u 11.62 (3.57) 11.35 (4.41) -0.71 (2.01) 0.04 (2.72) -0.57 (-2.17 – 1.04), p=0.48 0.23 (-0.43 – 
0.89) 
EQ-5D 
weighted 
Baseline 0.53 (0.23) 0.56 (0.27) N/A N/A N/A N/A 
Post 0.55 (0.23) 0.59 (0.23) 0.02 (0.18) 0.05 (0.17) -0.04 (-0.14 – 0.07), p=0.48 0.17 (-0.3 – 
0.61) 
F/u 0.54 (0.24) 0.58 (0.28) 0.01 (0.20) 0.02 (0.17) -0.02 (-0.13 – 0.09), p=0.71 0.08 (-0.35 – 
0.50) 
EQ-5D – Area 
under the 
curve 
Baseline N/A N/A N/A N/A N/A N/A 
Post 0.09 (0.04) 0.10 (0.04) N/A N/A 0.00 (-0.03 – 0.02), p=0.80 0.00 (-0.50 – 
0.75) 
F/u 0.24 (0.09) 0.24 (0.10) N/A N/A -0.01 (-0.08 – 0.05), p=0.71 0.10 (-0.50 – 
0.80) 
EQ-5D - 
Mobility 
Baseline 2.68 (1.03) 2.44 (1.16) N/A N/A N/A N/A 
Post 2.67 (1.24) 2.48 (1.12) -0.14 (0.58) 0.00 (0.85) -0.05 (-0.53 – 0.44), p=0.85 0.07 (-0.60 – 
0.73) 
F/u 2.81 (1.08) 2.43 (1.12) 0.00 (0.55) 0.04 (0.64) 0.07 (-0.31 – 0.46), p=0.70 0.11 (-0.78 – 
0.53) 
EQ-5D – Self-
care 
Baseline 1.72 (0.89) 1.64 (0.95) N/A N/A N/A N/A 
Post 1.81 (0.81) 1.70 (0.93) 0.00 (0.71) 0.00 (0.60) 0.02 (-0.38 – 0.42), p=0.92 0.03 (-0.65 – 
0.58) 
F/u 1.76 (0.89) 1.70 (0.88) 0.74 (-0.05) 0.09 (0.73) -0.07 (-0.51 – 0.38), p=0.77 0.10 (-0.52 – 
0.70) 
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EQ-5D – 
Usual 
activities 
Baseline 2.64 (0.91) 2.44 (1.19) N/A N/A N/A N/A 
Post 2.57 (0.87) 2.48 (1.12) 0.00 (0.89) 0.00 (1.04) 0.01 (-0.55 – 0.57), p=0.97 0.01 (-0.59 – 
0.57) 
F/u 2.52 (1.08) 2.57 (1.20) -0.05 (0.86) 0.13 (0.97) -0.11 (-0.67 – 0.46), p=0.69 0.12 (-0.51 – 
0.74) 
EQ-5D – Pain/ 
discomfort 
Baseline 2.72 (1.17) 2.60 (1.15) N/A N/A N/A N/A 
Post 2.62 (0.97) 2.61 (1.03) -0.10 (0.44) -0.04 (0.77) 0.03 (-0.32 – 0.39), p=0.86 0.05 (-0.63 – 
0.52) 
F/u 2.57 (1.03) 2.52 (1.16) -0.14 (0.57) -0.09 (0.73) -0.04 (-0.45 – 0.37), p=0.85 0.06 (-0.57 – 
0.69) 
EQ-5D – 
Anxiety/ 
depression 
Baseline 2.44 (0.82) 2.24 (0.83) N/A N/A N/A N/A 
Post 1.95 (0.67) 2.17 (0.89) -0.47 (0.68) -0.09 (0.73) -0.30 (-0.71 – 0.12), p=0.16 0.41 (-0.16 – 
0.97) 
F/u 1.95 (0.97) 2.13 (0.97) -0.48 (0.93) -0.13 (0.69) -0.21 (-0.74 – 0.31), p=0.42 0.26 (-0.38 – 
0.90) 
 
F/u – Follow up; N/A – Not applicable 
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Table  6.7 Adjusted scores (Age, sex, deprivation, previous meditation/yoga experience) for the Multiple Sclerosis Quality of Life Inventory 
 Mean (SD) Change from baseline Treatment effect* (95% 
CI), Significance 
(*Intervention-control) 
Effect size 
(Cohen’s ‘d’) (95% 
CI) 
Measure Time Intervention Control Intervention Control   
Modified 
fatigue impact 
scale - MFIS 
Baseline 53.21 (18.68) 54.26 (16.77) N/A N/A N/A N/A 
Post 38.47 (19.84) 49.91 (17.19) -13.33 (14.56) -4.18 (10.87) -8.32 (-16.87 – 0.24), 
p=0.06 
0.62 (-0.02 – 1.12) 
F/u 42.95 (18.58) 50.00 (15.54) -9.5 (14.58) -3.91 (11.15) -4.24 (-12.21 – 3.75), 
p=0.29 
0.33 (-0.29 – 0.94) 
Mental health 
inventory - 
MHI 
Baseline 68.92 (17.48) 67.45 (16.87) N/A N/A N/A N/A 
Post 83.52 (14.18) 74.22 (16.53) 13.43 (13.65) 6.10 (13.00) 7.34 (-0.36 – 15.05), 
p=0.06 
0.54 (-0.03 – 1.10) 
F/u 78.29 (19.60) 73.41 (17.08) 8.19 (18.44) 6.25 (8.73) 2.08 (-7.46 – 11.62), 
p=0.66 
0.14 (- 0.52 – 0.81) 
Perceived 
deficits scale - 
PDQ 
Baseline 38.48 (16.24) 39.04 (14.36) N/A N/A N/A N/A 
Post 29.05 (12.31) 34.32 (14.81) -9.00 (12.98) -4.10 (8.77) -4.77 (-11.17 – 1.64), 
p=0.14 
0.43 (-0.15 – 1.02) 
F/u 33.18 (16.94) 35.23 (14.65) -5.47 (7.16) -2.29 (7.71) -2.21 (-7.54 – 3.13), p=0.41 0.29 (-0.41 – 1.00) 
Modified 
social support 
survey - MSSS 
Baseline 44.61 (25.05) 43.12 (20.74) N/A N/A N/A N/A 
Post 45.60 (26.93) 41.45 (17.01) 0.99 (10.62) -1.67 (15.69) 0.47 (-8.05 – 8.99), p=0.91 0.03 (-0.59 – 0.66) 
F/u 44.00 (25.40) 45.27 (21.36) 0.61 (8.99) 2.15 (16.98) -5.60 (-14.34 – 3.15), 
p=0.20 
-0.39 (-0.99 – 0.22) 
Pain effects 
scale - PES 
Baseline 17.76 (5.75) 18.17 (6.04) N/A N/A N/A N/A 
Post 14.29 (4.71) 17.00 (5.65) -3.47 (4.13) -1.17 (5.48) -1.90 (-4.41 – 0.61), p=0.13 0.44 (-0.14 – 1.01) 
F/u 14.48 (5.73) 17.22 (5.69) -3.28 (4.82) -0.95 (4.70) -1.56 (-4.35 – 1.23), p=0.27 0.32 (-0.25 – 0.88) 
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Impact of 
visual 
impairment 
scale - IVIS 
Baseline 7.08 (3.29) 7.54 (3.64) N/A N/A N/A N/A 
Post 6.55 (2.52) 7.37 (3.12) -0.53 (3.36) -0.17 (3.16) -0.80 (-2.21 – 0.61), p=0.26 0.30 (-0.23 – 0.82) 
F/u 6.90 (2.77) 7.47 (3.30) -0.18 (3.14) -0.07 (3.23) 0.11 (-1.46 – 1.25), p=0.91 0.04 (-0.48 – 0.56) 
Bladder 
control scale - 
BCS 
Baseline 9.71 (6.15) 9.33 (5.82) N/A N/A N/A N/A 
Post 7.86 (4.79) 7.61 (4.67) -1.85 (3.94) -1.72 (3.72) 0.51 (-1.56 – 2.58), p=0.62 0.13 (-0.41 – 0.68) 
F/u 7.90 (4.75) 8.13 (5.21) -1.81 (4.50) -1.20 (3.15) -0.20 (-2.33 – 1.90), p=0.85 0.05 (-0.50 – 0.62) 
Bowel control 
scale - BWCS 
Baseline 11.87 (6.19) 9.04 (6.43) N/A N/A N/A N/A 
Post 9.80 (5.25) 8.09 (5.15) -2.07 (2.97) -0.95 (6.08) 0.77 (-2.02 – 3.56), p=0.58 0.16 (-0.41 – 0.72) 
F/u 10.05 (5.58) 8.09 (4.44) -1.82 (5.24) -0.95 (4.96) 1.40 (-1.37 – 4.17), p=0.31 0.28 (-0.27 – 0.83) 
Sexual 
satisfaction 
scale - SSS 
Baseline 13.00 (6.50) 13.84 (6.87) N/A N/A N/A N/A 
Post 8.80 (3.88) 14.89 (6.50) 4.20 (4.34) -1.05 (3.56) -2.68 (-6.11 – 0.75), p=0.12 0.70 (-0.20 – 1.60) 
F/u 8.90 (4.43) 14.69 (7.00) -4.10 (2.50) -0.85 (4.85) -2.46 (-6.01 – 1.08), p=0.16 0.57 (-0.25 – 1.38) 
F/u – Follow up; N/A – Not applicable 
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Table  6.8 Adjusted scores (Age, sex, deprivation, previous meditation/yoga experience) for Modified Fatigue Impact Scale sub-scales 
 Mean (SD) Change from baseline Treatment effect* (95% CI), 
Significance 
(*Intervention-control) 
Effect size 
(Cohen’s ‘d’) 
(95% CI) 
Measure Time Intervention Control Intervention Control   
Modified 
fatigue impact 
scale - overall 
Baseline 53.21 (18.68) 54.26 (16.77) N/A N/A N/A N/A 
Post 38.47 (19.84) 49.91 (17.19) -13.33 (14.56) -4.18 (10.87) -8.32 (-16.87 – 0.24), p=0.06 0.62 (-0.02 – 
1.12) 
F/u 42.95 (18.58) 50.00 (15.54) -9.5 (14.58) -3.91 (11.15) -4.24 (-12.21 – 3.75), p=0.29 0.33 (-0.29 – 
0.94) 
Modified 
fatigue impact 
scale - 
cognitive 
Baseline 24.04 (8.89) 23.75 (7.18) N/A N/A N/A N/A 
Post 16.90 (8.49) 22.04 (8.55) -6.55 (7.03) -1.77 (5.87) -3.91 (-8.09 – 0.27), p=0.07 0.57 (-0.04 - 
1.19) 
F/u 17.80 (9.51) 21.17 (7.37) -5.25 (7.13) -2.36 (5.54) -1.73 (-5.67 – 2.19), p=0.38 0.27 (-0.34 - 
0.88) 
Modified 
fatigue impact 
scale - 
physical 
Baseline 24.68 (9.30) 26.92 (11.22) N/A N/A N/A N/A 
Post 18.32 (10.08) 23.96 (8.23) -6.16 (6.94) -3.00 (7.64) -3.36 (-7.36 – 0.62), p=0.10 0.45 (-0.08 – 
0.99) 
F/u 21.19 (8.05) 24.13 (8.08) -3.48 (7.53) -2.56 (8.41) -1.38 (-5.35 – 2.60), p=0.49 0.17 (-0.33 – 
0.67) 
Modified 
fatigue impact 
scale - 
psychosocial 
Baseline 4.72 (2.42) 5.08 (2.30) N/A N/A N/A N/A 
Post 3.45 (2.30) 4.54 (2.04) -1.40 (1.79) -0.54 (1.47) -0.82 (-1.77 – 0.12), p=0.09 0.49 (-0.07 - 
1.07) 
F/u 3.95 (2.40) 4.70 (2.01) -0.90 (1.97) -0.39 (1.47) -0.50 (-1.51 – 0.51), p=0.32 0.23 (-0.30 – 
0.87) 
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Table  6.9 Adjusted scores (Age, sex, deprivation, previous meditation/yoga experience) for Mental Health Inventory sub-scales 
 Mean (SD) Change from baseline Treatment effect* (95% CI), 
Significance 
(*Intervention-control) 
Effect size (Cohen’s 
‘d’) (95% CI) 
Measure Time Intervention Control Intervention Control   
Mental health 
inventory - 
overall 
Baseline 68.92 (17.48) 67.45 (16.87) N/A N/A N/A N/A 
Post 83.52 (14.18) 74.22 (16.53) 13.43 (13.65) 6.10 (13.00) 7.34 (-0.36 – 15.05), p=0.06 0.54 (-0.03 – 1.10) 
F/u 78.29 (19.60) 73.41 (17.08) 8.19 (18.44) 6.25 (8.73) 2.08 (-7.46 – 11.62), p=0.66 0.14 (- 0.52 – 0.81) 
Mental health 
inventory - 
anxiety 
Baseline 51.84 (23.79) 51.84 (17.45) N/A N/A N/A N/A 
Post 72.76 (17.23) 59.65 (24.77) 18.86 (20.20) 8.17 (17.87) 11.15 (-0.04 – 22.34), p=0.05 0.85 (-0.01 – 1.69) 
F/u 67.43 (23.91) 57.56 (22.84) 13.52 (21.45) 6.26 (13.20) 7.96 (-2.88 – 18.81), p=0.15 0.82 (-0.29 – 1.93) 
Mental health 
inventory - 
depression 
Baseline 64.60 (23.14) 60.42 (24.04) N/A N/A N/A N/A 
Post 78.57 (17.19) 64.38 (20.18) 11.90 (17.43) 3.91 (19.24) 10.41 (0.84 – 20.00), p<0.05 1.35 (0.11 – 2.59) 
F/u 70.71 (23.04) 65.68 (22.43) 4.04 (21.72) 5.00 (14.83) -0.03 (-11.75 – 11.70), p=1.00 0.01 (-2.60 – 2.59) 
Mental health 
inventory – 
behavior 
control 
Baseline 62.80 (25.17) 57.29 (21.97) N/A N/A N/A N/A 
Post 78.33 (17.56) 68.33 (22.44) 14.29 (21.29) 9.57 (14.30) 6.01 (-3.80 – 15.81), p=0.22 0.51(-0.32 – 1.33) 
F/u 74.29 (23.84) 71.08 (20.34) 10.24 (24.92) 11.81 (13.68) -1.73 (-13.85 – 10.39), p=0.77 0.16 (-1.25 – 0.94) 
Mental health 
inventory – 
positive affect 
Baseline 46.60 (21.10) 48.00 (23.23) N/A N/A N/A N/A 
Post 62.62 (17.86) 53.12 (20.68) 14.29 (18.05) 4.37 (20.13) 7.80 (-2.39 – 18.00), p=0.13 0.87 (-0.27 – 2.00) 
F/u 55.24 (25.37) 51.52 (21.71) 6.90 (25.22) 1.96 (16.57) 3.91 (-8.92 – 16.75), p=0.54 0.90 (-1.88 – 3.89) 
F/u – Follow up; N/A – Not applicable 
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Table  6.10 Adjusted scores (Age, sex, deprivation, previous meditation/yoga experience) for Perceived Deficits Questionnaire sub-scales 
 Mean (SD) Change from baseline Treatment effect* (95% CI), 
Significance 
(*Intervention-control) 
Effect size 
(Cohen’s ‘d’) (95% 
CI) 
Measure Time Intervention Control Intervention Control   
Perceived 
deficits 
questionnaire - 
overall 
Baseline 38.48 (16.24) 39.04 (14.36) N/A N/A N/A N/A 
Post 29.05 (12.31) 34.32 (14.81) -9.00 (12.98) -4.10 (8.77) -4.77 (-11.17 – 1.64), p=0.14 0.43 (-0.15 – 1.02) 
F/u 33.18 (16.94) 35.23 (14.65) -5.47 (7.16) -2.29 (7.71) -2.21 (-7.54 – 3.13), p=0.41 0.29 (-0.41 – 1.00) 
Perceived 
deficits 
questionnaire - 
attention 
Baseline 11.74 (4.18) 11.08 (3.82) N/A N/A N/A N/A 
Post 8.75 (3.08) 10.22 (4.25) -2.72 (2.89) -1.05 (2.05) -1.59 (-3.05 - -0.12), p<0.05 0.62 (0.05 – 1.19) 
F/u 9.00 (4.61) 9.91 (4.05) -2.11 (2.72) -1.05 (2.46) -0.70 (-2.37 – 0.97), p=0.40 0.23 (-0.37 – 0.91) 
Perceived 
deficits 
questionnaire - 
retrospective 
memory 
Baseline 9.16 (4.5) 9.16 (4.10) N/A N/A N/A N/A 
Post 7.30 (3.66) 8.67 (4.12) -1.65 (3.78) -0.58 (2.84) -1.24 (-3.02 – 0.53), p=0.17 0.37 (-0.16 – 0.91) 
F/u 7.57 (4.56) 8.68 (4.02) -1.33 (2.99) -0.18 (2.63) -0.99 (-2.81 – 0.83), p=0.28 0.35 (-0.29 – 0.99) 
Perceived 
deficits 
questionnaire 
– prospective 
memory 
Baseline 7.42 (3.81) 7.28 (3.59) N/A N/A N/A N/A 
Post 5.75 (2.90) 7.25 (3.77) -1.58 (3.29) -0.05 (2.33) -1.61 (-3.25 – 0.03), p=0.05 0.56 (-0.01 – 1.14) 
F/u 6.00 (4.02) 7.05 (4.05) -2.00 (2.40) -0.09 (1.87) -1.88 (-3.34 - -0.41), p<0.05 0.81 (0.18 – 1.45) 
Perceived 
deficits 
questionnaire 
– planning/ 
organisation 
Baseline 9.80 (5.25) 10.48 (3.75) N/A N/A N/A N/A 
Post 7.15 (3.99) 8.87 (3.67) -2.15 (4.23) -1.57 (3.64) -1.15 (-3.21 – 0.92), p=0.27 0.29 (-0.24 – 0.85) 
F/u 7.90 (4.89) 9.59 (3.80) -1.70 (3.18) -0.64 (2.52) -0.90 (-2.64 – 0.84), p=0.30 0.31 (-0.29 – 0.92) 
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Table  6.11 Adjusted scores (Age, sex, deprivation, previous meditation/yoga experience) for Modified Social Support Survey sub-scales 
 Mean (SD) Change from baseline Treatment effect* (95% CI), 
Significance 
(*Intervention-control) 
Effect size 
(Cohen’s ‘d’) (95% 
CI) 
Measure Time Intervention Control Intervention Control   
Modified 
social support 
survey - 
overall 
Baseline 44.61 (25.05) 43.12 (20.74) N/A N/A N/A N/A 
Post 45.60 (26.93) 41.45 (17.01) 0.99 (10.62) -1.67 (15.69) 0.47 (-8.05 – 8.99), p=0.91 0.03 (-0.59 – 0.66) 
F/u 44.00 (25.40) 45.27 (21.36) 0.61 (8.99) 2.15 (16.98) -5.60 (-14.34 – 3.15), p=0.20 -0.39 (-0.99 – 0.22) 
Modified 
social support 
survey - 
tangible 
Baseline 58.85 (35.69) 57.50 (33.95) N/A N/A N/A N/A 
Post 64.88 (39.99) 59.78 (32.36) 4.68 (21.73) 3.53 (20.11) 5.30 (-7.86 – 18.46), p=0.42 0.26 (-0.38 – 0.89) 
F/u 62.20 (37.42) 59.23 (35.55) 0.63 (19.12) 2.98 (26.77) 1.07 (-13.51 – 15.56), p=0.88 0.05 (-0.58 – 0.67) 
Modified 
social support 
survey - 
emotional 
Baseline 63.88 (34.07) 62.13 (29.61) N/A N/A N/A N/A 
Post 64.38 (38.06) 63.32 (29.25) -4.84 (22.06) 0.27 (27.06) 0.29 (-15.53 – 16.00), p=0.98 0.01 (-0.63 – 0.64) 
F/u 60.27 (34.73) 63.32 (28.90) -6.84 (22.91) 0.82 (23.50) -5.12 (-19.27 – 9.04), p=0.47 -0.22 (-0.83 – 0.39) 
Modified 
social support 
survey - 
affection 
Baseline 53.67 (36.65) 53.00 (33.50) N/A N/A N/A N/A 
Post 57.54 (41.07) 53.82 (28.34) 1.59 (28.21) 24.08 (0.00) 3.43 (-11.55 – 18.41), p=0.65 0.13 (-0.45 – 0.71) 
F/u 58.73 (38.23) 60.98 (36.50) 2.78 (32.10) 7.19 (32.76) -1.83 (-20.68 – 17.01), p=0.85 0.06 (-0.53 – 0.64) 
Modified 
social support 
survey – 
positive 
interactions 
Baseline 69.10 (38.58) 64.00 (32.52) N/A N/A N/A N/A 
Post 61.11 (35.19) 55.80 (23.89) -13.33 (20.30) -6.16 (24.26) 0.85 (-10.74 – 12.44), p=0.88 0.04 (-0.48 – 0.55) 
F/u 66.67 (37.46) 64.13 (34.85) -10.96 (19.26) -0.36 (29.46) -2.85 (-17.37 – 11.66), p=0.69 0.11 (-0.45 - 0.69) 
F/u – Follow up; N/A – Not applicable 
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Table  6.12 Adjusted scores (Age, sex, deprivation, previous meditation/yoga experience) for the Mindful Attention Awareness Scale 
 Mean (SD) Change from baseline Treatment effect* (95% 
CI), Significance 
(*Intervention-control) 
Effect size 
(Cohen’s ‘d’) 
(95% CI) 
Measure Time Intervention Control Intervention Control   
Mindful 
attention 
awareness 
scale - MAAS 
Baseline 3.47 (1.15) 3.32 (0.72) N/A N/A N/A N/A 
Post 4.52 (0.65) 3.88 (0.94) 0.85 (0.67) -0.53 (0.77) 0.44 (-0.07 – 0.96), p=0.09 0.50 (-0.08 – 
1.09) 
F/u 4.42 (0.51) 3.45 (0.84) 1.04 (0.78) 0.11 (0.50) 0.96 (0.54 – 1.39), p<0.001 1.13 (0.63 – 
1.64) 
F/u – Follow up; N/A – Not applicable 
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Table  6.13 Adjusted scores (Age, sex, deprivation, previous meditation/yoga experience) for the Self-Compassion Scale-short form 
 Mean (SD) Change from baseline Treatment effect* (95% 
CI), Significance 
(*Intervention-control) 
Effect size 
(Cohen’s ‘d’) 
(95% CI) 
Measure Time Intervention Control Intervention Control   
Self-
compassion 
scale – short 
form - overall 
Baseline 2.63 (0.85) 2.71 (0.73) N/A N/A N/A N/A 
Post 3.56 (0.82) 2.82 (0.90) 0.92 (0.85) 0.11 (0.68) 0.68 (0.22 – 1.14), p<0.01 0.80 (0.26 – 
1.34) 
F/u 3.44 (0.98) 2.68 (0.80) 0.77 (0.92) 0.03 (0.61) 0.70 (0.17 – 1.23) p<0.05 0.83 (0.20 – 
1.46) 
Self-
compassion 
scale – short 
form – self 
kindness 
Baseline 5.00 (2.19) 5.28 (2.21) N/A N/A N/A N/A 
Post 6.90 (1.84) 5.46 (2.30) 1.95 (2.06) 0.17 (2.55) 1.08 (-0.12 – 2.27), p=0.08 0.44 (-0.05 – 
0.92) 
F/u 6.47 (2.48) 4.70 (2.03) 1.44 (2.66) -0.50 (2.24) 1.78 (0.36 – 3.19), p<0.05 0.72 (0.13 – 
1.22) 
Self-
compassion 
scale – short 
form – self 
judging 
Baseline 4.38 (2.22) 4.96 (2.17) N/A N/A N/A N/A 
Post 6.90 (2.10) 5.50 (2.30) 2.35 (2.66) 0.58 (2.24) 1.50 (0.12 – 2.88), p<0.05 0.58 (0.05 – 
1.12) 
F/u 6.58 (2.59) 5.75 (1.65) 2.00 (2.74) 0.85 (2.23) 0.85 (-0.58 – 2.29), p=0.24 0.34 (-0.23 - 
90) 
Self-
compassion 
scale – short 
form – 
common 
humanity 
Baseline 5.79 (2.20) 5.68 (2.25) N/A N/A N/A N/A 
Post 7.09 (2.07) 5.75 (2.25) 1.45 (2.61) 0.83 (2.26) 1.15 (-0.16-2.46), p=0.08 0.46 (-0.06 – 
0.99) 
F/u 7.67 (2.06) 4.95 (2.33) 1.76 (2.41) 0.65 (1.87) 2.46 (1.10 – 3.83), p<0.01 1.01 (0.45 – 
1.57) 
Self-
compassion 
scale – short 
form - 
isolation 
Baseline 4.92 (2.50) 5.20 (2.08) N/A N/A N/A N/A 
Post 7.24 (2.53) 5.37 (2.58) 2.20 (2.37) 0.21 (2.17) 2.03 (0.63 – 3.44), p<0.01 0.80 (0.26 – 
1.40) 
F/u 6.63 (2.24) 5.45 (2.21) 1.44 (2.71) 0.50 (2.59) 1.33 (-0.16 – 2.82), p=0.08 0.50  (-0.06 – 
1.06) 
Mindfulness-based interventions for people with MS 
 
 160 
Self-
compassion 
scale – short 
form - 
mindfulness 
Baseline 7.00 (2.06) 6.68 (1.95) N/A N/A N/A N/A 
Post 7.81 (2.20) 6.33 (2.23) 0.75 (1.92) 0.42 (1.98) 0.97 (-0.24 – 2.18), p=0.11 0.48 (-0.12 – 
1.08) 
F/u 7.74 (2.16) 6.20 (2.44) 0.28 (2.40) -0.55 (2.16) 0.73 (-0.69 – 2.14), p=0.30 0.32 (-0.30 – 
0.94) 
Self-
compassion 
scale – short 
form – over-
identification 
Baseline 4.50 (2.52) 4.76 (2.01) N/A N/A N/A N/A 
Post 6.76 (2.23) 5.38 (2.28) 2.30 (2.08) 0.75 (1.78) 1.12 (0.04 – 2.19), p<0.05 0.55 (0.02 – 
1.07) 
F/u 6.74 (2.58) 5.10 (2.13) 2.06 (2.21) 0.70 (1.63) 1.37 (0.10 – 2.64), p<0.05 0.68 (0.05 – 
1.31) 
F/u – Follow up; N/A – Not applicable 
Table  6.14 Adjusted scores (Age, sex, deprivation, previous meditation/yoga experience) for the Emotional Lability Questionnaire 
 Mean (SD) Change from baseline Treatment effect* (95% 
CI), Significance 
(*Intervention-control) 
Effect size 
Measure Time Intervention Control Intervention Control   
ELQ Baseline 15.19 (14.18) 15.46 (11.33) N/A N/A N/A N/A 
Post 9.56 (10.15) 9.14 (9.56) -5.63 (9.67) -6.32 (8.21) -0.55 (-6.47 – 5.36), 
p=0.85 
0.06 (-0.42 – 
0.51) 
F/u  8.72 (11.31) 11.00 (8.29) -6.47 (13.58) -4.46 (8.01) -0.79 (-6.76 – 5.18), 
p=0.79 
0.07 (-0.39 – 
0.30) 
F/u – Follow up; N/A – Not applicable.
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Discussion 
6.5.5 Summary of key findings 
This study assessed the key feasibility outcomes from a RCT delivering MBSR to 
people with MS. The recruitment target of 50 participants was met within the pre-
defined three-month period. Study retention rates were excellent (88% or above), and 
missing values generally low. In terms of primary patient outcomes, perceived stress 
scores improved at post-intervention for those receiving MBSR with a large effect 
size, although effect sizes at three-month follow-up were small. Improvements in 
QOL scores were very small at both the immediate post-intervention and three-month 
follow-up points. Secondary patient report outcomes showed improvements with 
large effect sizes immediately post-intervention in scores for depression, positive 
affect, anxiety, and self-compassion. At three-month follow-up, improvements with a 
persisting large effect size were evident for positive affect, anxiety, and self-
compassion, with large effect size improvements also being evident for mindfulness 
and prospective memory.  
6.5.6 Comparison with the existing literature and emergent 
recommendations 
6.5.6.1 Feasibility findings 
Previous studies of MBIs in MS have been diverse. A high quality RCT from 
Switzerland (n=150) [177] assessed standard MBSR in less disabled people with MS 
(mean EDSS 3.0; SD 1.0), in a university hospital setting. Recruitment methods were 
not well described by Grossman et al. [177], other than that over a six-month period a 
total of 164 patients with MS self-referred to the study in response to adverts placed 
in the hospital. The refusal rate was lower than in the current study (24%), at 9%, 
which may be down to the opt-in strategy Grossman et al. [177] employed, or that the 
current study recruitment strategy had a wider reach. Attendance in the Grossman et 
al. [177] study was very good (92%). Grossman et al. [250] did not report on the 
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extent of missing values in their study. Class sizes appear to have been smaller with 
10-15 participants per group, versus 25 in the current study, which may be a factor in 
the higher attendance rates. Average home practice times in Grossman et al. [177] of 
29.2 minutes/day was comparable to findings in the present study (32.5 minutes/day). 
MBSR teachers in Grossman et al. [177] were experienced (>9 years), versus 7.5 
years in the current study. Outcome measure completion in Grossman et al. [177] was 
91% at six-month follow-up, compared with 88% at three-month follow-up in this 
current study.  
In England, in a RCT using a Skype-delivered MBCT intervention with shortened 
mediation exercises of 10-20 minutes, Bogosian et al. [305] recruited participants 
with progressive MS, with the mean (SD) EDSS being 6.5 (1.5), indicating high 
levels of disability – in this current study the mean (SD) EDSS was 4.4 (1.8). 
Participants were only eligible if demonstrating baseline levels of distress, as 
measured by the General Health Questionnaire (GHQ). Bogosian et al. [305] removed 
mindful-movement from the course, based on limited stakeholder input. Bogosian et 
al. [305] reported an attrition rate of 20%, but reasons accounting for this finding 
were vague. Bogosian et al. [305] did not report on levels of missing values. From 
sending out 165 information packs, 115 people responded, 93 were screened, and 40 
were deemed eligible and included. Thus, from the figures provided by Bogosian et 
al. [305], response rate to invitation was 70% (115/165), refusal rate was 67% 
(77/115), and consent rate was 43% (40/93). Attendance at the shortened one-hour 
long MBCT classes in Bogosian et al. [305] was good (95%), compared with 60% in 
this current study, however, no figures were available for home practice times. In 
Bogosian et al. [305], the MBCT classes were taught by the study’s primary author 
(A. Bogosian), potentially introducing an important source of bias. A Bogosian had 
received mindfulness training and had run supervised pilot sessions prior to the 
MBCT course taking place, but no further details were available with respect to years 
of experience as a mindfulness teacher.  
6.5.6.2 Patient report outcome findings 
Improvements in perceived stress in those receiving MBSR were large in this study at 
the intermediate time point, whilst those for QOL were very small. No prior MBI 
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study in people with MS has measured the impact of mindfulness training on 
perceived stress using the PSS, although Bogosian et al. [305] reported a significant 
improvement in distress measured via the GHQ post-MBCT (ES 0.67; p<0.05), and 
three months later (ES 0.97; p<0.05). In addition, Kolahkaj and Zargar [306] 
described significantly improved stress scores on the stress subscale of the 
Depression, Anxiety, and Stress Scale-21 (DASS-21) post-MBSR (ES 1.91; p<0.001) 
and at one-month follow-up (ES 1.98; p<0.001) amongst Iranian women with MS. 
However, findings from this latter study should be interpreted with caution due to the 
low quality of methods and reporting (see Appendix D).  
In this current study, it is not clear why such small differences were found in QOL 
scores between the groups, but it is notable that the largest effect size for 
improvement was on the anxiety/depression subscale, and that higher levels of 
disability have recently been shown to exert an even greater negative impact on QOL 
than depression in people with MS [73]. This may partially explain why neither 
Bogosian et al. [305], nor this current study demonstrated improved QOL, where both 
were using the generic EQ-5D-5L, whilst those studies with lower mean EDSS scores 
(3.0) [177, 304] did find improved scores for QOL, using a mix of generic and/or MS-
specific scales [177] (generic: PQOLC - Profile of Health-Related Quality of Life in 
Chronic Disorders: ES 0.86; p<0.05; and MS-specific: HAQUAMS - Hamburg 
Quality of Life Questionnaire in Multiple Sclerosis: ES 0.43; p<0.05); or generic 
alone [304] (QLS - Quality of Life Satisfaction questionnaire: ES 1.03; p<0.05).  
With respect to secondary patient outcomes in the current study, improvements with a 
large effect size were evident at the intermediate time point for scores for depression, 
positive affect, anxiety, and self-compassion, whilst at follow-up large effect size 
improvements were evident for mindfulness, positive affect, anxiety, self-compassion, 
and prospective memory. In other MBI studies among people with MS that reported 
on mental health outcomes, Grossman et al. [177] described improvements in scores 
for depression at post-intervention (ES 0.65; p<0.001), which were smaller at six-
month follow-up (ES 0.36; p<0.05), and anxiety post-intervention (ES 0.39; p<0.001), 
which were sustained at six-month follow-up (ES 0.36; p<0.05). Grossman et al. 
[177] also carried out sub-group analyses, selecting only those participants with pre-
intervention impairment, where outcome measures indicated clinically significant 
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anxiety and depression. In both conditions, these ancillary analyses increased effect 
sizes to large. Bogosian et al. [305] reported medium-large beneficial effects on 
anxiety (ES 0.86; p<0.05); and depression (ES 0.65; p<0.05) post-MBCT, and three 
months later (ES 0.53; p<0.05). Kohlakaj and Zargar [306] reported significant 
improvements in depression at post-MBSR (ES 2.00; p<0.001), and at one-month 
follow-up (ES 2.16; p<0.001); as well as anxiety post-MBSR (ES 2.62; p<0.001) and 
at one-month follow-up (ES 2.23; p<0.001). For a summary of effect sizes for mental 
health outcomes reported in studies of standardised MBIs in people with MS, see 
Table 6.15. 
Table  6.15 Mental health outcomes in standardised MBIs for people with MS 
Study (n) Intervention Mental 
health 
outcome 
Post-
intervention 
effect size (p) 
Follow-up effect 
size* (p)/ timing 
Current study 
(50) 
MBSR   3-months post 
MBSR 
PSS 0.93 (<0.01) 0.26 (p=0.39) 
MHA 0.85 (0.05) 0.82 (0.15) 
MHD 1.35(<0.05)  0.01 (1.00) 
Kolhakaj and 
Zargar [306] 
(40) 
MBSR   1-month post 
MBSR 
DASS-A 2.62 (<0.001)
 ϕ
 2.23 (<0.001) 
DASS-D 2.00 (<0.001)
 ϕ
 2.16 (<0.001) 
DASS-S 1.72 (<0.001)
 ϕ
 1.75(<0.001) 
Bogosian et al. 
[305] 
(40) 
MBCT   3-months post 
MBCT 
GHQ 0.67 (<0.05) 0.97 (<0.05) 
HADS-A 0.40 (<0.05) 0.99 (<0.05) 
HADS-D 0.65 (<0.05) 0.65 (<0.05) 
Grossman et al. 
[177]
ϒ 
(150) 
MBSR   6-months post 
MBSR 
STAI 0.39 (p<0.001) 0.36 (p<0.05) 
CES-D 0.65 (p<0.0001) 0.36 (<0.05) 
1. Perceived Stress Scale; 2. MHD = Mental Health Inventory (MHI) – Depression; 3. MHA = MHI – Anxiety; 4. 
DASS-A Depression, Anxiety, and Stress score (DASS) – Anxiety; 5. DAAS-D = DASS – Depression; 6. DASS-
S = DASS – Stress; 7. GHQ = General Health Questionnaire; 8. HADS-A = Hospital Anxiety and Depression 
Scale (HADS) – anxiety; 9. HADS – D = HADS – Depression; 10. CES-D = Centre for Epidemiologic Studies 
scale – Depression; 11. STAI = Spielberger Trait Anxiety Inventory. 
*All effect sizes at three-months, apart from Kolhakaj and Zargar [306] (one-month); Grossman et al. [177] (six 
months) 
ϒ Effect sizes reported only for full group analysis in this case. 
ϕ Effect size not reported in publication, but calculated from mean between group treatment effects ÷standard 
deviations 
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Aside from this current study, only Grossman et al. [177] reported measuring 
cognitive function, at baseline and at six-month follow-up. However, the authors 
described the measure as a screening test, and no results were presented in their 
publication, or additional files. Direct comparison is thus impossible, but a systematic 
review [280] on the effects of MBIs on cognitive abilities amongst healthy and 
clinical samples reported that mindfulness training was associated with improvements 
in selective and executive attention, and working memory. However, most of the 
positive findings in this review related to healthy subjects, and beneficial effects in 
clinical groups were only recorded in subjects with MDD undertaking MBCT, where 
positive effects were limited to autobiographical memory tests alone [280]. 
In the case of mindfulness and self-compassion, no previous MBI studies in people 
with MS have measured mindfulness, so a direct comparison is not possible. 
However, in the case of self-compassion, Bogosian et al. [313] recently reported 
small, non-significant improvements in self-compassion in people with progressive 
MS completing a Skype-delivered MBCT programme, with effect sizes increasing 
from immediately post-intervention (ES 0.21; p=0.42) to three-month follow-up (ES 
0.45; p=0.35). Self-compassion was also included in a mediation analysis by 
Bogosian et al. [313], assessing the potential role self-compassion might have in 
improvements noted in GHQ scores for psychological distress. Self-compassion 
contributed 14.7% to improvements immediately post-MBCT, and 11.4% at three-
month follow-up. In cross-sectional studies, greater mindfulness has been associated 
with improved wellbeing and QOL, diminished distress, and improved coping in 
people with MS [200], besides enhanced positive affect, improved satisfaction in 
relationships, and diminished anxiety in couples facing the diagnosis [314]. More 
recently Schirda et al. [199] reported that trait mindfulness was correlated with higher 
QOL amongst people with MS, that the effect was mediated by better emotional 
regulatory skills, and moderated by pre-existing depression. In non-MS populations, 
Kuyken et al. [197] have described how improvements in mindfulness and self-
compassion mediate beneficial effects on mental health and resilience to relapses 
amongst people with recurrent depression, and Nyklicek and Kuijpers [315] have 
reported that enhanced mindfulness mediates stress reduction from training in MBSR 
amongst people who are stressed. Being more self-compassionate is also associated 
with greater resilience to stress, anxiety, and depression in people with other long-
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term neurological conditions [316], but more research is required to define clearly 
what impact, if any, adoption of this attitude has among people with MS. 
6.5.7 Strengths and weaknesses 
A major strength of this feasibility study is that it is embedded in a larger body of 
research for the thesis, based on the MRC guidance [19]. By using mixed-methods, 
the findings from the RCT can be combined with those from the parallel process 
evaluation, specifically relating to participant and instructor feedback from taking part 
in MBSR. For example, semi-structured interviews can explore how participants 
experienced the course, the perceived effects, and possibly provide an explanation as 
to why treatment adherence was sub-optimal. Such data can be used to inform 
accessibility, acceptability, and implementability of MBSR for people with MS. 
The major limitation of this study was its small size. However, this is acceptable in a 
feasibility study such as this. Not having an active control group such as a sham 
MBSR approach, like that developed by M
ac
Coon et al. [317], or a group/ duration/ 
homework-matched CBT-style intervention, or similar, is another potential drawback. 
However, the MRC guidance [19] suggests that introducing an active control too early 
in the pilot/feasibility process can obscure findings at this stage. Other limitations 
include the limited spread of ethnicity amongst participants, the study taking place 
only in Scotland, and not including a biological outcome marker for stress. 
6.5.8 Implications for practice/policy/future research 
Given the pilot/feasibility nature of this study, these results are not generalisable to 
the population of people with MS at large, and clinicians and researchers alike should 
exercise caution when considering using the findings from this study to inform 
practice. What the findings do demonstrate is that, despite the broad feasibility of 
MBSR and trial procedures for people with MS, further optimisation work is 
necessary, in order to improve engagement, uptake, and measurement of treatment 
effects in this context. 
Eligibility criteria appear to be acceptable both to referrers and potential participants, 
with only small numbers deemed ineligible on screening by the researcher. Retention 
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rates indicate that people with MS are willing to be randomised to either intervention 
or wait-list control groups. Despite the large volume of measures included in the 
participant questionnaire, there were no participant complaints, and missing values 
were not prohibitive when performing the a priori statistical analyses. The feasibility 
process has allowed collection of data for a range of relevant outcome measures. 
These findings can be used to optimise the intervention and its measurement.  
Although large and stable beneficial treatment effects were evident in those receiving 
MBSR at three-month follow-up for positive affect and anxiety, initial large 
improvements in stress and depression at the immediate post-intervention point fell to 
small and negligible at three-month follow-up respectively. Given the dearth of 
effective treatments for anxiety in people with MS [10], the beneficial effects from 
mindfulness training found in this study, alongside those reported elsewhere [177, 
289, 305, 306], could form the basis of an argument for proceeding to a phase-3 trial 
with anxiety as the primary outcome. However, as demonstrated in Chapter 4, both 
anxiety and depression are very common in MS, with depression known to increase 
morbidity and mortality in MS and to diminish QOL [5, 57]. Other studies of MBIs in 
MS have found improvements in depression following mindfulness training with 
more stable treatment effects where interventions included tailored MBCT [305], or a 
combination of MBSR/MBCT [306], but less so when simply using MBSR [177]. 
Thus, proceeding to a phase-3 trial at this point may be premature.  
Optimising the intervention might conceivably generate more stable treatment effects 
for stress and depression, and this could be explored via qualitative work examining 
participant and MBSR instructor views from those taking part. Potential modifications 
could relate to improving the acceptability of course content and/or delivery, and 
might involve the integration of regular follow-up/‘booster’ sessions, as there is some 
evidence that this can help to sustain beneficial treatment effects from MBCT in 
people with recurrent depression [318]. Further optimisation could focus on 
improving study outcome measures, with recent guidelines suggesting the Beck 
Depression Inventory (BDI) be used for detecting depression in people with MS, and 
the Center for Neurologic Study Emotional Lability Scale (CNS-ELS) for assessing 
emotional lability [83]. Further, given the mediating role recently described for 
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emotional regulatory skills for improving mindfulness and diminishing depression in 
MS patients, [199], a process measure of this construct could also be explored [319].  
6.6 Conclusion 
This study has demonstrated that delivering MBSR under trial conditions is feasible 
for people with MS in a UK NHS Integrative Care setting. Recruiting to target was 
feasible within three months, and rates of retention and follow-up were generally 
good. Treatment adherence was sub-optimal and initially encouraging beneficial 
effects on scores for negative stress appraisal and depression were not sustained 
beyond the intermediate assessment point. These factors raise important questions 
about optimisation of the intervention, and proceeding to a phase-3 trial at this stage 
should wait until these issues have been explored in detail and resolved. 
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Chapter 7 Qualitative research chapter 
7.1 Summary 
This chapter outlines the qualitative process evaluation that occurred in parallel to the 
RCT. It starts by setting out aims and objectives, which largely focused on gaining a 
deeper insight into participants’ and MBSR instructors’ perceptions and experiences 
of the MBI and how this knowledge could be used to understand more clearly 
potential barriers and facilitators to implementation. The methods used in the chapter 
are described along with justifications for their choice. Results are presented in 
diagrammatic and textual format, delineating four main themes that emerged from the 
thematic analysis. Following this, the findings are then conceptualised using an 
implementation theory – Normalisation Process Theory (NPT). Based on the findings, 
key recommendations are presented. Finally, the discussion compares the findings 
with the existing literature for the use of MBIs in people with MS. 
7.2 Aims and objectives 
The overall aims of this study were to explore the perceptions and views of people 
with MS participating in a MBI (MBSR) and to examine the potential barriers to and 
facilitators of implementing a MBI for people with MS. Specific objectives were to 
determine: 
 Pre-course expectations  
 Experience of the course  
 Which aspects of the intervention worked and/or did not, and why 
 What effects, if any, were noted by participants on their wellbeing 
 What factors influenced participation, completion, and drop-out rates 
 Barriers and facilitators to engagement, uptake, and implementation of MBSR 
in this population. 
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7.3 Introduction 
Building upon findings from the RCT, the next task was to collect participant views 
on the MBSR course. This information was sought in order to inform decision making 
about the feasibility of undertaking a large-scale trial of MBSR in MS, and also to 
inform thinking about the wider implementability of such a service. This parallel 
process evaluation aimed to clarify issues about how the course was delivered and 
received, and how it might be improved, in order to meet best the needs of people 
with MS, and to increase its future implementability. This work was intended to 
complement and add to the learning from the quantitative feasibility findings from the 
RCT. 
Research in other LTCs suggests that MBIs might help people cope better with 
chronic illness, by enhancing self-management skills, improving QOL, and helping to 
shape a more positive illness experience [320]. Aside from MBIs, other qualitative 
work suggests that people with MS value learning new self-management skills, 
particularly for dealing with the chronic stresses associated with the condition [62]. 
Identifying successful self-management strategies has been highlighted as a research 
priority for this group [12, 62]. 
Very little qualitative research exists addressing how individuals with MS find MBIs. 
Aside from Hankin [296], who provided just a cursory snippet from her conversations 
with couples facing a diagnosis of MS who took part in MBSR training, only 
Bogosian et al. [313] have reported substantive qualitative data in this area. Bogosian 
et al. [313] reported on thematic analysis findings from 15 semi-structured participant 
interviews, where participants had taken part in a Skype-delivered MBCT programme 
for people with progressive MS. Bogosian et al. [313] undertook both deductive, and 
inductive analyses. The deductive analyses attempted to understand potential 
treatment mediators, whilst the inductive analyses were interested in participant 
experiences. Deductive findings focused on finding support for the potential role of 
acceptance, decentring, self-compassion, and self-efficacy. Inductive findings 
reported that participants valued the peer support that came from being part of a 
group, that the course instructor was an important part of their experience, and that 
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some participants were not clear about what to expect from taking part in a MBI 
[313].  
Implementation is a complex phenomenon, whereby a new intervention makes the 
transition from theory into practice [321]. Potentially, it requires adaptation to take 
place on multiple levels, involving a range of stakeholders [321], and can be a 
protracted process [322]. On the ‘macro-’ level, it can necessitate socio-politico-
cultural change; on a ‘meso-’ level, teams working together differently; and on a 
‘micro-’ level, it involves individuals [321]. Thus, there are multiple potential barriers 
to success in the process of implementation [323]. Implementation forms a key 
component of the MRC guidance [19] on developing and evaluating complex 
interventions to improve health. The guidance suggests that the study of 
implementation processes should be theory-driven, and that it should not be viewed as 
the final step in new health service development [19]. Instead, implementation should 
feature as a consideration throughout. This parallel process evaluation considered 
implementation of a MBI for people with MS. It was theory based, drawing upon 
information from multiple data sources, including qualitative participant and MBSR 
instructor feedback, alongside the range of information already collected from the 
quantitative aspects of the RCT. 
7.4 Methods 
Following completion of the MBSR intervention in October 2014, a series of 19 semi-
structured interviews was conducted. In order to include as broad and representative a 
spread of views as possible, everyone who agreed to take part in the interview process 
was interviewed. This meant that 17 course participants and the two course instructors 
were interviewed. Interviewees comprised a range of participants of different age, 
gender, SES, and disability level, covering both those that completed the course 
(n=13), and those who had dropped out (n=4).  
The interviews were conducted face-to-face, in a research office at the NHS CIC, and 
used a topic guide that had been developed and agreed with the researcher’s 
supervisors. Questions were similar, though not identical, for both participants and 
MBSR instructors. The interview questions were informed by NPT and covered the 
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exploration of broad areas pertinent to stakeholder engagement and uptake of the 
course, such as pre-course expectations, experience of the course, the meditation 
practices, context, course logistics, and barriers and facilitators to participation (see 
Box 7.1 and Box 7.2 below, with questions mapped to NPT constructs).  
Box  7.1 Semi-structured interview questions – Participants 
 
 
1) How did you find the MBSR course? What were your expectations? (Coherence) 
2) What worked well in the MBSR course? What didn’t? What are your reasons? (Reflexive 
monitoring) 
3) Was the MBSR course helpful or not? In what way? (Reflexive monitoring) 
4) Was being in a group an advantage or disadvantage for you? Can you please explain your 
answer? (Collective action) 
5) How did you find the setting for the class? What are your reasons for this? (Collective 
action) 
6) Were there any barriers to your participation (both in relation to attendance or completion of 
tasks)? (Collective action) 
7) What encouraged you to attend and complete home practice tasks? (Cognitive participation) 
8) What are your thoughts on the duration of the course? The time the course took place at? 
(Collective action) 
9) What were your experiences of having the home-practices? Were you able to complete the 
self-study assignments or not? What factors influenced how much time you spent on the 
home-practice assignments? (Collective action) 
10) Have you noticed any differences since completing the MBSR course? If so, what? 
(Reflexive monitoring) 
11) What aspects of the MBSR course were most/least helpful and why? Can you suggest 
improvements for future courses? (Reflexive monitoring) 
12) Would you recommend MBSR to other people with MS? Why? (Reflexive monitoring) 
13) Since completing the MBSR course, have you noticed any effects (positive or negative) on 
your sense of physical wellbeing? If so, what? (Reflexive monitoring) 
14) Since completing the MBSR course, have you noticed any effects (positive or negative) on 
your sense of mental wellbeing? If so, what? (Reflexive monitoring) 
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Box  7.2 Semi structured interview questions – Instructors 
 
 
1) How did you find facilitating the MBSR course? What were your expectations? (Coherence) 
 
2) What worked well in the MBSR course? What didn’t? What are your reasons? (Reflexive 
monitoring) 
 
3) Do you think the MBSR course was helpful for participants or not? In what ways? 
(Reflexive monitoring) 
 
4) Was facilitating the course as a group an advantage or disadvantage for you? Can you please 
explain your answer? (Collective action) 
 
5) How did you find the setting for the class? What are your reasons for this? (Collective 
action) 
 
6) Were there any barriers to you in facilitating this course? (Cognitive participation) 
 
7) Did you encourage participants to attend and complete home-practice tasks? If so, how? 
What kinds of barriers to attendance and completion of home-practice tasks were mentioned 
by participants? (Cognitive participation) 
 
8) What are your thoughts on the duration of the course? The time the course took place at? 
(Reflexive monitoring) 
 
9) What were your experiences of setting the home-practices? Did you feel that completion of 
the standard self-study assignments were realistic or not in this current group? What factors 
influenced how much time you recommended for the home-practice assignments? 
(Collective action) 
 
10) Have you noticed any differences in yourself as a mindfulness facilitator since completing 
the MBSR course? If so, what? (Reflexive monitoring) 
 
11) What aspects of the MBSR course do you think were most/least helpful for this group and 
why? Can you suggest improvements for future courses? (Reflexive monitoring) 
 
12) Would you recommend MBSR to other people with MS? Why? (Reflexive monitoring) 
 
13) What are your thoughts on factors influencing dropouts’ from this study? (Reflexive 
monitoring) 
 
 
The qualitative data analysis in this chapter was informed by the framework approach 
to thematic analysis [211]. NPT [214] was the underlying theoretical framework that 
informed conceptualisation of the analysed data.  
For a detailed timeline of research activities see Appendix J. 
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The key steps of a framework approach are outlined below in Table 7.1. 
Table  7.1 Components of the Framework Approach 
 
Components of the framework approach to qualitative analysis 
 
1. Data management 
 
Familiarising oneself with the data via repeated reading 
Identification of preliminary themes/categories 
Development of a coding index 
Allocating the data into categories/themes in the coding index  
Iterative refinement of preliminary themes with repeated 
reading of the data 
2. Descriptive accounts 
 
Summarising then synthesising the range and variety of coded 
data 
The development of abstract concepts  
Modelling patterns/associations between themes and concepts 
3. Explanatory accounts 
 
Constantly referring back to the original data to ensure 
explanations are grounded in the views of the interviewees’, 
thus reducing the chance of misrepresentation 
Making interpretations and founding possible explanations for 
emergent themes and concepts 
Mapping concepts and themes to the empirical literature and 
evidence base 
 
Following completion of the thematic analysis, emergent themes were subsequently 
reviewed under the theoretical ‘lens’ of NPT, which has four key domains (each of 
which has four further sub-domains) (Figure 7.1). Practically, this process meant re-
visiting the emergent themes that had already been generated through the thematic 
analysis, and assessing how they might fit (or not) with the NPT domains. Each of the 
four main domains and their respective sub-domains were thus tested against the 
thematic analysis data for goodness of fit. Results for the NPT analysis are thus 
presented following the thematic analysis results.  
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Figure  7.1 Normalisation process theory (NPT) core constructs 
 
 
 
7.4.1 Thematic framework analysis. Stage 1 - Data 
management 
7.4.1.1 General overview 
Interviews were transcribed verbatim, and then checked by the researcher (RS), who 
listened to the interview audio files whilst simultaneously reading through the 
transcribed word files, making short notes and memos in the page margin. The 
researcher’s two supervisors independently read through a randomly chosen, un-
annotated transcript and made their own notes during this process, with all parties 
reconvening at the next supervision meeting to discuss their preliminary thoughts and 
findings. This introductory process allowed comparison between the researcher’s 
notes, and those of his more experienced colleagues. The meeting fostered discussion 
on the importance of researcher reflexivity at this stage, especially around the 
common tendency of inexperienced qualitative researchers to over-interpret the data 
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early on in the analysis, and the need to reflect routinely on any underlying 
assumptions about the meaning of the data. 
The next stage involved detailed immersion in the data. The researcher returned to the 
original data, reading through un-annotated transcripts, making notes on participant 
experience as close as possible to the original words and phrases used in the interview 
(‘in-vivo codes’), which would later be used to develop data categories. Similar 
categories were eventually grouped together to allow the development of initial 
themes. As the researcher worked through the 19 transcripts, a separate file was kept 
which allowed the researcher to list initial themes that were emerging from the data. 
As this process unfolded a coding index began to develop. Due to the different 
emphasis of the questions in the respective semi-structured interviews, separate lists 
of codes were initially documented for the participants and the MBSR instructors, 
with a view to the possibility of merging/triangulating data at a later stage in the 
analysis. Through this process of immersion the researcher was increasingly able to 
see recurrent themes emerging, but remained cognisant throughout of two points: a) 
the need to remain distant from any theoretical standpoint (such as a bio-medically 
informed view of MS and/or mental health), and b) that the index was subject to 
change as the iterative process of analysis continued. 
Data was thus arranged into thematic headings for each interview. At this stage, 
participant codes numbered 45, and those of the instructors’ numbered 14. Following 
completion of this stage, it was important once more to cross-reference the findings 
with the supervisor’s findings (Professor Stewart Mercer - SM), to check the 
reliability of the data [208], and again ensure that no underlying assumptions or 
interpretation had been applied to the data. SM reviewed a further two interview 
transcripts, noting emergent themes/concepts in the process. These were then cross-
referenced with the index of codes and associated themes identified by the researcher 
and a new and refined coding index emerged. By this stage, the researcher was able to 
draw up a coding index for each group of interviews, with participant codes reduced 
to 28, whilst those for the instructors’ numbered 15. Following this, the researcher 
went on to develop a merged index, where both participant and instructor findings co-
existed under higher order themes, each with associated sub-themes. This process 
took place using word files, both for the transcripts and for the emergent theme 
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documentation of each interview, allowing memoing and iterative reflection to take 
place throughout.  
For details of the final coding index, see Appendix K. 
7.4.2 Stage 2 - Descriptive accounts 
The next step involved summarising and synthesising the original interview data in 
descriptive terms. The option still remained thereafter to offer an explanatory account, 
with themes also being organised further in chart format, where emergent patterns 
could be sought in relation to important demographic data, including such items as 
participant age, sex, SES, and disability level. Critical thinking and reflexivity 
remained paramount during this stage, and care was taken not to stray beyond the 
veracity of the participants’ own accounts when seeking links and extrapolating into 
more abstract conceptual views of the data.  
When constructing the thematic matrix for the data, the guidance suggested in the 
methodological overview by Ritchie and Lewis [211] was followed. This meant that 
the matrix had to ensure that the data it contained remained ‘conceptually pure’, i.e. 
remained true to the original participant accounts, and avoided overlap with related 
themes, where possible, thus making meaningful distinctions between findings, and 
providing illuminating content.  
The next steps involved: 
1) Detection of substantive content and dimensions 
2) Categorisation, which meant description and refinement of the findings 
3) Classification, or the grouping of information into categories, which 
necessitated a subtle mode of abstraction 
 
7.4.3 Stage 3 - Explanatory accounts 
At the stage of developing explanations, the researcher interrogated the data in 
different ways, in order to ascertain what might be influencing or causing the 
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observed phenomena. This was initially undertaken individually, and subsequently 
critiqued, refined, and finessed during research supervision meetings. For this stage of 
the analysis, the researcher reflected carefully upon interpretation that could be based 
either upon whole group analysis (i.e. a single unit), or a participant-based group 
analysis (taken in the context of the whole). For example, explanations could come 
directly from participants themselves (either dispositional or situational), or from 
inferences drawn by the researcher. Thus, attempts at explanation were driven from 
first reflecting back on the raw data as a whole, and then to the various different 
analytical stages, in order to ensure once again that the data was not being made to fit 
a particular interpretation.  
Following on from this, an attempt was made to ascertain whether any emergent 
typologies could be identified which might explain the operation of the various 
concepts derived from the original data. Possible typologies are illustrated in the 
Results section, and the thematic matrix is available in Appendix L.  
An important consideration throughout was the role of the researcher as both 
interviewer and data analyser. Carrying out the research in this manner was 
necessitated by the limited resources that were available for the PhD study – had the 
option been available, it might have been preferable for another individual with no 
connection with the analysis to carry out the interviews. The approach used has 
inherent potential for bias, but specific and consistent steps were put in place in an 
attempt to minimise this possibility. For example, the potential for bias and the 
importance of reflexivity were discussed between the researcher and his supervisors 
from an early stage [208]. Any suspicion that bias might have crept in to the analysis 
was discussed openly during regular supervision meetings, where transcripts, coding, 
and emergent themes were reviewed between the researcher and his supervisors. 
7.5 Results 
Amongst the 17 participants interviewed, the mean (SD) age was 45.06 (9.34) years, 
and 15 of the 17 (88%) were female. The mean (SD) deprivation decile was 5.06 
(2.74), with a range across participants from decile 2 to decile 10 (where lower 
numbers indicate less deprivation). In terms of highest educational attainment, 3/17 
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(17%) had a secondary school education, 4/17 (24%) had a college education, and 
10/17 (59%) had completed a university education. The mean (SD) EDSS [117] score 
of disability amongst participants was 4.59 (1.84), which equates to ‘Significant 
disability but up and about much of the day, able to work a full day, may otherwise 
have some limitation of full activity or require minimal assistance. Able to walk 
without aid or rest for 300m’. In terms of MS phenotype, 15/17 (88%) had RRMS, 
whilst the remaining two had PPMS. With regards to comorbidity, the mean (SD) 
number of other LTCs amongst participants was 4.00 (2.89), whilst the range 
extended from 0-9 conditions. Eleven out of seventeen had at least one mental health 
condition (range 1-3). Of those interviewed, 13/17 (76%) met the cut-off criteria of 
attending four or more MBSR sessions required for course ‘completion’, and the 
median (range) amongst all participants interviewed for session attendance was 7.0 
(7.0). The MBSR instructors were both female medical doctors with backgrounds in 
General Practice, but working full time in Integrative Medicine. Table 7.2 outlines 
baseline demographic data for the interviewed participants. 
Four main themes emerged from participant and MBSR instructor accounts: 
1) ‘Coming together for the course – everyone has MS’ 
2) ‘Doing the work of mindfulness’  
3) ‘Getting it, or not’  
4) ‘Moving forward and improving the course’  
These themes largely reflected the process that participants and the MBSR instructors 
had experienced through engaging with the intervention, but also included details 
regarding the experiences of those (4/17) who had discontinued taking part in the 
course. Each of the four main themes was broad in its coverage, with several 
underlying sub-themes in every case. These are discussed in detail below. 
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Table  7.2 Participant characteristics and number of sessions attended 
No. Age in 
years 
Sex Ethnicity Deprivation 
decile 
Education EDSS 
score 
Type of 
MS 
Comorbidity count (number 
of mental conditions) 
Number of 
sessions/8 
attended 
P1 52 F WS
ϒ
 2 University 4.0 PPMS* 3 (1) 7 
P2 41 F WS 2 University 4.0 RRMS° 3 (1) 6 
P3 54 F WS 9 University 5.5 PPMS 0 (0) 8 
P4 36 M WS 3 2y School 2.5 RRMS 9 (3) 7 
P5 65 F WS 8 2y School 5.0 RRMS 9 (2) 7 
P6 44 F WS 8 University 6.5 RRMS 5 (2) 7 
P7 52 F WS 2 College 6.5 RRMS 5 (1) 3 
P8 34 F WS 3 University 3.5 RRMS 5 (1) 7 
P9 48 F WS 5 2y School 7.0 RRMS 1 (0) 2 
P10 43 F WS 7 University 7.0 RRMS 1 (0) 7 
P11 27 F WS 6 University 6.0 RRMS 4 (1) 8 
P12 38 F WS 3 College 2.5 RRMS 5 (2) 5 
P13 46 F WS 3 University 4.0 RRMS 8 (0) 1 
P14 32 F WS 10 College 4.0 RRMS 6 (2) 8 
P15 40 F WS 4 College 1.0 RRMS 2 (0) 1 
P16 44 M WS 8 University 6.5 RRMS 0 (0) 7 
P17 36 F WS 3 University 2.5 RRMS 2 (1) 6 
*PPMS – Primary Progressive MS ; °RRMS – Relapsing Remitting MS, EDSS – Expanded Disability Status Scale; 0 lowest level of disability  – 10 death. γWS – White Scottish ethnicity
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7.5.1 Theme 1 ‘Coming together for the course – everyone has 
MS’ 
The first major theme ‘Coming together for the course – everyone has MS’ reflected a 
group of 27 people all coming together for the first time to learn about the use of 
something new i.e. mindfulness in MS. The four subthemes reflected what 
participants and the MBSR instructors had expected of the course prior to taking part, 
what they had to do in order to be at the course, how they had experienced the venue, 
and what being part of this unique group had been like for them (Figure 7.2). 
These themes reflected that the course marked an ‘event’ for those taking part, 
involving some degree of not knowing what to expect or how to prepare, of becoming 
acquainted with their meeting ground for the next eight weeks, and coming together 
to learn mindfulness as a group entirely made up of people with MS. 
Figure  7.2 Theme 1 ‘Coming together for the course – everyone has MS’ 
 
 
7.5.1.1 Pre-course expectations – why people were taking part in MBSR 
Mindfulness was new for most people (13/17) and most did not know what to expect 
from the course. Some were sceptical (5/17), whilst others were more hopeful of 
deriving some benefit (7/17). One participant noted that the fact it was a ‘clinical trial’ 
for people with MS had acted as a motivator to her taking part, whilst another had 
thought the course would be quite MS-specific in its content: 
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‘I thought if I get anything out of it, it would be a bonus, I wasn’t really 
expecting too much I was kind of sceptical because I hadn’t really done 
anything like that before’ (P10)  
‘I hoped that there would be methods to try and cope with pain, stress, lack of 
sleep.’ (P13)  
For the instructors, pre-course expectations were influenced by prior teaching 
experience, assumptions about the MBSR course, assumptions about people with MS, 
along with the fact that this was a research project focusing on a specific condition:  
‘I expected it to be the same as all the other groups.. ..we have done it with 
people with chronic fatigue before and again it's got a particular atmosphere 
about it, a very heavy atmosphere.. This had a kind of hypersensitive 
atmosphere.. ..slightly different than a mixed group.. ..it does make it different 
yeah’ (I1)  
‘..because they had been very specifically recruited, they’d had a long 
interview with you beforehand.. I was expecting a fairly high degree of 
motivation’ (I2) 
7.5.1.2 Being prepared and getting there 
It was apparent from feedback that taking part in the course meant more than just 
turning up for two and a half hours each week, especially so in the context of 
disability. Participation required a lot of preparatory work, such as arranging time off 
work, organising childcare, securing transport, modifying routines in the home, and 
then dealing with the journey to and from the venue. 
One participant who ambulated with elbow crutches highlighted how getting there 
and finding parking was a source of distress: 
‘Parking was a real trauma, I had to leave the house an hour earlier to get 
here and to get a space and I found by the time I actually got into the 
reception area I was stressed’ (P6)   
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Because of the difficulties with parking, some participants opted instead for public 
transport, significantly increasing their journey time.  
7.5.1.3 Course context – getting it right 
The setting for the course, the NHS CIC, seemed to have had an impact on 
participants. For some (6/17), coming to the centre demarked quite a contrast to other 
hospital settings that they were more accustomed to: 
‘I think the hospital itself is lovely, it is. Right away you don’t think of it as 
being a hospital actually it's much nicer, which makes you feel more relaxed, 
it's less clinical and yeah that's it.. ..I think having the surroundings here is 
much more peaceful.. ..It was quite pleasant and you were pleasantly 
surprised .. and oh it is actually quite lovely here .. and being able to see the 
garden’ (P2)  
The first MBSR class took place in an upstairs seminar room, which was accessible 
either by a flight of stairs, or by a lift. The room had been chosen for the course 
because of its size, and availability. However, some important issues had been 
overlooked, again with a particular emphasis being placed on disability awareness:  
‘..as the day progressed, started and progressed there was things that kind of 
flagged up and kind of irritated me quite early on. One was the distance 
between the room where it was being facilitated and the bathroom.. The 
second thing which was one of my bugbears .. when you came into the room 
there was a semi-circle of chairs and literally each arm of each chair was 
touching each other with no gap..’. (P13) 
Another issue was the centre policy of not allowing drinks to be brought into the 
room, which some participants (2/17) complained about as it meant if someone had a 
dry mouth due to a medication side-effect, they could not immediately have a drink, 
or if someone needed to take medication during the class, no fluids were on hand.  
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These observations were fed back by the participants to the instructors via routine 
course session feedback forms. Based on these, the instructors moved quickly to make 
things right for the group the following week. This led to a subsequent change of class 
location to a ground floor room, which necessitated involving the wider MDT in the 
Centre, and shifting a Yoga Therapy course that was running at the same time. 
However, it was clear that participants appreciated this response: 
‘They kind of said that: “Obviously it was highlighted to us last week and we 
hope this is better” and they apologised and things like that so it wasn’t just 
brushed under the carpet or ignored and I thought that was good .. I think 
everybody in the group appreciated that’ (P17) 
7.5.1.4 Becoming a group 
One participant commented that the group structure was more acceptable to him than 
having to work on a one-to-one basis or in smaller groups, as he found this less 
daunting, but others (8/17) expressed preferring the group format. Participants 
appreciated that the issue of confidentiality was raised early on by the instructors 
(‘What happens in the room stays in the room’). A few participants (3/17) had 
worried about being asked to speak in public during course introductions. The 
instructors’ introductory exercise, that they normally used as an ‘ice-breaker’, 
introducing the person seated next to you and what you both had in common, seemed 
to backfire, producing an almost uniform response of ‘We both have MS!’. Many 
participants (7/17) spoke of their apprehension about being in a room full of people 
with MS, with a spectrum of ability levels: 
‘I’ll see somebody far more disabled or affected with MS and it hurts me too 
because it's like this could be your future’ (P13) 
Despite the difficulty in seeing others more or less disabled, all of the participants 
reported valuing being part of the group, with comments focusing on appreciating 
being able to see/hear others’ thoughts/views on their experiences. Many participants 
(8/17) expressed not actually knowing many other people with MS, and appreciated 
the opportunity of being able to come together in this way. 
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Despite these initial forebodings, the fact that everyone in the group had MS seemed 
to facilitate a sense of trust and safety: 
‘I just felt the same as them, even although everybody didn’t have a crutch or 
an eye problem like myself I still would have just went, everybody 
understands, that’s it’ (P11)  
7.5.2 Theme 2 ‘Doing the work of mindfulness’ 
The second main theme that emerged was ‘Doing the work of mindfulness’, and this 
captured various sub-themes relating to what taking part in the MBSR course actually 
involved for people. Sub-themes included what it was like for people with MS to 
experience the mindfulness approach of getting in touch with their senses, sensations, 
disabilities, and diagnosis of MS; how the participants made sense of the mindfulness 
practices, together as a group; how participants experienced the mindfulness practices 
on their own, away from the course; and what sustained or prevented their continued 
participation (Figure 7.3). 
Figure  7.3 Theme 2 ‘Doing the work of mindfulness’ 
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7.5.2.1  ‘Coming face-to-face with MS: senses, sensations, and 
disabilities’ 
The course commenced with the ‘Raisin Exercise’, which involved everyone being 
handed a raisin to hold in his or her hands. Everyone was then guided through a set of 
instructions designed to help notice in detail various different aspects of the 
experience relating to the raisin, such as size, texture, contours, and eventually taste. 
The raisin exercise is designed to bring an increased sense of awareness to mundane 
aspects of experience, and how these can be taken for granted [13]. Most people 
(15/17) did not comment specifically on the experience, but one individual described 
it as ‘weird’, whilst another found the focus it brought to her hands very distressing: 
‘..I thought oh great, of all the things to do my hands are the worst affected, I 
have the most pain in my hands 24/7 and I’m being asked to hold a raisin, but 
suck it up, these things happen when you’ve got MS..’. (P13) 
This was an unexpected and difficult experience for the instructors: 
‘I haven’t seen people cry at the raisin exercise before now so that was quite 
difficult and from one woman with the raisin exercise there was a very direct 
challenge of: “Am I right in thinking you’re asking us to really face our 
experience?”.. and we were like “Yeah, being present with your moment-to-
moment experience is what we are asking you to do” and she said: “That is so 
not what we do, what I do, how I manage this, this isn't going to work for 
me”.. So, there was one quite strong character who was very challenging 
and.. Well, it threw me a little bit’ (I1)  
Both of the instructors described their prior assumptions about MS. They felt that it 
was a difficult diagnosis that carried a strong illness identity. They both felt 
mindfulness would be very beneficial for people with MS, in helping participants ‘re-
connect’ with their bodies in a pleasant, and relaxing way. One of the instructors (I1) 
spoke about carefully bringing people close to their tolerance limits, in such a way 
that everyone could feel included, regardless of differing ability. Several participants 
(9/17) commented on the instructors’ style as being supportive for the mindfulness 
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practices, but for other participants (4/17) doing the practices accentuated a sense of 
disability: 
‘In the other exercise the one that we were doing that all these kind of things 
with the hands again it wasn’t suitable for everybody to do that in the class 
because I can’t move this right hand so exercises like that accentuate the 
disability that I have and I didn’t like it .. I just didn’t like the experience of it.’ 
(P6)  
‘On a personal matter, because of the tremor in my right hand I can’t write 
now, so if there's anything involving writing.... I found it personally 
embarrassing to me because it was barely legible, so I didn’t like they [those] 
parts of the course.’ (P16) 
Another dimension touched upon by the instructors related to the idea of bringing 
compassion to a struggling body, and the role that compassion might take in dealing 
with the condition: 
‘We did teach compassion practices as well and I think people found that 
useful, and actually it was a useful practice, but it was also a new and 
interesting idea that once one demonstrates compassion towards oneself, and I 
think people actually, you know, this was, actually brought up you know, that 
in MS the body is turning against itself and it's interesting to try and be, 
actually advocate kindness towards the body.’ (I2)  
7.5.2.2 Making sense of the mindfulness practices, together in the 
group 
Although most participants did not have prior experience of mindfulness specifically 
(13/17), several (11/17) had prior experience of meditation and/or yoga. This may 
have shaped their impressions of mindfulness. One participant who practised Sahaja 
Yoga described how the technique never focused on her condition (MS), whereas the 
MBSR session she attended did, which she thought was a mistake. Another, a 
qualified Ashtanga Yoga instructor, described the course content as very ‘basic’, and 
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he seemed to be making sense of it using terminology from the area that he was more 
familiar with, talking of experiencing his ‘Prana’ (A Vedic concept relating to ‘life 
force’, or ‘energy’ associated with the breath - [324]). 
One individual, who had one year previously taken a short introductory mindfulness 
course run by a trainee psychologist at a nearby hospital, was surprised at the depth of 
the compassion practices in the current course: 
‘Yeah, those ones in particular were about self-compassion or about loving 
yourself and I found those ones quite difficult. They didn’t drag up history I 
wouldn’t say, but I guess the very fact I was finding them difficult, I was 
looking for the reason why I was finding them difficult and that then went back 
to previous things that I suppose have shaped me, who I am today, going back 
to having been abused as a youngster and my self-image I suppose as a result 
of that’ (P12) 
However, as stated previously, mindfulness specifically was a new concept for most, 
especially in the context of managing symptoms associated with MS. Some (7/17) 
commented that they were still coming to terms with the experience, and one 
participant commented that she particularly liked the meditation practices because 
they were in some way less ‘artificial’ than taking medication. 
In particular, several people (6/17) found it hard to make sense of mindful walking. 
One participant described feeling quite taken-aback at being asked to do it: 
‘Yeah, yeah well because my mobility is quite bad the part of the course the 
mindfulness walking I just thought that was bizarre to say the least, asking 
people with MS to walk I thought that was bizarre.. .. Well like being asked to 
walk, I kind of took the huff .. I sat that one out.. I said to [instructor] you know 
I said “I'm not going to do this and then after they had done it I opened up a 
conversation with the rest of the group around that I openly said to them I felt 
that was really bizarre, wrong, to ask people with MS to walk’ (P16) 
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Others also found the mindful walking challenging in the group, but less so at home 
(5/17) where they felt there was more space to explore the experience. These 
participants reported being quite unsettled by the practice initially. However, when 
practising away from the course, they seemed to be deriving useful learning from it, 
either through exploring the process of balance, the different sensations on different 
underfoot surfaces, working to stop themselves from walking on the sides of their 
feet, or by challenging themselves to climb stairs without stopping. One participant 
summarised her thoughts on mindful walking:  
‘I think everyone in the room didn’t like it.. everybody kind of freaked 
thinking, even although I'm saying everybody had MS we all freaked thinking 
“I feel ridiculous doing this and staggering about the place and walking like a 
zombie round about a room”. Right that was my thoughts, so that .. but I've 
got benefit from it, I've realised, at the time I didn’t think so, I just thought it 
was “stupid, not doing this, that was ridiculous anyway” and then the 
homework was to keep doing it and I did struggle with it..’. (P11) 
A normal part of MBSR involves the ‘enquiry process’, where participants are invited 
to reflect and feedback on their experiences with the group [137]. This is used as a 
teaching tool in MBIs, where the instructor may pick-up and elaborate upon key 
mindfulness concepts for the benefit of the group, and is not designed to be 
instructive, or critical [137]. However, the enquiry process was met with mixed 
feelings from participants. A few (3/17) were not sure how to answer the questions. 
For one it was too intense, especially in the context of her fatigue: 
‘I just didn’t have the energy to be questioned in that detail, I was happy to 
give like a one or two-liner but I just didn’t have the energy to be drilled 
down, and down, and down, and down.’ (P6) 
7.5.2.3 Making sense of the mindfulness practices on one’s own, away 
from the course 
Both instructors felt strongly that home practice was a very important part of the 
course, basing their assumptions on literature they had read suggesting that those who 
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practise most derive the most benefit. They reported concern that very few 
participants were actually doing the home practices in the early weeks of the course, a 
time that they thought formative and particularly important. They saw the home 
practice as being the responsibility of the participants. 
Many participants (8/17) spoke about the home practices and their attitudes towards 
them, and views varied. One participant felt compelled to complete the home 
practices, given that a ‘doctor was advising it’. One participant described feeling a 
sense of rebellion at being asked to do ‘homework’, whilst another described wishing 
time doing the home practice was passing more quickly. Another participant 
described assuming that she would have a preference for shorter home practices, and 
was surprised to find that this was not necessarily the case, whilst another had an 
initial loathing towards it, which was eventually superseded by a change to looking 
forward to it as she started to feel benefit.  
Discussion and views around home practice covered a great deal of issues relating to 
practical barriers and facilitators in this area. For one participant the simple fact of not 
having a CD player at home presented itself as an immediate barrier, which she was 
able to overcome by borrowing from her ex-husband. More common comments 
related to making time and space for the practices. Being free from duties and/or 
distractions in the home featured repeatedly. 
7.5.2.4 Staying present, or dropping-out - sustaining participation  
Despite the difficulties experienced from the first MBSR session, several participants 
(7/17) commented on their commitment to see the course through: 
‘I suppose the group, the group as well sort of inspired me to go along..  ..I 
just knew that I had to give it a go and I had to see the programme through.. .. 
I wanted to get the full benefit of the course and to my mind if you’re coming 
to one and not another then you don’t get the full benefit of it’ (P1) 
One participant described a sense of obligation towards the course organisers’, despite 
encountering significant health problems in the course of events:  
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‘Yeah I’d kind of, I felt obliged to because you guys set this up I thought well 
at least I had to do that, it was just, just the one I missed was I couldn't 
actually, I couldn’t actually walk at that point at all so that was that one, that 
one finished’ (P16) 
Attendance on the course was varied, with completers citing various reasons for non-
attendance, such as inter-current illness in themselves or significant others. For a 
couple of participants (2/17), keeping up, or in mindfulness terms ‘staying present’ 
with the practices took on even more of a challenge by the occurrence of a MS relapse 
during the MBSR course. For one participant, who was in the process of changing her 
DMD regime, this facilitated a new and more favourable experience:  
‘I came off one [MS medication] so I needed a gap before going onto the 
second and I unfortunately had a relapse in that period, not a particularly 
severe one, but I feel that I have recovered far faster from that relapse. Now, 
whether that's me just thinking that that's what's happened, but during the 
relapse.. ..very different I didn’t get down, I didn’t get depressed the way that I 
have previously about friends or family having to help out .. Before I've really 
struggled with that, I've become angry, aggressive, as a result of being 
depressed about it. I guess I didn’t have that this time. I was fed up, I wasn’t 
happy about having a relapse, wasn’t happy I couldn't open a bar of chocolate 
very well one day when my hand wasn’t working, but I didn’t get down about 
it the way that I have before, and I genuinely think that mindfulness has helped 
with it.’ (P12) 
For another, having a relapse acted as a barrier to keeping up the home practices, 
impacting quite negatively on his outlook:  
‘That's when I stopped doing the practices, when that started, because it was 
pretty severe, it was. I hadn’t experienced this before, there was a lot of new 
things .. I kind of took the huff and thought “What's the point?” Having 
discussions with the people in the group I thought I was telling them what I 
was going through you know.. They were saying “Well this is probably the 
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best time to do it” and I was like “Yeah probably” ..I was just like “Och 
what's the point’’ (P16) 
For some participants (4/17), the instructors acted as facilitators in helping them to 
engage with the practices, and encouraging them to attend the MBSR sessions. For 
others (4/17), it was family members or significant others that they respected, such as 
their MS Specialist Nurse, or their GP.  
A majority of participants (10/17) were still practising since completing the course, 
although quantifying exactly how much and how often could not be determined 
clearly from their responses. One participant noted the difficulty of maintaining the 
practices without the incentive of a forthcoming weekly class. She revealed that she 
was still doing the meditations, but in a more narrow range than during the course. 
Another participant commented that it had been difficult following course completion, 
in that [you] went from an immersion in the routine to then being left on your own:  
‘I think, see because it's like practice, practice, practice, practice and you go 
to the group one and that's quite constant and all of a sudden it just goes stop’ 
(P11) 
Some participants (4/17) mentioned that they would have liked for the course to 
continue, and that they were keen to keep coming by attending a fortnightly drop-in 
session held at the centre (open to all completers of mindfulness courses run at the 
NHS CIC and not specifically part of the current course), but for at least one 
participant, the fact that this was scheduled to take place in the upstairs seminar room 
served as a strong barrier to taking part: 
‘I think the fact that the mindfulness course is continued every 2nd Friday or 
something is good, but again it's up in that room so that’s a barrier to me, I 
will not be attending and that’s a shame that it's away up there.’ (P6) 
The course was not for everyone. One of two male participants who dropped out 
following the first week could not be contacted again. The other divulged over the 
telephone that he had found the group format quite overwhelming. Another female 
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participant, who attended the first session only, expressed bemusement and frustration 
at the perceived emphasis on disability. This view was echoed by another lady who 
attended only two sessions, also feeling that there should have been emphasis placed 
on ‘pushing one’s limits’, instead of simply accepting one’s limitations/disabilities.  
Feedback gleaned by the course instructors highlighted that seeing others more or less 
disabled, the intensity of the course, the perception that the course was not MS-
specific, and the unacceptable venue set-up for the first week had all played a 
significant role in influencing dropouts. The instructors both remarked that through 
prior experience with teaching mindfulness they had recognised the need to have a 
pre-course orientation session to address expectations, and to make it easier for people 
to leave ‘gracefully’, at an early stage. The orientation session had been dropped from 
this course, for pragmatic, resource constraint reasons. In this course, they felt that 
people arriving on the first day had been wary and uneasy, unprepared, and not really 
sure what to expect. 
For those who dropped out from the course (3/17), the perceived focus of the 
mindfulness practices on acceptance of more negative aspects of experience, such as 
pain, functional limitations, or disability was a strong feature in their reasoning for 
leaving:  
‘I think it was great for some people but it just wasn’t for me because I took 
MS all the way through I've always had a positive attitude, I've never let it get 
controlling me, so when I was sitting listening to everybody I thought “There's 
too much negativity in here”. I'm not really into negativity, so that's why I 
thought: “No, I can’t go back to that”, because I needed more out of it’ (P9) 
7.5.3 Theme 3 ‘Getting it, or not’ 
The third main theme covered how/what people got, or did not get from the MBSR 
course. Once again, there were several sub-themes that fell into this category, 
including what it was like being ‘in the zone’, or a meditative state of mindful 
awareness; the perceived overall effects of the mindfulness practices; how being 
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mindful impacted on self-care; and how being mindful impacted on relationships with 
others (Figure 7.4).  
Figure  7.4 Theme 3 ‘Getting it, or not’ 
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Another participant described an awareness of change in her experience, where 
habitual responding to a source of fear had changed into a sense of wonder at what is: 
‘I'm talking about like two minutes to actually appreciate things that you 
would never have done before. I'm terrified of birds, but during the course I 
found myself at the kitchen window being in awe of a Robin and it was 
amazing. It was as if nothing else mattered in those two minutes and it made 
me feel really good’ (P8) 
There were further comments from participants (5/17) that seeing and hearing how 
others were experiencing the course helped with their own understanding and 
experience of the practices. However, for others (2/17), questions arose as to whether 
they were doing the practices correctly, although this lessened with time. For at least 
one participant, relaxation proved to be an insurmountable obstacle, as she felt that 
this was just not who she was.  
7.5.3.2 Perceived overall effects from taking part in MBSR 
The majority (13/17) of those who completed the MBSR course reported feeling 
better in a variety of ways. Of the more frequent reports, 13 people directly described 
feeling less stressed or more relaxed, and four people happier. One individual felt that 
she was finally getting back to being her old self: 
‘I'm going back to laughing or being the dolly person that I was before and 
that's the person that I liked, I didn’t like that person that I turned into at all.’ 
(P14)  
Another described feeling elated, with a new sense of wellbeing and optimism:  
‘I feel as if I'm much more in control of what's happening. I feel as if I can use 
almost like my mind to heal my body. I feel as if I no longer get stressed about 
things, I no longer worry, whereas I used to be a real worrier. I just, I'm quite 
accepting of things’ (P3) 
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From a physical perspective, several participants (5/17) reported feeling less pain 
during the practice: 
‘..It can help with the pain. I mean, I think you know, people may be quite 
sceptical at first, because I certainly was, but I would say to them”You've got 
to try it because it does help”.. ..So, for example, in the Body Scan I feel quite 
light afterwards, quite, I think the pain goes away. It may not stay away, but 
for that time it goes away and that's great.. .. I feel like I can at times control 
the pain’ (P2)  
For another, the practices were having a more lasting effect on pain and associated 
sensory disturbances:  
‘The numbness in my feet and my hands, I keep waiting for this. They're still 
burning at night. I notice that if I put it against my legs but I don’t actually 
notice it in my feet if you know what I mean and last night they used to go into 
kind of spasms and things and last night it was cooler and I thought “Well my 
feet will be going all that horrible way” and they weren’t, so there's been a 
definite improvement there, and my hands aren’t so numb, they don’t go so 
numb so quickly either’ (P5) 
For at least one participant, there was a change in how she related to sensory 
phenomena in her body:  
‘It didn’t change the sensations as such, it changed my way of thinking about 
the sensation.. ..my thought process, I wasn’t stressing about “Oh my 
goodness this is, there's a tingling here”, I was more relaxed about it and I 
accepted it you know’ (P1) 
Several participants (4/17) reported improvements in their walking, despite the initial 
difficulties mentioned earlier. 
One participant, who dropped out after the first session, reported feeling mentally 
worse as a result of taking part in the course. She had various complaints about the 
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session she had experienced, centring on perceived organisational and attitudinal 
failings from those running the course, but in particular she emphasised an increase of 
pain in her upper limbs and how this had affected her mental wellbeing: 
‘My mental wellbeing has taken a wee dunt because the pain has increased 
and certainly that one day I attended here really highlighted my hands and the 
roll-on effect of that has been quite large, but it wouldn’t be fair to say that my 
mental dunt is down to that one day. It's been a small proportion of it.’. (P13)  
Another participant, who dropped out after attending the first session, also reported 
briefly feeling quite low after attending the class, like she had a ‘chronic illness’ and 
was destined for a wheelchair. Following discussion with her MS Specialist Nurse 
and a senior colleague at work, she decided that the course was not for her and 
immediately felt better. 
7.5.3.3 Relating to one’s self 
Several participants described how a shift in awareness had led to a change in how 
they related to themselves (9/17). Many described having a realisation that they were 
being very hard on themselves (7/17), and that this needed to change: 
‘The course made me realise that I do beat myself up a lot and I don’t feel as 
if I'm doing that now.. I think before I was very much like “I've got this wrong 
with me and that wrong with me”, but thinking “well that is wrong with me 
but I can still do x, y and z”. So, making me aware that maybe my body isn't 
100%, but I can still do this and I can still do that and maybe one day if I 
couldn’t do something as well, I wasn’t putting myself down as much, because 
I would normally beat myself up about it’ (P14) 
One individual described the process of recognising that her mood was becoming low 
and being able to intervene before it became worse. Another described a similar 
process of becoming aware of rising stress, and acting on it in the moment:  
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‘Once I catch on that there's like there's something happening say, say if the 
wee one is running around and she's getting me quite uptight and I'm like “I 
need to pull myself back a wee bit here” and I'm like “Right, I'm going to do a 
quick breathing”.’ (P11)   
Another participant described how the realisation that she did not have to react to and 
follow her thoughts precipitated a positive change, which significantly improved her 
sleep: 
‘My whole mind is much calmer.. That settling the mind one, I really like that 
and I think yeah, I think my mind was a total jumble of all sorts of thoughts 
and worries and.. Oh there was one thing that really struck me, that one of the 
women [MBSR instructor] said “Thoughts are not facts”.. ..I think I used to 
get everything in my head and like I would lie awake worrying about things 
and I would decide “Oh that’s really bad” whereas that wasn’t really bad, or 
“I should have done that, I should have said this, I’ll need to try”, whereas 
now I just do the cycle in my mind and I just don’t even go there anymore and 
I don’t dwell on things, I used to be a great one for worrying and dwelling on 
things so now I'm just much more, much, much calmer in my mind and yeah.’ 
(P3) 
One individual implied a more contemplative approach to challenges, stopping to 
think before responding, and another described recognising her limits in terms of how 
much she could give to others. Finally, one participant relayed the process of seeing 
unhelpful behaviours in herself, but also seeing the opportunity for change. 
7.5.3.4 Relating to others 
Several participants noted improvements in relationships over the duration of the 
course (10/17). One participant offered a quite profound insight into her change 
process of sharing her MS burden: 
‘Uh huh and it kind of made me realise that I have to deal with certain things 
in my life rather than just putting them on the back-burner.. ..Just 
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relationships and things like with my parents and my husband, things that I 
don’t tell people because I feel that it would hurt them or I put on like a strong 
confident person just because I don’t want them to know how I feel, but 
actually, it's actually really important they know how I feel, because they can’t 
help me unless they .. I've tried to do that more.., let more people into my life 
and stop having a wall around and it's helped me as well to have more real 
confidence, rather than more fake confidence, which is good, yeah I feel 
happier for that, because I feel like I'm being me more, rather than having just 
the big smiley face on all the time.’ (P8) 
Various participants (4/17) described feeling closer to/more aware of their 
relationship with their children, whilst two revealed that their spouses had noted a 
positive change in their behaviour. One individual was using mindfulness techniques 
to help a cousin suffering with anxiety, whilst another taught the techniques to her 
elderly and infirm father who was struggling to come to terms with his declining 
capacity. Participants’ generally described feeling more aware of other peoples’ 
perspective, with more empathy, even compassion towards them. In one situation, 
where a participant had witnessed an apparent aggressive act from another partygoer, 
seemingly directed towards her, she described experiencing a new way of responding, 
which for her was more reflective and less argumentative: 
‘He's got all these pressures and I probably wouldn’t have recognised that 
before. I was more aware of my surroundings and more aware that everybody 
has got something going on in their life and there's probably a reason to why 
he's hitting out.. ..As I say I would have probably, maybe not started an 
argument with him, but I would have been more confrontational’ (P14) 
One participant commented how using the mindfulness techniques had helped her 
cope with family conflict. Another described greater tolerance towards other road 
users: 
‘I'm just thinking driving was a big one for me, where you know, where people 
cut you up or whatever and you start shouting or whatever, but I was more, 
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more just “Let it go”, I was definitely that sort of sense and as I say the people 
that I work with just too, just chilled out, more chilled out’ (P16) 
7.5.4 Theme 4 ‘Improving the MBSR course for people with 
MS’ 
The fourth main theme related to how participants and the MBSR instructors felt the 
course could be improved for people with MS. Sub-themes here centred on improved 
pre-course preparation; course content and relevance for people with MS; MBSR 
course delivery; and thinking about when might be the best time for someone with 
MS to take the course (Figure 7.5) 
Figure  7.5 Theme 4 ‘Improving the MBSR course for people with MS’  
 
 
7.5.4.1 Being better prepared 
From the participant and instructors interviews there was a general consensus that any 
future course should be more disability-friendly. For the instructors, thoughts focused 
on practical considerations such as knowing more about who was coming on the 
course, having skilled nursing help on hand for more disabled course participants, 
having tea and coffee brought to the room and not left on a trolley, having the pre-
course orientation session re-introduced, and having the necessary materials in place 
so that the home practices were available for a wider range of ability levels. 
Theme 4: 
 Improving 
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MS  
4.1 
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prepared 
4.2 
 Making MBSR 
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people with MS 
4.3 
 Improving 
delivery strategies 
of MBSR for 
people with MS 
4.4 
 Timing: when is 
the best time to 
learn MBSR if you 
have MS? 
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Participant views echoed this, suggesting a more accessible room such as that used 
from the second week onwards, and that people should be made more aware what 
would be required of them, both in terms of attendance and home practice. One 
participant who specialised in skills training through his job in human resources 
suggested making participant testimonials available to add credibility, and also 
suggested the use of visual aids in course delivery. 
One difference between the instructors and participants was that the latter expressed a 
desire for more time to be made available for getting to know the other course 
participants, as this was a valued part of their experience. 
In this context, it was also highlighted that the tea/coffee-break experience needed 
careful forethought in relation to the more disabled. One participant pointed out the 
difficulty fetching a hot drink from a trolley for someone like herself, dependent on 
elbow crutches. She also highlighted that mingling might also be difficult for those 
more disabled: 
‘I felt more disabled because I couldn’t go and just grab a biscuit and grab a 
cup of tea. I felt more disabled because I had to ask other people.. ..It’s easy to 
forget that this can also impact on the ability to socialise’ (P6)   
7.5.4.2 Making MBSR more relevant to people with MS 
Neither instructor felt that a great deal should be changed with respect to the course 
content. They both iterated that they saw MBSR as being a well-honed generic 
approach. However, they did think a more cautious approach was warranted for some 
aspects of the content, such as the mindful walking practice, which they felt should be 
referred to as ‘mindful locomotion’ and that there was some scope for making the 
practices more accessible: 
‘Cautious about the walking, very carefully framing that, adapting the mindful 
movement, making lots of choice, as the body scan, whether people are lying 
or sitting, so maybe on the one hand acknowledging that this is a shared 
illness, but on the other hand not being pulled down by it’ (I1)   
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One instructor felt that, ideally, it would be good to include a day retreat, but 
acknowledged the practical difficulties associated with this in an NHS setting. 
One participant, who left after the first week, felt that the course had been ‘cobbled 
together’. A few (4/17) stated that they would like more in the way of MS-specific 
material and practices, such as the science behind the mindfulness approach, and how 
that relates to what is known about MS and stress. Another felt strongly that mindful 
walking should not be included unless it was tailored in some way to meet with 
different ability levels. She felt that course delivery needed to be more sensitive 
towards the needs of those with MS, by differentiating it from other conditions, and 
ideally, that any future course design should be informed by someone with MS who is 
familiar with the experience of being chronically unwell:  
‘I don’t think you can have mixed abilities walking round and everybody 
happy.. ..I just felt the delivery needed to be a bit more sensitive to the needs 
of people with MS and MS is very different from chronic fatigue or any other 
thing like that.. It might have been better to have somebody who has actually 
been ill or not been well to have an input into the delivery on the course’ (P6) 
7.5.4.3 Improving delivery strategies of MBSR for people with MS 
Several participants (4/17) reported a dislike for the male voice that featured on some 
of the home practice CDs. One participant expanded on this by describing how she 
would prefer a softer, more gentle voice, with a couple of participants suggesting that 
familiarity with the instructor’s voice on another home practice CD made it easier to 
work with:  
‘I think the voices of the ladies who were taking the course were really nice. 
They were quite kind of soothing and there's nothing wrong with the male 
voice, it's just a few people in the class said: “I don’t really like that man’s 
voice”.’ (P10) 
One participant stated that she felt that the course manual was not appropriate for 
people with MS, that it was kind of ‘American’, and there was too much focus on 
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disability, rather than ability. Surprisingly, another participant described how she felt 
that the course manual was designed with another condition in mind (Stroke), which 
was of course not the case. 
7.5.4.4 Timing: when is the best time to learn mindfulness if you have 
MS? 
Participants held differing opinions about when might be the best time to learn 
mindfulness in the course of MS. Two commented that they wished they had been 
fitter before taking the course, in one case in relation to the mindful movement, and in 
the other relating to beliefs about certain yogic breath practices. 
One participant felt that it might be too much for someone who had been newly 
diagnosed: 
‘Well.., not so soon after diagnosis.. .. I think one girl in particular because it 
was very raw, it brought a lot of raw emotions to her, the sensation thing she 
was quite upset by it’ (P7)  
On the other hand, another individual iterated that she wished that she had been given 
the opportunity nearer the time of her diagnosis: 
‘When I was diagnosed, I mean it hit me quite severely and it was 
overwhelming and from a personal experience there was so much going on in 
my life and at the time I was alone with two children and I just was frantic, the 
whole time thinking “How am I going to manage if this happens again, how 
am I going to deal with things?” and it helps you put things in perspective. It's 
not saying “Well that's not going to happen” but it's kind of making you think 
“Don’t stress too much about that, just dwell on the here and the now and 
what you can do, and don’t beat yourself up for things that you can’t do”, you 
know. It's taken a lot of pressure off me, I know that whatever could happen 
might happen, but I'm not as panicked about it as I was before’ (P10) 
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7.5.5 Application of the Normalisation Process Theory ‘lens’ 
to the qualitative analysis findings 
 
Following completion of the qualitative analysis, emergent themes were subjected to 
a retrospective analysis under the theoretical ‘lens’ of NPT (Table 7.3 and Table 7.4). 
This was used as an implementation guide, and no attempt was made to ‘shoehorn’ 
themes to fit the theory. Table 7.3 outlines how the emergent themes relate to the NPT 
constructs and Table 7.4 illustrates the ‘NPT matrix’ for MBSR. 
Table  7.3 Mapping the emergent themes to the NPT constructs 
Theme NPT construct 
1. Coming together for the course 
 
 
- Pre-course expectations Coherence 
- Being prepared and getting there Cognitive participation 
- Course context; getting it right Collective action 
- Becoming a group Collective action 
2. Doing the work of mindfulness 
 
 
- Coming face-to-face with MS: senses, sensations, and 
disability 
Cognitive participation 
- Making sense of MBSR group practices Collective action 
- Making sense of MBSR self practices Cognitive participation 
- Staying present, or dropping out Cognitive participation 
3. Getting it, or not 
 
 
- Being in the zone Coherence 
- Perceived effects from MBSR Reflexive monitoring 
- Relating to one’s self Collective action 
- Relating to others Cognitive participation 
4. Improving the MBSR course for people with MS 
 
 
- Being better prepared Reflexive monitoring 
- Making MBSR more relevant to people with MS Reflexive monitoring 
- Improving the delivery of MBSR for people with MS Reflexive monitoring 
- Timing: when is best to learn MBSR if you have MS? Reflexive monitoring 
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Table  7.4 NPT coding matrix for MBSR 
 1. Coherence  2. Cognitive participation 3. Collective action 4. Reflexive monitoring 
a) Differentiation 
 
Is there a clear understanding of 
how the MBSR course differs 
from existing practice? 
a) Initiation 
 
Are key individuals willing to 
drive the implementation? 
a) Interactional workability 
 
Does the MBSR course make 
people’s work easier? 
a) Systematisation 
 
How are benefits or problems 
identified or measured? 
b) Communal specification 
 
Do individuals have a shared 
understanding of the aims, 
objectives and expected benefits 
of the MBSR course? 
b) Enrolment 
 
Do individuals “buy into” the idea 
of the MBSR course? 
b) Relational integration 
 
Do individuals have confidence in 
the MBSR course? 
b) Communal appraisal 
 
How do groups (patients/ 
clinicians/ managers/ MBSR 
instructors) judge the value of the 
MBSR course? 
c) Individual specification 
 
Do individuals have a clear 
understanding of their specific 
tasks and responsibilities in the 
implementation of the MBSR 
service? 
c) Legitimation 
 
Do individuals believe it is right 
for them to be involved? 
c) Skill-set workability 
 
How does the MBSR course 
affect roles and responsibilities/ 
training needs? 
c) Individual appraisal 
 
How do individuals appraise the 
effects on them and their work 
environment? 
d) Internalisation 
 
Do individuals understand the 
value, benefits and importance of 
the MBSR course? 
d) Activation 
 
Can individuals sustain 
involvement with the MBSR 
course? 
d) Contextual integration 
 
Is there organisational support for 
the MBSR course?  Are there 
contextual issues that matter? 
d) Reconfiguration 
 
Do individuals try to alter the 
MBSR course? How do 
individuals think MBSR needs 
altered to meet the needs of those 
with MS? 
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7.5.5.1 Coherence – making sense of the course 
Coherence is about how stakeholders make sense of a complex intervention [206].  
Findings from the qualitative analysis demonstrated that most of the course 
participants interviewed (13/17) were new to MBSR. In terms of how participants felt 
MBSR differed from other approaches for managing their condition, the qualitative 
findings suggest that MBSR was perceived as different from what most people had 
previously experienced. For some, this difference may have acted as a barrier to 
participation and engagement. Better pre-course preparation could have helped 
participants have a clearer idea of what to expect, and possibly also how best to 
engage with the experience. In the case of the instructors, there was an idea that 
MBSR could facilitate less focus on the MS-identity, something that they perceived as 
prevalent and problematic in the condition. They assumed that lessening this focus 
would be good for participants. Some participants were invested in the hope that 
MBSR might offer them some relief from their symptoms of stress, pain, or difficulty 
sleeping, and this might facilitate taking part in MBSR, given the high prevalence of 
such distressing symptoms in people with MS. Thus, expectations differed between 
the instructors and participants, in part due to the lack of the usual orientation session, 
which had been dropped due to anticipated increased costs associated with its 
inclusion. Lack of an orientation session was particularly emphasised by the MBSR 
instructors as contributing to initial difficulties with the course, and possibly the 
attrition seen thereafter. The instructors saw this as relating to not having the 
opportunity to address expectations at an early stage. The instructors considered that 
their role was to deliver an otherwise standard MBSR course, without specific repose 
to MS; on the other hand, participants expected that the course would be more MS-
specific. This mismatch in expectations could act as a potential barrier to future 
courses.  
Also relevant here is home-practice and the important role it seemed to play in 
helping people ‘get’ the practices and the benefits of MBSR. More emphasis on the 
importance of the home-practices, and the personal responsibility involved in 
maintaining them from an early stage, might act as a potent facilitator to achieving the 
benefits (‘success’) and engagement with the MBSR course. 
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Proponents of mindfulness have repeatedly underlined the importance of MBI 
instructors’ having their own dedicated practice [13, 153]. Interview feedback from 
participants suggested this emphasis was evident in this course too, where they 
relayed how the instructors were adamant about the importance of maintaining their 
own practice and how it had helped them. This may have helped participants to make 
sense of the benefits, value and importance of the practices, but others also pointed 
out that more could perhaps be done to communicate this point, including personal 
testaments from previous course completers, and inclusion of the aforementioned 
orientation session in future courses. See Box 7.3 for key message and 
recommendation regarding Coherence: 
Box  7.3 Coherence – key message and recommendation 
 
Key message: Expectations between participants and MBSR instructors were mismatched. 
Participants did not really know what to expect, and both they and the MBSR instructors had 
to ‘catch-up’ in this regard during the course. For some participants this was disappointing 
and is likely to have hindered their engagement. 
Key Recommendation: A pre-course MBSR orientation session seems essential in order to 
manage participant expectations 
 
7.5.5.2 Cognitive participation  
Cognitive participation refers to the relational work that stakeholders undertook to 
create and sustain a community of practice around the intervention [206], for example 
that between the participants and instructors, but also, more broadly, where 
participants had to engage with other people in their lives, for example to help arrange 
child care, or transportation for coming to the course. 
‘Buying in’ to the idea of MBSR does not appear to have been a problem for the 
initial recruitment target of 50 people, with 100% being recruited within the three-
month timescale, which is notable given that most trials of complex interventions fail 
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to meet their recruitment targets [216]. The instructors had a pre-existing rationale for 
how they thought MBSR would help people in general, and those with MS 
specifically, by softening the MS-identity, and by changing the way individuals 
related to their experiences, including distressing embodiment sensations. Many 
participants appear to have accepted these ideas as well, reflected perhaps by 
increased mindfulness and self-compassion scores in the RCT findings, and by the 
qualitative findings, where some considered themselves more ‘mindful’ and 
compassionate in their daily lives. However, others did not. It is interesting to 
speculate if those dropping out early on might have ‘bought in’ had the environment 
been more suitable, i.e. with more exposure to the techniques, or if the initial 
dynamics of the group and/or setting had been different. In any event, it highlights 
again the importance of managing expectations appropriately in advance of the 
intervention. 
There were several participants who dropped-out from the MBSR course (n=8). 
Reasons and timing varied. From those who attended any classes (n=21), some clearly 
did not feel it was right for them to be involved, with the mindfulness approach being 
perceived as counter-intuitive to at least three participants. Lack of an orientation 
session and/or a failure to identify and manage divergent expectations during 
recruitment may account for these discrepancies. However, most recognised that 
stress was a problematic area in their lives, including those who stopped attending, 
and many were keen to learn new ways of dealing with this issue.  
Of those interviewed, the majority (n=10/17) were able to sustain mindfulness 
practice in some way, and in this regard the availability of a drop-in session could act 
as a facilitator for many to keep up the practices beyond the eight-weeks of the 
course. However, treatment adherence was sub-optimal, and participant feedback 
suggested that perhaps the most important factor in this regard related to managing 
pre-course expectations. Similarly, other participant feedback suggested strategic 
alterations to class, practice, and course duration might each act to facilitate and 
sustain broader engagement and adherence. See Box 7.4 for key message for 
Cognitive participation: 
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Box  7.4 Cognitive participation – key message and recommendation 
 
Key message: Doing the mindfulness practices (treatment adherence) without a clear 
understanding of why they are being done, how they should be done, and why continued 
practice is required to see the benefits seems to be an important barrier to engagement and 
sustained involvement, especially in the early stages of the course. This may be even more 
strongly the case in those who have high levels of disability and comorbidity, or a strong 
illness identity. 
Key recommendation: The environment for an MBSR course for people with MS has to be 
right. Disability and/or comorbid conditions can act as barriers to participation in MBSR. 
When catering for disabled/multimorbid groups this should be anticipated, and practices 
tailored to meet the specific needs of each individual, and the group. 
 
7.5.5.3 Collective action 
Collective action is about the operational work that stakeholders have to do in order to 
enact the practices of the new intervention [206]. 
Many participants described deriving benefit from the MBSR practices, and being 
able to integrate the techniques to meet various challenges in their daily lives. 
However, an obvious obstacle highlighted was the impact of disability on being able 
to participate in the practices. The course instructors described assumptions they held 
about how mindfulness might help people with MS, and to some extent these 
correlate with qualitative participant feedback about how the practices were used to 
deal with stress, how they related to themselves, and how they related to others. 
Similarly, quantitative findings from the RCT, such as enhanced mindfulness and 
self-compassion, further support this hypothesis.  
Most participants reported benefit from the MBSR course, suggesting they had 
confidence in its potential role to assist with stress management, but this was not 
unanimous. An important, yet subtle shift in responsibility for symptom management 
may be evident amongst participants. For example, several participants described a 
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change in how they related to the fluctuation in their symptoms attributed to MS, with 
a more reflective attitude emerging in some. Others reported recognising a need to 
relate to their self differently, by being more self-compassionate. Some described a 
recognition that they needed to make more time for the practices, but simply couldn’t 
find it. 
On a macro- level, it is difficult to say whether organisational support exists for a 
MBI for people with MS. To assess adequately such issues would require a broader 
range of stakeholder interviews, to include MS clinicians and NHS managers. Both of 
the instructors used their administrative and lunch time to take part in the course, and 
thus their participation was in addition to their usual NHS workloads. Both reported 
that this presented challenges. Informal feedback from the instructors suggested that 
organisational support was not uniform, and following a change in management both 
were wary that they might not be similarly supported to take part in any future study. 
See Box 7.5 for key message from Collective action. 
Box  7.5 Collective action – key message and recommendation 
Key message: In order to get the benefit from MBSR, people have to do the practices. This 
relies on coherence and cognitive participation, where participants understand the importance 
of doing the practices, and ‘buying in’. Generic MBSR courses/materials may not be optimal 
for people with comorbid conditions/disabilities. Practising in the context of chronic pain, 
limited fitness, and impaired mobility may not be practicable, or safe. Wide stakeholder 
involvement is crucial in making preparations for a disabled group.  
Key recommendation: Enacting the MBSR practices relies on wide stakeholder engagement, 
understanding, and ‘buying-in’. Judicious planning could help overcome operational barriers 
to participation amongst more disabled groups. 
 
7.5.5.4 Reflexive monitoring 
Reflexive monitoring refers to on-going appraisal and assessment of how the new 
practices of the intervention impact on the stakeholders and those around them [206]. 
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The majority of participants who completed the course described using the MBSR 
practices in their daily lives in some form, with most describing benefit, feeling 
better, and being less stressed. Many described noticing beneficial changes in their 
relationships with others. However, two participants felt that attending a single class 
had been to their detriment. Nine out of 25 did not complete the course. 
The standard clinical governance practice of the MBSR instructors i.e. to phone 
course dropouts to check on their reasons for non-attendance allowed insight into 
some important aspects of non-attendance relating to course organisation, structure, 
perceived focus, and content. In addition, the collection of ‘informal’ participant 
feedback during the course, and then ‘formally’ in written format at course 
completion allowed the MBSR instructors to enhance intervention fidelity, and to act 
reflexively to address the multiple difficulties that were highlighted in the first week 
of the course. Such feedback proved to be useful in making logistical alterations to the 
course i.e. organisation, setting, content etc, generating useful insights into how the 
course could be optimally reconfigured in light of the high levels of physical 
disability. The process of formal written feedback from participants at course 
completion allowed the instructors to gain insight into the value of the practices to 
participants, and to judge where these could/should be improved or modified.  
As most participants were not normally patients at the NHS CIC, no formal 
arrangements were in place for ‘follow-up’. Under normal circumstances, patients 
attending a mindfulness course there would follow-up with their usual Integrative 
Care provider at the centre, where issues arising from the course could be brought to 
light and addressed. The instructors highlighted the lack of such feedback as 
problematic for them, raising an important question about continuity of care for 
course completers, who might not want to attend the drop-in sessions, or have access 
to anyone else suitably qualified/au fait with the MBSR approach and its place in the 
‘bigger picture’ of managing MS.  
Participants had various suggestions for improving the course. Suggested changes 
related to course design, such as inclusion of an introductory day; smaller class sizes; 
shorter classes and practices; more time spent socialising with other course 
participants; using a more accessible room; excluding mindful walking; and making 
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the course manual more MS-specific and ability-appropriate. See Box 7.6 below for 
key message and recommendation regarding Reflexive monitoring. 
Box  7.6 Reflexive monitoring – key message and recommendation 
 
Key message: Routine safety and governance measures are important for MBSR courses, 
including suitable class space, embedded continuity of care, and standard follow-up 
procedures. Such measures assist in the ongoing monitoring of intervention fidelity. Applying 
course material flexibly, in response to participant feedback seems necessary, especially so in 
a highly disabled/multimorbid group. 
Key recommendation: Generic MBSR courses are not suitable for everyone with MS. 
People who are highly disabled and/or multimorbid will likely need course organisation, 
structure, perceived focus, and content tailored to meet their specific needs. Changes to the 
generic course should be evidence-informed, monitored, and recorded. MBSR instructors 
may need additional training to deal with specialist groups, such as people with MS. 
 
 
 
7.6 Discussion 
7.6.1 Summary of key findings 
This chapter has examined qualitative feedback from participants and instructors on 
their experiences of using MBSR as a treatment strategy for people with MS. Through 
using a rigorous qualitative approach to analysis, emergent themes relating to 
accessibility and acceptability of the intervention have been identified and organised. 
Mapping these onto NPT allowed key issues to be conceptualised around 
expectations, engagement and sustainability, around practical considerations relating 
to course delivery, and regarding how the course may need to be reconfigured to meet 
better the needs of those with MS.   
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The four main emergent themes to come from this analysis were:  
1) ‘Coming together for the course – everyone has MS’ 
2) ‘Doing the work of mindfulness’  
3) ‘Getting it, or not’  
4) ‘Improving the MBSR course for people with MS’ 
Bringing together a group of people with MS with varied ability levels for a MBSR 
course requires careful forethought and preparation. People need to know what they 
are signing up to and what will be expected of them. Agreeing to take part in an eight-
week course is a considerable undertaking for anyone, and likely more so when 
disabled. The venue for such a course should be disability-friendly. 
Facing up to MS with a mindful and compassionate approach may have many 
benefits. However, turning attention to the areas of one’s body that are chronically in 
pain, or don’t work as well as they might otherwise, can be unpleasant for people, and 
these practices need to be couched carefully, in terms of language and connotation. 
Making sense of one’s experience of MS in a MBSR group could help some people, 
especially when being led through the practice by experienced instructors. Building 
upon such experiences with appropriate and accessible home practice materials seems 
to help some people with MS make a shift in attitude towards themselves, becoming 
more mindful and self-compassionate. In many cases, this beneficial effect may carry 
over into relationships with others, who can be important sources of social support.  
Seeing positive effects from taking part appears to be important for people with MS, 
in order to ‘buy in’ to the practices, and may act to sustain involvement. The majority 
of participants in this study (13/17) reported beneficial effects from MBSR, but others 
did not, and this mostly seems to come down to a mismatch between pre-course 
expectations and the focus of the generic MBSR course.  
These findings are further augmented by suggestions for improvement to the MBSR 
course. For example, a pre-course orientation session seems to be necessary, 
something which participants and instructors alike would value. There is perhaps 
scope also for tailoring the course content and delivery to make it more MS-specific, 
and bolstering teaching strategies to encompass a broad range of disabilities seems 
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sensible. At present, it remains unclear as to when might be the best time for people 
with MS to learn MBSR; in this study it was suggested by participants that times of 
high stress, such as around the initial diagnosis, or during a relapse are where having 
the MBSR skills on hand could be particularly helpful. 
These themes emerged during a thematic analysis of participant and instructor 
feedback. This methodology has protected the originality of the data, rendering it both 
reliable and valid for people with MS. Further, these emergent themes have been 
scrutinised with regards to implementability of MBSR, under the theory-driven ‘lens’ 
of NPT. Using an established theoretical framework has the advantage of allowing the 
researcher to link findings with well-validated models of knowledge, thus enhancing 
generalisability [325]. NPT in particular is designed for assessing implementation 
issues in complex interventions [215], and has allowed a closer evaluation of potential 
facilitators and barriers to successful implementation of MBSR in this population, as 
well as helping in the process of considering how best to optimise the intervention. 
This conceptualisation has helped identify four key issues and recommendations for 
anyone contemplating MBSR for people with MS: 
1) A pre-course MBSR orientation session seems essential for coherence, in 
order to manage participant expectations. 
2) In the case of collective action, the environment for a MBSR course for 
people with MS has to be right. Disability and/or comorbid conditions can 
act as barriers to participation in MBSR. When catering for disabled/ 
multimorbid groups this should be anticipated, and practices tailored to 
meet the specific needs of each individual, and the group. 
3) Regarding cognitive participation, enacting the MBSR practices relies on 
wide stakeholder engagement, understanding, and ‘buy-in’. Operational 
barriers to participation could be overcome by judicious planning when 
dealing with highly disabled groups.  
4) Lastly, when considering reflexive monitoring, MBSR courses are not 
suitable for everyone. People who are highly disabled and/or multimorbid 
will likely need the course organisation, structure, perceived focus, and 
content modified to meet their specific needs. Changes to the generic 
course should be based on empirical evidence and experience, monitored 
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and recorded. MBSR instructors may need additional training to deal with 
specialist groups, such as people with MS 
7.6.2 Relationship to published literature 
7.6.2.1 Emergent themes 
There are very few published research studies that report on qualitative findings about 
how people with MS find taking part in MBIs [296, 313]. In the case of Hankin [296],  
the data in this study relies upon informal, and un-systematically collected views from 
MS patients and their partners on the impact of MBSR training, limiting its relevance 
to the findings from this current study. In the only other qualitative study on the use of 
MBIs in MS, Bogosian et al. [313] provided a more detailed analysis of participant 
experiences (n=15) of a remote-delivered Skype MBCT intervention for people with 
progressive MS. The researchers were interested in examining the potential mediating 
roles of several theoretical variables thought to be important in MBI mechanisms. 
These included acceptance and experiential avoidance, the ability to decentre from 
one’s thoughts i.e. to see them as simply thoughts and not necessarily a reflection of 
reality, having compassion towards one’s self, and self-efficacy [313] i.e. belief in 
one’s ability to succeed in a particular situation/achieve a set task [326].  
In terms of potential mechanisms by which MBCT might lead to reduced 
psychological distress, Bogosian et al. [313] reported supportive qualitative findings 
for all of their deductive themes, but a concurrent quantitative analysis of these 
putative mediator variables suggested that they only partially explained how the 
intervention acted to reduce psychological distress. As in this current study, Bogosian 
et al. [313] reported that participants found staying with distressing thoughts and 
emotions difficult, but that those who persisted derived benefit, describing the 
mindfulness techniques as useful tools for managing, and coming to terms with MS. 
They also found that the mindfulness practices helped participants experience pain in 
a new and more beneficial way, and to recognise and prise apart automatic cycles in 
their emotions. In keeping with findings in this current study, Bogosian et al. [313] 
reported that course participants became more aware of tendencies for self-criticism, 
and gradually became more compassionate towards themselves as the course 
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progressed. Bogosian et al. [313] also reported that the mindfulness practices helped 
participants feel more calm, and more in control. 
In comparison with the emergent themes reported in this current study, Bogosian et al. 
[313] described the following inductive themes 1) Group dynamics, where being part 
of a regular group and everyone having progressive MS was seen as helpful by some 
participants, but not all. For example, hearing other MS patients’ perspectives was 
helpful, but seeing more disabled individuals was at times challenging; 2) How 
participant pre-course expectations and worldview impacted on their experience of 
the course – one individual reported being open to ‘Eastern philosophy’; whilst 
another saw herself as more pragmatic, and not really at ease with ‘self-help’ 
approaches [313].  
Aside from MS, MBIs have been quite widely reviewed in the qualitative literature 
amongst people with other LTCs, where reports mainly focus on their impact on 
mental health. The largest of these has been a meta-synthesis of 15 empirical studies, 
where Wyatt et al. [320] reviewed MBIs for people with mental health difficulties. 
Their thematic synthesis included a variety of MBIs (two using MBSR). They 
generated quite similar themes to the current study, with eight higher order categories: 
1) ‘prior experiences and expectations’, 2) ‘normalising and supportive process of the 
group’, 3) ‘relating differently to thoughts and feelings’, 4) ‘acceptance’, 5) ‘a sense 
of control and choice’, 6) ‘relationship with self and others’, 7) ‘struggles’, and 8) 
‘awareness’.  
In another qualitative review, Malpass et al. [327] used meta-ethnography to assess 
the literature in this area, collating data from 14 studies to assess how patients with 
chronic illness experience the mindfulness process. This included both mental health 
i.e. recurrent depression, and physical health conditions, such as pain, cancer, HIV, 
Parkinson’s Disease, and patients undergoing cardiac rehabilitation. They arrived at 
three broad categories of how people make sense of the eight-week course, namely 1) 
a period of exposure to maladaptive strategies; ‘perceived safe certainties’ where 
people learn about their usual, unhelpful ways of responding; 2) a period of learning 
new skills to cope; ‘safe uncertainty’ where seemingly counterintuitive skills are 
being learned and things may seem more difficult; 3) transformation of the illness 
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experience; ‘growing down’ which demarked a phase of becoming more expert in 
their own experience, associated with an increased sense of agency and self-efficacy. 
Some of the sub-themes were similar to the findings of this current study, with self-
control/regulation, acceptance, embodiment, and response flexibility featuring 
amongst them. Another, smaller meta-synthesis including seven qualitative studies 
looked at experiences of mindfulness training amongst people with stress, anxiety, 
recurrent depression, Parkinson’s Disease, or those taking part in cardiac 
rehabilitation [328]. The study examined how MBCT facilitates positive change, and 
again generated comparable themes to this current study: 1) ‘taking control through 
understanding’, 2)‘the impact of the group’, 3) ‘taking skills into everyday life’, 4) 
‘feelings towards the self’, and 5) ‘the role of expectations’. 
Being part of the group was highly valued by participants in this study, a finding that 
resonates with Bogosian et al. [313] and other accounts in the qualitative literature of 
MBIs in other chronic illnesses [329]. It has been suggested that such provisions 
should be made more widely available in the NHS [62] and that clinicians should 
remain cognisant of the benefits associated with peer support and socialisation in 
chronic illness, such as MS [329]. Qualitative findings from the use of MBIs in MS 
and other LTCs suggest an element of peer support, de-stigmatisation, and 
normalisation of common illness experiences may expedite a process of acceptance 
[313, 320, 327]. Social support improves QOL, impacts on perceived illness severity, 
and has been described as highly important for people with MS, in terms of adapting 
to receiving the diagnosis and subsequent illness adjustment [21]. Such a forum can 
allow for concerns, fears, and worries to be addressed between individuals with the 
condition, across disability levels [62]. 
In this study, participants mainly reported benefits from taking part in MBSR and 
learning to be ‘mindful’, both in the group, and away from the course on their own. 
Sirois et al. [316] suggest that a variety of skills are likely required for stress 
management in those with chronic illness. This fits with qualitative findings about 
MBIs in chronic illness other than MS, suggesting that individuals accessing MBIs 
tend to use techniques in a ‘mix and match’ type approach, away from the course in 
their daily lives [320], and that MBIs can facilitate a transformation in perspective on 
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both illness and the self. This may, however, depend upon the attainment of meta-
cognitive awareness, a key construct in the theoretical mindfulness literature [327].  
Some people did not benefit much from the MBSR course in this study. To a certain 
extent, there may be a process of learning the language of mindfulness that facilitates 
a more healthy view of and/or internal dialogue with/about the self, but this may be 
harder for some to adopt than others. Wyatt et al. [320] also describe something 
similar in their meta-synthesis, the so called ‘biggest challenge’, where they relate 
this to difficulties in keeping up the practices, especially during challenging times, 
where they possibly matter most. 
7.6.2.2 Implementation issues 
It is clear from this current study that generic MBIs are not suitable for everyone with 
MS, and identifying early on who will likely benefit seems necessary. Grossman et al. 
[177] conducted personal intake interviews prior to their MBSR intervention, in order 
to identify ‘realistic goals’ for taking part, and this may have contributed to the low 
attrition and high adherence in that study, although it should also be noted that the 
mean EDSS (disability) level in that study was less than in the current study (3.5 
versus 4.5), signifying a much lesser degree of mobility impairment. None of the five 
other MBI studies for people with MS described provision of an orientation session 
[289, 290, 304-306], and attrition was higher in these studies than in Grossman et al. 
[177] (range 12.5% - 43%). Findings from this current study also highlight another 
important consideration i.e. that MBSR facilitators may require enhanced training and 
supervision for working with disease-specific, specialist groups, which resonates with 
good practice guidelines for clinical MBI use in the UK 
(http://www.mindfulnessteachersuk.org.uk/) and also with general safety 
considerations [155]. In this study the mean number of years of mindfulness teaching 
experience between the instructors was 7.5 years, compared with nine years in 
Grossman et al. [177]. In general, other MBI studies in people with MS have not 
clearly described level of teaching experience [289, 290, 304-306].   
Previous MBIs for people with MS have either used a generic [177], or an adapted 
MBI, sometimes with justification [305], but more often without [289, 290, 304]. 
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From the qualitative findings in this current study, it seems likely that tailoring of 
MBIs will be required to meet the complex needs of people with MS, and that 
stratification by level of disability should be considered. Bogosian et al. [305] 
recruited more disabled individuals (mean EDSS 6.5), with considerable mobility 
impairment, but excluded mindful-movement from their MBI. The positive treatment 
effects generated in the Bogosian et al. [305] trial, alongside good levels of class 
attendance suggest that the modified MBI was acceptable in this context, but the 
study also failed to show improvements in fatigue scores, perhaps as a result of 
removing the mindfulness practices based in physical activity. Physical activity in 
general is regarded as integral to MS neuro-rehabilitation [44], and even quite 
disabled individuals (EDSS >6.5) report QOL benefits from exercise [330], whilst 
meditative movement in particular has shown wide-ranging QOL benefits amongst 
people with other LTCs, such as those with breast cancer, diabetes, heart failure, low 
back pain, and schizophrenia [331]. Bogosian et al. [305] also used shortened 
meditation and home-practice exercises. Qualitative findings from this current study 
suggest that some participants would appreciate shorter meditation practices and this 
alteration might improve treatment adherence. After Bogosian et al. [305], this current 
study has included the most disabled individuals. Thus, participants’ feedback 
regarding their experiences of mindful-movement will be important in any future 
tailoring of MBSR for disabled groups. 
In previous MBI studies in people with MS, settings have varied from within 
participant’s homes [289, 305], to university hospital locations [177, 290, 304], to 
local MS Society accommodations [306]. From reports of existing studies, it is not 
possible to determine how participants have experienced the range of settings, or 
which might be best, but findings from the current study support the view that a 
suitable setting is important, especially in the context of high levels of disability and 
comorbid conditions. In this current study, having the MBSR course in a NHS tertiary 
care centre, with experienced nursing staff on hand to help, proved to be beneficial, 
and allowed quick adaptation to difficulties encountered with running the course for 
more disabled participants.  
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7.6.3 Strengths and weaknesses 
The findings from this study add important information to the qualitative research 
literature on the use of MBIs for people with MS, where there is very little data. 
Through adopting a rigorous thematic analysis, informed by the framework approach, 
which involved senior qualitative researchers throughout, the reported findings can be 
confidently taken to represent the views of people with MS attending the course, and 
the MBSR course instructors. The iterative nature of the qualitative analysis and the 
involvement of multiple researchers in coding can be seen to enhance the internal 
validity and reliability of the findings. Use of NPT as a theoretical ‘lens’ through 
which to view implementation issues is a distinct strength, allowing valuable insights 
into what additional work may be needed to improve stakeholder uptake and 
engagement with a MBI for people with MS. The sample of participants covered a 
range of socio-demographic variables and MS phenotypes, making the findings 
applicable to wider MS populations in the community. The inclusion of instructor 
interviews allowed a degree of data triangulation, a different perspective on how the 
course had gone, and how it might be improved. Use of NPT as a theoretically based 
implementation analysis tool has allowed the development of key recommendations 
going forward, in terms of how MBSR can be optimised to meet the needs of people 
with MS. 
Limitations include the limited geographic and demographic spread of participants, 
most notable in terms of ethnicity, which was mainly White Scottish, and the fact that 
none of the interviewees had SPMS. Further, not all participants consented to being 
interviewed. Some who completed the course were unwilling, and others who 
dropped out were either unwilling, or un-contactable. Their input might have added 
substantially to the findings. However, interviews were relatively in-depth in nature, 
in that no stringent time constraints were imposed upon them. In the event, the 
average interview lasted 45 minutes.  
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7.7 Conclusions 
Findings from this study support the view that future MBIs should be specifically 
tailored to meet the complex needs of people with MS. In principle, MBSR appears to 
be a useful treatment option, but participant expectations need to be fully addressed 
before coming on the course, and an orientation session/interview seems necessary. 
Course venues for MBSR amongst people with MS should be carefully selected, to 
reflect likely ability and comfort levels of those participating. Certain modifications 
may be necessary to the meditation practices in order to make them more accessible 
and acceptable to people with MS, such as starting with shorter meditations and 
building up to longer durations as the course progresses. Home practice is deemed 
important by instructors and participants alike, especially by those participants who 
derive benefit from the intervention, and should be strongly emphasised from the 
outset. This work has demonstrated the value of broad stakeholder input in judging 
how best to implement MBIs in this population. 
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Chapter 8 General discussion 
8.1 Summary 
The aims and objectives of this thesis were to:  
1. Measure comorbidity in people with MS in Scotland by characterising the 
number and type of conditions compared with the general population. 
2. Delineate the existing evidence for effectiveness of MBIs in people with MS 
by carrying out a systematic review. 
3. Test the feasibility and effects of conducting a RCT of a MBI for people with 
MS, and clarify whether a future definitive trial is currently merited. 
4. Explore the perceptions and views of people with MS participating in a MBI 
(MBSR) 
5. Examine the potential barriers to and facilitators of implementing a MBI for 
people with MS 
This final chapter summarises the key findings of the thesis, discusses future 
optimisation considerations, and introduces possible future research directions. 
8.2 Key findings 
8.2.1 Epidemiology of comorbidity in people with MS – 
Chapter 4 
The study of a large and nationally representative cross-sectional primary care 
database demonstrated that physical and mental health comorbidity is extremely 
common in people with MS in Scotland. After adjusting for age, sex, and SES, people 
with MS were more than twice as likely to have multimorbidity of other conditions 
compared with controls. The odds of having constipation, visual impairment, pain, 
migraine, epilepsy, and IBS were all more likely in people with MS versus controls. 
As the number of other physical conditions increased in MS, so did the chance of 
having associated mental health comorbidity. Women with MS were significantly 
more likely than men with MS to have a comorbid mental health condition. Overall 
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there was a three-fold higher prevalence of anxiety and depression in people with MS 
compared with controls.  
8.2.2 Systematic review of MBIs in MS – Chapter 5 
The systematic review found preliminary evidence from three studies that MBIs may 
be effective in improving anxiety, depression, fatigue, chronic pain, balance and QOL 
in people with MS. However, there were major limitations in the quality of evidence 
for two out of the three published studies included in this review. There have been 
three additional MBI studies published since the systematic review was undertaken 
with results providing further evidence of effectiveness for improving anxiety [305, 
306], depression [304-306], distress, [305, 306], fatigue [304], balance and co-
ordination [304], QOL [304], as well as likely cost-effectiveness in people with 
progressive phenotypes [305]. However, despite these new additions to the literature, 
the quality, and thus weight of evidence supporting the use of MBIs in people with 
MS remains low (Chapter 5; Appendix D).  
8.2.3 Phase-2 feasibility RCT – Chapter 6 
A phase-2 RCT (n=50) was conducted to assess the acceptability, accessibility, 
feasibility, and likely effectiveness of MBSR in a future definitive trial. Recruitment 
was shown to be feasible, with the target of 50 patients being met inside the 
predefined recruitment period of three months. Outcome measure completion rates 
post-MBSR (90%) and at three-month follow-up (88%) were good. However, MBSR 
completion rates were less than optimal with only 60% of participants attending 
>50% of sessions in the current study, and were less favourable than those described 
in other studies of MBIs for people with MS that reported on this outcome (range 92-
95%) [177, 305]. Home practice completion in this study (average of 32.5 minutes per 
day) was lower than the 45 minutes per day suggested to participants at course 
commencement. 
At the completion of the MBSR course, large beneficial treatment effects were 
evident on the primary patient report outcome for perceived stress, but were generally 
very small for QOL (weighted EQ-5D-5L scores). Secondary patient report outcomes 
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revealed large beneficial effects on depression, positive affect, anxiety, and self-
compassion. 
End-point effect sizes for primary patient reported outcomes at three-months after the 
end of the MBSR course revealed small positive effects on the PSS-10, and generally 
very small effects on the EQ-5D-5L. Primary outcome sub-scale analysis at study 
end-point revealed a small beneficial effect on the stress resilience subscale of the 
PSS-10, and a small effect on the anxiety/depression subscale of EQ-5D-5L.  
For secondary patient report outcomes at study end-point (three months post-MBSR), 
improvements with large effect sizes were evident for mindfulness, positive affect, 
anxiety, self-compassion, and prospective memory. However, at this point the 
previously noted large beneficial effects on depression immediately post-MBSR were 
no longer apparent.  
8.2.4 Qualitative research findings – Chapter 7 
Participant interview feedback emphasised that being part of a group of people with 
MS was a valued (n=17/17) and acceptable (n=16/17) experience for most. However, 
the setting for the course was a source of concern for some (n=6/17), especially in the 
context of high levels of disability, as an upstairs room was being used for the course, 
with limited lift access, and the set up of chairs in the room had not left space for 
wheelchair users. Part of learning mindfulness meant coming face-to-face with having 
MS, and a few participants found this challenging (n=2/17). Most people (n=13/17) 
were new to MBSR, and a lack of an orientation session may have contributed to 
difficulties participants’ had in making sense of the practices. Course content was 
generally acceptable to the participants, although notable exceptions were evident 
where disability impeded participation, such as in mindful-walking. From those 
participants who initially found mindful walking difficult (n=6/17), those who 
persisted reported beneficial effects (n=5/17). Most people who completed the course 
felt less stressed (n=13/17), whilst others reported diminished pain (n=5/17), and 
improved walking (n=4/17). Other beneficial effects, that were not anticipated as 
patient report outcomes in the RCT, included improved relationships with one’s self 
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(n=9/17), and similarly with others (n=10/17). Course completers (n=14/17) thought 
that MBSR could be improved by making the content more MS-specific.  
8.3 Synthesis of key findings 
The epidemiology study (Chapter 4) demonstrated increased prevalence rates for 
physical and mental health comorbidity in people with MS. The systematic review 
(Chapter 5) revealed limited evidence of beneficial effects from MBIs on some of 
these comorbid conditions, such as anxiety, depression, and pain. In the feasibility 
RCT, besides the large beneficial study end-point effects on anxiety and cognitive 
function, small beneficial effects were also evident for pain (ES 0.32; p=0.27) and 
bowel symptoms (ES 0.28; p=0.31).  
With respect to the other prevalent comorbid physical conditions found on the cross-
sectional primary care database analysis (Chapter 4), some supportive evidence exists 
for the use of MBIs in these conditions too. The impact of MBSR training on 
migraine remains to be definitively established, although two RCTs [332, 333] 
suggest feasibility and likely effectiveness, with improvements noted in migraine 
frequency, severity, and duration. In the case of IBS there is a larger evidence base, 
with a recent review suggesting ‘strong level-2 evidence’ for effectiveness, based on 
the results of nine empirical studies, the majority of which have used internet-based 
MBI approaches [334]. For epilepsy, three RCTs support the use of MBIs, with 
beneficial effects noted on comorbid depression [335, 336] and anxiety [337], seizure 
frequency [337], memory [337] and QOL [335-337]. Thus, additional benefits from 
MBI training may be available to people with MS who also have these comorbid 
conditions, and this could be assessed in a future study (see section below on 
optimising MBSR for people with MS).  
In this study, patient report outcome measures from the phase-2 RCT at end-point 
(three months post-MBSR) (Chapter 6) suggested that the strongest beneficial effects 
from MBSR were on mental health and cognitive function i.e. positive affect, anxiety, 
and prospective memory. Mindfulness and self-compassion also had large effects at 
this point. Taken together with the large beneficial effects seen on stress and 
depression at the immediate post-MBSR time-point, these findings may indicate an 
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important potential role for mindfulness in helping people with MS improve aspects 
of their cognition function and cope better with psychological distress.  
In terms of potential mechanisms of action for MBIs in people with MS, being more 
mindful has been linked in a cross-sectional study (n=69) with better illness 
adjustment, and diminished anxiety and depression in people with MS [314]. Greater 
mindfulness in MS patients has also been shown in another cross-sectional study 
(n=119) to be associated with lower stress, improved coping, and greater wellbeing 
[200]. A further cross-sectional study in people with MS (n=95) showed that being 
more mindful was correlated with higher QOL; an effect which appeared to be 
mediated by an improved ability to regulate emotions, and moderated by pre-existing 
depression [199]. However, cross-sectional studies such as these are limited, in that 
their findings cannot be used to infer causality. High quality longitudinal research is 
required to understand more clearly the potential mechanisms of action of MBIs in 
people with MS.  
Recently, in a pilot RCT (n=40 people with progressive MS), using a remote Skype-
delivered MBCT intervention, Bogosian et al. [313] investigated the potential 
mediating effects of acceptance, decentring, self-compassion, and self-efficacy in 
improving psychological distress; i.e. examining what active role that these variables 
had in diminishing psychological distress. The intervention comprised MBCT minus 
mindful-movement, with the course materials and content adapted to progressive MS. 
The researchers reported the largest mediating effects of 31% for decentring i.e. being 
able to view ones thoughts as simply thoughts, and not facts. This was followed by a 
mediating effect from self-compassion of 11%, acceptance 11%, and self-efficacy 
8%. All of the mediator variables in the model had supportive qualitative findings 
derived from deductive thematic analyses, but the (mostly) small changes observed 
for the mediator variables could not explain the large reductions seen in psychological 
distress in the linked quantitative study [305, 313]. This could be because the analyses 
in Bogosian et al. [313] did not directly assess for the potential mediating role(s) of 
other variables that have been shown in meta-analysis as important mediator variables 
for improved mental health from mindfulness training, such as cognitive and 
emotional reactivity (strong, consistent evidence), mindfulness, and repetitive 
negative thinking (both of which have moderate, consistent evidence) [338].   
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Elsewhere in the mindfulness literature, Garland et al. [147] have reported from a 
prospective observational study of people with chronic pain (n=339) that a greater 
level of dispositional mindfulness was significantly and positively associated with 
positive-reappraisal coping (where SLEs are re-interpreted as either benign, 
meaningful, or growth-promoting) and finding beneficial meaning in adverse events 
(such as periods of illness). Garland et al. [147] also reported that positive-reappraisal 
coping mediated the stress-reductive effects of MBSR; that is to say, positive-
reappraisal coping had an active intermediary role in the effects of MBSR on stress 
reduction [339]. Kuyken et al. [197] found that greater levels of mindfulness and self-
compassion mediated resilience against recurrent depression in MBCT, whilst 
Nyklicek and Kuijpers [315] also reported that higher levels of mindfulness mediated 
the stress-reducing effects of MBSR in healthy subjects. 
In summary, the findings from this thesis suggest that certain comorbid conditions are 
very common in MS, and that MBIs have the potential to impact favourably on a 
number of these, such as anxiety, depression, fatigue, and pain. In the phase-2 RCT, 
MBSR training led to large initial reductions in stress, depression, and anxiety, as 
well as improvements in cognitive function. These beneficial effects coincided with 
improvements in mindfulness and self-compassion. Some of these beneficial changes 
were not sustained, which may be due to diminished practice once the course was 
completed. Overall, the evidence base for MBIs in people with MS remains limited, 
and more research is required. In the first instance, optimisation of MBSR could 
improve outcomes. For example, improvements in mental health outcomes might be 
rendered more stable by making MBSR drop-in sessions available post-course. 
Furthermore, relatively little is known about how MBIs work across the spectrum of 
people with MS, and more research is needed to clarify mechanisms of action. The 
sections below cover these themes in more detail. 
8.4 Future directions – Optimising MBSR for people 
with MS 
The MRC guidance [19] suggests that before proceeding to a phase-3 trial, a 
researcher should be confident that the intervention to be tested is fully optimised. 
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This is because making alterations during a definitive study can cause delays, increase 
costs, and confuse results. The MRC guidance [19] suggests developmental work, 
such as that outlined in this thesis, can pre-empt difficulties in a larger study, and thus 
save on costs.  
Phase-3 trials are designed to assess the effectiveness and safety of an intervention, 
normally involving randomisation, and usually testing the treatment against an active 
comparator group, such as CBT or another clinical intervention, under strictly 
controlled trial conditions. A phase-3 trial should be appropriately powered to detect 
clinically meaningful effects, and will be larger in scale than a feasibility study, with 
sample size often being informed by the outcome measurements from the 
feasibility/pilot work. Important factors include the observed effect sizes 
demonstrated on the patient report measures and the attrition rates. For example, if 
n% drop out of the feasibility study, one can assume that a similar percentage may 
drop out in a definitive study, and thus the sample size for a definitive study may need 
to be adjusted to take this possibility into account, so that the study power remains 
intact if the same percentage of participants drop out.  
In a phase-3 trial, a health-economic analysis will usually be important, examining all 
relevant aspects of health and social care utilisation and costs, such as care 
practitioner contacts in primary care, secondary care, care at home, and for equipment 
provision and prescribing costs. Involvement of a health economist is recommended 
[19]. As part of such an evaluation, EQ-5D-5L scores would be combined with 
length-of-life estimates, and Quality Adjusted Life Years (QALYs) derived, together 
with the costs of health care utilisation, contributing to an overall assessment of cost-
effectiveness [340].  
A phase-3 trial may also involve the intervention being delivered over multiple sites, 
which can be useful when considering reproducibility, but also means that more 
stringent measures should be in place to assess fidelity, such as direct observation and 
recording of session content and delivery [19, 178]. By the time of delivering a phase-
3 trial, the intervention to be used should ideally be in its final form, i.e. optimised, 
with no further modifications anticipated.  
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Campbell et al. [216] suggest that researchers should clearly define the problem and 
context, before setting out to optimise a complex intervention and its outcome 
assessment. The section below discusses suggested modifications to the MBSR 
intervention, with associated justifications from the thesis findings. 
8.4.1 Improving attendance 
The qualitative findings reported in this thesis (Chapter 7) suggest that the inclusion 
of a pre-course orientation session could improve engagement and uptake of MBSR, 
and by judicious management of participant expectations, potentially improve 
treatment adherence. Not knowing what the MBSR course involved, and the level of 
commitment required meant that some people who were recruited dropped out from 
class attendance early on. They were expecting more focus on MS (n=3/17), a 
positive psychology approach (n=2/17), more physical exercise (n=1/17), or one-to-
one treatment (n=1/17).   
Reasons for non-attendance at the individual MBSR sessions included difficulties 
with getting-up on time, arranging transport, arranging childcare, inter-current illness, 
work commitments, or holidaying. All of these issues could potentially be addressed, 
were the course materials made available online, or if the individual could remotely 
join the group i.e. via Skype. Tailored online MBCT has shown good levels of session 
attendance in epilepsy [335]; whilst a tailored Skype MBCT class was well attended 
in people with progressive MS [305]. However, such approaches using MBSR would 
need to be developed and piloted, before proceeding to a definitive phase-3 trial. 
8.4.2 MS-specific materials 
From participant interviews in this study, it seems that the MBSR course might have 
been better received had it been more MS-specific (n=6/17), and if the content had 
been made more disability friendly (n=6/17). Some participants (n=4/17) suggested 
course jargon should be minimised and carefully thought out, for example: ‘exercise’ 
should not be used interchangeably with ‘practice’ when describing the meditation 
practices, as this might make more disabled individuals feel excluded and unable to 
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participate. Furthermore, mindful-movement may also require careful consideration, 
with mindful-walking being re-branded as ‘mindful-locomotion’.   
8.4.3 Mindful-movement and disability 
Qualitative feedback from the RCT participants suggested that some of the standard 
MBSR practices, such as mindful-movement, were less accessible to more disabled 
individuals, where a sense of disability was accentuated (n=6/17). The optimum MBI 
movement strategy in MS is not known. Both Yoga and Tai Chi/Qi Gong have been 
used in previous MBI studies in MS [289, 290, 304], with studies that used the latter 
mostly recruiting less disabled individuals. The Hatha Yoga style postures typical to 
MBSR are relatively static in nature i.e. lying, seated, or standing, being held in a 
particular pose for a period of seconds to minutes [13], whilst Tai Chi forms are 
usually a more dynamic, flowing set of movements, most often performed in a 
standing posture [341]. Prescribing physical activities to disabled individuals seems 
desirable [330], but is a complex skill, especially as disability level increases [342], 
and involvement of a specialist physiotherapist in the design of future MBI movement 
practices for a range of ability levels could help. Both Yoga [343] and Tai Chi [344] 
can be adapted for more disabled participants, but more research is needed to assess 
which approach is best in MS across the spectrum of disability levels. For the next 
phase of study of MBSR for people with MS, having a range of Hatha Yoga postures 
on hand to recommend, in either a lying, seated, or standing position, makes sense. 
Any new movement practices could be piloted in a future study, prior to proceeding to 
a definitive phase-3 trial. 
8.4.4 Shortened practices 
A few participants (n=3/17) suggested that the duration of the meditation practices 
should be shortened, particularly at home. Optimum MBI session/ practice times have 
yet to be established [308], but shorter practices have been successfully used in other 
MBI studies in more disabled individuals with MS [305]. One approach may be to 
start all practices in a brief format, lengthening them depending on the ability of the 
individual. In the RCT, both pain (n=3/17) and fatigue (n=1/17) were reported as 
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problematic in terms of completing the practices; both are common in MS (Chapter 4; 
[277]) and potential barriers to participation. 
8.4.5 ‘Booster’ sessions 
Several participants (n=7/17) in this current study found it hard to keep-up the 
practices once the MBSR course had completed. This could potentially account for 
the loss in treatment effects on stress and depression at three-month follow-up. The 
provision of regular booster sessions may help; such measures have been shown to 
help sustain beneficial treatment effects from MBCT in people with recurrent 
depression for up to two years post-intervention [318].  
8.4.6 Outcome measurements 
Effective mental health treatments in MS are limited, especially so for anxiety [10]. 
Findings from the comorbidity study (Chapter 4) confirmed that anxiety and 
depression are particularly prevalent in people with MS, and the systematic review 
(Chapter 5), and subsequent literature developments (Appendix D), together with the 
RCT findings (Chapter 6), suggest likely effectiveness of MBIs at treating these 
comorbidities in people with MS. Further, qualitative findings (Chapter 7) suggested 
reduced stress, and enhanced quality of relationships with self and others from 
learning to be mindful. In light of these collective findings, making a mental health 
measure a primary outcome in future studies appears justified.  
Determining psychiatric ‘case-ness’ [345] may be of additional benefit in a future 
study, given that those patients with MS with case-ness for psychological distress, 
anxiety, depression, and fatigue appear to benefit most from mindfulness training 
[177, 305]. The Mental Health Inventory-18 (MHI-18) was used in this current study 
as part of the Multiple Sclerosis Quality of Life Inventory (MSQLI). MHI-18 missing 
values were generally low (0.3% at baseline to 12.1% at three-month follow-up), but 
the measure does not allow for estimation of psychiatric case-ness [346, 347]. Recent 
evidence-based guidelines [83] suggest that the best scale for detecting depression in 
MS patients is the Beck Depression Inventory (BDI) [348]; for general emotional 
disturbances, the General Health Questionnaire (GHQ) – both allow the assessment of 
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case-ness; and for emotional lability, the Centre for Neurologic Study - Emotional 
Lability Scale (CNS-ELS) [349] is suggested [83]. As a validated MS measure, the 
CNS-ELS would be a more suitable measure for assessing emotional lability in a 
future study.  
In the RCT (Chapter 6), there were sustained beneficial effects on anxiety (ES 0.82) 
noted at study endpoint. No guideline recommendation is available for measuring 
anxiety in MS, although Fiest et al. [10] suggest that in such a scenario, evidence-
based generic measures should be used. Once again, the MHI-18 subscale for anxiety 
does not allow for assessment of case-ness [346]. However, other generic scales do, 
such as the Hospital Anxiety and Depression Scale (HADS), which has been validated 
in MS [350], and used in prior MBI studies assessing the impact of mindfulness 
training on mental health [305]. Other generic measures that can determine case-ness 
include the Spielberger-Trait Anxiety Inventory (STAI) [351] (previously used to 
assess the impact of MBI training in MS - [177]); the Beck Anxiety Inventory (BAI) 
[352]; or the Generalised Anxiety Disorder-7 scale (GAD-7) [353]. 
From a physical perspective, comorbidities identified as prevalent in MS by the 
epidemiological study (Chapter 4) included functional bowel complaints (constipation 
and IBS), visual impairment, pain, migraine, and epilepsy. The MSQLI covers some 
of these conditions (bowel, vision, and pain), but not others (migraine and epilepsy). 
Outcome measures for migraine and epilepsy could be included in a future study, as 
could measures of co-ordination, standing and dynamic balance (shown to improve in 
other MBI studies in MS [289, 304]), and walking ability (as per improvements noted 
in qualitative accounts reported in Chapter 7). Table 8.1 provides a summary of 
suggested modifications to standard MBSR that have been discussed above. 
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Table  8.1 Optimising MBSR for people with MS 
Modifications Justification Evidence 
source 
1 Inclusion of a pre-
course orientation 
session 
Both MBSR teachers suggested such a move to convey the 
level of commitment required and help address pre-course 
expectations. At least 3/17 participants did not have an 
adequate understanding of what would be involved and 
dropped out after the first MBSR session 
- Thesis 
Chapter 7, 
page 193 
2 Consider 
development of 
online MBSR 
materials 
Reasons for non-attendance of the MBSR sessions 
included difficulties with getting up on time, arranging 
transport, arranging childcare, inter-current illness, work 
commitments, or holidaying. 
- Thesis 
Chapter 6, 
pages 139 - 
140 
3 Render course 
materials/ psycho-
education MS-
specific 
Several participants (6/17) fed back that the generic MBSR 
materials were inaccessible, preferring instead a more 
direct link to be made between mindfulness practices and 
MS–related problems 
- Thesis 
Chapter 7, 
page 202 
4 Render the course 
‘jargon’ disability-
friendly 
Some participants (4/17) felt that the language used to 
describe MBSR practices was insensitive towards MS and 
disability, such as ‘mindful walking’, or using the word 
‘exercise’ instead of ‘practice’ 
- Thesis 
Chapter 7, 
page 201 
5 Make movement 
practices 
disability-friendly 
Several of the more disabled participants (6/17) found 
certain movement practices accentuated a sense of 
disability. Both yoga and tai chi could be adapted to suit a 
range of ability levels. 
- Thesis 
Chapter 7, 
page 188 - 
189;  
- [343, 344] 
6 Shorten some 
MBSR practices 
Several participants stated a preference for shorter 
practices, particularly at home (3/17). Some (3/17) found 
sitting difficult due to pain; one person found fatigue 
limited the participation in the enquiry process. 
- Thesis 
Chapter 7, 
page 190 
7 Provide post-
MBSR ‘booster’ 
sessions 
Several participants (4/17) spoke about wishing to come to 
such sessions; two people cited practicing less after the 
course, as classes had finished. Such measures have been 
shown to sustain beneficial effects of MBCT for up to two 
years in people with recurrent depression 
- Thesis - 
Chapter 7, 
page 192 
- [318] 
8 Make a mental 
health outcome a 
primary outcome 
measure; one 
which allows 
assessment of 
case-ness for 
anxiety and/or 
depression 
Anxiety and depression are highly prevalent in MS. 
Effective treatments are limited. The RCT found sustained 
beneficial effects on anxiety. The largest effects found in 
other MBI studies in MS suggest that those with ‘case-
ness’ benefit most. 
Recent evidence-based guidelines stipulate that the 
General Health Questionnaire (GHQ) and the Beck 
Depression Inventory (BDI) are the most suitable 
instruments in the MS population; for anxiety, generic 
measures can be used 
- Thesis 
Chapter 4, 
page 90 - 91  
- Thesis 
Chapter 6, 
page 141-
146; 
- Appendix 
D. 
- [10, 83] 
9 Measure the 
impact of MBSR 
on other prevalent 
MS comorbidities 
The comorbidity study demonstrated an increased 
prevalence of constipation, migraine, epilepsy, and IBS – 
these areas were not explicitly included in the patient 
report outcomes, but have been shown elsewhere to 
improve with MBI training  
- Thesis 
Chapter 4, 
page 91 - 93  
- [334-336] 
10 Include physical 
outcomes shown to 
benefit from MBIs 
in other MBI in 
MS studies 
Mills and Allen [289] and Burschka et al. [304] 
demonstrated improved standing and dynamic balance, 
and co-ordination from training in mindfulness using Tai 
Chi 
- Thesis 
Chapter 5, 
page 113;  
- Appendix D 
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8.5 Possible future research directions 
8.5.1 Biologic outcome measures  
There are now six published outcome studies, in addition to the trial in this thesis, that 
provide evidence on the use of MBIs in people with MS for reducing stress, 
improving mental health, QOL, and some aspects of physical health such as fatigue, 
pain, co-ordination, and balance [177, 289, 290, 304-306]. Added to these are three 
cross-sectional studies that suggest benefits to people with MS from being mindful 
[199, 200, 314], such as enhanced illness adjustment, improved QOL, coping, 
wellbeing, and emotional regulatory skills. There is only one longitudinal study that 
has assessed potential mechanisms of action [313]. All of these studies have focused 
on patient report outcomes (Appendix D), but no study has assessed any biological 
effects from taking part in MBI training.  
It remains unclear from the existing literature how self-report effects from MBIs 
correlate with physical outcome measures. In the RCT (Chapter 6) training in 
mindfulness was associated with diminished stress and improved mental health, but 
there were also small beneficial sustained end-point effects (three months post-
MBSR) noted for fatigue (ES 0.33; p=0.27), pain (ES 0.32; p=0.27), and bowel 
function (ES 0.28; p=0.31), suggesting some positive impact on physical symptoms. 
Whether these improvements resulted from improved mental health, or reflected 
improved underlying physical processes/ functioning remains unclear. Linking self-
report outcomes with biological markers could provide further insight into how MBIs 
may work in this context.  
Contemporary models of RRMS and, to a lesser extent, progressive MS phenotypes, 
propose that inflammation is a key mechanistic component of pathological disease 
activity. In this context, peripheral episodes of inflammation i.e. outwith the CNS, 
have the potential to contribute to relapses in RRMS [1, 20, 25, 29]. One potential 
cause of peripheral inflammation in people with MS is perceived stress [98]. Stress-
related dysfunction in the neuroendocrine [303] and immune systems [94] are thought 
to be common problems in MS, and may also impact negatively on the risk of 
developing metabolic, and cardiopulmonary comorbidity in this group [263]. In the 
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general population, greater levels of perceived stress are associated with excess 
mortality [50]. A possible explanatory model for this in biologic terms is Allostatic 
Load (AL) [99]. AL reflects background inflammation and disordered homeostasis 
resulting from stress, all of which are problematic in MS [94]. AL measurements 
include those reflecting function in the neuroendocrine, immune, metabolic, and 
cardiopulmonary systems, alongside anthropometric recordings. A selection of such 
measures could be collected in future studies of MBSR for people with MS; for 
example to assess the impact of MBI training on autonomic nervous system activity 
i.e. heart rate variability, blood pressure, and pulse, and/or markers of peripheral 
inflammation, such as C-Reactive Protein (CRP), Tumour Necrosis Factor-Alpha 
(TNFα), and/or Interleukin-6 (IL-6) [302]. If MBI training decreased activity in the 
sympathetic nervous system (SNS) and/or reduced peripheral inflammation, then 
theoretically this could lead to diminished MS disease activity [98]. Collecting and 
processing such samples would require feasibility testing, prior to inclusion in a 
definitive trial of effectiveness, and the potential financial costs would need to be 
factored into consideration (Table 8.2).  
Table  8.2 Possible Allostatic Load biomarkers [91] 
System Measure(s) 
Neuroendocrine Cortisol, Dehydroepiandrosterone, Adrenaline, Noradrenaline, 
Dopamine, Aldosterone, Prolactin, Insulin-like growth factor 
Immune C-reactive protein, Interleukin-6, Tumour necrosis factor-Alpha, 
Fibrinogen 
Metabolic Total cholesterol (TC), Low- and High-density lipoproteins, High 
density lipoprotein/TC ratio, Glycosolated haemoglobin, Glucose, 
Insulin, Albumin, Creatinine, Homocysteine 
Cardiopulmonary Blood pressure (systolic and diastolic), Heart rate, Pulse, Peak 
expiratory flow rate 
Anthropometric Hip-waist ratio, Body mass index 
 
As discussed in Chapter 2, another approach that has been used to assess the biologic 
impact of CBT-based stress-reduction training in people with MS is Gadolinium-
enhanced Magnetic Resonance Imaging (Gd+MRI) [7]. Measuring MS relapses based 
on participant-report measures risks recall- and subjectivity-bias; Gd+MRI lesions are 
a highly sensitive indicator of MS disease activity and can be used to predict relapse 
[116]. Building upon the findings from Mohr et al. [7], Gd+MRI scanning at regular 
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pre-defined intervals (i.e. baseline, then monthly until study endpoint) could be used 
in a future study to assess objectively the effectiveness of MBSR at reducing relapse 
rate (number of BBB lesions) and CNS disease burden (size and number of T2 
lesions) in those receiving MBSR versus controls.  
MRI has also been used to study neuroplastic effects associated with MBIs [354], 
including in other neurodegenerative conditions such as Parkinson’s Disease [355], 
but not to date in MS. Such an approach, where the theoretical goal of MBI treatment 
lies in preserving brain reserve and/or enhancing cognitive function [356], could be 
studied using MRI to assess objective structural/ functional brain changes, such as 
improved connectivity/ adaptive cortical reorganisation. Such measures could be 
correlated with neuropsychological testing, may help in the development of much 
needed novel strategies for cognitive rehabilitation [357], and might add useful 
insights into putative MBI mechanisms of action.  
MRI also has a role in the study of cognitive impairment in MS [357] where 
subjective and objective reports of impairment often differ. Both show only limited 
correlations with T1 lesions (reflecting demyelination and axonal density) and T2 
lesions (MS pathology, such as inflammation, oedema, demyelination, axonal loss, 
gliosis, and re-myelination), but stronger associations with site-specific brain atrophy 
i.e. in the corpus callosum, or more widespread brain atrophy [357]. This current 
study found large improvements in prospective memory (ES 0.81; p<0.05); and non-
smaller improvements in retrospective memory (ES 0.35; p=0.35), as well as planning 
(ES 0.31; p=0.31), and attention (ES 0.23; p=0.40) at end-point, three months post-
MBSR (Chapter 6). Correlating such findings with objective MRI measures in a 
future study could help clarify potential mechanisms of action for mindfulness in this 
context, where associated cortical reorganisation, such as increased activation of the 
dlPFC may have important clinical implications i.e. maintaining memory function and 
processing speed in the face of declining neural reserve [357]. The financial costs 
associated with collecting and analysing MRI measures would require careful 
consideration. 
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8.6 How could the research in this thesis have been 
improved? 
Reflecting upon the process and findings from this thesis, the next steps for this body 
of work require careful consideration. The rationale for carrying out further research 
in this area seems justified, in that stress is prevalent and problematic in people with 
MS, existing interventions appear to be limited in scope and effectiveness, and that 
MBSR appears to be acceptable to people with MS. However, a retrospective analysis 
highlights that important questions in this realm remain unanswered at this point, and 
these could potentially have been more fully addressed in this thesis, had different 
methods been selected to carry out the work and time allowed. 
8.6.1 Was a RCT the right study design to use? 
Firstly, it should be considered whether proceeding to a RCT at the feasibility testing 
stage was premature. An alternative option that was also considered was to work 
instead on optimising the intervention first. This could have involved a pre – post- 
observational study to test the feasibility of delivering MBSR, where recruitment, 
retention, treatment adherence and outcome measure completion could all be tested. 
Nested semi-structured interviews could have been carried out in a similar fashion 
post-intervention to inform acceptability and accessibility, along with barriers and 
facilitators to implementability. Following this, optimisation changes could have been 
tested in a second pre-post- observational study, where a modified MBSR course 
would be delivered. By following this alternative pathway to a logical conclusion, 
iterative changes could be made to successive courses and outcome measures up until 
no further changes were adjudged necessary. Thus, a series of several pre- post- 
studies could have been used, potentially with smaller group sizes, testing a wider 
range of outcome measures for feasibility, acceptability, and cost at each iteration, for 
example the recently developed Brief Inventory of Perceived Stress (BIPS) [358], or 
more invasive measures, such as salivary cortisol testing or blood sampling [302]. 
However, testing such measures would require prior approval by the Research Ethics 
Committee and host Health Board. The timescale allowed for data collection for the 
PhD limited this option, where the early phases of the work focused instead on 
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delineating the epidemiology of comorbidity in MS in Scotland and on undertaking 
the systematic review.  
Collecting qualitative data between successive iterations of pre- post- MBSR groups 
could also have been advantageous. For example, such an approach could allow for 
successive modifications to be instituted following each course iteration, and 
thereafter assessed for feasibility, acceptability, and potential effectiveness in the 
subsequent iteration and so on. In this scenario, the qualitative data collected could be 
subject to rapid appraisal methods [359], whereby more pragmatic and expedient 
thematic analyses would be undertaken in a shorter timescale between successive 
MBSR courses, but this would have required a team of researchers, something which 
was not feasible within the constraints associated with the PhD. The benefit of this 
method is that each successive course could be optimised based on dynamic feedback 
from participants. 
Reflection on the participant responses following standard MBSR outlined in this 
thesis suggests that the topic guide for the semi-structured interviews could be 
improved upon, so that a greater focus be placed upon the acceptability and 
accessibility of specific MBSR practices and the content of the psycho-educational 
material. For example, questions could ask in particular about participant experiences 
and preferences concerning the ‘core’ practices of mindful breath awareness, mindful 
body awareness, and mindful movement. Furthermore, issues raised in the interviews 
reported in this thesis may be homed-in on further, such as whether mindful-walking 
is better received by a subsequent group when branded differently as ‘mindful 
locomotion’, or whether adaptations put in place for more disabled individuals are 
well received, or not.  
In terms of the NPT analysis, this could have been augmented by the inclusion of data 
from a broader range of stakeholders. This was considered at the time of protocol 
development, specifically where interviewing GPs, MS Clinicians and NHS Managers 
would have provided useful data that is absent in the current thesis, but important 
when considering the ‘bigger picture’, where potential factors that may influence the 
choice to support a new intervention such as MBSR, or not, could have been explored 
in greater depth. In keeping with national guidance on the management of MS in 
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primary and secondary care [44], the specialist MS service in the West of Scotland is 
a multidisciplinary agency including Neurologists, MS Specialist Nurses, 
Rehabilitation Medicine Consultants, Neuro-physiotherapists, Occupational 
Therapists, Neuropsychologists and other Allied Health Professionals. Interviews 
with MS clinicians could have explored current knowledge and understanding among 
such stakeholders of the potential role of MBIs in their clinical practice, where they 
think MBIs might fit, whether MBIs would be supported, or not, and why, and how 
best MBIs might be tailored to meet the complex needs across the spectrum of MS 
phenotypes and stages of disease progression. Interviewing such clinicians before 
testing MBSR could conceivably have fed into intervention design. However, due to 
the time and resource constraints associated with the PhD, extending the qualitative 
interviewing schedule to include these other stakeholders was not felt to be feasible. 
8.6.2 Assessing health economic benefits from MBSR 
The feasibility of carrying out a health economic evaluation was considered at the 
time of protocol development for the RCT reported in this thesis. However, practical 
time and resource constraints associated with the PhD were considered to render this 
option infeasible.  
Evaluating the health economics of complex interventions may be challenging, both 
in terms of the complexity of the intervention, such as multiple potential active 
components, and of the system in which it is to be evaluated, which may be non-linear 
and largely self-organising, such as the NHS, or, as evident from the qualitative 
findings in this thesis, even extending out to the patient’s family circle, and beyond. 
Similarly, deciding when to assess health economic benefit from a complex 
intervention is not necessarily a straightforward, or ‘one-off’, decision, and it is 
acknowledged in the empirical literature that the perceived ‘value’ attributed to an 
intervention is likely to increase substantially following successful implementation 
[360]. As an example to illustrate how this might apply in reference to the current 
thesis, as MBIs become more widely known about and used, a ‘phase-shift’ in 
perception, attitude towards, or against them may heavily influence economic 
benefits. In the case of MBSR for MS, this might mean that as MBSR becomes more 
widely known and/or accepted in the MS patient- and clinician- communities, then 
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more patients may seek to access the resource. As suggested by some of the 
qualitative findings in this thesis, having a mindful attitude towards previously 
distressing symptoms might influence how frequently patients seek healthcare 
provider advice/contact. This could conceivably have a spin-off effect on how MS 
patients use their GPs, the MS Specialist Nurses, or Consultant-led services.  
In any event, a health economic evaluation is increasingly seen as necessary for novel 
complex interventions, given that most health care systems around the world are 
resource limited, and is frequently used in the decision making process as to whether 
to make a new intervention available in routine practice, or not [361, 362]. 
Furthermore, Shiell et al. [360] suggest that not knowing the active components of a 
complex intervention, such as group psychotherapy, should not serve as a deterrent to 
undertaking a health economic evaluation, as long as resource use (‘inputs’) can be 
clearly identified and benefits measured (‘outputs’). The method is, however, 
necessarily limited, in that key aspects of the intervention, such as the skill of the 
individual MBSR instructor(s) (a ‘resource’), the dynamic content of each individual 
group, or the overall group dynamic are not directly measured or included in the 
analysis. Instead, ‘resource’ focuses on session numbers, session lengths, group ‘n’, 
instructor salary costs, venue costs, and ‘output’ focuses on what effect MBSR has on 
health outcomes and health service usage.  
A cost-effectiveness analysis is the most commonly used method of health economic 
evaluation, with a related alternative being a cost-utility analysis. Both measure the 
consequences of taking part in an intervention, versus not; in the former via practical 
units such as life years gained, or in the latter via preference-based health measures 
like quality- or disability-adjusted life years [361]. In the UK, NICE recommends the 
use of QALYs gained, as these standardised units allow for clinical benefits to be 
compared across conditions, whereby informed decisions can thus be made about how 
to prioritise access to clinical interventions [363]. 
The RCT wait-list control design used in this thesis would have allowed for an 
assessment of health economic benefits, as opposed to comparative-effectiveness, had 
an active comparator group instead been employed. Assessing health economic 
benefits could have scrutinised resource use by participants undertaking a MBSR 
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course versus controls. Bogosian et al. [305] used such an approach in a pilot study 
assessing the use of a SKYPE-delivered modified MBCT course against treatment as 
usual for people with progressive MS. They used the Client Service Receipt Inventory 
(CSRI), which measures ‘formal’ individual-level data relating to hospital, 
community, social care contacts, along with ‘informal’ care from friends and relatives 
[364]. They found that the modified MBCT training was associated with lower costs 
for both formal and informal care provision, using QALYs and distress scores on the 
GHQ as proxy measures. They reported no significant differences in QALYs between 
those receiving MBCT versus controls, which could be due to limitations of some 
aspects of the EQ-5D-5L, where physical/mobility issues are unlikely to improve in 
progressive phenotypes following mindfulness training.  
The same issues with the EQ-5D-5L may apply in the current study, where 
improvements noted in the RCT were mainly on the anxiety/depression subscale, and 
were very small, or negligible on the other components. Kuspinar and Mayo [187] 
suggest that generic QOL measures such as the EQ-5D-5L miss a great deal of 
what matters most to people with MS. Rawlins suggests that a key scientific 
value judgement when assessing health economic benefits from a new 
intervention relate to whether or not QALYs have been appropriately assessed 
[363]. Newer measures, based on MS patient preferences, such as the Multiple 
Sclerosis Impact Scale-29 (MSIS-29) could offer a better alternative in a future 
study, with a focus on common MS difficulties such as grip strength, carrying 
things, balance problems, difficulties moving about indoors, clumsiness, stiffness, 
weakness, ataxia, spasticity, and temperature disturbances [365].  
8.6.3 Patient and Public Involvement 
Patient and public involvement (PPI) in health and social care policy is a UK 
Government priority, with the aim being for individuals who use health technologies 
being able to shape the services they use [366]. Taking into account service user 
views fits with aspirational democratic sociocultural values in the UK, such as 
accountability, citizenship, and transparency [367]. On a more practical level, one of 
the aims of the work carried out in this thesis was to identify whether or not standard 
MBSR would be acceptable and accessible to people with MS. Thus, greater PPI 
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could have potentially improved the quality and relevance of the findings in this thesis 
by providing unique advice and insight from PPI sources into the choice of 
intervention and how it should be delivered to a more disabled group, and potentially 
also into the methods used to assess effectiveness, such as whether stress and QOL 
should feature as primary outcomes, or not. Recent systematic review evidence 
suggests that PPI positively impacts on the quality and appropriateness of research, 
where user-focused research objectives can be identified, user-relevant research 
questions highlighted, user-friendly information, research packs and interview 
questions developed, along with improved recruitment strategies and methods for 
effective dissemination of findings [368].  
In the UK, the national advisory group INVOLVE has created guidance for 
researchers regarding PPI with research. According to INVOLVE, PPI can mean 
public involvement in working with funding bodies to prioritise research, to sit on a 
research steering group, to contribute to the development of research materials, or to 
undertake interviews with research participants. INVOLVE suggest that PPI should 
ideally commence early in the research process, should involve multiple people with 
experience of the condition under question, so as to increase breadth and experience 
of the sample, although no clear guidance on an adequate ‘n’ is suggested [367]. At 
present there is no consensus in the literature as to what constitutes an adequate 
‘sample size’ for proper PPI, but another recent systematic review focusing on PPI in 
the UK presented data from 28 studies, where participant numbers ranged from six 
patients in a primary care trust, to 167 people, including 78 lay members, in a 
nationwide study [366].  
In this thesis, the RCT study protocol was subjected to prospective peer and lay 
review, including three patient members of the UK MS Society (Appendix A). 
Clearly, this small number of views cannot be said to be representative of the 
spectrum of people with MS who might wish to share views on the development of a 
bespoke MBSR course, nor can the consultation be described as dynamic, in that it 
was based on one-off responses to remote reading of the protocol. Other potential 
‘recruitment’ streams for PPI suggested by INVOLVE that could be used in a future 
study for consultation and/or collaboration include advertising in local GP surgeries 
or hospital outpatient departments, by contacting local NHS Trust Patient Advice and 
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Liaison Services, by using the ‘People in Research’ website, via local TV, radio, or 
newspaper media outlets, through local voluntary sector services, or via the social 
media [367]. In this study, such methods were used to recruit participants into the 
RCT, but could also have been used in advance of the study to facilitate broader PPI 
in the research design stage going forward.  
8.6.4 Was standard MBSR the right intervention? 
In this thesis MBSR was chosen as the intervention for the exploratory RCT based on 
the limited information that had emerged via the systematic review on its prior use in 
people with MS. The study by Grossman et al. [177] had suggested that delivering 
MBSR was generally feasible under RCT conditions, and likely to be acceptable, 
accessible, and potentially effective in less disabled people with MS. However, the 
aforementioned study had been purely quantitative in nature, with no participant 
feedback reported. Thus, it was unclear whether there was evidence and/or scope for 
judicious tailoring based on participant experiences. Furthermore, the systematic 
review had identified a total dearth of information on this subject, with only Hankin 
[296] providing cursory snippets of qualitative data on how couples faced with a 
diagnosis of MS had found MBSR. The other quantitative studies identified in the 
systematic review were of low quality, having small sample sizes, and questionable 
research design. The information they contained could provide little further guidance 
on whether to use a standardised MBI, or not.  
MBSR was designed to help reduce stress among people with LTCs. The only other 
standardised MBI that could have been chosen was MBCT. However, the focus of the 
thesis was on stress reduction, and although depression is common in people with 
MS, MBCT was specifically designed and manualised as a preventative treatment 
approach for recurrent depression. Thus, MBSR was felt to be the most appropriate. 
In this study, feedback from MBSR participants suggested that standard MBSR is 
likely to need modification in order to improve its acceptability, accessibility, and 
relevance to people with MS. In terms of effectiveness and health economic benefit, 
whether modifications should be made prior to testing the intervention based on PPI, 
or from participants after receiving the standard version is a moot point [366]. 
Mindfulness-based interventions for people with MS 
 
 244 
Bogosian et al. opted for the former in their study using SKYPE-delivered MBCT, 
where a series of experimental case studies with patients with progressive MS were 
undertaken prior to proceeding to the RCT that piloted the adapted course. This led to 
shortening of the practices, the removal of mindful-movement, the adaptation of 
cognitive therapy exercises to explore how thoughts and feelings related to anxiety 
and low mood in MS, and the development of bespoke home practice CDs [305]. The 
obvious limitation of the former method is that one cannot know whether the standard 
MBCT course would have been more or less effective than the modified version.  
What does seem clear, both from qualitative findings in this thesis and from the 
empirical literature [62], is that people with MS value effective stress management 
interventions, as well as clinicians’ having knowledge about their condition. Thus, the 
development of a tailored stress management course makes sense. The optimisation 
changes suggested in this chapter may go some of the way to addressing this, such as 
removing practices like mindful walking, or simplifying mindful movement. 
However, how best to adapt the psycho-educational material is potentially more 
challenging.  
Mohr has developed a CBT-based stress management intervention for people with 
MS, which makes clear for patients and therapists alike the links between stressful 
events, mental health, and MS relapse [369, 370]. As covered in Chapter 2, the 
empirical literature suggests that stress is detrimental in people with MS, in that it 
may increase the likelihood of developing mood disorders, diminish QOL, and 
possibly increase vulnerability to MS relapse. However, in the case of relapse, the 
data that exists is suggestive, but far from compelling. Furthermore, suggesting that 
stress may precipitate disease activity may actually be harmful to people with MS, in 
that they may feel responsible in some way for having the condition, and existing 
review literature on stress appraisal and coping in MS highlights that seeing the 
condition as having a psychological basis is associated with worse adjustment [3].  
An alternative solution could be to tailor the MBSR teaching materials to common 
MS problems, without seeking to make the link between stress and disease activity 
until such times as this area is more fully understood. The findings from this current 
study could inform the development of such a protocol specifically for people with 
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MS. Such an endeavour could also involve multiple stakeholder/source input, from 
patients with MS, to MS clinicians, to the empirical literature. Such workbooks have 
been widely produced for CBT-type interventions for specific health conditions [371], 
and other examples exist for MBIs where interventions have started out using 
standardised protocols and adapted to suit the ecology of specific health conditions 
such as Mindfulness-Based Relapse Prevention (MBRP) [372, 373], and Mindfulness-
Based Eating Awareness (MB-EAT) [374]. 
8.7 Conclusion 
To conclude, physical and mental health comorbidity is common in MS and current 
treatments are limited in scope and efficacy. MBIs are a potential treatment option, 
but current limitations in the evidence base preclude definite conclusions as to their 
utility. MBSR appears to be feasible, acceptable, and accessible to people with MS, 
including those with quite significant levels of disability. MBSR is also potentially 
effective at reducing stress and improving mental health and cognitive function. 
However, less than maximal levels of treatment adherence and small effect sizes on 
primary patient report outcome measures at end-point assessment in a feasibility RCT 
suggests that further optimisation work is necessary before proceeding to a definitive 
phase-3 trial. Optimisation of MBSR could potentially improve uptake and sustain 
engagement, whilst outcome measure refinement could be tested via further piloting, 
prior to undertaking a definitive phase-3 trial. Use of the MRC guidance [19] has 
allowed a comprehensive and systematic approach for investigating this complex area 
and it will be useful to continue to use this approach for any future research on the use 
of MBIs for people with MS.
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Appendix A - Patient and Public Involvement grant application to the UK 
Multiple Sclerosis Society. Lay reviewer feedback  
Reviewer #1 
Question: Q1. Please score relevance and importance this project might have for 
people with MS. 
Answer: 5 - Very good 
Question: Q2. If people with MS will be participants, please score how well the 
researchers have taken into account their needs. 
Answer: 4 - Good 
Question: Q3a. Please score how well the researchers have involved people with MS 
in the planning of this study. 
Answer: 4 - Good 
Question: Q3b. Please score how well the researchers have planned to involve people 
with MS during the study. 
Answer: 4 - Good 
Question: Q4. Did you find this lay summary easy to understand and well written? 
Answer:  
1. Relevance and importance. 
The accumulative, debilitating effects of MS, and the nature of this chronic disease, 
results in higher rates of anxiety and depression than in other comparable long term 
health conditions. Thus, the aim of this project, to investigate whether mindfulness 
therapy is an effective tool for stress management in MS, is highly relevant and 
potentially very exciting should it prove successful. It may, by alleviating stress, 
reduce relapses and further degeneration of the myelin sheath. As there is some 
evidence to suggest that extreme stress can exacerbate disease activity, which was 
certainly the case for my daughter and of many young people I know as a committee 
member of two MS branches, any study which may result in stress management is 
very important.  
MBSR was originally introduced to help people with chronic pain and  then 
depression -  commonly found in PaMS - and it is known that MBSR helps people 
with similar health problems to MS. However, research evidence which specifically 
investigates the effects of MBSR on MS is limited which this extensive feasibility 
study aims to address. 
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Currently, CBT is seen as the most successful psychological intervention but appears 
to be dependent on ongoing therapist contact which is especially difficult for those 
with transport problems, mobility issues and fatigue.  MBSR not only operates 
differently to CBT, but also can be learned and then practiced at home without the 
need of a facilitator.  This is especially important for PaMS who are not always well 
enough to attend classes and like anyone else, can not predict when a stressful 
situation might occur.  The emphasis on self - practice, daily and weekly homework 
to embed mindfulness techniques may make this a long-lasting alternative to CBT. 
The extensive qualitative and quantitative data to be assessed in the investigation will 
hopefully provide concrete evidence as to why PaMS should receive this treatment.  
As it does not require long term intervention from course facilitators, it would also be 
cost-effective.  
2.  How well researchers have considered needs of PaMS. 
Researchers have considered the needs of PaMS for most of the trial as far as I can 
tell although two and a half hour classes spread over a week for eight weeks could be 
onerous in terms of transport, access, and potential ill health. Additionally, using a 
broad inclusion EDDS scale of 1 to 7 might further exacerbate such issues. Weekly 
homework (specific form not included) and daily exercises to be carried out at home 
may also prove too ambitious for some participants.  Although the classes would be 
based on relaxing Yoga techniques, the length and content of each class within the 
week and where it would take place were not included in this application. Without 
this information, it is more difficult to assess how well the researchers have 
considered the needs of PaMS.  
Recruitment is more considerate as the feasibility study is open to interested, eligible 
individuals via their care providers. Getting in touch with the researcher is entirely up 
to the individual. Potential volunteers contact the researcher by phone, who will 
discuss the study, answer any questions, and arrange a mutually convenient time and 
venue in which to meet; helpful to people with MS who may have transport and 
mobility issues. Posting information is useful back-up especially as PaMS might 
struggle with concentration and memory. The researchers have explained exclusion 
criteria in depth which appears to be entirely logical. 
Both participants and course facilitators evaluate the effects of the lessons. I 
particularly like the fact that extensive questioning will be recorded instead of written 
as not only does this speeds up the process but also considers the needs of people who 
have limited motor skills and other health issues such as fatigue. 
I assume the answers to the four key research questions will be in written form in 
which case some PaMS may require additional time. 
3.  Involving PaMS in the planning now and in the future. 
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The applicant works with people with MS in his capacity as a Specialty Trainee in 
Rehabilitation Medicine where almost 50% of the patients have MS. The applicant 
has also involved people with MS via the MS Society Grant Pre-application review 
Research Network.  I was unable to understand the information contained in the 
subsequent sub-heading as it contained medical terminology. 
Should the study prove successful, a larger more definitive evaluation will be 
undertaken to investigate whether the intervention might be better tailored to meet the 
needs of PaMS and whether stress management can impact on disease activity. 
Assessing the overall cost effectiveness might also be undertaken. 
Results will be published and discussed on social media.  
An additional tool which I think would work very well, is a DVD of mindfulness 
classes supported by information presented as power points. 
 
Reviewer #2 
Question: Q1. Please score relevance and importance this project might have for 
people with MS. 
Answer: 4 - Good 
Question: Q2. If people with MS will be participants, please score how well the 
researchers have taken into account their needs. 
Answer: 3 - Acceptable 
Question: Q3a. Please score how well the researchers have involved people with MS 
in the planning of this study. 
Answer: 1 - Poor 
Question: Q3b. Please score how well the researchers have planned to involve people 
with MS during the study. 
Answer: 2 - Needs significant revision 
Question: Q4. Did you find this lay summary easy to understand and well written? 
Answer: Yes 
No comments. 
 
Reviewer #3 
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Question: Q1. Please score relevance and importance this project might have for 
people with MS. 
Answer: 4 - Good 
Question: Q2. If people with MS will be participants, please score how well the 
researchers have taken into account their needs. 
Answer: 3 - Acceptable 
Question: Q3a. Please score how well the researchers have involved people with MS 
in the planning of this study. 
Answer: 4 - Good 
Question: Q3b. Please score how well the researchers have planned to involve people 
with MS during the study. 
Answer: 4 - Good 
Question: Q4. Did you find this lay summary easy to understand and well written? 
Answer: Yes 
Page16, paragraph 1: 2.5hrs seems a long time to concentrate & work. No gifts should 
be needed as research is for their benefit & material gain will ultimately change 
motivation. 
Receipts should be required for transport, expenses etc  
I know this seems mean but I am one of the fundraisers who collect in the wind & 
rain & funds are VERY hard won so should not be wasted.  
Page 48 no authorised signatory?  
I assume access to toilets, indoors, rails, parking, help has been suitably provided for. 
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Appendix B – Read Code definitions  
Table B1: Read Code definitions of 31 other physical health conditions assessed. 
Physical health condition Name of variable Definition of variable 
Coronary heart disease CHD Read code ever recorded 
Chronic kidney disease CKD Read code ever recorded 
Asthma (active) Asthma Read code ever recorded AND any 
prescription in last year 
Atrial fibrillation Atrial Fibrillation Read code ever recorded 
Epilepsy Epilepsy Read code ever recorded AND epilepsy 
prescription in last year 
New cancer in the last 5 years Cancer Read code first recorded in last 5 years 
(Relevant Read Code recorded) 
Thyrotoxicosis/Thyroid disorders 
(includes hypothyroidism) 
Thyroid Disorders Read code ever recorded (Relevant Read 
Code recorded) 
Diabetes Diabetes Read code ever recorded 
Parkinson’s disease Parkinson’s disease Read code ever recorded (Relevant Read 
Code recorded) 
Stroke or transient ischaemic 
attack 
Stroke or TIA Read code ever recorded (Relevant Read 
Code recorded) 
Blindness & low vision Blindness Read code ever recorded (Relevant Read 
Code recorded) 
Glaucoma Glaucoma Read code ever recorded (Relevant Read 
Code recorded) 
Hearing loss Hearing Loss Read code ever recorded (Relevant Read 
Code recorded) 
Hypertension Hypertension Read code ever recorded (Relevant Read 
Code recorded) 
Heart failure Heart Failure Read code ever recorded 
Peripheral vascular diseases PVD Read code ever recorded (Relevant Read 
Code recorded) 
Chronic sinusitis Sinusitis Read code ever recorded (Relevant Read 
Code recorded) 
Bronchitis, emphysema & other 
chronic obstructive pulmonary 
diseases 
COPD Read code ever recorded (Relevant Read 
Code recorded) 
Bronchiectasis Bronchiectasis Read code ever recorded (Relevant Read 
Code recorded) 
Crohn’s disease & ulcerative 
colitis 
Inflammatory bowel 
disease 
Read code ever recorded (Relevant Read 
Code recorded) 
Diverticular disease of intestine Diverticular disease Read code ever recorded (Relevant Read 
Code recorded) 
Rheumatoid arthritis, other 
inflammatory polyarthropathies 
& systematic connective tissue 
disorders 
Inflammatory 
arthritis 
Read code ever recorded (Relevant Read 
Code recorded) 
Hyperplasia of prostate & 
prostate disorders 
Prostate Disease Read code ever recorded (Relevant Read 
Code recorded) 
Psoriasis or eczema Psoriasis/Eczema Read code ever recorded (M11% & 
M12%) AND ≥ 4 prescription in last year 
(BNF 13.4, excluding hydrocortisone, & 
BNF 13.5) 
Viral Hepatitis Viral Hepatitis Read code ever recorded (Relevant Read 
Code recorded) 
Irritable bowel syndrome Irritable bowel Read code ever recorded (Relevant Read 
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syndrome Code recorded) OR ≥ 4 antispasmodic 
prescription in last year (POM only, 
exclude kolanticon, alverine citrate & 
peppermint oil) 
Cirrhosis/chronic liver 
disease/alcoholic liver disease 
Chronic liver 
disease 
Read code ever recorded (Relevant Read 
Code recorded) 
 
Migraine Migraine ≥ 4 anti-migraine prescriptions in last year 
(BNF 040704%, POM only exclude 
migraleve) 
Dyspepsia Dyspepsia ≥ 4 prescriptions in last year BNF 0103% 
excluding antacids AND NOT ≥4 
NSAIDS OR ≥4 aspirin/clopidogrel 
 
Constipation Constipation ≥4 prescriptions in last year, BNF 0106% 
Pain Pain ≥4 specified analgesic prescriptions in last 
year (opioids/>8mg co-codamol/NSAIDS) 
OR ≥4 specified anti-epileptics in the 
absence of an epilepsy Read code in last 
year (gabapentin, pregabalin and 
carbamazepine) 
 
Table B2: Read Code definitions of seven mental health conditions assessed. 
 
Mental health condition Name of 
variable 
Definition of variable 
Depression Depression Read code recorded in last 12 months OR ≥ 4 anti-
depressant prescriptions (excluding low-dose tricyclics) 
in last 12 months 
Anxiety & other neurotic, 
stress related & 
somatiform disorders 
Anxiety Read code recorded in the last 12 months OR ≥ 4 
anxiolytic/hypnotic prescriptions in the last 12 months 
OR ≥4 10/25mg amitriptyline in the last 12 months and 
do not meet the criteria for ‘Pain’ 
Alcohol problems Alcohol Read code ever recorded 
Other psychoactive 
substance misuse 
Drugs Read code ever recorded 
Dementia Dementia Read code ever recorded 
Schizophrenia (and 
related non-organic 
psychosis) or bipolar 
disorder 
Schizo/bipolar Read code ever recorded/recorded in last 12 months 
(code dependent) OR Lithium prescribed in last 168 
days  
Learning disability Learning 
disability 
Read code ever recorded 
Anorexia or bulimia Eating disorder Read code ever recorded 
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Appendix C – Sample systematic review data extraction sheet.  
 
Data Extraction Sheet v.1Robert July 2013 
 
 
 
Study design Prospective non-randomised controlled trial 
Study Aim 
To investigate the effects of meditation on pain and 
QOL in MS and PN 
Inclusion criteria 
? any Dx of MS. (Also included a variety of PN 
patients) 
Exclusion criteria 
1) Previous meditation training in the past 6/12 
2) Severe cognitive impairment 
3) Unable to ambulate without assistance (EDSS 
>6.5) 
Characteristics of study sample  
 Intervention group 
Control /comparison 
group 
Sample size 10 (19 pre drop out) 7 (11 pre drop out) 
Recruited from where?  
Cleveland Clinic 
Neurological Institute 
Cleveland Clinic 
Neurological Institute 
Gender 7F 6F 
Age 48.10 (10.26) 49.29 (12.09) 
Ethnicity NA  
Socioeconomic status NA  
Employment status NA  
Marital status NA  
Educational status NA  
Living Arrangements NA  
Other (specify)   
Multiple Sclerosis 
Definition  Medical record review by Ix team. 
Bibliographic details  
Author Tavee 
Year 2010 
Country USA 
Citation  1.Tavee J, Rensel M, Planchon SP, Stone L. Effects of Meditation on Pain 
and Quality of Life in Multiple Sclerosis and Polyneuropathy: A Controlled 
Study. Neurology. 2010;74(9):A160-A. 
References 
identified from 
reference list 
yes/no   
If yes, please provide details:  
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Type e.g. Relapsing Remitting, 2y 
Progressive etc. 
  
Time since Dx 10.40 (6.47) 19.14 (14.15) 
MS stage e.g. EDSS score 3.25 (2.2) 2.79 (2.80) 
Cognitive impairment (number of 
participants; severity) 
NA 
 
Affective disorders (number of 
participants; severity) 
NA  
Co-morbidities (specify) NA  
 
 
Mindfulness Intervention 
Definition  
Course content 
Samatha (sitting and observing the breath); Moving meditation (Tai 
Chi, Qigong); Walking meditation. Homework encouraged. 
Duration & frequency 
4hr introductory session then weekly 90 minute Buddhist meditation 
class 
Who delivered the 
intervention?  
Buddhist monk 
Did they have specific 
training? 
NA other than taught by a ‘Buddhist Monk’ 
No. of participants per 
group 
19 in treatment group, 11 in control 
Intervention materials NA 
Intervention location NA 
Cost to participants NA 
Cost effectiveness NA 
Transport issues Excluded up to 16 participants overall (12 MS and 4 PN) 
Family involvement NA 
Other (specify)  
 
Intervention for control group 
Provide details: 
UC and instructed to avoid meditation practices for the study duration, but offered training on 
completion of the study. 
 
 
Outcomes measurement 
 Intervention group 
Control /comparison 
group 
Standardised outcomes 
measures (specify)   
SF36 QOL (mental health, physical 
health, vitality, physical role) 
MFIS - Fatigue 
VAS - Pain 
PDDS - Patient determined disease 
steps 
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Study-specific outcomes 
measures (provide details)   
NA 
 
Other outcomes measured 
(provide details)   NA 
 
No. of data collection time 
points 
2 (baseline and intervention 
completion) 
2 (baseline and 
intervention completion) 
Results 
After 8 weeks, study participants in the intervention group showed a significant improvement 
in pain scores on the VAS (P = .035 combined group, P = .044 PN) and SF-36 scores for 
overall summed physical health (P = .011 MS, P = .014 PN), mental health (P = .02 combined 
group), vitality (P = .005 combined group), and physical role (P = .003 combined group), 
while no change was observed in controls. MS patients in the intervention arm also 
demonstrated a significant improvement in scores for bodily pain (P = .031). 
For the secondary outcome measure of fatigue in MS patients, improved scores were seen in 
the intervention group with regard to the cognitive and psychosocial components of the MFIS 
(P = .037, P = .032). For PN patients, a slight trend toward improvement of the motor and 
sensory portions of the NIS was seen (mean reduction of −0.29 and −1.5 on the NIS-M and 
NIS-S, respectively), but the difference did not reach statistical significance (P = .66, P = .20). 
No statistically significant changes were seen in PDDS scores for MS patients in the 
intervention group. 
Participants in the MS and PN control groups showed no significant improvement at the end 
of the trial in any of the parameters measured except for a minor improvement in mobility 
seen in MS patients (P = .03). Furthermore, PN controls reported worsened scores for both the 
VAS (mean increase in pain of 1.21 ± 2.32) and all SF-36 measures except for bodily pain 
and mental health. Similarly, the MS control group showed increased pain on the VAS at the 
end of the trial (0.50 ± 2.74) and worsened SF-36 scores for all parameters except for vitality 
and social functioning 
Limitations noted by the 
authors 
Sample size small 
No randomisation 
No control group intervention 
Failure to record homework 
Authors’ conclusions 
Meditation may be helpful in reducing pain and improving 
quality of life in patients with MS and PN. The lack of 
changes seen in mobility (MS) and sensorimotor deficits (PN) 
suggests that meditation may not affect the overall clinical 
course. 
Reviewer’s comments 
Low quality study. 
Non-randomised. 
Intervention and who delivered it are unclear. 
Mixing results MS and PN make interpreting results difficult. 
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Appendix D 
Literature developments since completion of the systematic review 
Since the systematic review was completed and published in January 2014, two 
further relevant studies have been published looking at the use of MBIs in people with 
MS. These are summarised below, along the same lines taken in the systematic 
review, and in order of publication, with a short section at the end listing and 
tabulating how these study findings compare with those of the systematic review.  
1.  Burschka et al. [304] 
Study characteristics (see Table D1) 
In Germany, Burschka et al. [304] carried out a controlled trial examining the use of a 
MBI. Study participants were recruited from a local hospital Neurology department, 
and via local MS support organisations. There were 38 participants in total; split into 
active (n=21) and control/treatment as usual (n=17) groups. Attrition was reported at 
a rate of 30% (n=6) in the intervention group (not mentioned for the control group), 
but an ITT analysis was not conducted - those dropping out were excluded from the 
analysis, which is based on data for 32 individuals. Outcome data was collected at 
baseline, and at the six-month point (when the intervention ceased). 
Intervention characteristics (see Table D1) 
The researchers employed a controlled trial, utilising a MBI which emphasised 
mindfulness based on the Bishop et al. [129] working definition, i.e. being composed 
of both self-regulation of attention, and orientation to experience (in this case 
primarily via breath and body awareness Tai Chi exercises). The mode of teaching 
was a ‘Yang-style’ Tai Chi approach, with a total of 50 (90 minute) classes being 
offered throughout the course of the intervention. There was no home practice, or 
such materials included. Also, notably, the control group had prior Tai Chi experience 
from earlier pilot work, and it is not clear how many of them were actually continuing 
to practice during the period of study. 
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Participant characteristics (see Table D2) 
In this study, 69% (n=22) were female, with a mean (SD) age of 42.1 (8.7) years. The 
presence/absence of comorbid conditions, SES, level of education, and ethnicity were 
not delineated. The majority of participants had RRMS (85%, n=27), with four 
(12.5%) having SPMS, and one (2.5%) having the diagnostic label of Clinically 
Isolated Syndrome (CIS). Exclusion criteria were: EDSS score ≥5, current/recent 
(within the previous four weeks) relapse, or evidence of severe cognitive impairment. 
The researchers reported a higher median EDSS (4.0) for the control group, versus the 
median score for the intervention group (2.0).  
Outcomes 
The researchers were primarily concerned with measuring balance, and secondarily 
with fatigue, depression, and QOL. Along with co-ordination, static and dynamic 
balance was assessed via an established German language balance and co-ordination 
test [378]. Depression was assessed via the German language version of the CES-D, 
fatigue by the Fatigue Scale of Motor and Cognitive functions (FSMC), and QOL via 
the Questionnaire of Life Satisfaction. Cost/benefit was not included in the study 
design. No adverse events were reported. 
Physical measures (see Table D3) 
For balance, a significant pre-, post- improvement (p<0.05) in the intervention group 
was noted. This was associated with a significant time by group interaction. Similarly, 
there was a significant improvement in co-ordination (p<0.05) in the intervention 
group, which also had a significant time by group interaction. As for fatigue, there 
was no change in the intervention group, but a significant deterioration in the control 
group (p<0.05).  
Mental health (see Table D4) 
There was a significant decrease in depression scores amongst the intervention 
participants (p<0.05), whilst scores remained stable in the control group. 
Mindfulness-based interventions for people with MS 
 
 270 
Psychosocial outcomes (see Table D5) 
The researchers reported significantly improved QOL scores in the intervention group 
(p<0.05), which was not apparent amongst controls. 
Methodological quality (see Table D6) 
Going by the Cochrane Collaboration quality criteria [288], Burshka et al. [304] did 
not randomise, instead allocating to groups based on participant availability for the 
day of the intervention (High risk of bias), there was no allocation concealment (High 
risk of bias), they did not describe blinding of assessors, or during outcome 
assessment (both High risk of bias), did not follow an ITT analysis (High risk of bias), 
and finally, the intervention was delivered by the principle investigator (J Burschka). 
Overall, this means the study is at a High risk of bias, and thus low methodological 
quality. 
2. Bogosian et al. [305] 
Study characteristics (see Table D1) 
In England, Bogosian et al. [305] undertook a RCT involving 40 randomised 
individuals, being designed to evaluate the use of a novel Skype teleconference, 
distant-delivered MBI. The control group received usual NHS care. Participants were 
recruited nationally, from across the UK, via adverts on the UK MS Society website, 
and from MS centres across the country. Attrition was reported as low (5%), with 
18/19 of those randomised to receive the MBI completing more than four out of eight 
sessions; attendance was reported as 73.7% completing six or more of the eight 
sessions. The reasons given for the single drop out were vague (‘personal 
circumstances’).  
Intervention characteristics (see Table D1) 
The researchers piloted a live, online, ‘group’ MBI, which participants received in 
their own homes. Although separated in space, participants were able to see, hear, and 
interact with each other during the classes. The intervention was derived from MBCT, 
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the cognitive components having been adapted from those outlined in the original 
programme for depression; to focus instead on maladaptive cognitions thought to be 
common in the MS population. This intervention did not include any mindful 
movement, which the authors qualified as being guided by a small number (n=6) of 
case studies of people with progressive MS (Mean EDSS of 6.0), along with expert 
opinion from a Neurologist and MS Specialist Nurses. Again, based on preliminary 
work, the weekly classes (eight weeks in total) were shortened to one hour in 
duration, but otherwise included the recognisable core content familiar to traditional 
MBIs. Ten to twenty minutes of daily home practice was suggested (with 
accompanying CDs), but adherence rates were not reported. 
Participant characteristics (see Table D2) 
The study was designed specifically for people with progressive MS phenotypes, and 
as such excluded those with RRMS. From the total n of 40, 17 (42%) had PPMS, the 
remaining 23 (58%) having SPMS. Mean (SD) age of participants was 52.7 (9.5); 
55% were female, mainly being British Caucasian (90%). Seventy-eight percent were 
cohabiting. There was no information provided regarding comorbidity or SES. The 
mean (SD) EDSS score was 6.5 (1.5), which is considerably higher than any of the 
previous studies, and median (range) disease duration was 12 (1-38 years). Exclusion 
criteria were a MS diagnosis other than PPMS or SPMS, not being ‘distressed’ at 
baseline (as measured by the GHQ), not having internet access, having cognitive 
impairment (as measured by the Telephone Interview for Cognitive Status-Modified 
TICS-M), hearing impairment, being deemed at high risk of suicide (measured via the 
Clinical Outcome of Routine Evaluation - CORE), having psychosis, or other serious 
mental illness. Additionally, other psychological therapies or prior mindfulness 
training excluded individuals from taking part. 
4.7.2.5: Outcomes 
The primary outcome was distress, as measured by the GHQ. Secondary outcomes 
included: anxiety and depression (via the HADS); mental and physical impact of MS 
(via the Multiple Sclerosis Impact Scale – 29 - MSIS-29); pain (via the Numerical 
Rating Scale); fatigue (via the Fatigue Severity Scale – FSS); QALYs (via the 
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EuroQol – EQ5D); and service costs (via the Client Service Receipt Inventory - 
CSRI). 
Mental health (see Table D3) 
Distress (the primary outcome measure) significantly decreased in those receiving the 
intervention, both at intervention completion (ES -0.67; p<0.05), and at three-month 
follow-up (ES -0.97; p<0.05). HADS depression improved significantly amongst 
those receiving the MBI at intervention completion (ES -0.65; p<0.05) and at three-
month follow up (ES -0.53; p<0.05). HADS anxiety showed a similar trend at 
intervention completion (ES -0.40; p<0.05) and three-month follow up (ES -0.86; 
p<0.05). Similarly, at intervention completion MSIS-29 (psychological) had 
improved significantly (ES -0.99; p<0.05), with effects sustained at three-month 
follow-up (ES -1.12; p<0.05).  
Physical health (see Table D4) 
On the MSIS-29 (physical) subscale, a small significant benefit was evident at 
intervention completion (ES -0.36; p<0.05), although this narrowly lost its 
significance at three-month follow up (ES –0.28; p=0.05). For pain, no significant 
improvements were noted post-therapy, but were evident at three-month follow up 
(ES -0.59; p<0.05). Fatigue scores were not significantly improved at either time 
point.  
Service use/cost effectiveness 
The researchers reported that the MBI was associated (non-significantly) with 
reduced formal and informal service costs, and a 90% chance of being cost-effective 
(compared to usual care) at a threshold of £20,000. Adjusted QALYs were not 
different between the groups after the intervention. Societal cost-effects (generated 
from GHQ scores) were reported as the MBI being 87.4% more likely to be 
associated with cost savings.    
Methodological quality (see Table D6) 
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Following the Cochrane Collaboration [288] guidance on risk of bias, in the Bogosian 
et al. [305] study there was evidence of adequate (independent, blinded) random 
sequence allocation (Low risk of bias); allocation was concealed from the trial 
assessor, the statistician and health economists (Low risk of bias); group comparisons 
were assessed on an ITT basis (Low risk of bias); there was no evidence of 
incomplete outcomes, or selective reporting of data (Low risk of bias); or any other 
sources of concern. This study was therefore at low risk of bias, and can be deemed a 
study of higher methodological quality (the only caveat being that the trial involved 
low numbers, and was of a pilot design).  
 
3.  Kolahkaj and Zargar [306] 
Study characteristics (see Table D1) 
In Iran, Kolahkaj and Zargar [306] carried out a RCT testing a MBI in people with 
MS. Only females with MS between the ages of 20-50 years were eligible to 
participate and were recruited over a six-month period from the Ahvaz MS Society 
via a convenience sampling technique; this meant reviewing files on record at the 
Ahvaz MS Society, and calling patients to invite them to participate. If agreeable to 
participation at this point, participants were briefed about the study, and recruited. 
Sixty-four people were screened for eligibility, and 15 were excluded, leaving 48 to 
be randomised. However, eight participants were lost to follow up, and only 40 were 
included in the statistical analyses; thus there was no ITT. Attrition was reported as 
17%. Class attendance was not reported, nor was home practice time. Outcomes were 
recorded at baseline, post-intervention, and two months later.  
Intervention characteristics (see Table D1) 
The intervention was reported as based on both MBSR and MBCT, but was most 
frequently referred to in the paper as MBSR. The control group received their usual 
level of care. A trained psychologist delivered the intervention, but it is not clear what 
level of expertise in MBIs this individual held. Classes were two hours long, and took 
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place weekly over eight weeks. The authors reported that participants who missed 
classes were given additional sessions to cover the missed material and that those who 
missed more than two sessions were excluded from further participation.  
Participant characteristics (see Table D2) 
All participants in this study were female, aged 20-55, with the mean (SD) age being 
25.3 (4.1), with no significant differences between the intervention and control 
groups. Similarly, there was no significant difference in level of education. All 
participants were married. Level of disability was not reported. The authors reported 
that any diagnosis of MS rendered a participant eligible, but later stated that having 
relapsing MS was an exclusion – however, this may be a mistranslation, instead 
possibly meaning that a current MS relapse was an exclusion criterion. Further 
exclusion criteria were psychotic disorder, or psychotherapy in the previous six-
month period. Baseline Depression, Anxiety, and Stress Scale-21 (DASS-21) scores 
were higher than normative levels for depression and anxiety, but lower for stress 
[379]. 
Outcomes 
Mental health (see Table D4) 
The primary outcome in this study was the DASS-21. Results were reported as 
change in mean test scores from baseline at post-MBSR, and one month later. No 
effect sizes were reported. Significant improvements in all three sub-scales on the 
DASS-21 were reported, with a reduction in anxiety at post-MBSR that was sustained 
one month later (p<0.001); in depression at post-MBSR and one month later 
(p<0.001); and in stress post-MBSR and one month later (p<0.001). Improvements in 
depression were most notable, given that they decreased from abnormal levels (mean 
8.35; SD 1.78), to well below (mean 4.80; SD 0.83) normative values (mean 6.34; SD 
6.97) [379].   
Methodological quality (see Table D6) 
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In terms of the Cochrane Collaboration quality criteria [288], the researchers in this 
study did randomise using a random number table, although details regarding this 
procedure were sparse (Unclear risk of bias). No information was provided with 
respect to allocation concealment (Unclear risk of bias), or whether assessor/outcome 
assessment blinding took place (Unclear risk of bias). There was a failure to use an 
ITT (High risk of bias), but no evidence of selective outcome reporting (Low risk of 
bias). The selection criteria, based on convenience sampling, could potentially lead to 
selection bias on the part of the researchers (Unclear risk of bias). Overall, this study 
provided vague details and thus represents an unclear risk of bias, lowering its 
methodological quality. 
 
Summary of new findings (for direct comparison with systematic review findings, 
see Tables D1 - D6) 
What do these studies add to the findings from the systematic review? 
1. Bogosian et al. [305] reported statistically significant benefit in the mental 
health domain (anxiety, depression, distress), whilst Burschka et al. [304] also 
reported a beneficial effect on depression, as did Kolahkaj and Zargar [306] on 
depression, anxiety, and stress. 
2. Burschka et al. [304] reported further significant benefit in the physical health 
domain. 
3. Burschka et al. [304] reported significantly improved QOL. 
4. Bogosian et al. [305] reported service cost savings for their MBI. 
5. Bogosian et al. [305] extended the literature by including a more disabled 
group, finding that mental health improved in participants, even without a 
mindful-movement component to their MBI. They also demonstrated that 
shortened duration, of both classes and home practice materials may be 
acceptable and potentially effective. 
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6. Kolahkaj and Zargar [306] provided data on a previously unreported ethnic 
group, from Iran. 
4.7.3.1: Limitations of these three studies  
1. None of these studies measured mindfulness as an outcome. 
2. None of these studies employed an active comparator group.  
3. The vast majority of participants were female.  
4. All three studies have made changes to standard MBI packages, with minimal 
justification. 
5. Overall, study quality remains low. 
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1.RCT - Randomised Controlled Trial; 2.CT - Controlled Trial; 3.CES-D Center for Epidemiological Studies Depression scale ; 4.HAQUAMS - Hamburg Quality of life questionnaire in Multiple 
Mclerosis (German); 5.MFIS - Modified Fatigue Impact Scale; 6.POMS - Profile of Mood States; 7.PQOLC - Profile of health related Quality of Life in Chronic disorders (German); 8.SF-36 - Short Form 
36; 9.STAI - Spielberger Trait Anxiety Inventory; 10.VAS - Visual Analogue Scale for bodily pain; 11.PDDS - Patient Determined Disease Steps; 12.. FSMC – Fatigue Scale of Motor and Cognitive 
functions; 13 QLS – Questionnaire of Life Satisfaction; 14. GHQ – General Health Questionnaire. 15. HADS – Hospital Anxiety and Depression Scale; 16. MSIS – Multiple Sclerosis Impact Scale 17. 
DASS-21 – Depression, Anxiety, and Stress Scale-21; 18. NR - Not Recorded.  
Table D1 – Study characteristics 
Study (Country) Study design (Setting) Sample size (Attrition%) Intervention (duration) Outcome measures Data collection 
Mills and Allen [289] 
(Wales) 
RCT (Patients home) n = 16 (12.5%) Mindful breathing  
Tai Chi  
Self compassion  
Home study material  
(6/52 duration) 
POMS  
Standing balance  
Symptom rating 
questionnaire 
Baseline 
Post intervention 
3 months post 
intervention 
Grossman et al. [177] 
(Switzerland) 
RCT (University 
hospital) 
n = 150 (5%) Mindful breathing  
Hatha Yoga  
Body scan  
Home study material  
(8/52 duration) 
CES-D 
STAI  
MFIS  
HAQUAMS  
PQOLC 
Baseline 
Post intervention 
6 months post MBSR 
Tavee et al. [290] (USA) CT (University hospital) n = 17 (43%) Mindful breathing - 
Samatha  
Tai Chi  
(8/52 duration) 
SF-36  
MFIS  
VAS PDDS 
Baseline 
Post intervention 
NR 
Burschka et al. [304] 
(Germany) 
CT (University hospital) n = 38 (30%) 
Mindful breathing 
Tai Chi 
(6/12 duration) 
Balance/ co-ordination 
CES-D (German) 
FSMC 
QLS 
Baseline 
Post intervention 
NR 
Bogosian et al. [305] 
(England) 
RCT (Patients home) n = 40 (20%) 
Mindful breathing 
Body scan 
Home study material  
(8/52 duration) 
GHQ 
HADS 
MSIS 
FSS 
Baseline 
Post intervention 
3 months post MBCT 
Kolahkaj and Zargar 
[306] (Iran) RCT (MS society) n = 48 (17%) 
Mixture of MBSR/MBCT  
(8/52 duration) 
DASS-21 
Baseline 
Post intervention 
2 months post MBSR 
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1. SPMS - Secondary Progressive MS; 2. RRMS - Relapsing Remitting MS; 3. PPMS – Primary Progressive MS; 4. CIS – Clinically Isolated Syndrome; 5. EDSS - Expanded Disability Status Scale; 4. NR 
- Not Recorded  
Table D2 – Participant characteristics  
 Mills and 
Allen [289] 
Grossman et 
al. [177] 
Tavee et al. 
[290] 
Burschka et 
al. [304] 
Bogosian et al. [305] Kolahkaj and Zargar [306] 
Ethnicity NR NR NR NR 90% British caucasian NR 
Number of participants (% 
female) 
16 (80%) 150 (80%) 17 (78%) 38 (69%) 40 (55%) 48 (100%) 
Mean age (SD) 49.8 (6.8) 47.3 (10.3) 48.7 (11.2) 42.1 (8.7) 52.2 (9.1) 25.28 (4.08) 
Socio-economic status NR NR NR NR NR NR 
Employment status 4 employed 
(25%) 
NR NR NR NR NR 
Mean years of education 
(SD) 
NR 14.1 (1.9) NR NR NR, but 31 (77.5) had at 
least a college education 
NR, but 21 had at least high school, 
and 19 had a bachelor’s degree 
Disease phenotype SPMS 16 
(100%) 
RRMS 123 
(82%) 
SPMS 27 
(18%) 
NR RRMS 27 
(85%) 
SPMS 4 
(12.5%) 
CIS 1 (2.5%) 
SPMS 23 (57.5%) 
PPMS 17 (42.5%) 
NR 
EDSS score NR Mean (SD) 3.0 
(1.1) 
Mean (SD) 
3.0 (2.5) 
Median (range) 
3 (1 - 4.25) 
Mean (SD) 6.5 (1.5) NR 
Comorbidities NR NR NR NR NR NR 
Number taking disease 
modifying medication 
NR 91 (60.1%) NR NR NR NR 
Number taking 
psychotropic medication 
NR 30 (20%) NR NR NR NR 
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Table D3: Mental health outcomes 
Study Outcome (Measure) Post intervention effect size (p) Follow up effect size (p) and time point 
Grossman et al. [177] Full intervention group Anxiety (STAI) 0.39 (0.0006) 0.36 (0.02) at six months 
Sub-group analysis 1.00 (0.002) 0.64 (0.05) at six months 
Full intervention group Depression (CES-D) 0.65 (0.00001) 0.36 (0.03) at six months 
Sub-group analysis 1.06 (0.0002) 0.66 (0.03) at six months 
Mills and Allen [289] Anxiety (POMS) p > 0.05* p > 0.05* 
Depression (POMS) p < 0.01* NR 
Burschka et al. [304] Depression (CES-D) p = 0.007* NR 
Bogosian et al. [305] Distress (GHQ) 0.67 (<0.05) 0.97 (<0.05) at 3 months 
Anxiety (HADS) 0.40 (<0.05) 0.99 (<0.05) at 3 months 
Depression (HADS) 0.65 (<0.05) 0.65 (<0.05) at 3 months 
MSIS psychological 0.99 (<0.05) 1.12 (<0.05) 
Kolahkaj and Zargar [306] DASS-21 Depression p<0.001 p<0.001 
DASS-21 Anxiety p<0.001 p<0.001 
DASS-21 Stress p<0.001 p<0.001 
1.STAI - Spielberger Trait Anxiety Index; 2. CES-D - Centre for Epidemiological Studies Depression scale; 3.POMS - Profile of Mood States; 4.GHQ – General Health Questionnaire; 5.HADS – Hospital 
Anxiety and Depression Scale; 6. MSIS – Multiple Sclerosis Impact Scale; 7 DASS-21 – Depression, Anxiety, and Stress Scale-21; * Effect size not recorded. 
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Table D4: Physical health outcomes  
Study Outcome (Measure) Post intervention effect size (p) Follow up effect size (p) and time point 
Grossman et al. [177] Full intervention group Fatigue (MFIS) 0.41 (0.0001) 0.38 (0.001) at six months 
Sub-group analysis 1.27 (0.0005) 1.09 (0.02) at six months 
Mills and Allen [289] Fatigue (POMS) p < 0.05* NR 
Single leg standing balance p < 0.05* p < 0.05* at three months 
Tavee et al. [290] Fatigue (MFIS) p = 0.035* NR 
Pain (VAS) p = 0.031* NR 
PDDS p < 0.05* NR 
Burschka et al. [304] 
Balance p = 0.031* NR 
Co-ordination p = 0.003* NR 
Fatigue (FSMC) p = 0.182* NR 
Bogosian et al. [305] 
Fatigue (FSS) 0.30 (0.15) 0.29 (0.30) at 3 months 
Pain (Numerical rating scale) 0.27 (0.20) 0.59 (<0.05) at 3 months 
 MSIS physical 0.36 (<0.05) 0.28 (0.05) 
1.MFIS - Modified Fatigue Impact Scale; 2.POMS - Profile of Mood States; 3.VAS - Visual Analogue Scale for pain; 4.PDDS - Patient Determined Disease Steps; 5.FSMC - Fatigue Scale of Motor and 
Cognitive functions; 6.FSS – Fatigue Severity Scale; 7.MSIS – Multiple Sclerosis Impact Scale; 8.NR - Not Recorded;  *Effect size not recorded. 
 
 
Mindfulness-based interventions for people with MS 
 
 281 
Table D5: Quality of life outcomes 
Study Measure Post intervention effect size (p) Follow up effect size (p) and time point 
Grossman et al. [177] Full intervention group HAQUAMS 0.43 (0.0002) 0.28 (0.04) at six months 
PQOLC 0.86 (0.00000001) 0.51 (0.03) at six months 
Sub-group analysis HAQUAMS 1.01 (0.0001) 0.58 (0.04) at six months 
PQOLC 1.71 (0.00000001) 0.51 (0.003) at six months 
Burshka et al. [304] QLS p = 0.012* NR 
1.HAQUAMS - Hamburg Quality of life questionnaire in Multiple Sclerosis (German); 2.PQOLC - Profile of health-related Quality of Life in Chronic disorders (German); 3: Questionnaire of Life 
Satisfaction; *Effect size not recorded. 
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Table D6: Risk of bias summary  
 Grossmann et 
al. [177] 
Mills and Allen 
[289]  
Tavee et al. 
[290]  
Burschka et 
al. [304] 
Bogosian et 
al. [305] 
Kolahkaj and 
Zargar [306] 
Random sequence generation 
(selection bias) 
Low Unclear NA High Low Unclear 
Allocation concealment (selection 
bias) 
Low Unclear NA High Low Unclear 
Blinding of assessors (performance 
bias) 
Low Unclear High High Low Unclear 
Blinding of outcome assessment 
(detection bias) (patient reported 
outcomes) 
High High High High Low Unclear 
Incomplete outcome data addressed 
(attrition bias) 
Low Unclear High High Low High 
Selective outcome reporting 
(reporting bias) 
Low High Unclear Unclear Low Low 
Other sources of bias (ie baseline bias) Low Unclear Unclear High Low Unclear 
1.Low = Low risk of bias; 2.Unclear = Unclear risk of bias; 3.High = High risk of bias; 4.NA = Not available. 
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Appendix E – Clinician information sheet 
Clinician information sheet 
 
Study Title: Mindfulness-based stress reduction in multiple sclerosis. 
 
Study purpose: To evaluate the feasibility, acceptability, and accessibility of a mindfulness-based 
stress reduction (MBSR) intervention in people with multiple sclerosis (MS). 
 
Background: Existing evidence for psychological interventions in MS backs the use of cognitive 
behavioural therapy approaches (1), and some evidence also suggests that CBT derived stress 
modulation impacts positively on MS disease activity (2). However, beneficial results of such 
interventions may be short lived (2). MBSR-type approaches have good quality evidence for use in 
other long-term conditions (3) and are proposed to have a different mechanism of action to CBT. 
The evidence for the use of MBSR in MS is limited, with a small international literature leaving 
important gaps in the knowledge base (4).  
 
Methods: We propose to run a randomised controlled feasibility trial for MBSR use in people with 
MS. It is our intention to recruit up to 50 individuals, who will then be randomised to receive either 
MBSR or usual care (UC). We will collect quantitative measures pre-, post- and at 3-month follow 
up points, using generic health related quality of life (HRQOL), the Perceived Stress Scale (5), the 
Multiple Sclerosis Quality of Life Inventory (MSQLI) (6), and other MBSR specific measures. We 
will also seek participant qualitative data on a sub-sample of up to 20 participants via semi-
structured interviews. At the end of the 3-month follow up period, those initially randomised to UC 
will be offered the MBSR intervention. 
 
Eligibility: Criteria for inclusion in the current study are: 
1. Being >18 years of age; 
2. Having at baseline a Neurologist confirmed diagnosis of MS; 
3. Can understand spoken and written English; 
4. Having a score of less than or equal to 7 on the Expanded Disease Disability Score (7) 
(Unable to walk beyond approximately 5m even with aid. Essentially restricted to wheelchair; 
though wheels self in standard wheelchair and transfers alone. Up and about in wheelchair 
some 12 hours a day), in order to allow active participation in the typical Hatha Yoga Asana 
postures included in the standard MBSR programme. 
 
Exclusion criteria will include: 
1. Potentially life threatening physical or mental health comorbidities (i.e. suicidal ideation, 
active psychosis, terminal/life threatening intercurrent medical illness), or those with such 
conditions expected to significantly limit participation and adherence (e.g. dementia, 
pregnancy, ongoing substance abuse, active psychosis); 
2. Those currently receiving another form of psychological intervention (non-pharmacological). 
 
Contact details: Only those who give their permission to being referred for consideration of being 
included in the study, and have it recorded as such, should be referred. All potential study 
applicants should be referred to Dr Robert Simpson, who will carry the study phone: 07957 230 
224. Dr Robert Simpson will screen all potential participants, before making a final decision on 
eligibility. 
 
Dr Robert Simpson 
Clinical Academic Fellow 
Department of General Practice and Primary Care 
University of Glasgow 
Robert.Simpson@glasgow.ac.uk 
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Appendix F – Participant information sheet 
 
1. Study title 
 
Mindfulness-based stress reduction in multiple sclerosis 
 
2. Invitation paragraph 
 
You are being invited to take part in a research study exploring the use of Mindfulness-based stress 
reduction (MBSR) meditation techniques amongst people with Multiple Sclerosis (MS). Before 
you decide it is important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it with others if 
you wish. Ask us if there is anything that is not clear or if you would like more information. Take 
time to decide whether or not you wish to take part. 
 
3. What is the purpose of the study? 
 
MS is a condition that remains poorly understood and difficult to treat, from a medical perspective. 
It is also known that MS can be a very stressful condition to live with and thus having access to 
simple techniques to cope with stress seems desirable. Previous research in this area demonstrates 
that some forms of talking therapy that focus on changing how one thinks can help with stress in 
MS, but that beneficial effects tend to wear off if the contact with the therapist is lost. MBSR works 
in a different way from standard talking therapies and may be more or less lasting in its effects than 
talking therapies. It is important to answer this question in a fair way, and this trial aims to do just 
that by employing a randomisation process, meaning that some people will receive MBSR, whilst 
others wait and receive their usual care. The MBSR programme lasts for 8 weeks, and there will be 
a 3-month follow up period before the second MBSR group. At the completion of the study, those 
initially allocated to the usual care group will be offered the MBSR course. 
 
4. Why have I been chosen? 
 
This study will focus on people with MS who express an interest to take part. If you have expressed 
an interest in taking part, the researcher (Dr Robert Simpson) will telephone you to confirm that 
you are eligible to take part, and answer any questions that you may have about the study. There 
are certain conditions that must be met to take part, so that everyone in the trial can safely 
participate in the practices involved in the MBSR course. 
 
5. Do I have to take part? 
 
No, you do not have to take part in this study, and it is up to you to decide whether or not to take 
part. If you do decide to take part, you will be given this information sheet to keep and be asked to 
sign a consent form. If you decide to take part, you are still free to withdraw at any time and 
without giving a reason, and this will in no way affect your standard medical care. 
 
6. What will happen to me if I take part? 
 
If you agree to take part in this study, you will have the opportunity to take part in an MBSR 
course. A standard MBSR course focuses on teaching core ‘Mindfulness’ skills, designed to help a 
person deal better with stress. MBSR is delivered in a group setting, with a maximum of 25 people 
per group.  
 
Mindfulness means paying attention, on purpose, to your thoughts, feelings, and experiences, in a 
non-judgemental, open manner. This approach has been shown to reduce stress in some groups of 
people living with chronic illness. The core components of MBSR are: 
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- Mindful breath awareness: this is usually done in a sitting position. 
- Mindful body awareness: this is usually done in a lying position. 
- Mindful movement: this usually involves simple Yoga postures. 
 
The MBSR sessions last for 2.5 hours (usually with time for a tea/coffee break in the middle of 
this), during which time you will practise these simple exercises, as well as have the opportunity to 
reflect on these and feedback to the group (although such feedback is entirely optional - for 
example, if you do not feel comfortable about speaking in the group you will not be obliged to do 
so). 
 
The facilitators of the group will be general medical practitioners (both are fully qualified GPs and 
Associate Specialists in Integrative Medicine), who have extensive experience in teaching 
Mindfulness to people with chronic illnesses and in dealing with the medical problems faced by 
people with MS. 
 
It is normal practice for MBSR courses to emphasise weekly homework assignments (up to 45 
minutes per day), which focus on practising the Mindfulness exercises that have been covered in 
the preceding class. The homework assignments are encouraged, but not essential, so that if you are 
unable to do them you will still be part of the group and the study. It is also asked that participants 
keep a diary of how often they have practised, but again, this is not essential if you find that this is 
too much for you to do. 
 
All individuals completing the MBSR course will be eligible to attend a monthly ‘drop-in’ follow 
up class with the MBSR facilitators. Following all individuals completing the initial MBSR course 
versus usual care, and 3 month follow up, all results will be collated and analysed, before being 
written up as a PhD thesis.  
 
Whether you are initially allocated to the MBSR or not, you will be asked to fill in questionnaire 
(which may take up to 45 minutes to complete) before the first MBSR course starts, when it 
finishes (eight weeks later), and then 3 months after this. These can be done from home and mailed 
back to the researcher (Dr Robert Simpson), who will provide stamped addressed envelopes for this 
purpose. 
 
Some participants (not all) will also be asked to take part in more in-depth interviews about their 
experiences of the MBSR course – if you are one of these individuals you will be asked to provide 
separate consent for completing this type of interview.  
 
We request that you do your best to attend the MBSR course, and the sessions for filling in 
questionnaires, or having a more in depth interview if invited, throughout the duration of the study 
(however, please note that you do not have to answer any questions that you are not comfortable 
with, and you will not be penalised for not doing so). The researcher will be as flexible as possible 
with you over arranging times and dates that suit you for these purposes. 
 
Subject to funding, you will be offered a £5 gift voucher each time you fill-in and return the 
questionnaire (which will be on three occasions over the course of 20 weeks, and thus £15 in total). 
If there are some questions in the questionnaire that you do not wish to answer (because you find 
them too personal or embarrassing), you will still receive the £5 gift voucher. If you are invited to 
take part in an additional interview to discuss your views on the intervention, you will be offered an 
additional £20 gift voucher. This will only happen on one occasion, towards the end of the study. 
 
You will be involved in this project for no longer than 9 months: 
- allowing us to firstly run the 8-week MBSR course once (you will either be in this group, 
attending a weekly 2.5 hour class for 2 months, or in the waiting list/usual care group); 
- followed by a 3-month follow-up period; 
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- then, after that, if you were initially allocated in non-MBSR group, you will thereafter be offered 
the weekly 2.5-hour 8-week MBSR course at this point in time.  
 
Please see flowchart 1 for a visual representation: 
  
 
The methods used in this trial will be: 
 
Randomised controlled trial: 
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Sometimes because we do not know which way of treating participants is best, we need to make 
comparisons. People will be put into groups and then compared. The groups are selected by a 
computer, which has no information about the individual - i.e. by chance. Participants in each 
group then have a different treatment, and these are compared. In this study, everyone will 
eventually be offered the chance to receive the MBSR programme. The data collected will be both 
of a quantitative nature (scores on questionnaires), and of a qualitative nature (semi-structured 
interviews, with lots of space to hear your views, unabridged).  
 
You will be asked for your consent that your General Practitioner be informed that you are taking 
part in this study.  
 
7. What do I have to do? 
 
You can behave as you normally would for the duration of the trial. The only thing we ask is that if 
you start in the non-MBSR group, then not to start any new meditation practices out-with the trial. 
 
8. What are the possible disadvantages and risks of taking part? 
 
The only theoretical risk of taking part is that MBSR might make some people more aware of their 
feelings. When someone is anxious, or depressed, this might make the feelings more intense. If this 
happens in the MBSR class, you will be offered the chance to debrief with the course facilitators, 
who are highly experienced medical doctors. If this happens during an interview, you will similarly 
be offered a chance to debrief with the interviewer, who is a qualified General Practitioner. 
 
9. What are the possible benefits of taking part? 
 
The information that is collected during this study will give us a better understanding of stress 
management therapies for people with MS. Participants may also find that the MBSR helps with 
their own management of stress. 
 
10. Will my taking part in this study be kept confidential? 
 
All information collected about you during the course of the research will be kept strictly 
confidential. You will be identified by an ID number. Any information about you will have your 
name and address removed so that you cannot be recognised from it. Should you be invited to take 
part in a semi-structured interview, it will be recorded, and will thereafter be transcribed by 
departmental administrative staff. All transcriptions will be rendered anonymous and every effort 
will be made to protect your anonymity. 
 
It is important for you to know that there are certain circumstances under which the MBSR 
facilitator or the researcher may have to break confidentiality. These include if someone discloses 
an intention to harm either themselves, or another individual, in which case the 
facilitator/researcher would have to inform the relevant authorities such as an individual’s own 
Doctor, the Mental Health Team, or the police. 
 
Your anonymised information will be kept by the University of Glasgow for 10 years before being 
destroyed, in keeping with the University policies. After the researcher (Dr Robert Simpson) 
completes his PhD degree, your anonymised data will be kept safe by the researchers supervisors 
(Professor Stewart Mercer and Professor Frances Mair). You will be asked at the time of consent if 
you are happy to be contacted about this research following completion of the randomised 
controlled trial, and if you are happy that it may be used for teaching purposes. If you consent to 
this, you may be contacted at some point in the future (but not after 10 years time) by the 
researcher, or his supervisors. Should this happen, or if the data is used for teaching purposes, 
please be assured that your anonymity will remain protected throughout. 
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11. What will happen to the results of the research study? 
 
All participants will be provided with a written lay summary of the findings from this study. You 
will not be identified in any report/publication. However, the results will be written up as part of a 
PhD research thesis being undertaken by Dr Robert Simpson, which will be publicly available at 
the time of completion (August 2015), and will also be written up in an academic journal article 
format, once all of the data has been analysed.  
 
12. Who is organising and funding the research? 
 
This research has been organised by researchers in the University of Glasgow, Institute of Health 
and Wellbeing, Department of General Practice, and has been funded by the Scottish Homeopathic 
Research and Education Trust. 
 
13. Who has reviewed the study? 
 
This project has been reviewed by the National Health Service Research and Ethics Service. 
 
14. Contact for Further Information 
 
Dr Robert Simpson – Researcher for this study 
Robert.Simpson@glasgow.ac.uk  
General Practice and Primary Care 
University of Glasgow 
1 Horselethill Road 
Glasgow G12 9LX 
 
Professor Stewart Mercer – Dr Robert Simpson’s supervisor 
Stewart.Mercer@glasgow.ac.uk  
General Practice and Primary Care 
University of Glasgow 
1 Horselethill Road 
Glasgow G12 9LX 
 
Professor Frances Mair – Dr Robert Simpson’s supervisor 
Frances.Mair@glasgow.ac.uk 
General Practice and Primary Care 
University of Glasgow 
1 Horselethill Road 
Glasgow G12 9LX 
 
Professor Jill Morrison – Independent source of advice regarding this study 
Jill.Morrison@glasgow.ac.uk  
General Practice and Primary Care 
University of Glasgow 
1 Horselethill Road 
Glasgow G12 9LX 
0141 330 8330 
  
Study contact telephone number: 07957 230 224 
 
All participants will be given a copy of the information sheet and a signed consent form to keep. 
 
15. Thank you for reading this information sheet.
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Appendix G: MBSR course week-by-week session overview 
Class 
(week) 
number 
Main themes Home practice (45 minutes 
daily) 
1 Establishment of learning contract 
Theory underlying mind-body medicine and the 
development of self-regulatory skills 
Defining mindfulness 
Introduction to mindful eating (raisin exercise), 
mindful breathing, and mindful body awareness 
Mindful body awareness via the 
body scan CD 
Eat one meal mindfully 
2 Focused dialogue, reflection on how individual 
perception and conditioning affects us 
Affirming self-responsibility and the role of health-
enhancing behaviours 
Body scan CD 
Short sitting practices 10-15 
minutes daily 
Reflecting on the integration of 
mindfulness into everyday life 
Pleasant events diary 
3 Introducing mindful movement (flexible application 
of core Hatha yoga postures, mindful locomotion) 
Group enquiry/discussion of their experiences 
Review pleasant events calendar 
Alternate body scan with mindful 
movement CD/hand-outs 
Sitting meditation practice 10-15 
minutes daily 
Unpleasant events diary 
4 Body scan, mindful movement, sitting meditation, 
with emphasis on developing concentration in the 
practices and an enhanced field of awareness 
Alternate body scan with mindful 
movement CD/hand-outs 
Sitting meditation practice 20 
minutes daily 
Practising awareness of stress 
reactions and behaviours, without 
taking action to change these 
Remaining present with ‘feeling 
stuck/ blocking/ numbing/ 
shutting off’ 
5 Halfway point. 
Emphasis on development of adaptation skills, 
including problem-, emotion-, and solution-focussed 
approaches to coping, and how this relates to being 
aware, ‘staying present’, choosing more effective 
responses, and the development of resilience/ 
enhanced recovery from stressful experiences 
Investigating the ‘shadow side’ of stress responses/ 
trying to escape difficulty 
45 minute sitting practice CD 
Alternate body scan/ mindful 
movement 
Complete difficult 
communications diary 
Integrate mindful awareness into 
daily life experiences 
6 Discussion around transformation of stress coping 
strategies, attitudes and behaviours – developing 
resilience 
Emphasis on broadening inner resources and health-
promoting attitudes and behaviours, with discussion 
focused on practical application 
Particular emphasis on stress and knowing one’s 
feelings during communications, with overview of 
different communication styles 
Alternate sitting meditation with 
body scan/ mindful movement 
CDs 
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7 Mountain meditation, introducing metaphors to 
reconceptualise the self as ‘stable’, ‘flexible’, and 
‘strong’ 
Review of core MBSR concepts and introducing 
idea of choice in personal practices, but importance 
of maintaining 45 minutes daily 
Loving kindness/ compassion meditation, with 
strong emphasis on silence, and developing an 
attitude of loving kindness towards self/others 
Choice between all practise 
introduced thus far 
Continued ‘informal’ practise in 
daily experiences 
8 Review of core MBSR concepts. 
Opportunity to ask any remaining questions. 
Mostly silent sitting meditation 
Guided reflection on experience of the course 
Standard course evaluation forms  
Optional, but strongly 
encouraged to continue with a 
daily practice of any of the core 
techniques learned. 
Integration of practices into daily 
life. 
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Appendix H - Missing data.  
As the primary objective of this exploratory phase-2 study was to assess feasibility of 
trial procedures, no data imputation was used for missing values. This plan was 
agreed in advance between the researcher, his supervisors (SM, FM), and a statistician 
from the RCB at the University (SL). However, frequencies and percentages for all 
items on the respective outcome measures are recorded below (see Table H1). Rates 
of missing values recorded on the primary outcome measures (EQ-5D-5L, PSS-10) 
ranged from 0-14.4%. Rates for missing values on the MSQLI measures ranged from 
0.2 – 17.2%; they were highest for the SSS, which could indicate that this is a 
sensitive area. The measures of mindfulness had relatively low rates of missing values 
at 2-22%; their being higher than the MSQLI measures could reflect the nuanced, and 
potentially unfamiliar language associated with the constructs. However, an anecdotal 
observation from the researcher (RS) was that the mindfulness measures came after 
the ELQ in the questionnaire packs; the wording of the ELQ was unfortunate in that if 
participants did not have positive responses to the questions in the ELQ, the form 
suggested that the questionnaire was now complete. It is possible that this led to 
participants thinking that they were not required to proceed on to the mindfulness 
measures that followed the ELQ. Further analysis confirms that this may have been 
the case in 6/44 (14%) individuals (P7, P8, P11, P13, P25, P27) (see Table H3). 
Missing values for the ELQ ranged from 0.4-14.1%.  
In total, 34/50 (68%) individuals taking part returned at least one scale with some data 
missing. More detailed analysis of participant characteristics revealed a non-
significant trend for those with missing values as more likely to be older (mean age 
47.12 [SD 10.44] vs. 44.96 [SD 10.90]; p= 0.39), more disabled (mean EDSS 4.51 
[SD 1.77] vs. 4.41 [SD 1.75]; p=0.40), but less deprived (mean deprivation decile 
5.08 [SD 2.64] vs. 5.22 [SD 2.71]; p=0.60). The most frequently omitted question 
from those completing measures at each stage was Q12 from the MAAS (‘I drive 
places on ‘automatic pilot’ and then wonder why I went there’), left unanswered by 
four separate individuals. In future studies, should this trend recur, it might be of 
interest to correlate this finding with the individual’s driving status; if they were not 
 
Mindfulness-based interventions for people with MS 
 
 292 
driving, then answering this question might not make much sense (see Table H2 and 
H3). 
All of the measures in this study can be completed by either the individual alone, or 
with assistance (i.e. the researcher, or a family member/friend). In this study, the first 
iteration was completed with the researcher present in the room, available to assist as 
required. Why some measures were not completed at all in this context remains 
unclear (SCS-sf baseline – P27; IVIS baseline - P38; BCS baseline – P50). Besides 
the possibility that these participants may have felt inhibited from asking for help at 
the initial interview, it is perhaps easy to understand how measures might have been 
missed - accidentally, or through a lack of understanding when completing them on 
one’s own. This remains an invalidated assumption from the researcher. 
As a part of this analysis, the researcher sought to clarify normative values for 
missing values for each of the measures used. This involved literature searching on 
each measure, which revealed a dearth of information on the subject for all of the 
measures. Only the EQ-5D-5L had any information available, reporting an average 
level for missing values of 0.8% [380]. Rates were higher at post-MBSR and three-
month follow-up. Why this was the case is not clear. For each of the other measures, 
the researcher contacted the respective authors via email. All reported that they had 
no knowledge of normative values for missing data on the measures. Thus, the 
researcher then spoke again with his supervisors (SM, FM), and with a senior 
statistician from the RCB (Dr. Alex McConnachie - AM). These discussions 
cemented the earlier decision not to impute for missing values, but instead to continue 
with the analysis in its current format, and to seek trends in the data that might help 
explain participant characteristics contributing to missing-ness. 
In the event of proceeding to a definitive trial, missing baseline data may be included 
in ANCOVA models, and sensitivity analyses may be carried out, whereby the 
missing baseline data is imputed using multiple imputation methods. The choice of 
such methods would depend on the degree of missing-ness. 
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Table H1 – True rates for missing values for participant questionnaires. 
 Participant questionnaire missing values n (%) 
Measure (total 
number of scale 
items x 50) 
Baseline 2-months 5-months 
EQ-5D-5L (900) 0 (0%) 36 (12%) 36 (12%) 
PSS-10 (1500) 1 (0.2%) 72 (14.4%) 67 (13.4%) 
MFIS (3150) 3 (0.3%) 109 (10.4%) 126 (12%) 
MHI (2700) 3 (0.3%) 91 (10.1%) 109 (12.1%) 
PDQ (3000) 4 (0.4%) 107 (10.7%) 130 (13%) 
MSSS (2700) 3 (0.3%) 94 (10.4%) 110 (12.2%) 
PES (900) 3 (1%) 31 (10.3%) 36 (12%) 
IVIS (750) 5 (2%) 30 (12%) 30 (12%) 
BCS (600) 5 (2.5%) 21 (10.5%) 24 (12%) 
BWCS (750) 5 (2%) 31 (12.4%) 31 (12.4%) 
SSS (750) 24 (9.5%) 43 (17.2%) 42 (16.8%) 
MAAS (2250) 19 (2.5%) 94 (12.5%) 155 (20.7%) 
SCS-sf (1800) 12 (2%) 60 (10%) 132 (22%) 
ELQ (4950) 6 (0.4%) 171 (10.4%) 233 (14.1%) 
EQ5D – EuroQol 5D-5L QOL measure; PSS – Perceived Stress Scale; MFIS – Modified Fatigue Impact Scale; 
MHI – Mental Health Inventory; PDQ – Perceived Deficits Questionnaire; MSSS – Modified Social Support 
Survey; PES – Pain Effects Scale; IVIS – Impact of Visual Impairment Scale; BCS – Bladder Control Scale; 
BWCS – Bowel Control Scale; MAAS – Mindful Attention Awareness Scale; SCSsf – Self-Compassion Scale – 
short form; ELQ – Emotional Lability Questionnaire.
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Table H2 - Missing values: Any, all, or specific questions 
Measure  Any missing 
values n (%) 
All values 
missing n (%) 
>50% missing 
values n (%) 
Specific question numbers missing (in those completing any questions) 
Question number(s), Participant number(s), n/50 (%) 
EQ5D 
baseline  
0 (0%) 0 (0%) 0 (0%)  
EQ5D 2/12  6 (12%) 6 (12%) 6 (12%) P2, P6, P21, P26, P45, P49 all; 
EQ5D 5/12  6 (12%) 6 (12%) 6 (12%) P2, P6, P15, P21, P26, P49 all; 
PSS-10 
baseline  
1 (2%) 0 (0%) 0 (0%) P21 Q4 1 (2%) 
PSS-10 2/12  8 (16%) 7 (14%) 7 (14%) P2, P6, P21, P26, P27, P45, P49 all;  
P34 Q2 1 (2%), Q7 1 (2%) 
PSS-10 5/12  7 (14%) 6 (12%) 7 (14%) P2, P6, P15, P21, P26, P49 all;  
P14 Q2 1 (2%), Q4 1 (2%), Q5 1 (2%), Q7 1 (2%), Q8 1 (2%), Q9 1 (2%), 
Q10 1 (2%) (All from same individual) 
MFIS 
baseline  
3 (6%) 0 (0%) 0 (0%) P35 Q3 1 (2%); P49 Q9 1 (2%); P36 Q19 1 (2%) 
MFIS 2/12  8 (16%) 5 (10%) 0 (0%) P2, P6, P21, P26, P49 all; 
P29 Q6 1 (2%); P12 Q9 1 (2%), Q10 1 (2%); P20 Q15 1 (2%) 
MFIS 5/12  6 (12%) 6 (12%) 0 (0%) P2, P6, P15, P21, P26, P49 all; 
PES 
baseline  
2 (4%) 0 (0%) 0 (0%) P47 Q2 1 (2%); P49 Q3 1 (2%), Q4 1 (2%) 
PES 2/12  6 (12%) 5 (10%) 5 (10%) P2, P6, P21, P26, P49 all; 
P41 Q1 1  (2%) 
PES 5/12  6 (12%) 6 (12%) 6 (12%) P2, P6, P15, P21, P26, P49 all; 
SSS baseline  17 (34%) 15 (30%) 15 (30%) P4, P5, P12, P13, P14, P20, P22, P27, P29, P31, P33, P37, P39, P40, P42 all; 
P17 Q2 1 (2%); P17, Q3 1 (2%), Q4 1 (2%), Q5 1 (2%) 
SSS 2/12  23 (46%) 22 (44%) 22 (44%) P2, P4, P6, P12, P13, P14, P15, P17, P19, P21, P22, P26, P27, P28, P29, P31, 
P33, P36, P37, P39, P40, P41, all;  
P9 Q3 1 (2%), Q4 1 (2%) 
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SSS 5/12  24 (48%) 24 (48%) 24 (48%) P2, P4, P6, P9, P12, P13, P14, P15, P17, P19, P21, P22, P26, P27, P28, P29, 
P31, P33, P36, P37, P39, P40, P41, P49 all; 
BCS 
baseline  
2 (4%) 1 (2%) 1 (2%) P50 all; 
P19 Q4 1 (2%) 
BCS 2/12  6 (12%) 5 (10%) 5 (10%) P2, P6, P21, P26, P49 all; 
P9 Q3 1 (2%) 
BCS 5/12  7 (14%) 6 (12%) 6 (12%) P2, P6, P15, P21, P26, P49 all; 
P12 Q4 1 (2%) 
BWCS 
baseline  
0 (0%) 0 (0%) 0 (0%)  
BWCS 2/12  7 (14%) 6 (12%) 6 (12%) P2, P6, P9, P21, P26, P49 all;  
P29 Q1 1 (2%) 
BWCS 5/12  8 (16%) 7 (14%) 7 (14%) P2, P6, P15, P21, P26, P49 all;  
P32 Q1 1 (2%) 
IVIS 
baseline  
1 (2%) 1 (2%) 1 (2%) P38 all;  
IVIS 2/12  6 (12%) 6 (12%) 6 (12%) P2, P6, P21, P26, P28, P49 all; 
IVIS 5/12  6 (12%) 6 (12%) 6 (12%) P2, P6, P15, P21, P26, P49 all; 
PDQ 
baseline  
3 (6%) 0 (0%) 0 (0%) P36 Q5 2 (4%); P27 Q7 1 (2%); P48 Q17 1 (2%)  
PDQ 2/12  9 (18%) 5 (10%) 5 (10%) P2, P6, P21, P26, P49 all;  
P34 Q1 2 (4%); P29 Q2 1 (2%); P12 Q7 1 (2%), Q12 2 (4%), Q13 1 (2%),  
PDQ 5/12  11 (22%) 6 (12%) 6 (12%) P2, P6, P15, P21, P26, P49 all;  
P9, P19 Q3 2 (4%); P9 Q4 1 (2%), Q6 1 (2%), Q8 1 (2%), Q11 1 (2%), Q13 
2 (4%), Q16 2 (4%) (All from same individual) 
MHI 
baseline  
3 (6%) 0 (0%) 0 (0%) P20 Q3 1 (2%); P34 Q9 1 (2%); P47 Q16 1 (2%) 
MHI 2/12  6 (12%) 5 (10%) 5 (10%) P2, P6, P21, P26, P49 all;  
P9 Q4 1 (2%) 
MHI 5/12  7 (14%) 6 (12%) 6 (12%) P2, P6, P15, P21, P26, P49 all;  
Q12 1 (2%) 
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MSSS 
baseline  
2 (4%) 0 (0%) 0 (0%) P27 Q1 1 (2%), Q4 1 (2%); P29 Q10 1 (2%) 
MSSS 2/12  8 (16%) 5 (10%) 5 (10%) P2, P6, P21, P26, P49 all; 
P9 Q4 1 (2%), P20 Q10 1 (2%); P42 Q12 1 (2%); P9 Q15 1 (2%) 
MSSS 5/12  8 (16%) 6 (12%) 6 (12%) P2, P6, P15, P21, P26, P49 all; 
Q9 1 (2%); P20 Q10 1 (2%)  
ELQ 
baseline  
44 (88%) 0 (0%) 21 (42%) P27, Q4 (2%); P27 Q5 (2%); P14 Q11 (2%); P4 Q18 (2%); P32, 39 Q22 (4%) 
ELQ 2/12  47 (94%) 4 (8%) 28 (56%) P2, P6, P21, P26, P49 all; 
P34 Q8 (2%); P45 Q12 (2%); P29 Q15 (2%); P26 Q16 (2%); P12 Q20 (2%); 
P34 Q30 (2%) 
ELQ 5/12  46 (92%) 6 (12%) 33 (66%) P2, P6, P15, P19, P21, P26, P49 all; 
P32 Q22 (2%); P14 Q29 (2%) 
MAAS 
baseline  
5 (10%) 1 (2%) 1 (2%) P27 all;  
P45 Q10 1 (2%); P20, P31, P33 Q12 3 (6%) 
MAAS 2/12  10 (20%) 6 (12%) 6 (12%) P2, P6, P11, P21, P26, P49 all;  
P17, Q4 1 (2%); P12 Q10 1 (2%); P32 Q12 1 (2%,); P12 Q13 1 (2%) 
MAAS 5/12  13 (26%) 10 (20%) 10 (20%) P2, P6, P7, P8, P13, P15, P21, P25, P26, P49 all;  
P48 Q4 1 (2%); P29 Q9 1 (2%); P17 Q13 1 (2%); P17 Q14 1 (2%), P17 Q15 
1 (2%) 
SCS-sf 
baseline  
1 (2%) 1 (2%) 1 (2%) P27 all; 
SCS-sf 2/12  5 (10%) 5 (10%) 5 (10%) P2, P6, P21, P26, P49 all; 
SCS-sf 5/12  12 (24%) 11 (22%) 11 (22%) P2, P6, P7, P8, P13, P15, P17, P21, P25, P26, P49 all;  
P43 Q10 1 (2%) 
EQ5D – EuroQol 5D-5L QOL measure; PSS – Perceived stress scale; MFIS – Modified fatigue impact scale; MHI – Mental health inventory; PDQ – Perceived deficits questionnaire; MSSS – 
Modified social support survey; PES – Pain effects scale; IVIS – Impact of visual impairment scale; BCS – Bladder control scale; BWCS – Bowel control scale; MAAS – Mindful attention 
awareness scale; SCSsf – Self-compassion scale – short form; ELQ – Emotional lability questionnaire. 
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Table H3 – Participant characteristics for missing values 
Participant 
number 
Group 
allocation 
Age in 
years 
Sex 
M/F 
Deprivation 
decile 
Level of 
education 
EDSS 0-
7 
Missing values - all Missing values – specific 
questions 
P2 Intervention 38 F 3 University 2.5 All measures from 
2/12 onwards  
 
P4 Intervention 46 F 3 College 4.0 SSS baseline, SSS 
2/12, SSS 5/12 
ELQ baseline Q18 
P5 Control 46 M 3 University 3.5 SSS baseline  
P6 Intervention 26 M 7 University 3.0 All measures from 
2/12 onwards 
 
P7 Control 45 F 3 University 4.0 MAAS 5/12, SCS-sf 
5/12 
 
P8 Control 35 M 8 University 2.5 MAAS 5/12, SCS-sf 
5/12 
 
P9 Control 48 F 3 2y School 7.0 SSS 5/12, BWCS 
2/12 
SSS 2/12 Q3 
P11 Control 42 F 1 University 4.0 MAAS 2/12  
P12 Intervention 52 F 2 University 4.0 SSS baseline MFIS 2/12 Q9, Q10; BCS 5/12 
Q4; PDQ 2/12 Q7; MAAS 2/12 
Q10, Q13; ELQ 2/12 Q20 
P13 Control 55 F 4 University 6.0 SSS baseline, SSS 
2/12, SSS 5/12, 
MAAS 5/12, SCS-sf 
5/12 
 
P14 Intervention 41 F 2 University 4.0 EQ5D 5/12, SSS 
baseline, SSS 2/12, 
SSS 5/12 
PSS 5/12 Q2, 4, Q5, Q7, Q8, Q9, 
Q10; ELQ baseline Q11; ELQ 
5/12 Q29 
P15 Control 50 F 9 University 6.5 All measures from 
5/12 onwards 
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P17 Intervention 44 F 8 University 6.5 SSS 2/12, SSS 5/12, 
SCS-sf 5/12 
SSS baseline Q2, Q3; MAAS 
2/12 Q4; MAAS 5/12 Q13, Q14, 
Q15 
P19 Intervention 63 F 9 University 7.0 SSS 2/12, SSS 5/12, 
ELQ 5/12 
BCS baseline Q4; PDQ 5/12 Q3, 
SSS baseline Q1, Q3, Q4, Q5 
P20 Control 53 F 5 College 4.0 SSS baseline MFIS 2/12 Q15; MHI baseline 
Q3; MSSS 2/12 Q10; MSSS 5/12 
Q10; MAAS baseline Q12 
P21 Intervention 33 F 2 College 4.0 All measures from 
2/12 onwards 
 
P22 Control 61 F 6 University 6.5 SSS 2/12, SSS 5/12  
P25 Intervention 36 F 3 University 2.5 MAAS 5/12, SCS-sf 
5/12 
 
P26 Intervention 40 F 4 College 4.0 All measures from 
2/12 onwards 
 
P27 Intervention 65 F 8 2y School 5.0 PSS-10 2/12, SSS 
baseline, SSS 2/12, 
SSS 5/12, SCS-sf 
baseline 
PDQ baseline Q7; MSSS baseline 
Q1; ELQ baseline Q4, Q5 
P28 Intervention 54 F 9 University 5.5 SSS 2/12, SSS 5/12  
P29 Intervention 54 F 3 College 6.5 SSS baseline, SSS 
2/12, SSS 5/12 
MFIS 2/12 Q6; BWCS 2/12 Q1; 
PDQ 2/12 Q2; MSSS baseline 
Q10; MAAS 5/12 Q9; ELQ 2/12 
Q15, Q16 
P31 Control 51 F 3 University 1.5 SSS baseline, SSS 
2/12, SSS 5/12 
MAAS baseline Q12 
P32 Intervention 27 F 6 University 6.0  ELQ baseline Q22; ELQ 5/12 
Q22 
P33 Intervention 52 F 1 College 6.5 SSS baseline, SSS 
2/12, SSS 5/12 
MAAS baseline Q12 
P34 Control 40 F 4 2y School 4.0  PSS 2/12 Q2; PDQ 2/12 Q1; MHI 
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EQ5D – EuroQol 5D-5L QOL measure; PSS – Perceived stress scale; MFIS – Modified fatigue impact scale; MHI – Mental health inventory; PDQ – Perceived deficits questionnaire; MSSS – 
Modified social support survey; PES – Pain effects scale; IVIS – Impact of visual impairment scale; BCS – Bladder control scale; BWCS – Bowel control scale; MAAS – Mindful attention 
awareness scale; SCSsf – Self-compassion scale – short form; ELQ – Emotional lability questionnaire. 
baseline Q9; ELQ 2/12 Q8, Q30 
P35 Intervention 43 F 7 University 7.0  MFIS baseline Q3 
P36 Control 56 F 9 College 4.5 SSS 2/12, SSS 5/12 MFIS baseline Q19; PDQ 
baseline Q5 
P37 Intervention 61 F 10 University 6.5 SSS baseline  
P38 Control 46 F 7 University 2.5 IVIS baseline  
P39 Control 21 F 6 2y School 2.0 SSS 5/12 ELQ baseline Q22 
P40 Intervention 36 M 3 2y School 2.5 SSS baseline, SSS 
2/12, SSS 5/12 
 
P41 Control 66 F 6 University 6.5 SSS 5/12 PES 2/12 Q1  
P42 Intervention 40 F 4 College 1.0  MSSS 2/12 Q12 
P43 Intervention 50 F 2 University 2.5  SCS-sf 5/12 Q10 
P45 Control 65 F 10 College 3.5 EQ5D 2/12, PSS-10 
2/12 
MAAS baseline Q10; ELQ 2/12 
Q12 
P47 Control 38 F 6 University 6.0  PES baseline Q2; MHI baseline 
Q16 
P48 Intervention 48 F 5 2y School 7.0  PDQ baseline Q17; MAAS 5/12 
Q4 
P49 Control 47 F 5 2y School 4.0 All measures from 
2/12 onwards 
 
P50 Control 51 F 5 College 6.0 BCS baseline  
Totals 39 
Intervention 
n=20 
Control n=19 
Mean 
47.12 (SD 
10.44) 
35F 
(90%) 
 
Mean 5.08 
(SD 2.64) 
University 
22 
College 10 
2y School 7 
Mean 
4.51 (SD 
1.77)  
All measures from 
2/12 n=5 
All measures from 
5/12 n=6 
From partially completed scales, 
the most frequently missed 
individual question was MAAS 
Q12, at 4 individual times 
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Appendix I Unadjusted RCT patient report outcome models 
 Table I1: Unadjusted scores for primary outcome measures 
 Mean (SD) Change from baseline Treatment effect* (95% 
CI), Significance 
(*Intervention-control) 
Effect size 
(Cohen’s 
‘d’); 95% CI 
Measure Time point Intervention Control Intervention Control N/A N/A 
EQ-5D 
(utility score) 
Baseline 0.53 (0.23) 0.56 (0.27) N/A N/A N/A N/A 
Post 0.55 (0.23) 0.59 (0.23) 0.02 (0.18) 0.05 (0.17) -0.04 (-0.13 – 0.06), 
p=0.44 
-0.17 (-0.57 – 
0.26) 
F/u 0.54 (0.24) 0.58 (0.28) 0.01 (0.20) 0.02 (0.17) -0.02 (-0.13 – 0.09), 
p=0.67 
-0.08 (-0.50 – 
0.35) 
EQ5D - AUC Baseline N/A N/A N/A N/A N/A N/A 
Post 0.09 (0.04) 0.10 (0.04) N/A N/A -0.00 (-0.03 – 0.02), 
p=0.82 
0.00 (-0.13 – 
0.09) 
F/u 0.24 (0.09) 0.24 (0.10) N/A N/A -0.01 (-0.07 – 0.05), 
p=0.74 
0.10 (-0.27 – 
0.19) 
F/u – Follow up; N/A – Not applicable 
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Table I2: Unadjusted scores for primary outcome measures 
 Mean (SD) Change from baseline Treatment effect* (95% 
CI), Significance 
(*Intervention-control) 
Effect size 
(Cohen’s ‘d’) 
(95% CI) 
Perceived 
stress scale - 
overall 
Baseline 21.08 (1.72) 21.96 (1.34) N/A N/A N/A N/A 
Post 13.50 (7.62) 21.77 (8.01) -7.50 (-8.00)
  
-0.32 (-6.27) -7.34 (-11.44 - -3.23), 
p=<0.01 
0.93 (0.41 – 
1.44) 
F/u 16.05 (7.94) 18.83 (5.93) -4.40 (7.16) -2.87 (4.60) -1.51 (-5.04 – 2.20), p=0.39 0.26 (-0.37 – 
0.85) 
Perceived 
stress scale – 
negative 
stressors 
Baseline 14.56 (6.09) 14.60 (4.97) N/A N/A N/A N/A 
Post 9.10 (5.26) 14.23 (5.80) -5.00 (5.96) -0.27 (4.76) -4.92 (-7.86 - -1.98), 
p<0.05 
0.85 (0.34 – 
1.35) 
F/u 10.15 (6.55) 11.48 (5.30) -3.75 (5.81) -3.13 (3.60) -0.84 (-3.60 – 1.92), p=0.54 0.14 (-0.33 – 
0.62) 
Perceived 
stress scale – 
stress 
resilience 
Baseline 6.79 (2.82) 7.36 (2.72) N/A N/A N/A N/A 
Post 4.40 (2.58) 7.54 (2.91) 2.50 (2.48) 0.04 (2.64) -2.75 (-4.21 - -1.30), 
p<0.001 
0.98 (0.46 – 
1.49) 
F/u 5.90 (1.92) 7.34 (1.72) 0.65 (2.28) 0.26 (2.78) -1.31 (-2.73 - -0.25), 
p<0.05 
0.51 (0.10 – 
1.06) 
F/u – Follow up; N/A – Not applicable 
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Table I3: Unadjusted scores for Multiple Sclerosis Quality of Life Inventory 
 Mean (SD) Change from baseline Treatment effect* (95% 
CI), Significance 
(*Intervention-control) 
Effect size 
(Cohen’s 
‘d’); 95% CI 
Measure  Intervention Control Intervention Control   
MFIS Baseline 53.21 (18.68) 54.26 (16.77) N/A N/A N/A N/A 
Post 38.47 (19.84) 49.91 (17.19) -13.33 (14.56) -4.18 
(10.87) 
-9.46 (-17.24 - -1.67), 
p<0.05 
0.71 (0.13 – 
1.29) 
F/u 42.95 (18.58) 50.00 (15.54) -9.5 (14.58) -3.91 
(11.15) 
-5.72 (-13.10 – 1.66), 
p=0.13 
0.44 (-1.00 - 
-0.13) 
MHI Baseline 68.92 (17.48) 67.45 (16.87) N/A N/A N/A N/A 
Post 83.52 (14.18) 74.22 (16.53) 13.43 (13.65) 6.10 
(13.00) 
8.38 (1.09 - 15.68), 
p<0.01 
0.61 (0.08 – 
1.15) 
F/u 78.29 (19.60) 73.41 (17.08) 8.19 (18.44) 6.25 (8.73) 2.40 (-6.46 – 11.26), 
p=0.59 
0.17 (-0.44 – 
1.09) 
PDQ Baseline 38.48 (16.24) 39.04 (14.36) N/A N/A N/A N/A 
Post 29.05 (12.31) 34.32 (14.81) -9.00 (12.98) -4.10 (8.77) -5.02 (-11.27 – 1.23), 
p=0.11 
0.46 (0.11- 
1.03) 
F/u 33.18 (16.94) 35.23 (14.65) -5.47 (7.16) -2.29 (7.71) -2.93 (-8.00 – 2.12), 
p=0.25 
0.38 (0.28 – 
1.05) 
MSSS Baseline 44.61 (25.05) 43.12 (20.74) N/A N/A N/A N/A 
Post 45.60 (26.93) 41.45 (17.01) -3.83 (10.62) -0.18 
(15.69) 
-1.90 (-10.08 – 6.28), 
p=0.64 
0.14 (-0.74 – 
0.46) 
F/u 44.00 (25.40) 45.27 (21.36) -6.56 (8.99) 2.45 
(16.98) 
-7.76 (-16.28 – 0.76), 
p=0.07 
0.53 (-1.12 – 
0.05) 
PES Baseline 17.76 (5.75) 18.17 (6.04) N/A N/A N/A N/A 
Post 14.29 (4.71) 17.00 (5.65) -2.90 (4.13) -1.18 (5.48) -2.09 (-4.62 – 0.45), 
p=0.11 
-0.43 (-0.94 
– 0.09) 
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F/u 14.48 (5.73) 17.22 (5.69) -2.71 (4.82) -1.00 (4.70) -1.96 (-4.60 – 0.67), 
p=0.14 
-0.41 (-0.96 
– 0.14) 
IVIS Baseline 7.08 (3.29) 7.54 (3.64) N/A N/A N/A N/A 
Post 6.55 (2.52) 7.37 (3.12) -0.85 (3.36) -0.22 (3.16) -0.78 (-2.32 – 0.76), 
p=0.31 
-0.24 (-0.72 
– 0.24) 
F/u 6.90 (2.77) 7.47 (3.30) -0.38 (3.14) -0.41 (3.23) -0.14 (-1.67 – 1.38), 
p=0.85 
0.04 (-0.53 – 
0.44) 
BCS Baseline 9.71 (6.15) 9.33 (5.82) N/A N/A N/A N/A 
Post 7.86 (4.79) 7.61 (4.67) -1.75 (3.94) -1.95 (3.72) 0.13 (-1.76 – 2.02), 
p=0.89 
0.03 (-0.47 – 
0.53) 
F/u 7.90 (4.75) 8.13 (5.21) -1.32 (4.50) -1.09 (3.15) -0.33 (-2.37 – 1.71), 
p=0.74 
0.09 (-0.63 – 
0.45) 
BWCS Baseline 11.87 (6.19) 9.04 (6.43) N/A N/A N/A N/A 
Post 9.80 (5.25) 8.09 (5.15) -2.11 (2.97) -1.09 (6.08) 0.21 (-2.41 – 2.82), 
p=0.87 
0.04 (-0.49 – 
0.57) 
F/u 10.05 (5.58) 8.09 (4.44) -1.06 (5.24) -1.22 (4.96) 1.27 (-1.36 – 3.90), 
p=0.34 
0.25 (-0.27 – 
0.77) 
SSS Baseline 13.00 (6.50) 13.84 (6.87) N/A N/A N/A N/A 
Post 8.80 (3.88) 14.89 (6.50) -1.11 (4.34) 0.23 (3.56) -2.38 (-5.53 - -0.03), 
p=0.13 
0.62 (0.01 -
1.45) 
F/u 8.90 (4.43) 14.69 (7.00) -1.67 (2.50) 1.64 (4.85) -3.80 (-7.24 – - 0.01), 
p<0.05 
0.88 (0.01 – 
1.67) 
F/u – Follow up; N/A – Not applicable 
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Table I4: Unadjusted scores for measures of Mindfulness and Self-Compassion 
 Mean (SD) Change from baseline Treatment effect* (95% 
CI), Significance 
(*Intervention-control) 
Effect size 
(Cohen’s 
‘d’); 95% 
CI 
Measure  Intervention Control Intervention Control   
MAAS Baseline 52.09 (17.29) 49.81 (10.89) N/A N/A N/A N/A 
Post 57.76 (9.81) 58.17 (14.06) 12.80 (10.14) 8.5 (11.60) 6.22 (-0.90 – 13.35), 
p=0.09 
0.56 (-0.08 - 
1.21) 
F/u 66.24 (7.64) 51.70 (12.60 15.6 (11.75) 1.65 (7.52) 14.67 (8.87 – 20.48), 
p<0.001 
1.23 (0.80 – 
1.72) 
SCS-sf Baseline 31.58 (10.17) 32.56 (8.70) N/A N/A N/A N/A 
Post 42.71 (9.80) 33.79 (10.84) 11.00 (10.21) 1.38 (8.21) 9.44 (4.21 – 14.67), 
p<0.01 
0.92 (0.41 – 
1.43) 
F/u 41.27 (11.75) 32.15 (9.65) 9.18 (11.05) 0.35 (7.34) 8.99 (3.09 – 14.89) p<0.01 0.89 (0.31 – 
1.47) 
F/u – Follow up; N/A – Not applicable 
 
Table I5: Unadjusted scores for the Emotional Lability Questionnaire 
 Mean (SD) Change from baseline Treatment effect* (95% 
CI), Significance 
(*Intervention-control) 
Effect size 
Measure  Intervention Control Intervention Control   
ELQ Baseline 15.19 (14.18) 15.46 (11.33) N/A N/A N/A N/A 
Post 9.56 (10.15) 9.14 (9.56) -5.79 (9.67) -5.05 (8.21) -0.55 (-5.88 – 4.76), 
p=0.83 
0.06 (-0.46 – 
0.37) 
F/u  8.72 (11.31) 11.00 (8.29) -5.25 (13.58) -5.12 (8.01) -1.22 (-7.03 – 4.60), 
p=0.67 
0.12 (-0.41 – 
0.27) 
F/u – Follow up; N/A – Not applicable 
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Figure I1: Unadjusted treatment effects with confidence intervals for MBSR at two 
months: 
 
EQ5D – EuroQol QOL measure; AUC – EuroQol Area Under the Curve; PSS – Perceived Stress Scale; MFIS – 
Modified Fatigue Impact Scale; MHI – Mental Health Inventory; PDQ – Perceived Deficits Questionnaire; MSSS 
– Modified Social Support Survey; PES – Pain Effects Scale; IVIS – Impact of Visual Impairment Scale; BCS – 
Bladder Control Scale; BWCS – Bowel Control Scale; SSS – Sexual Satisfaction Scale; MAAS – Mindful 
Attention Awareness Scale; SCS-sf – Self-Compassion Scale – short form; ELQ – Emotional Lability 
Questionnaire  
0
2
4
6
8
10
12
14
16
-1 -0.5 0 0.5 1 1.5 2
Effect size                    Favours intervention (MBSR) 
EQ5D
2/12
AUC
2/12
PSS
2/12
MFIS
2/12
MHI
2/12
PDQ
2/12
MSSS
2/12
PES
2/12
IVIS
2/12
BCS
2/12
BWCS
2/12
SSS 2/12
MAAS
2/12
SCSsf
2/12
ELQ
2/12
 
Mindfulness-based interventions for people with MS 
 
 306 
Figure I2: Unadjusted treatment effects with confidence intervals for MBSR at five 
months: 
 
EQ5D – EuroQol QOL measure; AUC – EuroQol Area Under the Curve; PSS – Perceived Stress Scale; MFIS – 
Modified Fatigue Impact Scale; MHI – Mental Health Inventory; PDQ – Perceived Deficits Questionnaire; MSSS 
– Modified Social Support Survey; PES – Pain Effects Scale; IVIS – Impact of Visual Impairment Scale; BCS – 
Bladder Control Scale; BWCS – Bowel Control Scale; SSS – Sexual Satisfaction Scale; MAAS – Mindful 
Attention Awareness Scale; SCS-sf – Self-Compassion Scale – short form; ELQ – Emotional Lability 
Questionnaire 
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Appendix J – Timeline of activities for qualitative research 
 
31
st
 October 2014 
- MBSR intervention completed 
1
st
 Nov – 3rd Dec 2014 
- Seventeen participant and two instructor semi-structured interviews carried out, 
mainly in office space at the NHS CIC, but also in one participant’s home (as he had 
suffered from a relapse and had become less mobile). 
4
th
 Dec 2014 – 2nd Feb 2015 
- Interview transcription by administrative staff in GPPC. 
3
rd
 Feb – 3rd March 2015  
- Immersion in the audio files for the interviews. Researcher (RS) listened carefully to 
the content of each, and took care to cross-reference this with the typed transcripts to 
check their fidelity. Following on from this the researcher carried out a first sweep of 
the data, carefully reading through and reflecting on each interview transcript, noting 
down and memo-ing on interesting thoughts  
4
th
 March 2015 
- Researcher randomly selected two original interview transcripts to share with his 
supervisors via the university shared hard-drive. The researcher’s supervisors then 
blind coded these, ahead of the next supervision meeting.  
19
th
 March 2015 
- Researcher met with his supervisors to discuss/compare notes following blind 
coding/first sweep of the data, focusing in particular on the two transcripts that had 
been sent, but also reflecting on his experience with the data corpus in general. 
Agreed outcome was for the researcher to move on to develop a coding index. Given 
the slight differences in emphasis between them, it was agreed at this point that the 
researcher should develop a coding index for the participants and instructors’ 
interviews separately, with a view to possibly merging themes at a later date. 
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2
nd
 April 2015 
- Researcher met with supervisor (Professor Frances Mair - FM) to discuss possible 
frameworks for coding and thematic analysis. Researcher discussed once more the 
importance of reflexivity and remaining true to the original data at this point. In-vivo 
coding validity once more checked by supervisor (FM) from two further interviews.  
6
th
 May 2015 
- Researcher met with supervisor (SM) to discuss the outline of the coding indexes he 
had developed, for both the participants and the instructors. For the participants, this 
meant a group of 45 codes, and for the instructors, 14. The researchers supervisor had 
applied the indexes to two further interview transcripts, noting any discrepancies, and 
suggesting any potential new codes that may have been overlooked, or viewed 
differently. Thus, any categories that were too broad were exploded, and the themes 
surrounding each code explored in further detail. 
18
th
 June 2015 
- Researcher met with his supervisor (SM) to discuss further refinement of the coding 
indexes. It was agreed at this point that the researcher should now refine the initial 
codes (45, 14), and the supervisor provided guidance on a few examples of how to go 
about collapsing codes into more succinct groupings. The researcher then went off to 
complete this task before the next meeting, setting out on an A3 sized piece of paper a 
diagram detailing all 45 of the original participant, and 14 instructor codes (including 
examples to back these up). The researcher continued to keep this separate (on 
separate papers). It was agreed that over the following week the researcher would 
check these back with the original data, to ensure their accuracy and 
representativeness, in relation to the original transcripts. 
23
rd
 June 2015 
- Researcher again met with his supervisor (SM) to present an overview for each 
category (participants and instructors). At this session, the researcher presented the 
‘story’ that was emerging through the refining of the codes. This session allowed 
reflection with the supervisor on the direction that seemed to be emerging from the 
data, and it was agreed that ahead of the next meeting, the researcher should aim to 
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finesse the coding indexes in their current form, and then attempt to ‘stand back’ from 
them, and take an overview of the data corpus as a whole, to include reflecting on the 
process of conducting the interviews, listening to the audio files, proofreading/editing 
the transcripts, memo-ing, and all the subsequent stages of revisiting and refinement 
outlined above. 
2
nd
 July 2015 
- Researcher met with his supervisor (SM) to present the grouping of themes that had 
emerged from the data up until this point. This session again focused on a ‘standing 
back’ perspective, where higher order, meta-themes were discussed (i.e. those themes 
that were not initially obvious, but arose out of the process of iterative analysis, 
discussion, and synthesis of findings). Any models arising were discussed and tested 
against the data. One notable model that emerged was (see Figure J1): 
Figure J1: An exploratory model for emergent higher order themes 
It was agreed that the researcher would test this model against the data, and refine 
further, as required. An important point was that it might fit one set of codes 
(participants), but not the other (instructors), and that whilst an attempt to merge the 
groups was desirable, it might not be possible. The perceived advantage was that this 
might allow synthesis of distinct input from participants and instructors, and the 
potential for emergence of further, new ‘higher order’ themes in the process. 
1. 'Learning 
the language' 
(of 
mindfulness) 
2. 'Doing the 
work' 
3. 'Getting it', 
or not 
4. 'Moving 
forward' 
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16
th
 July 2015 
- At this point the researcher had tested and subsequently refined the above model, as 
it did not fit perfectly with either the individual groups, or the merged data that 
contained both participants and instructors’ views. Indeed, the idea of learning the 
language of mindfulness seemed as if it might well be an implicit higher order theme 
in some senses, but it was difficult to group enough data with confidence under this 
construct. Refinement produced the following model (see Figure J2): 
Figure J2: Refined model for higher order themes 
This model was thus tested against the merged data, and it held up well with the 
original accounts. The merged categories thus formed the headings that would order 
and structure the results section, describing the emergent narrative from the 
participant and instructor experiences, in an accurate and comprehensive manner. 
23
rd
 July 2015 
The researcher again met with his supervisor (SM) to discuss the synthesis of results, 
including how certain codes might still be amenable to being collapsed under a 
common heading. Thus, the thematic matrix was refined into its final form.
1. 'Coming 
together for the 
course - 
everyone has 
MS' 
2. 'Doing the 
work of 
mindfulness' 
3. 'Getting it', or 
not 
4. 'Improving 
the MBSR 
course for 
people with MS' 
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Appendix K - Higher order coding index – Merged themes (participant/ 
instructor) 
 
1. Coming together for the course – everyone has MS 
 Pre-course expectations 
 Being prepared and getting there 
 Course context – getting it right 
 Becoming a group 
2. Doing the work of mindfulness 
 Coming face to face with MS; senses, sensations, and disabilities 
 Making sense of the practices together, in the group 
 Making sense of the practices on one’s own, away from the group 
 Staying present or dropping out – sustaining involvement 
3. Getting it, or not 
 Being in the zone 
 Perceived overall effects from MBSR 
 Relating to one’s self 
 Relating to others 
4. Improving the MBSR course for people with MS 
 Being better prepared 
 Making MBSR more relevant to people with MS 
 Improving delivery strategies of MBSR for people with MS 
 Timing; when is the best time to learn MBSR if you have MS? 
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Appendix L – Thematic matrices 1-4 
 
1. Coming 
together for the 
course – 
everyone has 
MS 
1.1 1.2 1.3 1.4 
 
 
Subject no  
No. sessions 
attended 
Age 
Sex 
Ethnicity 
Deprivation 
decile 
Education 
EDSS 
MS phenotype 
MM count 
(MH) 
MHI baseline 
score 
Pre-course expectations Being prepared and getting 
there 
Course context – getting it 
right 
Becoming a group 
 
 
No. 1 
Att: 7/8 
52F 
White Scottish 
DD 2 
University 
EDSS 4 
PPMS 
Unsure, willing to try anything 
that was going to help, thought it 
might help with stressful 
situations 
Was off work with wrist fracture so had 
time available (otherwise it wouldn’t 
have worked for pt), parking was an 
issue, took the train 
Setting was fine, preferred the 
upstairs room as it was more 
intimate, second room was bigger, 
colder and had more distractions 
Thought week 1 was not well set up 
for those with disabilities 
Thought room 6 temperature was not 
ideal and lighting too bright 
Found working as a group beneficial, 
everyone in same boat (a ‘unity’), 
instructors good and engaging 
Pt thought that the instructors were good 
and engaging 
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3 (1) 
69 
No. 2 
Att: 6/8 
41F 
White Scottish 
DD 2 
University 
EDSS 4 
RRMS 
3 (1) 
46 
Unsure, a bit reserved, worried 
about speaking in the group 
Pt lived quite far away. Found parking 
ok. Centre hard to find with no street 
names. Wasn’t able to come when had 
an illness. 
Morning not a good time for pt. 
Pt would have preferred a morning 
class, more together then, normally 
naps in afternoon. Found setting 
lovely, less clinical, ‘a pleasant 
surprise’, preferred downstairs room 
and view out to the garden 
Wished course could have lasted for 
longer. 2.5 hrs seemed a lot at the 
start. 
First thing on arrival was to do a 
meditation, which calmed and relaxed pt 
right away, calmed nerves and anxiety 
Pt liked hearing others experiences as 
they were similar to her own, and this 
validated her own in a way. Normally 
never meets others with MS 
Instructors put pt mind at rest ‘you don’t 
have to talk if you don’t want to’. Pt then 
found she wanted to and was so relaxed 
after meditating that this was easier than 
expected 
No. 3 
Att: 8/8 
54F 
White Scottish 
DD 9 
University 
EDSS 5.5 
PPMS 
0 (0) 
64 
 
Didn’t have any expectations, was 
open minded and thought it was 
worth trying 
Was not expecting HP 
Pt drives and parking was ok for pt 
Pt noting that for those who couldn’t 
drive, getting to the Centre could have 
been difficult, getting on and off buses 
etc 
As course fell over lunch hour, pt had 
to adjust her eating routine 
 
Pt noting that everyone appreciated 
and spoke about the garden, with the 
beautiful autumn colours. Found it 
peaceful, with a lovely atmosphere. 
Ground floor (room 6) had good 
disabled access 
Pt noting course fell over lunch hour 
and people with MS can easily get 
fatigued 
Thinks 8/52 required to embed the 
practices fully 
2.5 hours ok with a break 
Liked the group format, and got a lot out 
of it, liked speaking to others about their 
perspective and feedback. Found it 
interesting to see how people were 
reacting to things. Thinks it doesn’t 
happen naturally to find yourself in a 
group of people with MS. 
Pt describing how the old cliché ‘what 
happens in the room stays in the room’ 
helped people trust and open up about 
personal issues, knowing they wouldn’t 
find their details turning up on the social 
media etc. Felt this gave the group a real 
positive feeling 
Pt notes that if people didn’t want to 
speak in the group, that 1 to 1 was 
available at the end of the sessions 
No. 4 
36M 
Att: 7/8 
White Scottish 
Pt thought that people with MS 
would find ‘sitting’ difficult 
Pt initially drove, but found parking 
difficult, eventually giving up and 
taking the bus instead. This meant 
much longer journey times in both 
Pt found strip lighting gave him a 
headache and reclined seats in room 
6 made it difficult not to get sleepy 
Thinks course should have been 
Pt found it insightful to see others with 
MS at different stages and to compare to 
his own experiences with the condition 
Pt liked being in a group as he is a 
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DD 3 
2y school 
EDSS 2.5 
RRMS 
9 (3) 
58 
directions longer ‘loner’ and this made him deal with his 
social anxiety. Felt sad seeing others 
suffering.  
Had never been in a group of people 
with MS before 
No. 5 
Att: 7/8 
65F 
White Scottish 
DD8 
2y school 
EDSS 5 
RRMS 
9 (2) 
75 
 
No expectations, but willing to try 
new things unless good reason not 
to do so 
 Pt liked the view out to the garden 
from room 6. 
Thinks 8/52 good as each week had a 
lot of material to cover. 2.5 hrs ok, 
and passed quickly 
Enjoyed the opportunity to meet others 
with MS, which she would otherwise 
rarely do 
Felt more understanding of others 
problems and how similar they were to 
her own 
No. 6 
Att: 7/8 
44 F 
White Scottish 
DD 8 
University 
EDSS 6.5 
RRMS 
5 (2) 
49 
Pt was keen to reduce stress, 
wanted to feel more balanced in 
her attitude towards life, hoped 
would derive some physical 
benefits 
Pt found parking traumatic and 
stressful. Had to leave the house an 
hour before class started 
Pt was annoyed by hospital policy 
regarding taking drinks into the 
seminar room in case of damaging 
the carpets.  
Waiting room was difficult for pt to 
navigate due to crutches and would 
have preferred direct access to the 
room to settle herself 
Pt found there was a ‘wall of heat’ 
that met her in room 6 
Pt felt her blood sugars were ‘all 
over the place’ 
Pt thinks 8/52 good, but was a lot for 
her 
Pt found it difficult seeing others in week 
1 who were more disabled than her 
Pt found instructors patronizing and that 
when pt raised a concern about MW one 
off them put her down. Also pt had to 
leave for the toilet and was apparently 
told to stay until the end, which she 
found embarrassing. Noting that with 
MS you might not have much time to 
make it to the toilet  
No. 7 
Att: 3/8 
52F 
White Scottish 
Had thought there would be more 
meditation practices, but that class 
times would be shorter 
Pt lived nearby, which helped. 
Pt found parking an issue, on one 
occasion having to park illegally – was 
issued a ticket, but had it rescinded.  
Pt thought the lift was small and 
notes that on week 1 the upstairs 
disabled toilet wasn’t working, 
meaning people had to go 
Pt thought being in a group was an 
advantage in some ways, valuing the 
opportunity to share experiences, but 
does notes that people with MS can tend 
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DD 2 
College 
EDSS 6.5 
RRMS 
5 (1) 
63 
Takes pt a few hours to get going. Was 
late on one occasion and decided not to 
come 
downstairs/take the lift 
Pt noted a distracting ticking clock in 
room 6 was removed the following 
week 
Pt felt 12 noon was early enough, 
and that people need to make 
arrangements to get here etc, and that 
Friday is a busy traffic day. 
Thinks 8/52 too long, and content 
could be covered in less time. 2.5 hrs 
ok 
to focus on the negatives 
Pt described the instructors as lovely, 
and encouraging 
No. 8 
Att: 7/8 
34F 
White Scottish 
DD 3 
University 
EDSS 3.5 
RRMS 
5 (1) 
72 
Pt was a bit wary, not knowing 
much about Mindfulness. Tried to 
be open minded 
Wanted to reduce stress, pain 
Pts expectations were exceeded as 
she never thought simple exercises 
like those on the course could 
alleviate pain 
 Pt thought the Centre was wonderful 
‘a box on nature’.  Liked looking out 
to the garden. 
Pt appreciated room 6 lighting could 
be adjusted. 
Pt likes it because its not like a 
hospital (grey/bleak/smell of 
cleaning fluids), where Drs 
(especially Neurologists) act aloof. 
Pt thought afternoon timing was 
soothing, and that she is not a 
morning person 
Thinks 8/52 ok, but could have gone 
on for longer 
Pt found it really good to meet other 
people with MS, as she only knows one 
other person with the condition. 
Pt thought it was an advantage that 
everyone had MS as they were ‘all in the 
same boat’ together 
Pt thought that as everyone had MS, you 
didn’t have to explain, people just 
understood, e.g. if you were tired they 
wouldn’t ask did you need more sleep, or 
coffee 
Pt thought the instructors were flexible 
and that they could move about if they 
needed to 
No. 9 
Att: 2/8 
48F 
White Scottish 
DD 5 
2y school 
EDSS 7 
RRMS 
1 (0) 
84 
Pt thought course would be more 
focused on MS and ways she 
could make herself better, that 
there might be exercise included 
in it, or other ways to push 
yourself to do better 
Wondered if she might be able to 
say something to help others in the 
group 
 Thought the venue was fine, as was 
time of day, course duration etc. 2.5 
hrs felt like 9hrs for pt 
Pt liked that others were expressing their 
problems and this made her feel less 
alone  
Pt thought the instructors were really 
nice 
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No. 10 
Att: 7/8 
43F 
White Scottish 
DD 7 
University 
EDSS 7 
RRMS 
1 (0) 
71 
Pt was skeptical, having not done 
anything like it in the past. 
Thought getting anything out of 
the course would be a bonus 
Pt was reliant on others for transport 
and getting there, with a 1 hour journey 
each direction. Finds sitting in a car 
difficult, meaning that she was tired by 
the end of the day. 
Thought the venue was really nice 
Room 6 was very noisy, but liked the 
view out to the garden 
Room 6 was too hot 
Pt noting time of day might be an 
issue for those depending on 
transport 
Thought 8/52 fine. 2.5 hrs fine 
Pt thought that as everyone was in the 
same position they made allowances for 
each other 
Pt found the instructors easy to listen to 
and soothing, and couldn’t do enough to 
help 
No. 11 
Att: 8/8 
27F 
White Scottish 
DD 6 
University 
EDSS 6 
RRMS 
4 (1) 
66 
Didn’t know what to expect 
Hoped to come out on the other 
side better 
 Awkward time of day for pt, an 
‘eating time’, had to eat an early 
lunch, as did her toddler, missed a 
medication dosage. 
Thought might be nice for course to 
go on for longer 
2.5 hrs initially felt like a lot but later 
flew by 
Pt felt the same as the other pts, and that 
‘everybody understands’ 
No. 12 
Att: 5/8 
38F 
White Scottish 
DD 3 
College 
EDSS 2.5 
RRMS 
5 (2) 
79 
Pt had previously done an 
introductory Mindfulness course, 
which helped with stress and some 
physical symptoms like a lump in 
her throat.  
 Pt thinks that firstly the seminar 
room wasn’t big enough on day 1, 
and then afterwards room 6 wasn’t 
big enough for the Mindfulness 
practices (MW/MM) 
Time of day fine 
Liked 8/52 duration 
Pt liked hearing others views, which on 
occasion surprised her 
Pt liked being in group with other people 
with MS as they were all there for the 
same reasons and understood each other  
Pt found the instructors organized and 
disciplined 
No. 13 
Att: 1/8 
46F 
White Scottish 
DD 3 
Pt hoped for new techniques/tools 
for helping to deal with 
stress/pain/sleeping difficulties 
Pt found parking difficult. Pt was quite upset that better 
provisions had not been made for 
people with wheelchairs, for 
example, no spaces in the semi-circle 
of chairs – this is a bug bearer of hers 
Pt found seeing people more disabled 
than her hurt her as she felt she was 
sseing the range unfold in front of her 
Pt liked the social aspect of the session 
she attended, and that others were open 
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University 
EDSS 4 
RRMS 
8 (0) 
100 
Pt thinks Centre is lovely, with nice 
views 
Time of day/2.5hrs fine 
and supportive, giving her empathy for 
her tears 
Pt felt able to hide her annoyances in the 
big group 
Pt felt there was an assumption on day 1 
that everyone knew what Mindfulness 
was all about and there was some jargon 
being used 
Pt describes the thumbs up/down safety 
mechanism if someone became 
distressed 
Pt found one of the instructors like a 
headmistress 
No. 14 
32F 
Att: 8/8 
White Scottish 
DD 10 
College 
EDSS 4 
RRMS 
6 (2) 
42 
Pt thought she had nothing to lose 
and was willing to try anything 
that might help 
  Pt made a couple of friends for life and 
started an email group so that everyone 
could stay in contact. Noting that pts 
‘could vent to each other’ 
Pt thinks the response from the 
instructors to the difficulties of week 1 
was good and changed the whole attitude 
of the group 
No. 15 
Att: 1/8 
40F 
White Scottish 
DD 4 
College 
EDSS 1 
RRMS 
2 (0) 
103 
Was keen to be in a clinical trial 
that might lead to new Rx for 
people with MS 
Expected course to be more 
interactive and for there to be 
more meditation 
 Pt thought the Centre was alright, 
with plenty of space 
Time of day ok 
Pt thinks that 2.5 hrs is too long, 
especially for people expected to sit 
for that time 
Pt commenting on seeing others more 
disabled in week 1 and how this 
emphasized the ruthless nature of MS 
Pt does not know anyone else with MS 
Pt thought it was good to see/hear how 
others were experiencing MS, but that 
being in the group was ‘total conflict’ 
and that people were moaning and 
thinking themselves unwell. Pt felt this 
was a ‘greetin meeting’ and a risk to her 
health. 
Ins called pt after she dropped out and pt 
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found her challenging on the phone 
No. 16 
Att: 7/8 
44M 
White Scottish 
DD 8 
University 
EDSS 6.5 
RRMS 
0 (0) 
53 
Pt was cynical about ‘all that sort 
of stuff’ but had Googled 
Mindfulness and was surprised by 
how mainstream it was, with BBC 
coverage and pt testimonials 
 Pt liked the setting for the Centre, 
and that it was modern, and less 
clinical than the other hospitals he 
attends which are filled with sick 
people. 
Was disgruntled that the course was 
making people with MS walk up 
stairs, and was tired by the time he 
had walked along the corridor to the 
seminar room 
Pt liked settling himself in the 
waiting room before the class 
Room 6 was too noisy. 
Pt would prefer 230pm start, around 
time of finishing work 
2.5 hrs flew by 
Pt thought the RE was weird 
Thinks it was an advantage that everyone 
had MS, but notes that it was ‘hard not to 
start a bitching session’, which could 
make staying on track difficult 
Preferred group format to working in 
pairs as it is less ‘up close and personal’ 
No. 17 
Att: 6/8 
36F 
White Scottish 
DD 3 
University 
EDSS 2.5 
RRMS 
2 (1) 
75 
Expected to benefit  Pt comments on Ins apologizing for 
the difficulties of week 1 and making 
improvements, which were 
appreciated 
Friday was good for pt, more 
relaxed. As was time of day.  
Felt 8/52 about right. 
2.5hrs flew by 
Pt thought that the instructors were very 
good at listening and showing empathy, 
as well as directing the flow of the 
conversation 
Course 
instructors 
    
I1 Ins thought it would be the same 
as any other course 
  Ins describing the paired off get to know 
one and other introductory exercise they 
normally use backfiring so that what 
everyone reported as having in common 
was simply MS 
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Ins thinks there was a a lot of 
comparison going on between pts 
I2 Ins thought that because there had 
been screening and recruitment 
that it might be an easy course, 
with high levels of motivation 
from those taking part 
Ins noting that she thinks parking is a 
real problem at the Centre, and that the 
buses do not drop off at this particular 
building. Also noting that hospital 
transport is unreliable, and hence not 
allowed for the course, as it leads to 
interruptions with people coming and 
going at unhelpful times. 
Ins commented on the rule about not 
bringing drinks into the seminar 
room and how this was difficult for 
people with a dry mouth, or needing 
to take medication etc 
Ins spoke about the MDT in the 
Centre pulling together to deal with 
the difficulties that had arisen in 
week 1. Specifically the PT moving 
the class, the nurses helping with pts, 
and the tea/coffee being brought to 
the room. 
 
 
 
 
2. Doing the 
work of 
mindfulness 
2.1  
 
2.2 2.3 2.4 
 
Subject no  
No. sessions 
attended 
Age 
Sex 
Ethnicity 
Deprivation 
decile 
Education 
EDSS 
MS 
Coming face-to-face 
with MS: senses, 
sensations, and 
disabilities 
 
Making sense of the 
practices together, in the 
group 
Making‎sense‎of‎the‎practices‎on‎one’s‎
own, away from the group 
Staying present, or dropping 
out – sustaining involvement 
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phenotype 
MM count 
(MH) 
MHI baseline 
score 
No. 1 
Att: 7/8 
52F 
White Scottish 
DD 2 
University 
EDSS 4 
PPMS 
3 (1) 
69 
Pt feels more accepting towards 
her MS and the way she thinks 
about her sensations, and this 
has made her feel more relaxed 
about having MS and what 
each new Sx might mean 
 
 
 Pt commenting that being asked to do HP was like 
being at school, which she rebelled against, but did 
do the HP because she felt she wanted to 
Pt noting that other things going on in the house 
acted as a distraction 
Pt found that the group inspired her 
to attend the course, felt that she had 
to attend regularly and not miss 
sessions in order to derive the 
benefit 
Pt missed the MW and had to try 
and learn it from the book 
No. 2 
Att: 6/8 
41F 
White Scottish 
DD 2 
University 
EDSS 4 
RRMS 
3 (1) 
46 
Pt feels happier and more 
excited about speaking to Drs 
about her MS 
Pt prefers MBSR to taking 
medication, which she describes as 
artificial and limited in duration of 
effect 
Pt commenting that initially thought shorter HP 
would be easier, but that in fact the reverse was 
true. Found it harder to remember to do the shorter 
practices and that it was easier to get into it in a 
longer practice. Had to make it clear to kids that 
this was her time 
Missed one session through illness 
Pt missed the MW day and is not 
sure how to learn it 
No. 3 
Att: 8/8 
54F 
White Scottish 
DD 9 
University 
EDSS 5.5 
PPMS 
0 (0) 
Pt feels more accepting towards 
her MS 
Feels like she can use her mind 
to heal her body 
 Pt noting that as she was living in her fathers 
house, she had to create a space to practice in, 
somewhere peaceful where she could concentrate 
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64 
 
No. 4 
36M 
Att: 7/8 
White Scottish 
DD 3 
2y school 
EDSS 2.5 
RRMS 
9 (3) 
58 
 Pt thought the MBSR practices 
were ‘like learning to walk again in 
Mindfulness terms’ 
Pt makes reference to his own 
understanding of the practices and 
their relationship with ‘Prana’ 
Pt found discussing experiences 
with others tedious 
  
No. 5 
Att: 7/8 
65F 
White Scottish 
DD8 
2y school 
EDSS 5 
RRMS 
9 (2) 
75 
 
 Pt found MW in the group difficult 
as she has vertigo, but was fine in 
the house, where she can hold on to 
things and falling doesn’t matter as 
much 
Pt noted that even though she has time available in 
the day, it was difficult to allocate time for the HP. 
Pt states that it was easier to practise if her 
husband was out golfing, as if he were at home she 
would just watch TV with him. Preferred MBCT 
book to FCL. 
Pt stating that she committed to the 
8 weeks and that if she commits to 
something she likes to see it through 
Missed one session through illness 
and not wanting to spread it to 
others 
No. 6 
Att: 7/8 
44 F 
White Scottish 
DD 8 
University 
EDSS 6.5 
RRMS 
5 (2) 
49 
Pt felt that a lot of emphasis 
was put on the senses in week 
1, and notes that this can be 
challenging for people with 
MS. 
Pt found MM difficult as she 
couldn’t do hand exercises and 
this accentuated her sense of 
disability 
However, pt feels the 
Mindfulness takes the focus off 
the illness/ pain/ disability 
Pt thinks MBSR course has 
provided her with food for thought 
in relation to thoughts and 
emotions 
Pt found MW very difficult, 
accentuating her sense of disability 
Pt found enquiry process very 
intense and this put her off 
contributing as she didn’t feel she 
had the energy for it 
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No. 7 
Att: 3/8 
52F 
White Scottish 
DD 2 
College 
EDSS 6.5 
RRMS 
5 (1) 
63 
 Pt thinks enquiry process laboured 
the point too much and that pts 
didn’t know how to answer and 
eventually just said whatever they 
felt the ins wanted them to say 
 Had a flare of arthritis which meant 
missing one session 
No. 8 
Att: 7/8 
34F 
White Scottish 
DD 3 
University 
EDSS 3.5 
RRMS 
5 (1) 
72 
 Pt didn’t initially like MW in the 
group as it made her feel like being 
back at school in a line up, felt 
vulnerable. Found looking at feet 
and walking difficult. Really got 
into the MW at home and enjoyed 
exploring nuances of it 
Pt was surprised to learn that others 
were experiencing the practices 
differently to how she was 
Pt noting that being told to do the HP by a Dr 
makes her more likely to do it 
Pt noting that noises in the house were distracting 
Missed one session through illness 
Pt commenting that seeing that the 
Drs were into the practices acted as 
an inspiration, helped the pt look 
forward to learning new things and 
to carry on 
No. 9 
Att: 2/8 
48F 
White Scottish 
DD 5 
2y school 
EDSS 7 
RRMS 
1 (0) 
84 
   Pt dropped out as she felt course 
emphasis and participants were too 
negative. Pt prefers a positive 
attitude, pushing herself, and more 
exercise. Thinks she is not a 
‘relaxation person’ 
No. 10 
Att: 7/8 
43F 
White Scottish 
DD 7 
   Pt likes to see through things she 
has committed to. Had to force 
herself on a few occasions where 
she was tired, or not feeling well 
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University 
EDSS 7 
RRMS 
1 (0) 
71 
No. 11 
Att: 8/8 
27F 
White Scottish 
DD 6 
University 
EDSS 6 
RRMS 
4 (1) 
66 
Pt did not like the RE as it 
made her more aware of her 
visual impairment 
Pt thinks no one liked MW in the 
group and that everyone ‘freaked’. 
Pt felt ridiculous ‘staggering about 
the room’. Pt kept practising it as 
HW 
Pt relays a story where she told ins in class that she 
hadn’t done the HP. Ins asked her why are you 
here? and this made pt reflect and realize that in 
order to give herself a chance at benefit, she would 
have to do it. This made her determined 
Pt was determined to get to the 
course and in order to do this, had to 
organize things better 
No. 12 
Att: 5/8 
38F 
White Scottish 
DD 3 
College 
EDSS 2.5 
RRMS 
5 (2) 
79 
Pt thinks from practising 
Mindfulness, her MS Sx have 
become less apparent 
Pt had taken previous intro course 
to Mindfulness. Found MBSR self 
compassion practices difficult, 
prompting a deep inner enquiry and 
history of abuse 
Pt found MW unsettling, brought 
into awareness aspects of her 
walking that were not good. Pt still 
practising, finds this challenging, 
but likes the challenge 
 Pt had a relapse during course 
(switching from one MS drug to 
another). Found relapse a lot less 
difficult than previously and puts 
this down to practising mindfulness 
during it. 
No. 13 
Att: 1/8 
46F 
White Scottish 
DD 3 
University 
EDSS 4 
RRMS 
8 (0) 
100 
Pt felt RE was focusing in on 
where she is worst affected. 
Felt obliged to continue for 
sake of group. Sx came into 
sharp and painful focus, and 
hammered home sense of 
disability 
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No. 14 
32F 
Att: 8/8 
White Scottish 
DD 10 
College 
EDSS 4 
RRMS 
6 (2) 
42 
  Initially, pt just wanted HP to be over and done 
with, but by about week 3-5 something changed 
and she was then looking forward to the HP as it 
was relaxing and good for her 
Pts Mother and MS Nurse 
encouraged her to attend, both of 
whom she respects 
Seeing other pts drop out inspired pt 
to keep going 
No. 15 
Att: 1/8 
40F 
White Scottish 
DD 4 
College 
EDSS 1 
RRMS 
2 (0) 
103 
Pt recounts how another pt got 
upset in RE as it focused her 
attention on something she 
couldn’t do. Pt thought this 
represented a misdirection for 
the course to focus on disability 
Pt notes that in Sahaja meditation 
there is no focus on any particular 
condition, whereas the Mindfulness 
course focused too much on the 
physical, which she thinks is not 
good for MS pts 
 Pt commenting on another pt (26/6 
yo M) who dropped out after week 
1. Thinks he was disillusioned with 
respect to his future with having 
MS. 
Pt felt course focused too much on 
disability. Felt group need 
counseling, not meditation, and that 
they were having a ‘greetin 
meeting’, grieving for the lives they 
had lost to MS 
No. 16 
Att: 7/8 
44M 
White Scottish 
DD 8 
University 
EDSS 6.5 
RRMS 
0 (0) 
53 
Initially pt did not get the 
purpose of the RE, but does 
now, having completed the 
course 
Pt found that being asked to 
write was embarrassing 
because his tremor makes this 
barely legible 
  Pt felt obliged to attend as the 
course had been set up and run by 
‘you guys’ 
Pt had a UTI and relapse at week 3. 
This made pt ‘take the huff with 
life’ and stopped doing HP from this 
point, thinking ‘what’s the point?’ 
Did continue to attend classes 
though, only missing one, where he 
couldn’t walk 
No. 17 
Att: 6/8 
36F 
White Scottish 
  Pt noting that she might find it easier to implement 
the HP if she weren’t back working. Found it 
difficult to prioritise time for it, and instead did the 
housework 
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DD 3 
University 
EDSS 2.5 
RRMS 
2 (1) 
75 
Course 
instructors 
    
I1 Normally starts with RE, thinks 
it’s a lovely sensory exercise 
for people 
Never seen someone cry in it 
Recognised a need to become 
vigilant 
Thinks pt was hypersensitive 
and then ‘numbed out’ to deal 
with this, and noting this might 
be a theme with MS as a 
condition 
Ins thinks MS a very difficult 
condition with serious 
consequences. 
Ins felt Mindfulness would be 
very beneficial for people with 
MS, in particular to feel more 
in charge of themselves 
Ins makes note of MS pts being 
hypersensitive, or numb, both 
physically and emotionally.  
Ins talks about benefits of 
paying attention, noticing, 
checking thought content etc 
and bringing compassion to a 
struggling body 
Ins noting MW was very difficult, a 
lot of pts didn’t like it, and the 
group required a lot of holding by 
both ins’ which was hard 
Ins describes how other ins brought 
in some writing about another WC 
pt’s experience of MW and how he 
adapted to it and found benefit 
Ins notes that they let people know at start of 
course that HP will be there and that those who do 
it are likely to benefit most. Ins notes that weeks 1-
3 are important HP times, as this is where a 
‘bedding in’ of the practices takes place. Ins felt 
that HP was not being done so put in an 
intervention by reading an excerpt from FCL to the 
group emphasizing that its hard, but you just need 
to do it 
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I2 Realised things not going well, 
started to panic, wanted pts to 
feel comfortable 
Ins thought pts were sticky 
with respects to their MS Dx, 
and referred to previous 
experience with CFS pts. 
Thought pts were looking for 
special dispensations 
Ins mentions the idea of how in 
MS the body has turned against 
itself – thought this was an 
interesting area to examine the 
role for compassion towards 
the body 
 Ins thinks HP very important and that the evidence 
says that those who do it benefit most. Notes that 
they have changed name from HW to HP, as 
people don’t like feeling that they are being told 
what to do 
Ins thinks that the set up had not 
been right for people with 
disabilities/ needs of people with 
MS on day 1. 
Ins makes note of the importance of 
the OS, giving people a chance to 
know what they are in for with the 
course, and a chance to leave 
gracefully 
Ins routinely phones drop outs and 
feedback she got was that people 
who had had wanted more focus on 
the positives, and seeing others 
more disabled with MS was difficult 
for people 
 
3. Getting it, 
or not 
3.1 3.2 3.3 3.4 
 
 
Subject no  
No. sessions 
attended 
Age 
Sex 
Ethnicity 
Deprivation 
decile 
Education 
EDSS 
MS 
phenotype 
Being‎‘in‎the‎zone’ Relating‎to‎one’s‎self Relating to others Perceived overall effects 
from MBSR 
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MM count 
(MH) 
MHI baseline 
score 
No. 1 
Att: 7/8 
52F 
White Scottish 
DD 2 
University 
EDSS 4 
PPMS 
3 (1) 
69 
Pt found sitting practices 
uncomfortable, so tended to 
avoid these, opting for lying 
instead 
During the BS, pt was able to 
change how she related to 
sensations in her body 
Pt describes recognizing 
the signs that her mood is 
dropping, and being able to 
intervene then 
Pt more aware of others perspective, especially 
that of her children 
Pt feels calmer, less stressed and less 
uptight 
 
No. 2 
Att: 6/8 
41F 
White Scottish 
DD 2 
University 
EDSS 4 
RRMS 
3 (1) 
46 
Initially pt struggled to see the 
point of the practices, but 
during the Mountain med 
something clicked for pt, felt 
fantastic and this feeling lasted, 
making doing the practices 
easier  
Pt found starting the group with 
a meditation helped her to relax 
and get into the mood for it 
Sees Mindfulness practice 
as her time, not to be 
interrupted by kids 
Pt feels more connected with her children and 
they have commented that her MS had ‘stopped 
working’ 
Pt is using her mindfulness skills with her son, 
who she thinks is naturally mindful 
Pts pain has improved 
Pt feels happier, calmer, has more 
energy. 
Pt feels that she is more in the 
moment, with less negative thinking 
 
No. 3 
Att: 8/8 
54F 
White Scottish 
DD 9 
University 
EDSS 5.5 
PPMS 
0 (0) 
64 
** Pt found ‘thoughts are not 
facts’ allowed her to let go 
of thoughts and worries 
which has meant she is 
now sleeping better instead 
of lying awake fretting 
Pt more aware of her father’s suffering and has a 
feeling of compassion towards him. Has used 
Mindful skills to relate to him when he is 
struggling. 
Friends have commented how happy pt is, 
which she puts down to learning Mindfulness 
Pt feels much more in control of 
what is happening in her life, feels 
less stressed. 
Pt is walking better and feeling 
stronger. 
Pt feels more content, is calmer and 
is sleeping better (less wakening, 
more refreshed) and less rumination 
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No. 4 
36M 
Att: 7/8 
White Scottish 
DD 3 
2y school 
EDSS 2.5 
RRMS 
9 (3) 
58 
** Pt describes being more 
aware of the need to 
practise regularly 
Pt had his social anxiety challenged by coming 
to the group, but managed to come to almost all 
sessions 
 
No. 5 
Att: 7/8 
65F 
White Scottish 
DD8 
2y school 
EDSS 5 
RRMS 
9 (2) 
75 
 
Pt found it useful to both do the 
practice, and then to discuss it 
Pt liked being led through the 
practice 
Pt really liked the poetry 
Pt is being kinder to 
herself, less critical and 
judgemental of herself 
Pt describes being more 
likely to think before 
speaking 
Pts spouse commented to her that she seemed 
happier and was being nicer to him 
Numbness in pts feet and hands is 
improved 
Pt is walking more slowly and 
mindfully and thinks this makes 
falling less likely 
Pt is feeling calmer, is feeling more 
and noticing more 
No. 6 
Att: 7/8 
44 F 
White Scottish 
DD 8 
University 
EDSS 6.5 
RRMS 
5 (2) 
49 
Pt thought meditation on arrival 
helped calm the group 
Pt found the poetry touching 
Pt realised she wasn’t 
doing enough to rejuvenate 
herself, and that it was all 
chores 
Pt recognized she found it 
easier to offer compassion 
to another than to herself 
Pt feels more in control 
and is taking the day in 
chunks 
 
 
Pt feels she has less mind chatter, 
less anxiety 
Pt more aware of her thoughts and 
behavior and their impact 
Pt feels she is more in the moment 
 
No. 7 
Att: 3/8 
52F 
Pt liked the Mountain 
meditation, being able to sink 
in and connect with the earth, 
 Pt has used Mindfulness skills to deal with 
family relationship difficulties 
Pt feels more relaxed and chilled, 
less worried and anxious 
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White Scottish 
DD 2 
College 
EDSS 6.5 
RRMS 
5 (1) 
63 
linked the seasons metaphor to 
the seasons of her life 
No. 8 
Att: 7/8 
34F 
White Scottish 
DD 3 
University 
EDSS 3.5 
RRMS 
5 (1) 
72 
Pt described seeing something 
that had previously terrified her 
in a new light (a bird), which 
made her feel amazing 
Pt loved being guided through 
the practice on the floor 
Pt describes that on hearing the 
bells, you immediately went 
into the zone 
Pt found that the longer 
practices were easier to get into 
the zone, and that she adapted 
the shorter practices to make 
this easier, such as using a 
painting or apple instead 
Pt describes no longer 
taking herself for granted 
anymore, is more confident 
being herself, and is no 
longer giving of herself 
when she has nothing left 
to give 
Pt realized that she had to share her struggles 
with her family, to let them in, to stop having a 
wall around herself, and to get real confidence, 
as opposed to that which is fake 
Left foot pain is better 
Pt feels happier, calmer and more 
confident, grateful, less stressed and 
more relaxed, more together 
emotionally, with a stronger core. Pt 
less prone to avoiding difficult 
emotions 
Pt feels less muddled up 
No. 9 
Att: 2/8 
48F 
White Scottish 
DD 5 
2y school 
EDSS 7 
RRMS 
1 (0) 
84 
Pt found sitting in the class 
difficult, as she could not relax, 
and describes herself as 
someone who doesn’t relax 
  Pt thought that the focus of the 
course participants was too negative 
and that she has found staying 
positive more helpful. Pt felt she 
needed more out of the course. 
No. 10 
Att: 7/8 
43F 
 Pt decided during the 
course that she could only 
do what she could and she 
 Pt feels calmer, especially in a crisis 
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White Scottish 
DD 7 
University 
EDSS 7 
RRMS 
1 (0) 
71 
was no longer going to 
beat herself up about this 
No. 11 
Att: 8/8 
27F 
White Scottish 
DD 6 
University 
EDSS 6 
RRMS 
4 (1) 
66 
 Pt described recognizing 
that she was not being very 
nice to herself and that this 
needed to change 
Describes being more 
aware of things getting out 
of hand and recognising 
the need to practise to 
offset this 
Pt realized that she was moving too fast in life 
and that she needed to slow down and appreciate 
her time with her daughter 
** 
Pt thinks that she is walking better, 
more on the flats of her feet 
Pt feels calmer and that she is living 
more in the moment 
No. 12 
Att: 5/8 
38F 
White Scottish 
DD 3 
College 
EDSS 2.5 
RRMS 
5 (2) 
79 
   Pt thinks her balance has improved 
Pt feels less stressed and more 
committed 
No. 13 
Att: 1/8 
46F 
White Scottish 
DD 3 
University 
EDSS 4 
RRMS 
   Pt found the chronic pain and 
paraesthesias that she has in her 
hands was made worse by bringing 
Mindful awareness to them on the 
day she attended. 
Feels that her mental health took a 
dunt and that she is still a bit raw on 
this front 
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8 (0) 
100 
No. 14 
32F 
Att: 8/8 
White Scottish 
DD 10 
College 
EDSS 4 
RRMS 
6 (2) 
42 
Pt found it easier to concentrate 
in the group, and was initially 
struggling at home, but then 
found something clicked for 
her and the practices became a 
pleasure to do. 
Pt thinks that BS helped her to 
tune into the body in a non-
judging, non-critical way  
Pt realised a propensity 
towards beating herself up 
a lot and not to appreciate 
what she does well 
Pt is taking more interest in 
health promoting 
behaviours such as 
exercise and diet 
Pt describes a situation at a party, where a man 
pushed a balloon into her face - in the past she 
would have reacted, possibly with a 
confrontation. Pt was far more reflective in the 
situation, and gained insight into his motivations 
and suffering, which it turned out were due to 
his mother and sister having MS. Pt spoke to 
him and counseled him about this. 
Pt using Mindful skills to help another family 
member with anxiety. 
Pt is feeling more back to her old 
self and is happier 
Pt has noted a positive change in her 
attitude towards her chronic pain 
Pt feels less highly strung and more 
positive 
Pt thinks she is  less short of breath 
from anxiety 
No. 15 
Att: 1/8 
40F 
White Scottish 
DD 4 
College 
EDSS 1 
RRMS 
2 (0) 
103 
   Pt felt unwell from attending on 
week 1, thinks this was from seeing 
and being around so many negative, 
moaning people. Pt felt this posed a 
risk to her health, so did not come 
back. Saw herself ending up in a 
wheelchair with a chronic condition. 
Pt felt that the focus of the course 
should have been more firmly on 
ability 
Pt felt that the other participants 
were being negative, that it was a 
greeting meetin, and that they 
needed counseling, not meditation. 
Pt thought the negativity affected 
her. 
Pt thinks a positive attitude is more 
helpful. 
No. 16 
Att: 7/8 
44M 
White Scottish 
DD 8 
Pt found being shown how to 
do the practices really helped 
 Pts partner saw a difference in him when 
practicing. 
Pt was getting less annoyed with work 
colleagues and experiencing less road rage. 
Pt feeling less uptight and stressed, 
calmer, and more chilled, better able 
to let go of things, and that the 
critical voices in his head have 
become less prominent 
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University 
EDSS 6.5 
RRMS 
0 (0) 
53 
No. 17 
Att: 6/8 
36F 
White Scottish 
DD 3 
University 
EDSS 2.5 
RRMS 
2 (1) 
75 
Pt found the meditation 
exercises were easier in a 
group, with everyone doing the 
same thing, facilitating 
concentration 
Pt describes having insight 
into why she doesn’t 
practise, in that she 
prioritizes other things 
 Pt felt calmer on leaving the classes 
Course 
instructors 
    
I1  Ins found this a 
challenging course. Talked 
with other ins and 
colleagues at the Centre 
about this, and took the 
difficult aspects of the 
experience to supervision 
  
I2     
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4. Improving the 
MBSR course for 
people with MS 
4.1 4.2 4.3 4.4 
Subject no  
No. sessions 
attended 
Age 
Sex 
Ethnicity 
Deprivation 
decile Education 
EDSS 
MS phenotype 
MM count (MH) 
MHI baseline 
score 
Making MBSR more relevant to 
people with MS 
Being better prepared Improving delivery 
strategies of MBSR for 
people with MS 
Timing: when is the 
best time to learn 
MBSR if you have 
MS? 
No. 1 
Att: 7/8 
52F 
White Scottish 
DD 2 
University 
EDSS 4 
PPMS 
3 (1) 
69 
Pt planning to use her Mindfulness skills in 
dealing with the stress of returning to work, 
when communicating with others, and when 
managing uncertainty. Varies the practice, 
depending on what she is faced with 
Pt would like for there to be more time to 
socialize with other pts 
  
No. 2 
Att: 6/8 
41F 
White Scottish 
DD 2 
University 
Pt now sees Mindfulness as her hobby and 
wants to learn more about it and is thinking of 
taking up Yoga. 
Practices MM 2x/wk 
Pt tries to be mindful whilst doing things 
through the day 
  Pt did not like mans voice on 
the CDs 
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EDSS 4 
RRMS 
3 (1) 
46 
Planning to attend drop in sessions 
No. 3 
Att: 8/8 
54F 
White Scottish 
DD 9 
University 
EDSS 5.5 
PPMS 
0 (0) 
64 
 
Practises daily and feels confident about this 
Uses 3MBS as a security blanket 
Pt has found practices useful in acute stress 
situations 
Pt has found dissociating helpful in stressful 
scenarios 
 
Pt thinks an introductory day would help, 
where expectations could be addressed, pt 
testimonials shared, let people know in 
advance about needing a CD player, 
letting family know what is involved 
Pt would like to see more on 
the research science associated 
with MBSR 
 
Pt thinks it needs to be made 
clearer how important HP is 
No. 4 
36M 
Att: 7/8 
White Scottish 
DD 3 
2y school 
EDSS 2.5 
RRMS 
9 (3) 
58 
** **  Pt thinks there should be less 
led exercises so that people 
can learn to do it on their 
own 
Pt thinks that for some of the 
meditation exercises people 
could have been better 
prepared physiologically 
No. 5 
Att: 7/8 
65F 
White Scottish 
DD8 
2y school 
EDSS 5 
RRMS 
9 (2) 
75 
**   Did not like FCL, but did 
like MBCT book 
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No. 6 
Att: 7/8 
44 F 
White Scottish 
DD 8 
University 
EDSS 6.5 
RRMS 
5 (2) 
49 
Pt would like to attend drop in sessions, but as 
they are in the seminar room this is a barrier 
for her 
Pt thinks course should be informed by 
someone with MS who has been unwell 
Pt thinks course should not be held over 
lunchtime 
Pt thinks it should be more MS 
specific 
Pt thinks MW should only be 
included if ability appropriate 
Pt thinks there should be more 
group interaction and that 
instructors should remember 
that impaired mobility can 
impair mingling 
Pt thinks Ins should be more 
sensitive to the needs of 
people with MS 
Pt thinks the CDs could be 
shorter 
No. 7 
Att: 3/8 
52F 
White Scottish 
DD 2 
College 
EDSS 6.5 
RRMS 
5 (1) 
63 
Pt uses breath awareness as a means of 
managing sleep difficulty and a s a way of 
relaxing 
Pt thinks Tea/ coffee should be in the 
room 
Pt thinks manual should cover 
a wider range of ability levels  
Pt thinks the course should 
be shortened to 4-6/52. 
Pt thinks more emphasis 
should be placed on HP 
Pt thought not too soon after 
the Dx, as the whole thing 
might be a bit raw 
No. 8 
Att: 7/8 
34F 
White Scottish 
DD 3 
University 
EDSS 3.5 
RRMS 
5 (1) 
72 
Pt has been looking to carry on the practices 
and uses Youtube to find new ones too 
Should be closer to pts home 
Should be more disability friendly from 
the start 
 Ins should be firmer about 
importance of HP 
Pt did not like mans voice on 
the CD, found it ‘shouty’ 
No. 9 
Att: 2/8 
48F 
White Scottish 
 ** Should include more physical 
exercise 
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DD 5 
2y school 
EDSS 7 
RRMS 
1 (0) 
84 
No. 10 
Att: 7/8 
43F 
White Scottish 
DD 7 
University 
EDSS 7 
RRMS 
1 (0) 
71 
Pt uses materials flexibly 
Uses shorter practices to help herself calm 
down and reassess things 
Pt thinks course should be informed by 
someone with MS 
Extra help should be on hand 
Pt thinks materials should be 
more MS-specific, with 
exercises specifically for pain 
etc 
Pt thinks that pt input should 
be garnered at the time of the 
course itself 
Pt didn’t like mans voice on 
CD; liked female voice on 
CD as it was soothing 
Pt wished she had had the 
opportunity to learn 
Mindfulness around the time 
of her Dx to help her cope 
No. 11 
Att: 8/8 
27F 
White Scottish 
DD 6 
University 
EDSS 6 
RRMS 
4 (1) 
66 
Pt still practicing, but less of a range 
Notes that being immersed in the practices 
helped 
Pt would prefer it to be held later in the 
day 
Pt would prefer last day was 
more about meditation, and less 
about filling in forms 
 
No. 12 
Att: 5/8 
38F 
White Scottish 
DD 3 
College 
EDSS 2.5 
RRMS 
5 (2) 
Pt found knowing that there was a class next 
week helped her keep up the practices – an 
incentive of sorts 
Pt thinks being able to contact the 
instructors during the course would help 
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79 
No. 13 
Att: 1/8 
46F 
White Scottish 
DD 3 
University 
EDSS 4 
RRMS 
8 (0) 
100 
 Pt thinks a greater understanding over the 
practical difficulties associated with MS 
should be used to inform design etc 
  
No. 14 
32F 
Att: 8/8 
White Scottish 
DD 10 
College 
EDSS 4 
RRMS 
6 (2) 
42 
Pt thinks her changed way of thinking has 
made her less stressed in day to day life - 
moving house was much less stressful than 
anticipated 
Planning to attend drop in sessions 
   
No. 15 
Att: 1/8 
40F 
White Scottish 
DD 4 
College 
EDSS 1 
RRMS 
2 (0) 
103 
 Pt thinks mixed Dx would work better Pt thinks it should be more like 
‘Mindstore’. 
Pt thinks it should have a more 
positive focus 
Pt thinks to be careful with 
words like ‘exercise’, which 
can easily be misinterpreted. 
Pt thinks there should be 
personal goal setting for pts. 
Pt thinks pts should be 
encouraged to challenge 
themselves 
Pt thinks manual and 
materials should be more MS 
specific 
No. 16 
Att: 7/8 
44M 
Pt found the practices were helpful when he 
was practicing, and will go back to them once 
relapse settles. 
Pt thinks testimonials from completers 
would help 
Pt thinks an orientation session would help 
 Pt thinks visual aids would 
help 
Pt thinks best not to start 
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White Scottish 
DD 8 
University 
EDSS 6.5 
RRMS 
0 (0) 
53 
with the RE 
No. 17 
Att: 6/8 
36F 
White Scottish 
DD 3 
University 
EDSS 2.5 
RRMS 
2 (1) 
75 
    
Course 
instructors 
    
I1   Thinks MBSR well sculpted Ins thinks need for caution 
around MW 
I2  Ins thinks OS is needed  Ins would be cautious about 
language 
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